NZ709564B2 - Halogen-substituted pyrazol derivatives as pest-control agents - Google Patents
Halogen-substituted pyrazol derivatives as pest-control agents Download PDFInfo
- Publication number
- NZ709564B2 NZ709564B2 NZ709564A NZ70956414A NZ709564B2 NZ 709564 B2 NZ709564 B2 NZ 709564B2 NZ 709564 A NZ709564 A NZ 709564A NZ 70956414 A NZ70956414 A NZ 70956414A NZ 709564 B2 NZ709564 B2 NZ 709564B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- methyl
- alkyl
- ethyl
- spp
- cyclopropyl
- Prior art date
Links
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 167
- 241000238631 Hexapoda Species 0.000 claims abstract description 27
- 241000244206 Nematoda Species 0.000 claims abstract description 9
- 241000239223 Arachnida Species 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 4
- -1 hydroxy, formyl Chemical group 0.000 claims description 907
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 99
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 88
- 229910052739 hydrogen Inorganic materials 0.000 claims description 65
- 239000001257 hydrogen Substances 0.000 claims description 65
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 62
- 239000000203 mixture Substances 0.000 claims description 61
- 150000003254 radicals Chemical class 0.000 claims description 56
- 150000002431 hydrogen Chemical group 0.000 claims description 53
- 229910052757 nitrogen Inorganic materials 0.000 claims description 52
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 50
- 229910052736 halogen Inorganic materials 0.000 claims description 47
- 150000002367 halogens Chemical class 0.000 claims description 47
- 241001465754 Metazoa Species 0.000 claims description 45
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 37
- 239000000460 chlorine Chemical group 0.000 claims description 30
- 125000000623 heterocyclic group Chemical group 0.000 claims description 30
- 125000001424 substituent group Chemical group 0.000 claims description 30
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 27
- 229910052794 bromium Inorganic materials 0.000 claims description 27
- 229910052801 chlorine Chemical group 0.000 claims description 27
- 239000011737 fluorine Chemical group 0.000 claims description 27
- 229910052731 fluorine Inorganic materials 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 27
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 27
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 25
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 24
- 229910052760 oxygen Inorganic materials 0.000 claims description 24
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 23
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 22
- 239000001301 oxygen Substances 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 21
- 125000003545 alkoxy group Chemical group 0.000 claims description 20
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 20
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 20
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 20
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 claims description 19
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 19
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims description 17
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 17
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 16
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 15
- 125000000304 alkynyl group Chemical group 0.000 claims description 15
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 15
- 125000001072 heteroaryl group Chemical group 0.000 claims description 15
- 244000045947 parasite Species 0.000 claims description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 14
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 14
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 13
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 13
- 125000004775 chlorodifluoromethyl group Chemical group FC(F)(Cl)* 0.000 claims description 13
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 13
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 13
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 13
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 13
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 claims description 12
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 claims description 11
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 11
- 125000004414 alkyl thio group Chemical group 0.000 claims description 11
- 125000004774 dichlorofluoromethyl group Chemical group FC(Cl)(Cl)* 0.000 claims description 11
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims description 11
- 150000002390 heteroarenes Chemical class 0.000 claims description 10
- 125000002053 thietanyl group Chemical group 0.000 claims description 10
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 claims description 9
- 125000004780 2-chloro-2,2-difluoroethyl group Chemical group [H]C([H])(*)C(F)(F)Cl 0.000 claims description 9
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 239000005864 Sulphur Substances 0.000 claims description 9
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 9
- FKTXDTWDCPTPHK-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical group FC(F)(F)[C](F)C(F)(F)F FKTXDTWDCPTPHK-UHFFFAOYSA-N 0.000 claims description 8
- 125000006002 1,1-difluoroethyl group Chemical group 0.000 claims description 8
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical group C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims description 8
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 8
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 8
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 8
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 8
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 8
- 125000001188 haloalkyl group Chemical group 0.000 claims description 8
- 125000006341 heptafluoro n-propyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)* 0.000 claims description 8
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 8
- 125000006344 nonafluoro n-butyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 claims description 8
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 7
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 7
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 claims description 7
- 125000005347 halocycloalkyl group Chemical group 0.000 claims description 7
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 claims description 6
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 6
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 6
- 125000003566 oxetanyl group Chemical group 0.000 claims description 6
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 claims description 6
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims description 6
- 125000001847 2-phenylcyclopropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1([H])C([H])([H])C1([H])* 0.000 claims description 5
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 5
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 5
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 claims description 5
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims description 5
- 125000006252 n-propylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 4
- 125000006426 1-chlorocyclopropyl group Chemical group [H]C1([H])C([H])([H])C1(Cl)* 0.000 claims description 4
- 125000006420 1-fluorocyclopropyl group Chemical group [H]C1([H])C([H])([H])C1(F)* 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims description 4
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 4
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 4
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical group C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims description 4
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 4
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims description 4
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 claims description 4
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 claims description 4
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical group C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 4
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 4
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 125000005767 propoxymethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])[#8]C([H])([H])* 0.000 claims description 4
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 4
- 125000006513 pyridinyl methyl group Chemical group 0.000 claims description 4
- 229930192474 thiophene Chemical group 0.000 claims description 4
- 150000003852 triazoles Chemical group 0.000 claims description 4
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims description 3
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 3
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims description 3
- 125000005108 alkenylthio group Chemical group 0.000 claims description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 125000005087 alkynylcarbonyl group Chemical group 0.000 claims description 3
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 3
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 claims description 3
- 125000005109 alkynylthio group Chemical group 0.000 claims description 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000004665 trialkylsilyl group Chemical group 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 125000006424 1-bromocyclopropyl group Chemical group [H]C1([H])C([H])([H])C1(Br)* 0.000 claims description 2
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 claims description 2
- 125000006017 1-propenyl group Chemical group 0.000 claims description 2
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 claims description 2
- OKDGRDCXVWSXDC-UHFFFAOYSA-N 2-chloropyridine Chemical compound ClC1=CC=CC=N1 OKDGRDCXVWSXDC-UHFFFAOYSA-N 0.000 claims description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims description 2
- 125000001769 aryl amino group Chemical group 0.000 claims description 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 2
- 125000005110 aryl thio group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 2
- 125000001589 carboacyl group Chemical group 0.000 claims description 2
- 150000003857 carboxamides Chemical class 0.000 claims description 2
- 125000004465 cycloalkenyloxy group Chemical group 0.000 claims description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 2
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 claims description 2
- 125000004993 haloalkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004692 haloalkylcarbonyl group Chemical group 0.000 claims description 2
- 125000006419 fluorocyclopropyl group Chemical group 0.000 claims 2
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical group C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims 2
- IJOSVNBGIKAARU-UHFFFAOYSA-N 3-chloro-2-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=NC=CC=C1Cl IJOSVNBGIKAARU-UHFFFAOYSA-N 0.000 claims 1
- DJMBNPTZWGPMIR-UHFFFAOYSA-N 5-(4-bromopyrazol-1-yl)-1-methyl-4-methylsulfinyl-3-(trifluoromethyl)pyrazole Chemical compound CN1N=C(C(F)(F)F)C(S(C)=O)=C1N1N=CC(Br)=C1 DJMBNPTZWGPMIR-UHFFFAOYSA-N 0.000 claims 1
- 239000004606 Fillers/Extenders Substances 0.000 claims 1
- JUQJCAMVXDQFCM-UHFFFAOYSA-N chembl561056 Chemical group O1N=C(C)C=C1C1=C(C=2C=CC(OCC=3N=C4C=CC=CC4=CC=3)=CC=2)NN=C1 JUQJCAMVXDQFCM-UHFFFAOYSA-N 0.000 claims 1
- 125000004789 chlorodifluoromethoxy group Chemical group ClC(O*)(F)F 0.000 claims 1
- 125000004788 dichlorofluoromethoxy group Chemical group ClC(O*)(F)Cl 0.000 claims 1
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 56
- 244000078703 ectoparasite Species 0.000 abstract description 28
- 229910052721 tungsten Inorganic materials 0.000 abstract description 13
- 239000000543 intermediate Substances 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 206
- 238000005160 1H NMR spectroscopy Methods 0.000 description 146
- WEVYAHXRMPXWCK-MICDWDOJSA-N 2-deuterioacetonitrile Chemical compound [2H]CC#N WEVYAHXRMPXWCK-MICDWDOJSA-N 0.000 description 63
- BQQPGDLQJFZZKE-UHFFFAOYSA-N CCC(NC(C1=NN(C)C=C1C(F)F)=O)OCC(C=CC(Cl)=C1)=C1Cl Chemical compound CCC(NC(C1=NN(C)C=C1C(F)F)=O)OCC(C=CC(Cl)=C1)=C1Cl BQQPGDLQJFZZKE-UHFFFAOYSA-N 0.000 description 59
- 108090000623 proteins and genes Proteins 0.000 description 59
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 49
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 45
- 125000004432 carbon atom Chemical group C* 0.000 description 44
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 42
- DNKCLBOOIWTJGD-UHFFFAOYSA-N 1h-imidazole-2-carbothioic s-acid Chemical compound SC(=O)C1=NC=CN1 DNKCLBOOIWTJGD-UHFFFAOYSA-N 0.000 description 30
- 239000003112 inhibitor Substances 0.000 description 30
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 30
- 235000018102 proteins Nutrition 0.000 description 30
- 102000004169 proteins and genes Human genes 0.000 description 30
- 150000003839 salts Chemical class 0.000 description 27
- 230000000749 insecticidal effect Effects 0.000 description 26
- 230000008569 process Effects 0.000 description 25
- 230000014759 maintenance of location Effects 0.000 description 24
- 241000607479 Yersinia pestis Species 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 23
- 230000009261 transgenic effect Effects 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- 241000193388 Bacillus thuringiensis Species 0.000 description 17
- 240000008042 Zea mays Species 0.000 description 17
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 16
- 235000009973 maize Nutrition 0.000 description 16
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 15
- 235000019253 formic acid Nutrition 0.000 description 15
- 230000036541 health Effects 0.000 description 15
- 239000012071 phase Substances 0.000 description 15
- 241000238876 Acari Species 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 229940097012 bacillus thuringiensis Drugs 0.000 description 14
- 125000004122 cyclic group Chemical group 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 239000004009 herbicide Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 125000006414 CCl Chemical group ClC* 0.000 description 13
- 244000005700 microbiome Species 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 241001128004 Demodex Species 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
- 239000003054 catalyst Substances 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 241000193830 Bacillus <bacterium> Species 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 description 11
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 11
- 125000004076 pyridyl group Chemical group 0.000 description 11
- 229920006395 saturated elastomer Polymers 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 125000003277 amino group Chemical group 0.000 description 10
- 230000001276 controlling effect Effects 0.000 description 10
- 230000002068 genetic effect Effects 0.000 description 10
- 238000010353 genetic engineering Methods 0.000 description 10
- 125000005842 heteroatom Chemical group 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 230000009466 transformation Effects 0.000 description 10
- 229920000742 Cotton Polymers 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 241000219146 Gossypium Species 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 230000002363 herbicidal effect Effects 0.000 description 9
- 230000001976 improved effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 8
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- 241000238421 Arthropoda Species 0.000 description 8
- 241000193755 Bacillus cereus Species 0.000 description 8
- 241000233866 Fungi Species 0.000 description 8
- 241001480803 Hyalomma Species 0.000 description 8
- 241001113970 Linognathus Species 0.000 description 8
- 241000283898 Ovis Species 0.000 description 8
- 241000509416 Sarcoptes Species 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 244000038559 crop plants Species 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 244000000013 helminth Species 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 7
- 240000002791 Brassica napus Species 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 240000002024 Gossypium herbaceum Species 0.000 description 7
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 7
- 239000005799 Isopyrazam Substances 0.000 description 7
- 108700019146 Transgenes Proteins 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 230000000895 acaricidal effect Effects 0.000 description 7
- 238000009395 breeding Methods 0.000 description 7
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Aalpha Natural products C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 7
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 7
- 229930195733 hydrocarbon Natural products 0.000 description 7
- 150000002430 hydrocarbons Chemical class 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 239000011630 iodine Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- 125000000547 substituted alkyl group Chemical group 0.000 description 7
- 239000003643 water by type Substances 0.000 description 7
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 6
- 235000006008 Brassica napus var napus Nutrition 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 101710151559 Crystal protein Proteins 0.000 description 6
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- 206010021929 Infertility male Diseases 0.000 description 6
- 208000007466 Male Infertility Diseases 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000000642 acaricide Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 125000003636 chemical group Chemical group 0.000 description 6
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 125000000466 oxiranyl group Chemical group 0.000 description 6
- 230000003032 phytopathogenic effect Effects 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 6
- ZCVAOQKBXKSDMS-PVAVHDDUSA-N (+)-trans-(S)-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-PVAVHDDUSA-N 0.000 description 5
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 description 5
- RAUWPNXIALNKQM-UHFFFAOYSA-N 4-nitro-1,2-phenylenediamine Chemical compound NC1=CC=C([N+]([O-])=O)C=C1N RAUWPNXIALNKQM-UHFFFAOYSA-N 0.000 description 5
- 108010000700 Acetolactate synthase Proteins 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 238000006555 catalytic reaction Methods 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 125000004430 oxygen atom Chemical group O* 0.000 description 5
- 235000011007 phosphoric acid Nutrition 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 5
- 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 5
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 4
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 4
- 125000004008 6 membered carbocyclic group Chemical group 0.000 description 4
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 4
- 241001580860 Acarapis Species 0.000 description 4
- 102000012440 Acetylcholinesterase Human genes 0.000 description 4
- 108010022752 Acetylcholinesterase Proteins 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000272517 Anseriformes Species 0.000 description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- 241000238678 Boophilus Species 0.000 description 4
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108010009685 Cholinergic Receptors Proteins 0.000 description 4
- 241001307956 Chorioptes bovis Species 0.000 description 4
- 241001124179 Chrysops Species 0.000 description 4
- 241000577477 Dermacentor reticulatus Species 0.000 description 4
- 241000255925 Diptera Species 0.000 description 4
- 239000005899 Fipronil Substances 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 241001660203 Gasterophilus Species 0.000 description 4
- 241001480796 Haemaphysalis Species 0.000 description 4
- 241000562576 Haematopota Species 0.000 description 4
- 241000775881 Haematopota pluvialis Species 0.000 description 4
- 241000771999 Hippobosca Species 0.000 description 4
- 241000561960 Hybomitra Species 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 241001084186 Neotrombicula Species 0.000 description 4
- 241000238887 Ornithodoros Species 0.000 description 4
- 241000722350 Phlebotomus <genus> Species 0.000 description 4
- 241001674048 Phthiraptera Species 0.000 description 4
- 241001649229 Psoroptes Species 0.000 description 4
- 241001481703 Rhipicephalus <genus> Species 0.000 description 4
- 241000831652 Salinivibrio sharmensis Species 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 241000255626 Tabanus <genus> Species 0.000 description 4
- 241000216750 Wilhelmia Species 0.000 description 4
- 230000036579 abiotic stress Effects 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 102000034337 acetylcholine receptors Human genes 0.000 description 4
- 229940022698 acetylcholinesterase Drugs 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 125000003282 alkyl amino group Chemical group 0.000 description 4
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 4
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 4
- 244000079386 endoparasite Species 0.000 description 4
- 238000000105 evaporative light scattering detection Methods 0.000 description 4
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 4
- 229940013764 fipronil Drugs 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- IGMNYECMUMZDDF-UHFFFAOYSA-N homogentisic acid Chemical compound OC(=O)CC1=CC(O)=CC=C1O IGMNYECMUMZDDF-UHFFFAOYSA-N 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- RONFGUROBZGJKP-UHFFFAOYSA-N iminoctadine Chemical compound NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N RONFGUROBZGJKP-UHFFFAOYSA-N 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 125000002950 monocyclic group Chemical group 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- HQUIFHINFGFWLJ-UHFFFAOYSA-N n-[(cyclopropylmethoxyamino)-[6-(difluoromethoxy)-2,3-difluorophenyl]methylidene]-2-phenylacetamide Chemical compound FC(F)OC1=CC=C(F)C(F)=C1C(NOCC1CC1)=NC(=O)CC1=CC=CC=C1 HQUIFHINFGFWLJ-UHFFFAOYSA-N 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 125000000369 oxido group Chemical group [*]=O 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- JGCSKOVQDXEQHI-UHFFFAOYSA-N phenazine-1-carboxylic acid Chemical compound C1=CC=C2N=C3C(C(=O)O)=CC=CC3=NC2=C1 JGCSKOVQDXEQHI-UHFFFAOYSA-N 0.000 description 4
- 229960003536 phenothrin Drugs 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000005871 repellent Substances 0.000 description 4
- 230000002940 repellent Effects 0.000 description 4
- 125000006413 ring segment Chemical group 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 238000000825 ultraviolet detection Methods 0.000 description 4
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 4
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 3
- CXBMCYHAMVGWJQ-CABCVRRESA-N (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-CABCVRRESA-N 0.000 description 3
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 3
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 3
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 3
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 3
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- OXDDDHGGRFRLEE-UHFFFAOYSA-N 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]-n-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide Chemical compound C12=CC=CC=C2C(C(=O)NCC(=O)NCC(F)(F)F)=CC=C1C(C1)=NOC1(C(F)(F)F)C1=CC(Cl)=CC(C(F)(F)F)=C1 OXDDDHGGRFRLEE-UHFFFAOYSA-N 0.000 description 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000193747 Bacillus firmus Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- 241001266001 Cordyceps confragosa Species 0.000 description 3
- 239000005946 Cypermethrin Substances 0.000 description 3
- 239000005892 Deltamethrin Substances 0.000 description 3
- 239000005896 Etofenprox Substances 0.000 description 3
- 239000005562 Glyphosate Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000005906 Imidacloprid Substances 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 3
- MWMQNVGAHVXSPE-UHFFFAOYSA-N Pyriprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SC(F)F)=C1NCC1=CC=CC=N1 MWMQNVGAHVXSPE-UHFFFAOYSA-N 0.000 description 3
- 239000005927 Pyriproxyfen Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000005929 Spinetoram Substances 0.000 description 3
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 description 3
- 239000005930 Spinosad Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000005940 Thiacloprid Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 3
- 229960000982 afoxolaner Drugs 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 3
- 229940024113 allethrin Drugs 0.000 description 3
- 229960002587 amitraz Drugs 0.000 description 3
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 3
- 229960001901 bioallethrin Drugs 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 235000010290 biphenyl Nutrition 0.000 description 3
- QLHULAHOXSSASE-UHFFFAOYSA-N butan-2-yl 2-(2-hydroxyethyl)piperidine-1-carboxylate Chemical compound CCC(C)OC(=O)N1CCCCC1CCO QLHULAHOXSSASE-UHFFFAOYSA-N 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 229960001591 cyfluthrin Drugs 0.000 description 3
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 3
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 3
- 229960005424 cypermethrin Drugs 0.000 description 3
- 229960002483 decamethrin Drugs 0.000 description 3
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 3
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 3
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 3
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 3
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 3
- 229950005085 etofenprox Drugs 0.000 description 3
- JISACBWYRJHSMG-UHFFFAOYSA-N famphur Chemical compound COP(=S)(OC)OC1=CC=C(S(=O)(=O)N(C)C)C=C1 JISACBWYRJHSMG-UHFFFAOYSA-N 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- GBIHOLCMZGAKNG-CGAIIQECSA-N flucythrinate Chemical compound O=C([C@@H](C(C)C)C=1C=CC(OC(F)F)=CC=1)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 GBIHOLCMZGAKNG-CGAIIQECSA-N 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 229940097068 glyphosate Drugs 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 229950011440 icaridin Drugs 0.000 description 3
- 229940056881 imidacloprid Drugs 0.000 description 3
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000012770 industrial material Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 229930014550 juvenile hormone Natural products 0.000 description 3
- 239000002949 juvenile hormone Substances 0.000 description 3
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 3
- NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 125000002757 morpholinyl group Chemical group 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 3
- 229940079888 nitenpyram Drugs 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 125000004043 oxo group Chemical group O=* 0.000 description 3
- 229960000490 permethrin Drugs 0.000 description 3
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 3
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 3
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 3
- 239000000018 receptor agonist Substances 0.000 description 3
- 229940044601 receptor agonist Drugs 0.000 description 3
- 229940108410 resmethrin Drugs 0.000 description 3
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 description 3
- 230000035806 respiratory chain Effects 0.000 description 3
- HPYNBECUCCGGPA-UHFFFAOYSA-N silafluofen Chemical compound C1=CC(OCC)=CC=C1[Si](C)(C)CCCC1=CC=C(F)C(OC=2C=CC=CC=2)=C1 HPYNBECUCCGGPA-UHFFFAOYSA-N 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 229940014213 spinosad Drugs 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical compound OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 3
- 229960005199 tetramethrin Drugs 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- FJDPATXIBIBRIM-QFMSAKRMSA-N (1R)-trans-cyphenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 FJDPATXIBIBRIM-QFMSAKRMSA-N 0.000 description 2
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 description 2
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- FZRBKIRIBLNOAM-UHFFFAOYSA-N (E,E)-2-propynyl 3,7,11-trimethyl-2,4-dodecadienoate Chemical compound CC(C)CCCC(C)CC=CC(C)=CC(=O)OCC#C FZRBKIRIBLNOAM-UHFFFAOYSA-N 0.000 description 2
- NFGXHKASABOEEW-GYMWBFJFSA-N (S)-methoprene Chemical compound COC(C)(C)CCC[C@H](C)C\C=C\C(\C)=C\C(=O)OC(C)C NFGXHKASABOEEW-GYMWBFJFSA-N 0.000 description 2
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- QVCUKHQDEZNNOC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.2]octane Chemical compound C1CC2CCN1NC2 QVCUKHQDEZNNOC-UHFFFAOYSA-N 0.000 description 2
- XQEMNBNCQVQXMO-UHFFFAOYSA-M 1,2-dimethyl-3,5-diphenylpyrazol-1-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C[N+]=1N(C)C(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 XQEMNBNCQVQXMO-UHFFFAOYSA-M 0.000 description 2
- TUBQDCKAWGHZPF-UHFFFAOYSA-N 1,3-benzothiazol-2-ylsulfanylmethyl thiocyanate Chemical compound C1=CC=C2SC(SCSC#N)=NC2=C1 TUBQDCKAWGHZPF-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- IAQLCKZJGNTRDO-UHFFFAOYSA-N 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C(=CC=CC=2F)F)CC1 IAQLCKZJGNTRDO-UHFFFAOYSA-N 0.000 description 2
- FEWLNYSYJNLUOO-UHFFFAOYSA-N 1-Piperidinecarboxaldehyde Chemical compound O=CN1CCCCC1 FEWLNYSYJNLUOO-UHFFFAOYSA-N 0.000 description 2
- HVQHXBNMBZJPLK-UHFFFAOYSA-N 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methylprop-2-en-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound CC(=C)CNC1=C([S+]([O-])C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl HVQHXBNMBZJPLK-UHFFFAOYSA-N 0.000 description 2
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- PPJVXZVTPWQOQS-UHFFFAOYSA-N 1-ethoxy-1-(1-ethoxyethoxy)ethane Chemical compound CCOC(C)OC(C)OCC PPJVXZVTPWQOQS-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 2
- BEIGRUGXKZTAIB-UHFFFAOYSA-N 2,3-dibutyl-5-chlorothieno[2,3-d]pyrimidin-4-one Chemical compound O=C1N(CCCC)C(CCCC)=NC2=C1C(Cl)=CS2 BEIGRUGXKZTAIB-UHFFFAOYSA-N 0.000 description 2
- JYYNAJVZFGKDEQ-UHFFFAOYSA-N 2,4-Dimethylpyridine Chemical compound CC1=CC=NC(C)=C1 JYYNAJVZFGKDEQ-UHFFFAOYSA-N 0.000 description 2
- DNBMPXLFKQCOBV-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OCCOCCOCC)=NC2=C1 DNBMPXLFKQCOBV-UHFFFAOYSA-N 0.000 description 2
- FXJRDUKXWHFPND-NSHDSACASA-N 2-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=NC=CN1 FXJRDUKXWHFPND-NSHDSACASA-N 0.000 description 2
- QKJJCZYFXJCKRX-HZHKWBLPSA-N 2-[(2s,3s,6r)-6-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-3,6-dihydro-2h-pyran-2-yl]-5-(diaminomethylideneamino)-2,4-dihydroxypentanoic acid Chemical compound O1[C@H](C(O)(CC(O)CN=C(N)N)C(O)=O)[C@@H](NC(=O)[C@H](CO)N)C=C[C@@H]1N1C(=O)N=C(N)C(CO)=C1 QKJJCZYFXJCKRX-HZHKWBLPSA-N 0.000 description 2
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 2
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- 229940061334 2-phenylphenol Drugs 0.000 description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 2
- ZVOWUYIDRJPVTD-UHFFFAOYSA-N 3,4,5-trichloropyridine-2,6-dicarbonitrile Chemical compound ClC1=C(Cl)C(C#N)=NC(C#N)=C1Cl ZVOWUYIDRJPVTD-UHFFFAOYSA-N 0.000 description 2
- SWBHWUYHHJCADA-UHFFFAOYSA-N 3-(2-chlorophenyl)-6-(2,6-difluorophenyl)-1,2,4,5-tetrazine Chemical compound FC1=CC=CC(F)=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 SWBHWUYHHJCADA-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- RUXHWBMJNBBYNL-UHFFFAOYSA-N 3-hydroxy-1,2-dihydropyrrol-5-one Chemical class OC1=CC(=O)NC1 RUXHWBMJNBBYNL-UHFFFAOYSA-N 0.000 description 2
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FXSRCEOKVUFSGM-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine Chemical compound C=1C=C(Cl)C=CC=1C=1C(C)=NN=C(C)C=1C1=C(F)C=CC=C1F FXSRCEOKVUFSGM-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- NNPRCLUGHFXSOU-UHFFFAOYSA-N 4-chloro-n-[cyano(ethoxy)methyl]benzamide Chemical compound CCOC(C#N)NC(=O)C1=CC=C(Cl)C=C1 NNPRCLUGHFXSOU-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- FJVPSOPCFRAJEF-UHFFFAOYSA-N 5-(4-bromopyrazol-1-yl)-1-methyl-3-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole Chemical compound CN1N=C(C(F)(F)C(F)(F)F)C(C(F)(F)F)=C1N1N=CC(Br)=C1 FJVPSOPCFRAJEF-UHFFFAOYSA-N 0.000 description 2
- GDGIVSREGUOIJZ-UHFFFAOYSA-N 5-amino-3h-1,3,4-thiadiazole-2-thione Chemical compound NC1=NN=C(S)S1 GDGIVSREGUOIJZ-UHFFFAOYSA-N 0.000 description 2
- GABNAHQQEVWYNS-UHFFFAOYSA-N 5-phenyl-2,3-dihydro-1,4-dithiine 1,1,4,4-tetraoxide Chemical compound O=S1(=O)CCS(=O)(=O)C(C=2C=CC=CC=2)=C1 GABNAHQQEVWYNS-UHFFFAOYSA-N 0.000 description 2
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 239000005660 Abamectin Substances 0.000 description 2
- 241001580838 Acarapis woodi Species 0.000 description 2
- 241000934067 Acarus Species 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
- 241000256111 Aedes <genus> Species 0.000 description 2
- 241000256118 Aedes aegypti Species 0.000 description 2
- 241000256173 Aedes albopictus Species 0.000 description 2
- 239000005877 Alpha-Cypermethrin Substances 0.000 description 2
- 241000238679 Amblyomma Species 0.000 description 2
- 241000238682 Amblyomma americanum Species 0.000 description 2
- 241001480735 Amblyomma cajennense Species 0.000 description 2
- 241001480736 Amblyomma hebraeum Species 0.000 description 2
- 241001480737 Amblyomma maculatum Species 0.000 description 2
- 241001480834 Amblyomma variegatum Species 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 241000256186 Anopheles <genus> Species 0.000 description 2
- 241000256182 Anopheles gambiae Species 0.000 description 2
- 241000132163 Anopheles maculipennis Species 0.000 description 2
- 241000256837 Apidae Species 0.000 description 2
- 241001480748 Argas Species 0.000 description 2
- 241001480752 Argas persicus Species 0.000 description 2
- 241001480754 Argas reflexus Species 0.000 description 2
- 241000238888 Argasidae Species 0.000 description 2
- 241000238708 Astigmata Species 0.000 description 2
- 241000982146 Atylotus Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 108010018763 Biotin carboxylase Proteins 0.000 description 2
- 241000238662 Blatta orientalis Species 0.000 description 2
- 241000216129 Boophthora Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000322475 Bovicola Species 0.000 description 2
- 241000322476 Bovicola bovis Species 0.000 description 2
- 241001283755 Bovicola caprae Species 0.000 description 2
- 241000463528 Bovicola limbata Species 0.000 description 2
- 241001113967 Bovicola ovis Species 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 2
- 240000000385 Brassica napus var. napus Species 0.000 description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 241000941072 Braula Species 0.000 description 2
- 241000941069 Braula coeca Species 0.000 description 2
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- FILRLZNBFWWYCQ-UHFFFAOYSA-N C1=CC(=C(C(=C1)F)CC2=C(N=NC=C2C3=CC=C(C=C3)Cl)Cl)F Chemical compound C1=CC(=C(C(=C1)F)CC2=C(N=NC=C2C3=CC=C(C=C3)Cl)Cl)F FILRLZNBFWWYCQ-UHFFFAOYSA-N 0.000 description 2
- IPQJVAGGRJROJT-UHFFFAOYSA-N CC(C(NC(C(C=C1)=CC=C1Cl)C#N)=O)C(C=CC=C1OC)=C1OC#CC Chemical compound CC(C(NC(C(C=C1)=CC=C1Cl)C#N)=O)C(C=CC=C1OC)=C1OC#CC IPQJVAGGRJROJT-UHFFFAOYSA-N 0.000 description 2
- RHRMYBNOJCLASO-HMTLIYDFSA-N CC1=CC(C(F)(F)F)=NN1CC(N(CCCC1)C1C1=CSC(C(N(C)[C@@H]2C3=CC=CC=C3CCC2)=O)=N1)=O Chemical compound CC1=CC(C(F)(F)F)=NN1CC(N(CCCC1)C1C1=CSC(C(N(C)[C@@H]2C3=CC=CC=C3CCC2)=O)=N1)=O RHRMYBNOJCLASO-HMTLIYDFSA-N 0.000 description 2
- RHRMYBNOJCLASO-ZMFCMNQTSA-N CC1=CC(C(F)(F)F)=NN1CC(N(CCCC1)C1C1=CSC(C(N(C)[C@H]2C3=CC=CC=C3CCC2)=O)=N1)=O Chemical compound CC1=CC(C(F)(F)F)=NN1CC(N(CCCC1)C1C1=CSC(C(N(C)[C@H]2C3=CC=CC=C3CCC2)=O)=N1)=O RHRMYBNOJCLASO-ZMFCMNQTSA-N 0.000 description 2
- YZEACUPQOAZGAJ-KHPPLWFESA-N CCOC(/C(\C1=CC=CC=C1)=C(/C#N)\N)=O Chemical compound CCOC(/C(\C1=CC=CC=C1)=C(/C#N)\N)=O YZEACUPQOAZGAJ-KHPPLWFESA-N 0.000 description 2
- KADWTJRRNXRZOH-UHFFFAOYSA-N CN(C(C(C(F)(F)F)(F)F)=C1C(F)(F)F)N=C1N1C(C(C(Cl)=CC=C2)=C2C(NCC2=CC=CC=C2)=O)=NC=C1 Chemical compound CN(C(C(C(F)(F)F)(F)F)=C1C(F)(F)F)N=C1N1C(C(C(Cl)=CC=C2)=C2C(NCC2=CC=CC=C2)=O)=NC=C1 KADWTJRRNXRZOH-UHFFFAOYSA-N 0.000 description 2
- XYJMGUPVSQPITR-UHFFFAOYSA-N CN(C(C(C(F)(F)F)(F)F)=C1C(F)(F)F)N=C1N1C(C2=CC=CC(C(O)=O)=C2Cl)=NC=C1 Chemical compound CN(C(C(C(F)(F)F)(F)F)=C1C(F)(F)F)N=C1N1C(C2=CC=CC(C(O)=O)=C2Cl)=NC=C1 XYJMGUPVSQPITR-UHFFFAOYSA-N 0.000 description 2
- KVCUAFOFFZREDP-UHFFFAOYSA-N CN(C(C(C(F)(F)F)(F)F)=C1C(F)(F)F)N=C1N1C(C2=CC=CC(C(OC)=O)=C2Cl)=NC=C1 Chemical compound CN(C(C(C(F)(F)F)(F)F)=C1C(F)(F)F)N=C1N1C(C2=CC=CC(C(OC)=O)=C2Cl)=NC=C1 KVCUAFOFFZREDP-UHFFFAOYSA-N 0.000 description 2
- SNVJEXAAIRESHD-UHFFFAOYSA-N CNC(C(C=C(CC#N)C=C1)=C1NC(C(C(CN1N=NC(C(F)(F)F)=N1)=C1)=NN1C1=NC=CC=C1Cl)=O)=O Chemical compound CNC(C(C=C(CC#N)C=C1)=C1NC(C(C(CN1N=NC(C(F)(F)F)=N1)=C1)=NN1C1=NC=CC=C1Cl)=O)=O SNVJEXAAIRESHD-UHFFFAOYSA-N 0.000 description 2
- 241000257160 Calliphora Species 0.000 description 2
- 241000257163 Calliphora vicina Species 0.000 description 2
- 241000333978 Caloglyphus Species 0.000 description 2
- 241000282832 Camelidae Species 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 239000005973 Carvone Substances 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241001098608 Ceratophyllus Species 0.000 description 2
- 229940127437 Chloride Channel Antagonists Drugs 0.000 description 2
- 241000359266 Chorioptes Species 0.000 description 2
- 241000983417 Chrysomya bezziana Species 0.000 description 2
- 241001262789 Chrysomya chloropyga Species 0.000 description 2
- 241001574870 Chrysops caecutiens Species 0.000 description 2
- 241001414836 Cimex Species 0.000 description 2
- 241000224483 Coccidia Species 0.000 description 2
- 241000239250 Copepoda Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 241000258922 Ctenocephalides Species 0.000 description 2
- 241000490513 Ctenocephalides canis Species 0.000 description 2
- 241000258924 Ctenocephalides felis Species 0.000 description 2
- 241000256054 Culex <genus> Species 0.000 description 2
- 241000256059 Culex pipiens Species 0.000 description 2
- 241000256057 Culex quinquefasciatus Species 0.000 description 2
- 241000256061 Culex tarsalis Species 0.000 description 2
- 241000134316 Culicoides <genus> Species 0.000 description 2
- 241001635274 Cydia pomonella Species 0.000 description 2
- 239000005755 Cyflufenamid Substances 0.000 description 2
- 239000005756 Cymoxanil Substances 0.000 description 2
- 239000005891 Cyromazine Substances 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 239000005644 Dazomet Substances 0.000 description 2
- 241001128002 Demodex canis Species 0.000 description 2
- 241000445733 Demodex caprae Species 0.000 description 2
- 241001480824 Dermacentor Species 0.000 description 2
- 241000865080 Dermacentor albipictus Species 0.000 description 2
- 241001480819 Dermacentor andersoni Species 0.000 description 2
- 241000227772 Dermacentor marginatus Species 0.000 description 2
- 241001480793 Dermacentor variabilis Species 0.000 description 2
- 241001481694 Dermanyssus Species 0.000 description 2
- 241001481695 Dermanyssus gallinae Species 0.000 description 2
- 241000202828 Dermatobia hominis Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 2
- LBGPXIPGGRQBJW-UHFFFAOYSA-N Difenzoquat Chemical compound C[N+]=1N(C)C(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 LBGPXIPGGRQBJW-UHFFFAOYSA-N 0.000 description 2
- 239000005893 Diflubenzuron Substances 0.000 description 2
- 239000005947 Dimethoate Substances 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 102000016680 Dioxygenases Human genes 0.000 description 2
- 108010028143 Dioxygenases Proteins 0.000 description 2
- 102000015782 Electron Transport Complex III Human genes 0.000 description 2
- 108010024882 Electron Transport Complex III Proteins 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 description 2
- VZRKEAFHFMSHCD-UHFFFAOYSA-N Ethyl 3-(N-butylacetamido)propionate Chemical compound CCCCN(C(C)=O)CCC(=O)OCC VZRKEAFHFMSHCD-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 239000005897 Etoxazole Substances 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- 241000216093 Eusimulium Species 0.000 description 2
- SGKBMXABPQWYSK-UHFFFAOYSA-N FCC1=CC(C(C(F)(F)F)(F)F)=NN1C(F)(F)F Chemical compound FCC1=CC(C(C(F)(F)F)(F)F)=NN1C(F)(F)F SGKBMXABPQWYSK-UHFFFAOYSA-N 0.000 description 2
- YMPHPMDJJALTGX-UHFFFAOYSA-N FCOC1=CC=CC(OCF)=C1CC(N=C1Cl)=CN1C1=CC=CN=C1Cl Chemical compound FCOC1=CC=CC(OCF)=C1CC(N=C1Cl)=CN1C1=CC=CN=C1Cl YMPHPMDJJALTGX-UHFFFAOYSA-N 0.000 description 2
- 241000371383 Fannia Species 0.000 description 2
- 241000953886 Fannia canicularis Species 0.000 description 2
- 241000322646 Felicola Species 0.000 description 2
- 241000322648 Felicola subrostratus Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 239000005898 Fenoxycarb Substances 0.000 description 2
- 239000005779 Fenpyrazamine Substances 0.000 description 2
- 239000005657 Fenpyroximate Substances 0.000 description 2
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 2
- 239000005901 Flubendiamide Substances 0.000 description 2
- 239000005783 Fluopyram Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 239000005902 Flupyradifurone Substances 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000692264 Gasterophilus haemorrhoidalis Species 0.000 description 2
- 241001660201 Gasterophilus intestinalis Species 0.000 description 2
- 241001194754 Gasterophilus nasalis Species 0.000 description 2
- 241000510076 Gasterophilus nigricornis Species 0.000 description 2
- 241001194755 Gasterophilus pecorum Species 0.000 description 2
- 241000257324 Glossina <genus> Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 241001046324 Haemaphysalis concinna Species 0.000 description 2
- 241000179419 Haemaphysalis leachi Species 0.000 description 2
- 241000179420 Haemaphysalis longicornis Species 0.000 description 2
- 241000227776 Haemaphysalis punctata Species 0.000 description 2
- 241000257224 Haematobia Species 0.000 description 2
- 241001481667 Haematobia irritans exigua Species 0.000 description 2
- 241001276563 Haematobia irritans irritans Species 0.000 description 2
- 241000562487 Haematobosca stimulans Species 0.000 description 2
- 241000790933 Haematopinus Species 0.000 description 2
- 241000875835 Haematopinus asini Species 0.000 description 2
- 241000894055 Haematopinus eurysternus Species 0.000 description 2
- 241000670091 Haematopinus suis Species 0.000 description 2
- 241000047428 Halter Species 0.000 description 2
- 241000771993 Hippobosca equina Species 0.000 description 2
- 241000750136 Hyalomma anatolicum Species 0.000 description 2
- 241001480807 Hyalomma marginatum Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000238729 Hydrotaea Species 0.000 description 2
- 241000402053 Hydrotaea albipuncta Species 0.000 description 2
- 241000562421 Hydrotaea irritans Species 0.000 description 2
- 241001590577 Hypodectes Species 0.000 description 2
- 241000257176 Hypoderma <fly> Species 0.000 description 2
- 241000543830 Hypoderma bovis Species 0.000 description 2
- 241000257174 Hypoderma lineatum Species 0.000 description 2
- 239000005907 Indoxacarb Substances 0.000 description 2
- 239000005867 Iprodione Substances 0.000 description 2
- VROYMKJUVCKXBU-UHFFFAOYSA-N Irumamycin Natural products CCC(=O)C1(C)OC1C(C)CC(C)C1C(C)C(O)C(C)C=CC(OC2OC(C)C(O)C(OC(N)=O)C2)CCCC=C(C)C(O2)C(C)=CCC2(O)CC(=O)O1 VROYMKJUVCKXBU-UHFFFAOYSA-N 0.000 description 2
- 241000238681 Ixodes Species 0.000 description 2
- 241000545319 Ixodes canisuga Species 0.000 description 2
- 241001480840 Ixodes hexagonus Species 0.000 description 2
- 241000922049 Ixodes holocyclus Species 0.000 description 2
- 241000179530 Ixodes pilosus Species 0.000 description 2
- 241001480843 Ixodes ricinus Species 0.000 description 2
- 241000472347 Ixodes rubicundus Species 0.000 description 2
- 241000238703 Ixodes scapularis Species 0.000 description 2
- 241000238889 Ixodidae Species 0.000 description 2
- 241001467800 Knemidokoptes Species 0.000 description 2
- 241000670112 Linognathus ovillus Species 0.000 description 2
- 244000309753 Linognathus pedalis Species 0.000 description 2
- 241001113946 Linognathus vituli Species 0.000 description 2
- 241000692237 Lipoptena Species 0.000 description 2
- 241000786150 Lipoptena capreoli Species 0.000 description 2
- 241000692235 Lipoptena cervi Species 0.000 description 2
- 241001535742 Listrophorus Species 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241001332052 Longipalpa Species 0.000 description 2
- 241000257162 Lucilia <blowfly> Species 0.000 description 2
- 241000257166 Lucilia cuprina Species 0.000 description 2
- 241000736227 Lucilia sericata Species 0.000 description 2
- 239000005912 Lufenuron Substances 0.000 description 2
- 241000255134 Lutzomyia <genus> Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241000721703 Lymantria dispar Species 0.000 description 2
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 2
- 241000677589 Macrocephalus Species 0.000 description 2
- 241000273338 Macronyssidae Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 239000005949 Malathion Substances 0.000 description 2
- 241000771995 Melophagus Species 0.000 description 2
- 241000771994 Melophagus ovinus Species 0.000 description 2
- 241000035436 Menopon Species 0.000 description 2
- 241001481698 Mesostigmata Species 0.000 description 2
- 239000005914 Metaflumizone Substances 0.000 description 2
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 description 2
- 241000223250 Metarhizium anisopliae Species 0.000 description 2
- 239000005916 Methomyl Substances 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 241001351098 Morellia Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000257229 Musca <genus> Species 0.000 description 2
- 241000238745 Musca autumnalis Species 0.000 description 2
- 241000257159 Musca domestica Species 0.000 description 2
- 241001373727 Myobia Species 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- XFOXDUJCOHBXRC-UHFFFAOYSA-N N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide Chemical compound CCN(C)C(=O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C(OC)C(OC)=C1 XFOXDUJCOHBXRC-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- 150000001204 N-oxides Chemical class 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- VJAWBEFMCIINFU-UHFFFAOYSA-N Nitrothal-isopropyl Chemical compound CC(C)OC(=O)C1=CC(C(=O)OC(C)C)=CC([N+]([O-])=O)=C1 VJAWBEFMCIINFU-UHFFFAOYSA-N 0.000 description 2
- 241000562097 Notoedres Species 0.000 description 2
- 241000562094 Notoedres cati Species 0.000 description 2
- 241000036147 Ochlerotatus taeniorhynchus Species 0.000 description 2
- 241000543819 Oestrus ovis Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 241000273340 Ornithonyssus Species 0.000 description 2
- 241000566163 Ornithonyssus bursa Species 0.000 description 2
- 241000273374 Ornithonyssus sylviarum Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001480755 Otobius Species 0.000 description 2
- 241001480756 Otobius megnini Species 0.000 description 2
- 241000790250 Otodectes Species 0.000 description 2
- 241000790252 Otodectes cynotis Species 0.000 description 2
- 241000919536 Panstrongylus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000517325 Pediculus Species 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 241000517306 Pediculus humanus corporis Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 241000238675 Periplaneta americana Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 241001432757 Philipomyia Species 0.000 description 2
- 241000932963 Philopteridae Species 0.000 description 2
- 241001157810 Phlebotomus papatasi Species 0.000 description 2
- 239000005921 Phosmet Substances 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 description 2
- 108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 description 2
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000238705 Prostigmata Species 0.000 description 2
- 241000543705 Przhevalskiana silenus Species 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241001016411 Psorergates Species 0.000 description 2
- 241000620638 Psoroptes cuniculi Species 0.000 description 2
- 241001649230 Psoroptes ovis Species 0.000 description 2
- 241001534486 Pterolichus Species 0.000 description 2
- 241000517309 Pthirus Species 0.000 description 2
- 241000517304 Pthirus pubis Species 0.000 description 2
- 241001675082 Pulex Species 0.000 description 2
- 241000718000 Pulex irritans Species 0.000 description 2
- 241001465752 Purpureocillium lilacinum Species 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
- 241001408411 Raillietia Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241001236639 Relictus Species 0.000 description 2
- 241001194723 Rhinoestrus Species 0.000 description 2
- 241001480837 Rhipicephalus annulatus Species 0.000 description 2
- 241001481704 Rhipicephalus appendiculatus Species 0.000 description 2
- 241000949016 Rhipicephalus bursa Species 0.000 description 2
- 241000864246 Rhipicephalus decoloratus Species 0.000 description 2
- 241000864202 Rhipicephalus evertsi Species 0.000 description 2
- 241000238680 Rhipicephalus microplus Species 0.000 description 2
- 241001481696 Rhipicephalus sanguineus Species 0.000 description 2
- 241001481697 Rhipicephalus turanicus Species 0.000 description 2
- 241000864200 Rhipicephalus zambeziensis Species 0.000 description 2
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 2
- 241000722251 Rhodnius Species 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 102000001424 Ryanodine receptors Human genes 0.000 description 2
- 241000257190 Sarcophaga <genus> Species 0.000 description 2
- 241000304160 Sarcophaga carnaria Species 0.000 description 2
- 241000509427 Sarcoptes scabiei Species 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 241000256108 Simulium <genus> Species 0.000 description 2
- 241000925083 Simulium ornatum Species 0.000 description 2
- 241000861933 Simulium reptans Species 0.000 description 2
- 241000258242 Siphonaptera Species 0.000 description 2
- 108010052164 Sodium Channels Proteins 0.000 description 2
- 102000018674 Sodium Channels Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 241000044136 Solenopotes Species 0.000 description 2
- 241000044147 Solenopotes capillatus Species 0.000 description 2
- 239000005664 Spirodiclofen Substances 0.000 description 2
- 239000005665 Spiromesifen Substances 0.000 description 2
- 239000005931 Spirotetramat Substances 0.000 description 2
- 241001147695 Staphylococcus caprae Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 241001513492 Sternostoma Species 0.000 description 2
- 241001494139 Stomoxys Species 0.000 description 2
- 241001494115 Stomoxys calcitrans Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 241001649251 Supella Species 0.000 description 2
- 241000255632 Tabanus atratus Species 0.000 description 2
- 241000925066 Tabanus bromius Species 0.000 description 2
- 241000511648 Tabanus sudeticus Species 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 241000131345 Tipula <genus> Species 0.000 description 2
- 241000511627 Tipula paludosa Species 0.000 description 2
- 241000869417 Trematodes Species 0.000 description 2
- 241001414833 Triatoma Species 0.000 description 2
- 239000005847 Triazoxide Substances 0.000 description 2
- NHTFLYKPEGXOAN-UHFFFAOYSA-N Trichlamide Chemical compound CCCCOC(C(Cl)(Cl)Cl)NC(=O)C1=CC=CC=C1O NHTFLYKPEGXOAN-UHFFFAOYSA-N 0.000 description 2
- 241001259047 Trichodectes Species 0.000 description 2
- 241001259048 Trichodectes canis Species 0.000 description 2
- 241000223260 Trichoderma harzianum Species 0.000 description 2
- 239000005942 Triflumuron Substances 0.000 description 2
- 241000790999 Trinoton Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 241000331598 Trombiculidae Species 0.000 description 2
- 241001232874 Tunga Species 0.000 description 2
- 241001584775 Tunga penetrans Species 0.000 description 2
- 241000132125 Tyrophagus Species 0.000 description 2
- 241000895647 Varroa Species 0.000 description 2
- 241000895650 Varroa jacobsoni Species 0.000 description 2
- 241000061203 Werneckiella Species 0.000 description 2
- 241000061220 Werneckiella equi Species 0.000 description 2
- 241000609108 Wohlfahrtia Species 0.000 description 2
- 241000353224 Xenopsylla Species 0.000 description 2
- 241000353223 Xenopsylla cheopis Species 0.000 description 2
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 2
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 2
- INISTDXBRIBGOC-CGAIIQECSA-N [cyano-(3-phenoxyphenyl)methyl] (2s)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate Chemical compound N([C@@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-CGAIIQECSA-N 0.000 description 2
- DFVKOWFGNASVPK-BWHPXCRDSA-N [cyano-(4-phenoxyphenyl)methyl] (1s,3s)-3-[(z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)OC(C#N)C(C=C1)=CC=C1OC1=CC=CC=C1 DFVKOWFGNASVPK-BWHPXCRDSA-N 0.000 description 2
- XXFXTBNFFMQVKJ-UHFFFAOYSA-N [diphenyl(trityloxy)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)OC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XXFXTBNFFMQVKJ-UHFFFAOYSA-N 0.000 description 2
- RGVCOYRFWYWFBG-UHFFFAOYSA-N acetamide;ethyl heptanoate Chemical compound CC(N)=O.CCCCCCC(=O)OCC RGVCOYRFWYWFBG-UHFFFAOYSA-N 0.000 description 2
- WEVYAHXRMPXWCK-FIBGUPNXSA-N acetonitrile-d3 Chemical compound [2H]C([2H])([2H])C#N WEVYAHXRMPXWCK-FIBGUPNXSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003281 allosteric effect Effects 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 244000000054 animal parasite Species 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- 239000000921 anthelmintic agent Substances 0.000 description 2
- 229940124339 anthelmintic agent Drugs 0.000 description 2
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 2
- 239000003904 antiprotozoal agent Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 description 2
- 229940005348 bacillus firmus Drugs 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 2
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000010352 biotechnological method Methods 0.000 description 2
- 230000004790 biotic stress Effects 0.000 description 2
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 2
- 229960005286 carbaryl Drugs 0.000 description 2
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- FWXAUDSWDBGCMN-ZEQRLZLVSA-N chiraphos Chemical compound C=1C=CC=CC=1P([C@@H](C)[C@H](C)P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 FWXAUDSWDBGCMN-ZEQRLZLVSA-N 0.000 description 2
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003467 chloride channel stimulating agent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- DVBUIBGJRQBEDP-UHFFFAOYSA-N cyantraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl DVBUIBGJRQBEDP-UHFFFAOYSA-N 0.000 description 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 2
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 description 2
- YUAUPYJCVKNAEC-SEYXRHQNSA-N cymiazole Chemical compound CC1=CC(C)=CC=C1\N=C/1N(C)C=CS\1 YUAUPYJCVKNAEC-SEYXRHQNSA-N 0.000 description 2
- OAWUUPVZMNKZRY-UHFFFAOYSA-N cyprosulfamide Chemical compound COC1=CC=CC=C1C(=O)NS(=O)(=O)C1=CC=C(C(=O)NC2CC2)C=C1 OAWUUPVZMNKZRY-UHFFFAOYSA-N 0.000 description 2
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 2
- 229950000775 cyromazine Drugs 0.000 description 2
- NMCCNOZOBBWFMN-UHFFFAOYSA-N davicil Chemical compound CS(=O)(=O)C1=C(Cl)C(Cl)=NC(Cl)=C1Cl NMCCNOZOBBWFMN-UHFFFAOYSA-N 0.000 description 2
- QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical compound CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 description 2
- 229950003960 demiditraz Drugs 0.000 description 2
- 229960003887 dichlorophen Drugs 0.000 description 2
- UWQMKVBQKFHLCE-UHFFFAOYSA-N diclomezine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1=NNC(=O)C=C1 UWQMKVBQKFHLCE-UHFFFAOYSA-N 0.000 description 2
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 2
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 2
- 229940019503 diflubenzuron Drugs 0.000 description 2
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 2
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical compound PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 description 2
- GMNGEQJIDVLLHG-UHFFFAOYSA-N ditert-butyl-[ditert-butyl(methyl)silyl]oxy-methylsilane Chemical compound CC(C)(C)[Si](C)(C(C)(C)C)O[Si](C)(C(C)(C)C)C(C)(C)C GMNGEQJIDVLLHG-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 2
- 229960003997 doramectin Drugs 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- ZMQMTKVVAMWKNY-YSXLEBCMSA-N emodepside Chemical compound C([C@@H]1C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@H](C(O[C@H](CC=2C=CC(=CC=2)N2CCOCC2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O1)=O)CC(C)C)C(C=C1)=CC=C1N1CCOCC1 ZMQMTKVVAMWKNY-YSXLEBCMSA-N 0.000 description 2
- 108010056417 emodepside Proteins 0.000 description 2
- 229960001575 emodepside Drugs 0.000 description 2
- 239000004495 emulsifiable concentrate Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- WPNHOHPRXXCPRA-TVXIRPTOSA-N eprinomectin Chemical compound O1[C@@H](C)[C@@H](NC(C)=O)[C@H](OC)C[C@@H]1O[C@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C\C=C/[C@@H]2C)\C)O[C@H]1C WPNHOHPRXXCPRA-TVXIRPTOSA-N 0.000 description 2
- 229960002346 eprinomectin Drugs 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- 125000006437 ethyl cyclopropyl group Chemical group 0.000 description 2
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 2
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 2
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 description 2
- YOWNVPAUWYHLQX-UHFFFAOYSA-N fluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC=2C(=CC(=CN=2)C(F)(F)F)Cl)=C1 YOWNVPAUWYHLQX-UHFFFAOYSA-N 0.000 description 2
- 229950006719 fluazuron Drugs 0.000 description 2
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 2
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 description 2
- IPENDKRRWFURRE-UHFFFAOYSA-N fluoroimide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(Cl)=C(Cl)C1=O IPENDKRRWFURRE-UHFFFAOYSA-N 0.000 description 2
- QOIYTRGFOFZNKF-UHFFFAOYSA-N flupyradifurone Chemical compound C=1C(=O)OCC=1N(CC(F)F)CC1=CC=C(Cl)N=C1 QOIYTRGFOFZNKF-UHFFFAOYSA-N 0.000 description 2
- MLBZKOGAMRTSKP-UHFFFAOYSA-N fluralaner Chemical compound C1=C(C(=O)NCC(=O)NCC(F)(F)F)C(C)=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=C1 MLBZKOGAMRTSKP-UHFFFAOYSA-N 0.000 description 2
- 229960004498 fluralaner Drugs 0.000 description 2
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 description 2
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000003966 growth inhibitor Substances 0.000 description 2
- 125000000262 haloalkenyl group Chemical group 0.000 description 2
- CKAPSXZOOQJIBF-UHFFFAOYSA-N hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 238000003898 horticulture Methods 0.000 description 2
- 230000007366 host health Effects 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 2
- 229940027359 ir-3535 Drugs 0.000 description 2
- VROYMKJUVCKXBU-YACXGCCLSA-N irumamycin Chemical compound CCC(=O)[C@@]1(C)OC1[C@H](C)C[C@@H](C)[C@@H]1[C@H](C)C(O)[C@@H](C)/C=C/[C@H](OC2O[C@H](C)[C@@H](O)[C@H](OC(N)=O)C2)CCC/C=C(C)/[C@@H](O2)C(C)=CC[C@]2(O)CC(=O)O1 VROYMKJUVCKXBU-YACXGCCLSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 229960002418 ivermectin Drugs 0.000 description 2
- 229930001540 kinoprene Natural products 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940058352 levulinate Drugs 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229960000521 lufenuron Drugs 0.000 description 2
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229960000453 malathion Drugs 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 2
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 2
- IXJOSTZEBSTPAG-UHFFFAOYSA-N methasulfocarb Chemical compound CNC(=O)SC1=CC=C(OS(C)(=O)=O)C=C1 IXJOSTZEBSTPAG-UHFFFAOYSA-N 0.000 description 2
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 2
- RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- CPZBTYRIGVOOMI-UHFFFAOYSA-N methylsulfanyl(methylsulfanylmethoxy)methane Chemical compound CSCOCSC CPZBTYRIGVOOMI-UHFFFAOYSA-N 0.000 description 2
- 229960001952 metrifonate Drugs 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical class O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 2
- CKVMAPHTVCTEMM-ALPQRHTBSA-N milbemycin oxime Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\2)O)C[C@H]4C1.C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\1)O)C[C@H]4C2 CKVMAPHTVCTEMM-ALPQRHTBSA-N 0.000 description 2
- 229940099245 milbemycin oxime Drugs 0.000 description 2
- KCIRYJNISRMYFI-UHFFFAOYSA-N mildiomycin Natural products NC(CO)C(=O)NC1C=CC(OC1C(O)(CC(O)CNC(=N)N)C(=O)O)N2CN=C(N)C(=C2)CO KCIRYJNISRMYFI-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 201000002266 mite infestation Diseases 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 2
- 229960004816 moxidectin Drugs 0.000 description 2
- BLCKKNLGFULNRC-UHFFFAOYSA-L n,n-dimethylcarbamodithioate;nickel(2+) Chemical compound [Ni+2].CN(C)C([S-])=S.CN(C)C([S-])=S BLCKKNLGFULNRC-UHFFFAOYSA-L 0.000 description 2
- PEQJBOMPGWYIRO-UHFFFAOYSA-N n-ethyl-3,4-dimethoxyaniline Chemical compound CCNC1=CC=C(OC)C(OC)=C1 PEQJBOMPGWYIRO-UHFFFAOYSA-N 0.000 description 2
- BUYMVQAILCEWRR-UHFFFAOYSA-N naled Chemical compound COP(=O)(OC)OC(Br)C(Cl)(Cl)Br BUYMVQAILCEWRR-UHFFFAOYSA-N 0.000 description 2
- 239000004311 natamycin Substances 0.000 description 2
- 235000010298 natamycin Nutrition 0.000 description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 2
- 229960003255 natamycin Drugs 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- ZHCAAFJSYLFLPX-UHFFFAOYSA-N nitrocyclohexatriene Chemical group [O-][N+](=O)C1=CC=C=C[CH]1 ZHCAAFJSYLFLPX-UHFFFAOYSA-N 0.000 description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 235000010292 orthophenyl phenol Nutrition 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 125000000160 oxazolidinyl group Chemical group 0.000 description 2
- 230000010627 oxidative phosphorylation Effects 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- WPIFGDDVIKNHOC-UHFFFAOYSA-N pentyl n-[6-[[[(1-methyltetrazol-5-yl)-phenylmethylidene]amino]oxymethyl]pyridin-2-yl]carbamate Chemical compound CCCCCOC(=O)NC1=CC=CC(CON=C(C=2N(N=NN=2)C)C=2C=CC=CC=2)=N1 WPIFGDDVIKNHOC-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- TYZYRCHEVXXLSJ-UHFFFAOYSA-N phenylmethoxymethoxymethoxymethylbenzene Chemical compound C=1C=CC=CC=1COCOCOCC1=CC=CC=C1 TYZYRCHEVXXLSJ-UHFFFAOYSA-N 0.000 description 2
- 150000008048 phenylpyrazoles Chemical class 0.000 description 2
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 2
- 229950001664 phoxim Drugs 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- BZNDWPRGXNILMS-VQHVLOKHSA-N propetamphos Chemical compound CCNP(=S)(OC)O\C(C)=C\C(=O)OC(C)C BZNDWPRGXNILMS-VQHVLOKHSA-N 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 description 2
- 229960002132 pyrrolnitrin Drugs 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- UIQFAODJHJZOHK-UHFFFAOYSA-N quinolin-2-yl hydrogen sulfate Chemical compound C1=CC=CC2=NC(OS(=O)(=O)O)=CC=C21 UIQFAODJHJZOHK-UHFFFAOYSA-N 0.000 description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 108091052345 ryanodine receptor (TC 1.A.3.1) family Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- AFJYYKSVHJGXSN-KAJWKRCWSA-N selamectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(O[C@@H]([C@@H](C)CC2)C2CCCCC2)C2)C[C@@H]2OC(=O)[C@@H]([C@]23O)C=C(C)C(=N\O)/[C@H]3OC\C2=C/C=C/[C@@H]1C AFJYYKSVHJGXSN-KAJWKRCWSA-N 0.000 description 2
- 229960002245 selamectin Drugs 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- IYYIUOWKEMQYNV-UHFFFAOYSA-N sodium;ethoxy-oxido-oxophosphanium Chemical compound [Na+].CCO[P+]([O-])=O IYYIUOWKEMQYNV-UHFFFAOYSA-N 0.000 description 2
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 2
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 2
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000004546 suspension concentrate Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- LWLJEQHTPVPKSJ-UHFFFAOYSA-N tebufloquin Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)C)=C(C)C(C)=NC2=C1F LWLJEQHTPVPKSJ-UHFFFAOYSA-N 0.000 description 2
- ROZUQUDEWZIBHV-UHFFFAOYSA-N tecloftalam Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C(=O)NC1=CC=CC(Cl)=C1Cl ROZUQUDEWZIBHV-UHFFFAOYSA-N 0.000 description 2
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 2
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 150000004867 thiadiazoles Chemical group 0.000 description 2
- 125000001984 thiazolidinyl group Chemical group 0.000 description 2
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- DHYDHYSPOGYCBO-UHFFFAOYSA-N tris(trimethylsilyl)-tris(trimethylsilyl)silyloxysilane Chemical compound C[Si](C)(C)[Si]([Si](C)(C)C)([Si](C)(C)C)O[Si]([Si](C)(C)C)([Si](C)(C)C)[Si](C)(C)C DHYDHYSPOGYCBO-UHFFFAOYSA-N 0.000 description 2
- 241000701451 unidentified granulovirus Species 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000000664 voltage gated sodium channel blocking agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (+)-β-citronellol Chemical compound OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- YASHSAMOKSQSHZ-UHFFFAOYSA-N (1,1,1-trichloro-2-methylpropan-2-yl) hydrogen carbonate Chemical compound ClC(Cl)(Cl)C(C)(C)OC(O)=O YASHSAMOKSQSHZ-UHFFFAOYSA-N 0.000 description 1
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- CXBMCYHAMVGWJQ-LOACHALJSA-N (1R)-tetramethrin Chemical compound CC1(C)C(C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-LOACHALJSA-N 0.000 description 1
- KAATUXNTWXVJKI-GGPKGHCWSA-N (1R)-trans-(alphaS)-cypermethrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-GGPKGHCWSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 description 1
- GBLRQXKSCRCLBZ-AJSYEDJNSA-N (1S,2R,1'S,2'R)-doxacurium Chemical compound COC1=C(OC)C(OC)=CC(C[C@@H]2[N@@+](CCC3=C2C(=C(OC)C(OC)=C3)OC)(C)CCCOC(=O)CCC(=O)OCCC[N@+]2(C)[C@H](C3=C(OC)C(OC)=C(OC)C=C3CC2)CC=2C=C(OC)C(OC)=C(OC)C=2)=C1 GBLRQXKSCRCLBZ-AJSYEDJNSA-N 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 1
- XPPHUWQIZFQGEX-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy-[(2-methylpropan-2-yl)oxy-diphenylsilyl]oxy-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(OC(C)(C)C)O[Si](OC(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 XPPHUWQIZFQGEX-UHFFFAOYSA-N 0.000 description 1
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 1
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 1
- ZWQHSKHUDBTICM-RCGFYEORSA-N (2e)-2-methoxyimino-n-methyl-2-[2-[[(e)-2-[3-(trifluoromethyl)phenyl]ethylideneamino]oxymethyl]phenyl]acetamide Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C\CC1=CC=CC(C(F)(F)F)=C1 ZWQHSKHUDBTICM-RCGFYEORSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- ZTESKPLFUKCHOF-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methyl hydrogen carbonate Chemical compound COC1=CC=C(COC(O)=O)C=C1OC ZTESKPLFUKCHOF-UHFFFAOYSA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 1
- FYQGBXGJFWXIPP-HNNXBMFYSA-N (7S)-hydroprene Chemical compound CCOC(=O)C=C(C)C=CC[C@@H](C)CCCC(C)C FYQGBXGJFWXIPP-HNNXBMFYSA-N 0.000 description 1
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 1
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 1
- PCKNFPQPGUWFHO-SXBRIOAWSA-N (Z)-flucycloxuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1)=CC=C1CO\N=C(C=1C=CC(Cl)=CC=1)\C1CC1 PCKNFPQPGUWFHO-SXBRIOAWSA-N 0.000 description 1
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QUSKGEMGNZXRRQ-UHFFFAOYSA-N 1,1,1-trichloro-2-(2,2,2-trichloroethoxy)ethane Chemical compound ClC(Cl)(Cl)COCC(Cl)(Cl)Cl QUSKGEMGNZXRRQ-UHFFFAOYSA-N 0.000 description 1
- DNKORVAXOJKDEO-UHFFFAOYSA-N 1,1,1-trichloro-2-(2,2,2-trichloroethoxymethoxymethoxy)ethane Chemical compound ClC(Cl)(Cl)COCOCOCC(Cl)(Cl)Cl DNKORVAXOJKDEO-UHFFFAOYSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- SYYSBZOSEAUMEY-UHFFFAOYSA-N 1,1,1-trifluoro-2-$l^{1}-sulfanylethane Chemical group FC(F)(F)C[S] SYYSBZOSEAUMEY-UHFFFAOYSA-N 0.000 description 1
- YCABKYHNWMZGBG-UHFFFAOYSA-N 1,1,3,3-tetrabutyl-2-cyclohexylguanidine Chemical compound CCCCN(CCCC)C(N(CCCC)CCCC)=NC1CCCCC1 YCABKYHNWMZGBG-UHFFFAOYSA-N 0.000 description 1
- SEQRDAAUNCRFIT-UHFFFAOYSA-N 1,1-dichlorobutane Chemical compound CCCC(Cl)Cl SEQRDAAUNCRFIT-UHFFFAOYSA-N 0.000 description 1
- VYKNVAHOUNIVTQ-UHFFFAOYSA-N 1,2,2,3,3-pentamethylpiperidine Chemical compound CN1CCCC(C)(C)C1(C)C VYKNVAHOUNIVTQ-UHFFFAOYSA-N 0.000 description 1
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
- SSUJUUNLZQVZMO-UHFFFAOYSA-N 1,2,3,4,8,9,10,10a-octahydropyrimido[1,2-a]azepine Chemical compound C1CCC=CN2CCCNC21 SSUJUUNLZQVZMO-UHFFFAOYSA-N 0.000 description 1
- 125000004529 1,2,3-triazinyl group Chemical group N1=NN=C(C=C1)* 0.000 description 1
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 description 1
- WDRLWNTYPXZHLB-UHFFFAOYSA-N 1,2,3-tris(4-methoxyphenyl)-4-[[2,3,4-tris(4-methoxyphenyl)phenyl]methoxymethyl]benzene Chemical compound C1=CC(OC)=CC=C1C(C(=C1C=2C=CC(OC)=CC=2)C=2C=CC(OC)=CC=2)=CC=C1COCC(C(=C1C=2C=CC(OC)=CC=2)C=2C=CC(OC)=CC=2)=CC=C1C1=CC=C(OC)C=C1 WDRLWNTYPXZHLB-UHFFFAOYSA-N 0.000 description 1
- DDQSFPWLVMWAHC-UHFFFAOYSA-N 1,2,4,5-tetrafluoro-3-[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenoxy]-6-(trifluoromethyl)benzene Chemical compound FC1=C(F)C(C(F)(F)F)=C(F)C(F)=C1OC1=C(F)C(F)=C(C(F)(F)F)C(F)=C1F DDQSFPWLVMWAHC-UHFFFAOYSA-N 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- 125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- KNKRKFALVUDBJE-UHFFFAOYSA-N 1,2-dichloropropane Chemical compound CC(Cl)CCl KNKRKFALVUDBJE-UHFFFAOYSA-N 0.000 description 1
- GOYDNIKZWGIXJT-UHFFFAOYSA-N 1,2-difluorobenzene Chemical compound FC1=CC=CC=C1F GOYDNIKZWGIXJT-UHFFFAOYSA-N 0.000 description 1
- ITFCEERPJPLHPQ-UHFFFAOYSA-N 1,3-dichloro-2-[(2,6-dichlorophenyl)methoxymethyl]benzene Chemical compound ClC1=CC=CC(Cl)=C1COCC1=C(Cl)C=CC=C1Cl ITFCEERPJPLHPQ-UHFFFAOYSA-N 0.000 description 1
- SYAKLHLWZJMBEZ-UHFFFAOYSA-N 1,3-dimethyl-N-(1,3,3-trimethyl-1,2-dihydroinden-2-yl)pyrazole-4-carboxamide Chemical compound CN1N=C(C(=C1)C(=O)NC1C(C2=CC=CC=C2C1C)(C)C)C SYAKLHLWZJMBEZ-UHFFFAOYSA-N 0.000 description 1
- RFXVTCUQHINPPN-UHFFFAOYSA-N 1,3-dimethylimidazolidine-4,5-dione Chemical compound CN1CN(C)C(=O)C1=O RFXVTCUQHINPPN-UHFFFAOYSA-N 0.000 description 1
- 150000000185 1,3-diols Chemical class 0.000 description 1
- VAYTZRYEBVHVLE-UHFFFAOYSA-N 1,3-dioxol-2-one Chemical compound O=C1OC=CO1 VAYTZRYEBVHVLE-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- UUMQLZASCQVMNL-UHFFFAOYSA-N 1-(2-chloroethoxy)-1-[1-(2-chloroethoxy)ethoxy]ethane Chemical compound ClCCOC(C)OC(C)OCCCl UUMQLZASCQVMNL-UHFFFAOYSA-N 0.000 description 1
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 1
- BRNCNEUPWYIVHH-UHFFFAOYSA-N 1-(4-bromophenyl)-2-[4-[[[4-[2-(4-bromophenyl)-2-oxoethoxy]phenyl]-diphenylmethoxy]-diphenylmethyl]phenoxy]ethanone Chemical compound C1=CC(Br)=CC=C1C(=O)COC1=CC=C(C(OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC(OCC(=O)C=3C=CC(Br)=CC=3)=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)C=C1 BRNCNEUPWYIVHH-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- WRGKWWRFSUGDPX-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(1,2,4-triazol-1-yl)cycloheptan-1-ol Chemical compound C=1C=C(Cl)C=CC=1C1(O)CCCCCC1N1C=NC=N1 WRGKWWRFSUGDPX-UHFFFAOYSA-N 0.000 description 1
- RMOGWMIKYWRTKW-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)CC1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 description 1
- KDWSQWLDGXGQTK-UHFFFAOYSA-N 1-(pyren-1-ylmethoxymethyl)pyrene Chemical compound C1=C2C(COCC=3C4=CC=C5C=CC=C6C=CC(C4=C65)=CC=3)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 KDWSQWLDGXGQTK-UHFFFAOYSA-N 0.000 description 1
- GDZNXYAOQBCEHE-UHFFFAOYSA-N 1-(trifluoromethyl)-2-[[2-(trifluoromethyl)phenyl]methoxymethyl]benzene Chemical compound FC(F)(F)C1=CC=CC=C1COCC1=CC=CC=C1C(F)(F)F GDZNXYAOQBCEHE-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- ULCWZQJLFZEXCS-UHFFFAOYSA-N 1-[[2-(2,4-dichlorophenyl)-5-(2,2,2-trifluoroethoxy)oxolan-2-yl]methyl]-1,2,4-triazole Chemical compound O1C(OCC(F)(F)F)CCC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 ULCWZQJLFZEXCS-UHFFFAOYSA-N 0.000 description 1
- YETCUDWWCXAHRH-UHFFFAOYSA-N 1-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole Chemical compound FC1=CC(F)=CC=C1C1(CN2N=CN=C2)C(C=2C(=CC=CC=2)Cl)O1 YETCUDWWCXAHRH-UHFFFAOYSA-N 0.000 description 1
- HSVFHSAXCXUCLU-UHFFFAOYSA-N 1-[[bis(4-methoxyphenyl)-phenylmethoxy]-(4-methoxyphenyl)-phenylmethyl]-4-methoxybenzene Chemical compound C1=CC(OC)=CC=C1C(C=1C=CC(OC)=CC=1)(C=1C=CC=CC=1)OC(C=1C=CC(OC)=CC=1)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 HSVFHSAXCXUCLU-UHFFFAOYSA-N 0.000 description 1
- WCZCUFUSTALRPJ-UHFFFAOYSA-N 1-[[naphthalen-1-yl(diphenyl)methoxy]-diphenylmethyl]naphthalene Chemical compound C=1C=CC=CC=1C(C=1C2=CC=CC=C2C=CC=1)(C=1C=CC=CC=1)OC(C=1C2=CC=CC=C2C=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WCZCUFUSTALRPJ-UHFFFAOYSA-N 0.000 description 1
- GAHRWPUTGHCERR-UHFFFAOYSA-N 1-[bis(2-chloroethoxy)methoxy-(2-chloroethoxy)methoxy]-2-chloroethane Chemical compound ClCCOC(OCCCl)OC(OCCCl)OCCCl GAHRWPUTGHCERR-UHFFFAOYSA-N 0.000 description 1
- 125000005939 1-azabicyclo[2.2.1]heptyl group Chemical group 0.000 description 1
- LOWMYOWHQMKBTM-UHFFFAOYSA-N 1-butylsulfinylbutane Chemical compound CCCCS(=O)CCCC LOWMYOWHQMKBTM-UHFFFAOYSA-N 0.000 description 1
- BFCFYVKQTRLZHA-UHFFFAOYSA-N 1-chloro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1Cl BFCFYVKQTRLZHA-UHFFFAOYSA-N 0.000 description 1
- HILAYQUKKYWPJW-UHFFFAOYSA-N 1-dodecylguanidine Chemical compound CCCCCCCCCCCCN=C(N)N HILAYQUKKYWPJW-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- NVJUHMXYKCUMQA-UHFFFAOYSA-N 1-ethoxypropane Chemical compound CCCOCC NVJUHMXYKCUMQA-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- TZWQLTARMYBCOA-UHFFFAOYSA-N 1-methoxy-1-(1-methoxycyclohexyl)oxycyclohexane Chemical compound C1CCCCC1(OC)OC1(OC)CCCCC1 TZWQLTARMYBCOA-UHFFFAOYSA-N 0.000 description 1
- GPAAEZIXSQCCES-UHFFFAOYSA-N 1-methoxy-2-(2-methoxyethoxymethoxymethoxy)ethane Chemical compound COCCOCOCOCCOC GPAAEZIXSQCCES-UHFFFAOYSA-N 0.000 description 1
- WPGFNVSGRUMSRU-UHFFFAOYSA-N 1-methoxy-4-[(4-methoxyphenoxy)methoxymethoxy]benzene Chemical compound C1=CC(OC)=CC=C1OCOCOC1=CC=C(OC)C=C1 WPGFNVSGRUMSRU-UHFFFAOYSA-N 0.000 description 1
- SDTORDSXCYSNTD-UHFFFAOYSA-N 1-methoxy-4-[(4-methoxyphenyl)methoxymethyl]benzene Chemical compound C1=CC(OC)=CC=C1COCC1=CC=C(OC)C=C1 SDTORDSXCYSNTD-UHFFFAOYSA-N 0.000 description 1
- OZQMQVHPYMSUIL-UHFFFAOYSA-N 1-methoxy-4-[3,3,3-trichloro-2-[(4-methoxyphenyl)methyl]-2-[1,1,1-trichloro-3-(4-methoxyphenyl)-2-[(4-methoxyphenyl)methyl]propan-2-yl]oxypropyl]benzene Chemical compound C1=CC(OC)=CC=C1CC(C(Cl)(Cl)Cl)(OC(CC=1C=CC(OC)=CC=1)(CC=1C=CC(OC)=CC=1)C(Cl)(Cl)Cl)CC1=CC=C(OC)C=C1 OZQMQVHPYMSUIL-UHFFFAOYSA-N 0.000 description 1
- 125000006432 1-methyl cyclopropyl group Chemical group [H]C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- JSZOAYXJRCEYSX-UHFFFAOYSA-N 1-nitropropane Chemical compound CCC[N+]([O-])=O JSZOAYXJRCEYSX-UHFFFAOYSA-N 0.000 description 1
- BQCCJWMQESHLIT-UHFFFAOYSA-N 1-propylsulfinylpropane Chemical compound CCCS(=O)CCC BQCCJWMQESHLIT-UHFFFAOYSA-N 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- UNCVXXVJJXJZII-QLETUHIQSA-N 1k1cu6363a Chemical compound OC(=O)C(/C)=C/C=C/[C@@](C)([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@]1(C)[C@@H]2CC2=C1N1[C@@H](C(=C)C)C(=O)C3=C([C@@H](O)[C@@H]4C(OC(C)(C)C=C44)(C)C)C4=CC2=C31 UNCVXXVJJXJZII-QLETUHIQSA-N 0.000 description 1
- BRRSNXCXLSVPFC-UHFFFAOYSA-N 2,3,4-Trihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1O BRRSNXCXLSVPFC-UHFFFAOYSA-N 0.000 description 1
- NFTOEHBFQROATQ-UHFFFAOYSA-N 2,3-dihydrofuran-5-carboxylic acid Chemical compound OC(=O)C1=CCCO1 NFTOEHBFQROATQ-UHFFFAOYSA-N 0.000 description 1
- NIOPZPCMRQGZCE-WEVVVXLNSA-N 2,4-dinitro-6-(octan-2-yl)phenyl (E)-but-2-enoate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)\C=C\C NIOPZPCMRQGZCE-WEVVVXLNSA-N 0.000 description 1
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 1
- VFXFHLGYUDXEKM-UHFFFAOYSA-N 2-(1,4-dioxan-2-yloxy)-1,4-dioxane Chemical compound C1OCCOC1OC1OCCOC1 VFXFHLGYUDXEKM-UHFFFAOYSA-N 0.000 description 1
- MEQLNUTUGWFNIB-UHFFFAOYSA-N 2-(2,2,3,3,4,4,5,5-octafluoropentyl)-2-(3,3,3-trifluoropropyl)propanedinitrile Chemical compound FC(F)C(F)(F)C(F)(F)C(F)(F)CC(C#N)(C#N)CCC(F)(F)F MEQLNUTUGWFNIB-UHFFFAOYSA-N 0.000 description 1
- PIDORWGUVHFLRF-UHFFFAOYSA-N 2-(2,2,3,3,4,4,5,5-octafluoropentyl)-2-(3,3,4,4,4-pentafluorobutyl)propanedinitrile Chemical compound FC(F)C(F)(F)C(F)(F)C(F)(F)CC(C#N)(C#N)CCC(F)(F)C(F)(F)F PIDORWGUVHFLRF-UHFFFAOYSA-N 0.000 description 1
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 1
- HKGFCBLEZLVKOK-UHFFFAOYSA-N 2-(2,4-dinitrophenyl)ethyl hydrogen carbonate Chemical compound OC(=O)OCCC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HKGFCBLEZLVKOK-UHFFFAOYSA-N 0.000 description 1
- ZICPUOCGGSEVTK-UHFFFAOYSA-N 2-(2-benzylsulfanylethoxy)ethylsulfanylmethylbenzene Chemical compound C=1C=CC=CC=1CSCCOCCSCC1=CC=CC=C1 ZICPUOCGGSEVTK-UHFFFAOYSA-N 0.000 description 1
- OILIYWFQRJOPAI-UHFFFAOYSA-N 2-(2-chlorophenyl)-1h-benzimidazole Chemical compound ClC1=CC=CC=C1C1=NC2=CC=CC=C2N1 OILIYWFQRJOPAI-UHFFFAOYSA-N 0.000 description 1
- CALZWRITFOWNNV-UHFFFAOYSA-N 2-(2-phenylselanylethoxy)ethylselanylbenzene Chemical compound C=1C=CC=CC=1[Se]CCOCC[Se]C1=CC=CC=C1 CALZWRITFOWNNV-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 description 1
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 description 1
- NAUQLLOQBHWGPP-UHFFFAOYSA-N 2-(4-nitrophenyl)ethyl hydrogen carbonate Chemical compound OC(=O)OCCC1=CC=C([N+]([O-])=O)C=C1 NAUQLLOQBHWGPP-UHFFFAOYSA-N 0.000 description 1
- AGVACZYQCJRDQE-UHFFFAOYSA-N 2-(6-benzylpyridin-2-yl)quinazoline Chemical compound C=1C=CC(C=2N=C3C=CC=CC3=CN=2)=NC=1CC1=CC=CC=C1 AGVACZYQCJRDQE-UHFFFAOYSA-N 0.000 description 1
- PGTRXPWCFSKHIL-UHFFFAOYSA-N 2-(benzenesulfonyl)ethyl hydrogen carbonate Chemical compound OC(=O)OCCS(=O)(=O)C1=CC=CC=C1 PGTRXPWCFSKHIL-UHFFFAOYSA-N 0.000 description 1
- VWBPOCCATLFKEP-UHFFFAOYSA-N 2-(cyclohepten-1-yl)-n-octylcycloheptene-1-carboxamide Chemical compound C1CCCCC(C(=O)NCCCCCCCC)=C1C1=CCCCCC1 VWBPOCCATLFKEP-UHFFFAOYSA-N 0.000 description 1
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 1
- YFEXZJKJPFNYKB-UHFFFAOYSA-N 2-(oxolan-2-yloxy)oxolane Chemical compound C1CCOC1OC1OCCC1 YFEXZJKJPFNYKB-UHFFFAOYSA-N 0.000 description 1
- FIGFULPPXLXUPY-UHFFFAOYSA-N 2-(pentan-2-yloxymethoxymethoxy)pentane Chemical compound CCCC(C)OCOCOC(C)CCC FIGFULPPXLXUPY-UHFFFAOYSA-N 0.000 description 1
- GBWMWHHLQDBPFP-UHFFFAOYSA-N 2-(thian-2-yloxy)thiane Chemical compound S1CCCCC1OC1SCCCC1 GBWMWHHLQDBPFP-UHFFFAOYSA-N 0.000 description 1
- JMTBNBFBHBCERV-UHFFFAOYSA-N 2-(thiolan-2-yloxy)thiolane Chemical compound C1CCSC1OC1SCCC1 JMTBNBFBHBCERV-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 1
- OEVPVIOYGHWVBJ-UHFFFAOYSA-N 2-[2-[[2-(2-hydroxyphenyl)ethenyl-di(propan-2-yl)silyl]oxy-di(propan-2-yl)silyl]ethenyl]phenol Chemical compound C=1C=CC=C(O)C=1C=C[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)C=CC1=CC=CC=C1O OEVPVIOYGHWVBJ-UHFFFAOYSA-N 0.000 description 1
- PLCDBHWEGWAWRP-UHFFFAOYSA-N 2-[2-[[2-(2-hydroxyphenyl)ethenyl-dimethylsilyl]oxy-dimethylsilyl]ethenyl]phenol Chemical compound C=1C=CC=C(O)C=1C=C[Si](C)(C)O[Si](C)(C)C=CC1=CC=CC=C1O PLCDBHWEGWAWRP-UHFFFAOYSA-N 0.000 description 1
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 description 1
- SPGSOULKMFCKIF-UHFFFAOYSA-N 2-[5-(dimethylamino)naphthalen-1-yl]sulfonylethyl hydrogen carbonate Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)CCOC(O)=O SPGSOULKMFCKIF-UHFFFAOYSA-N 0.000 description 1
- MQFJRLQNQOJQEI-UHFFFAOYSA-N 2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]-1-[4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C=CC=CC=2)CC1 MQFJRLQNQOJQEI-UHFFFAOYSA-N 0.000 description 1
- ZRILNQDGSZOKID-UHFFFAOYSA-N 2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]-1-piperidin-1-ylethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCCCC1 ZRILNQDGSZOKID-UHFFFAOYSA-N 0.000 description 1
- VNSVUCYVBBYLQR-UHFFFAOYSA-N 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl]-1h-1,2,4-triazole-3-thione Chemical compound FC1=CC(F)=CC=C1C1(CN2C(NC=N2)=S)C(C=2C(=CC=CC=2)Cl)O1 VNSVUCYVBBYLQR-UHFFFAOYSA-N 0.000 description 1
- NCDBYAPSWOPDRN-UHFFFAOYSA-N 2-[dichloro(fluoro)methyl]sulfanylisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)F)C(=O)C2=C1 NCDBYAPSWOPDRN-UHFFFAOYSA-N 0.000 description 1
- PVTHJAPFENJVNC-UHFFFAOYSA-N 2-amino-2-[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyl)oxyoxan-3-yl]iminoacetic acid Chemical compound NC1CC(N=C(N)C(O)=O)C(C)OC1OC1C(O)C(O)C(O)C(O)C1O PVTHJAPFENJVNC-UHFFFAOYSA-N 0.000 description 1
- PARCUCWFQOWGFX-UHFFFAOYSA-N 2-butan-2-ylsulfinylbutane Chemical compound CCC(C)S(=O)C(C)CC PARCUCWFQOWGFX-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 description 1
- DBTOOKULZYKHHL-UHFFFAOYSA-N 2-chloro-n-[2-(4-ethynylphenyl)phenyl]pyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1C1=CC=C(C#C)C=C1 DBTOOKULZYKHHL-UHFFFAOYSA-N 0.000 description 1
- CDHAQCOUYILIRY-UHFFFAOYSA-N 2-chloro-n-[2-(4-prop-1-ynylphenyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(C#CC)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl CDHAQCOUYILIRY-UHFFFAOYSA-N 0.000 description 1
- SLHPVQGXHAIIAB-UHFFFAOYSA-N 2-cyano-3-(difluoromethoxy)-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=CC(OC(F)F)=C1C#N SLHPVQGXHAIIAB-UHFFFAOYSA-N 0.000 description 1
- BZJMCXRJRICDPD-UHFFFAOYSA-N 2-cyano-3-(difluoromethoxy)-n-ethylbenzenesulfonamide Chemical compound CCNS(=O)(=O)C1=CC=CC(OC(F)F)=C1C#N BZJMCXRJRICDPD-UHFFFAOYSA-N 0.000 description 1
- FTRBGJBAWNIOCJ-UHFFFAOYSA-N 2-cyano-3-(difluoromethoxy)-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(OC(F)F)=C1C#N FTRBGJBAWNIOCJ-UHFFFAOYSA-N 0.000 description 1
- LMDPNRIZSVFXLG-UHFFFAOYSA-N 2-cyclohexyl-1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(N(C)C)=NC1CCCCC1 LMDPNRIZSVFXLG-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- WAVYAFBQOXCGSZ-UHFFFAOYSA-N 2-fluoropyrimidine Chemical compound FC1=NC=CC=N1 WAVYAFBQOXCGSZ-UHFFFAOYSA-N 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- AWSZRJQNBMEZOI-UHFFFAOYSA-N 2-methoxyethyl 2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate Chemical compound C=1C=C(C(C)(C)C)C=CC=1C(C#N)(C(=O)OCCOC)C(=O)C1=CC=CC=C1C(F)(F)F AWSZRJQNBMEZOI-UHFFFAOYSA-N 0.000 description 1
- ZTQNUTNKGQGWCM-UHFFFAOYSA-N 2-methoxyquinoline Chemical compound C1=CC=CC2=NC(OC)=CC=C21 ZTQNUTNKGQGWCM-UHFFFAOYSA-N 0.000 description 1
- QCFAKTACICNQGT-UHFFFAOYSA-N 2-methyl-2-[(2-methylpropan-2-yl)oxymethoxymethoxy]propane Chemical compound CC(C)(C)OCOCOC(C)(C)C QCFAKTACICNQGT-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 229940044120 2-n-octyl-4-isothiazolin-3-one Drugs 0.000 description 1
- PLAZTCDQAHEYBI-UHFFFAOYSA-N 2-nitrotoluene Chemical compound CC1=CC=CC=C1[N+]([O-])=O PLAZTCDQAHEYBI-UHFFFAOYSA-N 0.000 description 1
- AVGVFDSUDIUXEU-UHFFFAOYSA-N 2-octyl-1,2-thiazolidin-3-one Chemical compound CCCCCCCCN1SCCC1=O AVGVFDSUDIUXEU-UHFFFAOYSA-N 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 description 1
- LDZNCSVWVMBVST-UHFFFAOYSA-N 2-trimethylsilylethyl hydrogen carbonate Chemical compound C[Si](C)(C)CCOC(O)=O LDZNCSVWVMBVST-UHFFFAOYSA-N 0.000 description 1
- IPHPFXHEWMVPQA-UHFFFAOYSA-N 2-triphenylphosphaniumylethyl carbonate Chemical compound C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCOC(=O)[O-])C1=CC=CC=C1 IPHPFXHEWMVPQA-UHFFFAOYSA-N 0.000 description 1
- SELKVOUVWXWOSJ-UHFFFAOYSA-N 3,4,4a,5,6,7-hexahydro-2h-cyclopenta[c]pyridazine Chemical compound C1CNN=C2CCCC21 SELKVOUVWXWOSJ-UHFFFAOYSA-N 0.000 description 1
- FHNCCAGEZMNIHZ-UHFFFAOYSA-N 3,4,5,5a,6,7,8,9-octahydro-2h-1,2-benzodiazepine Chemical compound N1CCCC2CCCCC2=N1 FHNCCAGEZMNIHZ-UHFFFAOYSA-N 0.000 description 1
- AUQAUAIUNJIIEP-UHFFFAOYSA-N 3,4,5-trimethylphenyl methylcarbamate Chemical compound CNC(=O)OC1=CC(C)=C(C)C(C)=C1 AUQAUAIUNJIIEP-UHFFFAOYSA-N 0.000 description 1
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 1
- NRAYWXLNSHEHQO-UHFFFAOYSA-N 3-(1-benzothiophen-2-yl)-5,6-dihydro-1,4,2-oxathiazine 4-oxide Chemical compound O=S1CCON=C1C1=CC2=CC=CC=C2S1 NRAYWXLNSHEHQO-UHFFFAOYSA-N 0.000 description 1
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 1
- BZGLBXYQOMFXAU-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate Chemical compound CC1CCCCN1CCCOC(=O)C1=CC=C(Cl)C(Cl)=C1 BZGLBXYQOMFXAU-UHFFFAOYSA-N 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- KKADPXVIOXHVKN-UHFFFAOYSA-M 3-(4-hydroxyphenyl)pyruvate Chemical compound OC1=CC=C(CC(=O)C([O-])=O)C=C1 KKADPXVIOXHVKN-UHFFFAOYSA-M 0.000 description 1
- DXYZFGGPWDUUTH-UHFFFAOYSA-N 3-[(2-chloro-1,3-thiazol-4-yl)methyl-(2-fluoroethyl)amino]-2H-furan-5-one Chemical compound ClC=1SC=C(N=1)CN(C1=CC(OC1)=O)CCF DXYZFGGPWDUUTH-UHFFFAOYSA-N 0.000 description 1
- QDEISQXCEWERID-UHFFFAOYSA-N 3-[(6-chloropyridin-2-yl)methyl-(2-fluoroethyl)amino]-2H-furan-5-one Chemical compound ClC1=CC=CC(=N1)CN(C1=CC(OC1)=O)CCF QDEISQXCEWERID-UHFFFAOYSA-N 0.000 description 1
- BIKMXXALCZALFI-UHFFFAOYSA-N 3-[(6-chloropyridin-2-yl)methyl-methylamino]-2h-furan-5-one Chemical compound C=1C(=O)OCC=1N(C)CC1=CC=CC(Cl)=N1 BIKMXXALCZALFI-UHFFFAOYSA-N 0.000 description 1
- HWVSWOSCYCXBSO-UHFFFAOYSA-N 3-[2,2-difluoroethyl-[(6-fluoropyridin-2-yl)methyl]amino]-2H-furan-5-one Chemical compound FC1=CC=CC(=N1)CN(C1=CC(OC1)=O)CC(F)F HWVSWOSCYCXBSO-UHFFFAOYSA-N 0.000 description 1
- DHTJFQWHCVTNRY-UHFFFAOYSA-N 3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine Chemical compound CN1OC(C=2C=CC(Cl)=CC=2)CC1(C)C1=CC=CN=C1 DHTJFQWHCVTNRY-UHFFFAOYSA-N 0.000 description 1
- DPYDQXCMDBCRRK-UHFFFAOYSA-N 3-bromo-2-(3-bromooxan-2-yl)oxyoxane Chemical compound BrC1CCCOC1OC1C(Br)CCCO1 DPYDQXCMDBCRRK-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- WBUOVKBZJOIOAE-UHFFFAOYSA-N 3-chlorobenzonitrile Chemical compound ClC1=CC=CC(C#N)=C1 WBUOVKBZJOIOAE-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- WXYDKGMJJFFORR-UHFFFAOYSA-N 3-methyl-1-(3-methylbutylsulfinyl)butane Chemical compound CC(C)CCS(=O)CCC(C)C WXYDKGMJJFFORR-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- HRDCVMSNCBAMAM-UHFFFAOYSA-N 3-prop-2-ynoxyprop-1-yne Chemical compound C#CCOCC#C HRDCVMSNCBAMAM-UHFFFAOYSA-N 0.000 description 1
- HSRXLAJZZXXCNQ-UHFFFAOYSA-N 4,4,5-trifluoro-3,3-dimethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC(F)=C2C(F)(F)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 HSRXLAJZZXXCNQ-UHFFFAOYSA-N 0.000 description 1
- SWTPIYGGSMJRTB-UHFFFAOYSA-N 4,4-difluoro-3,3-dimethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC=C2C(F)(F)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 SWTPIYGGSMJRTB-UHFFFAOYSA-N 0.000 description 1
- PKTIFYGCWCQRSX-UHFFFAOYSA-N 4,6-diamino-2-(cyclopropylamino)pyrimidine-5-carbonitrile Chemical compound NC1=C(C#N)C(N)=NC(NC2CC2)=N1 PKTIFYGCWCQRSX-UHFFFAOYSA-N 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- LABQLTFAPITERI-UHFFFAOYSA-N 4-(1-but-2-ynoxyethyl)-1,2-dimethoxybenzene Chemical compound COC1=CC=C(C(C)OCC#CC)C=C1OC LABQLTFAPITERI-UHFFFAOYSA-N 0.000 description 1
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 1
- KJODWAHKHVUXEU-UHFFFAOYSA-N 4-(difluoromethoxy)-n-ethyl-n-methyl-1,1-dioxo-1,2-benzothiazol-3-amine Chemical compound C1=CC(OC(F)F)=C2C(N(C)CC)=NS(=O)(=O)C2=C1 KJODWAHKHVUXEU-UHFFFAOYSA-N 0.000 description 1
- JTSSUEWTRDWHGY-UHFFFAOYSA-N 4-(pyridin-4-ylmethoxymethyl)pyridine Chemical compound C=1C=NC=CC=1COCC1=CC=NC=C1 JTSSUEWTRDWHGY-UHFFFAOYSA-N 0.000 description 1
- KTFBMMKWTQVUIV-UHFFFAOYSA-N 4-[(3,4-dimethoxyphenyl)methoxymethyl]-1,2-dimethoxybenzene Chemical compound C1=C(OC)C(OC)=CC=C1COCC1=CC=C(OC)C(OC)=C1 KTFBMMKWTQVUIV-UHFFFAOYSA-N 0.000 description 1
- OBXUXLBEGTZOSY-UHFFFAOYSA-N 4-amino-1-fluoropyrimidin-2-one Chemical compound NC=1C=CN(F)C(=O)N=1 OBXUXLBEGTZOSY-UHFFFAOYSA-N 0.000 description 1
- WVGCPEDBFHEHEZ-UHFFFAOYSA-N 4-bromo-1h-pyrazole Chemical compound BrC=1C=NNC=1 WVGCPEDBFHEHEZ-UHFFFAOYSA-N 0.000 description 1
- PGYDGBCATBINCB-UHFFFAOYSA-N 4-diethoxyphosphoryl-n,n-dimethylaniline Chemical compound CCOP(=O)(OCC)C1=CC=C(N(C)C)C=C1 PGYDGBCATBINCB-UHFFFAOYSA-N 0.000 description 1
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- ZQVMXWDQXLWKLE-UHFFFAOYSA-N 4-methoxy-2-(4-methoxyoxan-2-yl)oxyoxane Chemical compound C1C(OC)CCOC1OC1OCCC(OC)C1 ZQVMXWDQXLWKLE-UHFFFAOYSA-N 0.000 description 1
- ZXTCTDQZUWWAEY-UHFFFAOYSA-N 4-methoxy-2-(4-methoxythian-2-yl)oxythiane Chemical compound C1C(OC)CCSC1OC1SCCC(OC)C1 ZXTCTDQZUWWAEY-UHFFFAOYSA-N 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- PFDRKWSBABBSID-UHFFFAOYSA-N 4-oxo-2-(2-phenylethylamino)butanoic acid Chemical compound O=CCC(C(=O)O)NCCC1=CC=CC=C1 PFDRKWSBABBSID-UHFFFAOYSA-N 0.000 description 1
- JOOXCMJARBKPKM-UHFFFAOYSA-M 4-oxopentanoate Chemical compound CC(=O)CCC([O-])=O JOOXCMJARBKPKM-UHFFFAOYSA-M 0.000 description 1
- RGUKYNXWOWSRET-UHFFFAOYSA-N 4-pyrrolidin-1-ylpyridine Chemical compound C1CCCN1C1=CC=NC=C1 RGUKYNXWOWSRET-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- CWPPCBQVPBXGCV-UHFFFAOYSA-N 5-(difluoromethyl)-2-methyl-n-[2-[4-(trifluoromethyl)phenyl]phenyl]-1h-pyrazole-5-carboxamide Chemical compound C1=CN(C)NC1(C(F)F)C(=O)NC1=CC=CC=C1C1=CC=C(C(F)(F)F)C=C1 CWPPCBQVPBXGCV-UHFFFAOYSA-N 0.000 description 1
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 1
- NEKULYKCZPJMMJ-UHFFFAOYSA-N 5-chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methylpyrimidin-4-amine Chemical compound C=1C=C(OC(F)F)C=CC=1C(CC)NC1=NC=NC(C)=C1Cl NEKULYKCZPJMMJ-UHFFFAOYSA-N 0.000 description 1
- VNHBYKHXBCYPBJ-UHFFFAOYSA-N 5-ethynylimidazo[1,2-a]pyridine Chemical compound C#CC1=CC=CC2=NC=CN12 VNHBYKHXBCYPBJ-UHFFFAOYSA-N 0.000 description 1
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- BHCMXJKPZOPRNN-UHFFFAOYSA-N 5-iodo-1h-imidazole Chemical compound IC1=CN=CN1 BHCMXJKPZOPRNN-UHFFFAOYSA-N 0.000 description 1
- AGQOIYCTCOEHGR-UHFFFAOYSA-N 5-methyl-1,2-oxazole Chemical compound CC1=CC=NO1 AGQOIYCTCOEHGR-UHFFFAOYSA-N 0.000 description 1
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 1
- SJVWWZAQSFIQDP-UHFFFAOYSA-N 5-methyl-5-[2-[2-(1-methylcyclohexa-2,4-dien-1-yl)oxyethoxy]ethoxy]cyclohexa-1,3-diene Chemical compound C1C=CC=CC1(C)OCCOCCOC1(C)CC=CC=C1 SJVWWZAQSFIQDP-UHFFFAOYSA-N 0.000 description 1
- PRZRAMLXTKZUHF-UHFFFAOYSA-N 5-oxo-n-sulfonyl-4h-triazole-1-carboxamide Chemical compound O=S(=O)=NC(=O)N1N=NCC1=O PRZRAMLXTKZUHF-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- VSVKOUBCDZYAQY-UHFFFAOYSA-N 7-chloro-1,2-benzothiazole Chemical compound ClC1=CC=CC2=C1SN=C2 VSVKOUBCDZYAQY-UHFFFAOYSA-N 0.000 description 1
- INFWBGQYCBUADA-UHFFFAOYSA-N 9-anthracen-9-yloxyanthracene Chemical compound C1=CC=C2C(OC=3C4=CC=CC=C4C=C4C=CC=CC4=3)=C(C=CC=C3)C3=CC2=C1 INFWBGQYCBUADA-UHFFFAOYSA-N 0.000 description 1
- PZAUZOXWTHJXKO-UHFFFAOYSA-N 9-methyl-1,2,6,7,8,9a-hexahydropyrimido[1,2-a]pyrimidine Chemical compound C1=CCNC2N(C)CCCN21 PZAUZOXWTHJXKO-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 239000005651 Acequinocyl Substances 0.000 description 1
- 239000005875 Acetamiprid Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229940121683 Acetylcholine receptor antagonist Drugs 0.000 description 1
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 1
- 239000005652 Acrinathrin Substances 0.000 description 1
- 241000589159 Agrobacterium sp. Species 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- 239000005952 Aluminium phosphide Substances 0.000 description 1
- 239000005726 Ametoctradin Substances 0.000 description 1
- 239000005727 Amisulbrom Substances 0.000 description 1
- 241000501766 Ampelomyces quisqualis Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241001661349 Anthracocystis flocculosa Species 0.000 description 1
- 241000486791 Antonospora locustae Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241001167018 Aroa Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 108010016529 Bacillus amyloliquefaciens ribonuclease Proteins 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000278457 Bacillus siamensis Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000193365 Bacillus thuringiensis serovar israelensis Species 0.000 description 1
- 241000193367 Bacillus thuringiensis serovar san diego Species 0.000 description 1
- 101710183938 Barstar Proteins 0.000 description 1
- 241000751139 Beauveria bassiana Species 0.000 description 1
- 239000005734 Benalaxyl Substances 0.000 description 1
- 239000005735 Benalaxyl-M Substances 0.000 description 1
- 239000005736 Benthiavalicarb Substances 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 239000005884 Beta-Cyfluthrin Substances 0.000 description 1
- 239000005653 Bifenazate Substances 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- ZNSMNVMLTJELDZ-UHFFFAOYSA-N Bis(2-chloroethyl)ether Chemical compound ClCCOCCCl ZNSMNVMLTJELDZ-UHFFFAOYSA-N 0.000 description 1
- 239000005738 Bixafen Substances 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 241000498637 Brevibacillus agri Species 0.000 description 1
- 241000193417 Brevibacillus laterosporus Species 0.000 description 1
- 239000005741 Bromuconazole Substances 0.000 description 1
- 239000005742 Bupirimate Substances 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- YCPNMUVYNHIJGR-UHFFFAOYSA-N C#CC(C=C1)=CC=C1C1=C(CNC(C2(C(F)F)NNC=C2)=O)C=CC=C1 Chemical compound C#CC(C=C1)=CC=C1C1=C(CNC(C2(C(F)F)NNC=C2)=O)C=CC=C1 YCPNMUVYNHIJGR-UHFFFAOYSA-N 0.000 description 1
- UCJJHXJDIWAKFH-UHFFFAOYSA-N C1=C(C2=CC=CC(C3=NC=CC=N3)=N2)N=C(C2=NC=CC=C2)S1 Chemical compound C1=C(C2=CC=CC(C3=NC=CC=N3)=N2)N=C(C2=NC=CC=C2)S1 UCJJHXJDIWAKFH-UHFFFAOYSA-N 0.000 description 1
- TXSZQMJKHRYJIC-UHFFFAOYSA-N CC#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C(F)F)NN(C)C=C1)=O Chemical compound CC#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C(F)F)NN(C)C=C1)=O TXSZQMJKHRYJIC-UHFFFAOYSA-N 0.000 description 1
- HTKCFOOGNOHLRP-UHFFFAOYSA-N CC#CN(C1=CC=CC=C1)NS(C(S1)=CC=C1Cl)(=O)=O Chemical compound CC#CN(C1=CC=CC=C1)NS(C(S1)=CC=C1Cl)(=O)=O HTKCFOOGNOHLRP-UHFFFAOYSA-N 0.000 description 1
- AUJLGPCEZRGSFC-UHFFFAOYSA-N CC(C(C(C(F)(F)F)(F)F)=NN1C(F)(F)F)=C1N1C=NC(I)=C1 Chemical compound CC(C(C(C(F)(F)F)(F)F)=NN1C(F)(F)F)=C1N1C=NC(I)=C1 AUJLGPCEZRGSFC-UHFFFAOYSA-N 0.000 description 1
- ZCJQCDCPYWDKNB-UHFFFAOYSA-N CC(C(C(Cl)=C1)=NC=C1Br)NC(C(C=CC(F)=N1)=C1I)=O Chemical compound CC(C(C(Cl)=C1)=NC=C1Br)NC(C(C=CC(F)=N1)=C1I)=O ZCJQCDCPYWDKNB-UHFFFAOYSA-N 0.000 description 1
- UQDYJSXHEWDCLR-UHFFFAOYSA-N CC(C(C(Cl)=C1)=NC=C1Br)NC(C1=NC=CC(F)=C1I)=O Chemical compound CC(C(C(Cl)=C1)=NC=C1Br)NC(C1=NC=CC(F)=C1I)=O UQDYJSXHEWDCLR-UHFFFAOYSA-N 0.000 description 1
- XAXZCBVZFGOTQR-UHFFFAOYSA-N CC(C(N(C(C1=CC=CC(Cl)=C1C(N)=O)=O)C1=C(C)C=C(C(C(F)(F)F)(C(F)(F)F)F)C=C1)=O)C#N Chemical compound CC(C(N(C(C1=CC=CC(Cl)=C1C(N)=O)=O)C1=C(C)C=C(C(C(F)(F)F)(C(F)(F)F)F)C=C1)=O)C#N XAXZCBVZFGOTQR-UHFFFAOYSA-N 0.000 description 1
- BNTHFWVENBSFMO-UHFFFAOYSA-N CC(C(NCC(C=C1)=CC=C1Cl)=O)C(C=CC=C1OC)=C1OC#CC Chemical compound CC(C(NCC(C=C1)=CC=C1Cl)=O)C(C=CC=C1OC)=C1OC#CC BNTHFWVENBSFMO-UHFFFAOYSA-N 0.000 description 1
- UHQUHKNGYQGXHI-UHFFFAOYSA-N CC(C(NCC(C=C1)=CC=C1Cl)=O)C(C=CC=C1OC)=C1OCC#C Chemical compound CC(C(NCC(C=C1)=CC=C1Cl)=O)C(C=CC=C1OC)=C1OCC#C UHQUHKNGYQGXHI-UHFFFAOYSA-N 0.000 description 1
- POQMDJBSDKYDAQ-UHFFFAOYSA-N CC(C)(C)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C)NN(C)C=C1F)=O Chemical compound CC(C)(C)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C)NN(C)C=C1F)=O POQMDJBSDKYDAQ-UHFFFAOYSA-N 0.000 description 1
- WCOFNNUPLZEPGR-UHFFFAOYSA-N CC(C)(C)C#CC(C=C1)=CC=C1C1=C(CNC(C2(C(F)F)NNC=C2)=O)C=CC=C1 Chemical compound CC(C)(C)C#CC(C=C1)=CC=C1C1=C(CNC(C2(C(F)F)NNC=C2)=O)C=CC=C1 WCOFNNUPLZEPGR-UHFFFAOYSA-N 0.000 description 1
- BBTGYAGNUTUHAQ-UHFFFAOYSA-N CC(C)(C)CC(N1C(C(O)=O)=NC=C1)OC(C=C1)=CC=C1OC Chemical compound CC(C)(C)CC(N1C(C(O)=O)=NC=C1)OC(C=C1)=CC=C1OC BBTGYAGNUTUHAQ-UHFFFAOYSA-N 0.000 description 1
- JADCMWRFVPQNHM-UHFFFAOYSA-N CC(C)(C)NC(C(C(CC#N)=CC=C1)=C1NC(C1=NN(CN2N=NC(C(F)(F)F)=N2)C=C1C1=NC=CC=C1Cl)=O)=O Chemical compound CC(C)(C)NC(C(C(CC#N)=CC=C1)=C1NC(C1=NN(CN2N=NC(C(F)(F)F)=N2)C=C1C1=NC=CC=C1Cl)=O)=O JADCMWRFVPQNHM-UHFFFAOYSA-N 0.000 description 1
- NCMAFNFTUXHJGU-UHFFFAOYSA-N CC(C)(C)NC(C(C(CC#N)=CC=C1)=C1NC(C1=NN(CN2N=NN=C2C(F)(F)F)C=C1C1=NC=CC=C1Cl)=O)=O Chemical compound CC(C)(C)NC(C(C(CC#N)=CC=C1)=C1NC(C1=NN(CN2N=NN=C2C(F)(F)F)C=C1C1=NC=CC=C1Cl)=O)=O NCMAFNFTUXHJGU-UHFFFAOYSA-N 0.000 description 1
- ACDLEXGVOVGFMV-QHCPKHFHSA-N CC(C)[C@@H](C(NCCC(C=C1)=CC=C1OCOC#CCC(C=C1)=CC=C1Cl)=O)NS(C)(=O)=O Chemical compound CC(C)[C@@H](C(NCCC(C=C1)=CC=C1OCOC#CCC(C=C1)=CC=C1Cl)=O)NS(C)(=O)=O ACDLEXGVOVGFMV-QHCPKHFHSA-N 0.000 description 1
- GLLJZMBGLSLZAF-UHFFFAOYSA-N CC(C1CC1)NC(C(C(Br)=C(C=C1)NC(C(C=C2)(NN2C2=NC=CC=C2Cl)Br)=O)=C1Cl)=O Chemical compound CC(C1CC1)NC(C(C(Br)=C(C=C1)NC(C(C=C2)(NN2C2=NC=CC=C2Cl)Br)=O)=C1Cl)=O GLLJZMBGLSLZAF-UHFFFAOYSA-N 0.000 description 1
- VFVVRXIDKISSCH-UHFFFAOYSA-N CC(CC1)CCN1C1=CN2N=C(C(C(F)=CC(F)=C3)=C3F)N=C2N=C1Cl Chemical compound CC(CC1)CCN1C1=CN2N=C(C(C(F)=CC(F)=C3)=C3F)N=C2N=C1Cl VFVVRXIDKISSCH-UHFFFAOYSA-N 0.000 description 1
- GEXPXHYWEBIMMS-UHFFFAOYSA-N CC(CCCC(C)(C)C)C(C(C=CC(Cl)=C1)=C1Cl)(N1N=CNC1=S)O Chemical compound CC(CCCC(C)(C)C)C(C(C=CC(Cl)=C1)=C1Cl)(N1N=CNC1=S)O GEXPXHYWEBIMMS-UHFFFAOYSA-N 0.000 description 1
- SZCCIXMHULYHFO-UHFFFAOYSA-N CC(CO)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C(C=CC=N1)=C1Cl)=O Chemical compound CC(CO)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C(C=CC=N1)=C1Cl)=O SZCCIXMHULYHFO-UHFFFAOYSA-N 0.000 description 1
- RJNNAAOZSUWNPU-UHFFFAOYSA-N CC(CO)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C)NN(C)C(F)=C1)=O Chemical compound CC(CO)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C)NN(C)C(F)=C1)=O RJNNAAOZSUWNPU-UHFFFAOYSA-N 0.000 description 1
- GQOYIIUDVZMNSV-UHFFFAOYSA-N CC(COC)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C(C=CC=N1)=C1Cl)=O Chemical compound CC(COC)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C(C=CC=N1)=C1Cl)=O GQOYIIUDVZMNSV-UHFFFAOYSA-N 0.000 description 1
- MLJNWXYEAZVNKK-UHFFFAOYSA-N CC(COC)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C)NN(C)C(F)=C1)=O Chemical compound CC(COC)C#CC(C=C1)=CC=C1C(C=CC=C1)=C1NC(C1(C)NN(C)C(F)=C1)=O MLJNWXYEAZVNKK-UHFFFAOYSA-N 0.000 description 1
- WASCNSZAPOEPBD-UHFFFAOYSA-N CC(COC)C#CC(C=C1)=CC=C1C1=C(CNC(C2(C(F)F)NNC=C2)=O)C=CC=C1 Chemical compound CC(COC)C#CC(C=C1)=CC=C1C1=C(CNC(C2(C(F)F)NNC=C2)=O)C=CC=C1 WASCNSZAPOEPBD-UHFFFAOYSA-N 0.000 description 1
- WINLDLOAHLHFEE-UHFFFAOYSA-N CC1(C(NC(C=CC=C2)=C2C(C=C2)=CC=C2C#C)=O)NN(C)C=C1F Chemical compound CC1(C(NC(C=CC=C2)=C2C(C=C2)=CC=C2C#C)=O)NN(C)C=C1F WINLDLOAHLHFEE-UHFFFAOYSA-N 0.000 description 1
- KGJQEBCZVNGPKF-UHFFFAOYSA-N CC1(C(NC(C=CC=C2)=C2C(C=C2)=CC=C2C#CC)=O)NN(C)C(F)=C1 Chemical compound CC1(C(NC(C=CC=C2)=C2C(C=C2)=CC=C2C#CC)=O)NN(C)C(F)=C1 KGJQEBCZVNGPKF-UHFFFAOYSA-N 0.000 description 1
- OWSUZZPIFPOJJZ-UHFFFAOYSA-N CC1(COC(COCC(OCC2(CC=CC=C2)C)F)F)CC=CC=C1 Chemical compound CC1(COC(COCC(OCC2(CC=CC=C2)C)F)F)CC=CC=C1 OWSUZZPIFPOJJZ-UHFFFAOYSA-N 0.000 description 1
- GWRWHSQBFNPDHW-UHFFFAOYSA-N CC1(COCCOCCOCC2(C)C=CC=CC2)C=CC=CC1 Chemical compound CC1(COCCOCCOCC2(C)C=CC=CC2)C=CC=CC1 GWRWHSQBFNPDHW-UHFFFAOYSA-N 0.000 description 1
- GOXBDHAZXIIUFX-UHFFFAOYSA-N CC1=C(C(F)F)N=C(C(NC(C=CC=C2)=C2C2=CC=C(C(F)(F)F)C=C2)=O)S1 Chemical compound CC1=C(C(F)F)N=C(C(NC(C=CC=C2)=C2C2=CC=C(C(F)(F)F)C=C2)=O)S1 GOXBDHAZXIIUFX-UHFFFAOYSA-N 0.000 description 1
- PNCLRSYFKJEHJO-UHFFFAOYSA-N CC1=C(C2=NC(Cl)=CC=C2)N=NC(Cl)=C1C(C(F)=CC(F)=C1)=C1F Chemical compound CC1=C(C2=NC(Cl)=CC=C2)N=NC(Cl)=C1C(C(F)=CC(F)=C1)=C1F PNCLRSYFKJEHJO-UHFFFAOYSA-N 0.000 description 1
- RHRMYBNOJCLASO-UHFFFAOYSA-N CC1=CC(C(F)(F)F)=NN1CC(N(CCCC1)C1C1=CSC(C(N(C)C2C3=CC=CC=C3CCC2)=O)=N1)=O Chemical compound CC1=CC(C(F)(F)F)=NN1CC(N(CCCC1)C1C1=CSC(C(N(C)C2C3=CC=CC=C3CCC2)=O)=N1)=O RHRMYBNOJCLASO-UHFFFAOYSA-N 0.000 description 1
- TWDQAZDFUMJIKJ-UHFFFAOYSA-N CC1=CC(OCC2=C(COCC(NC)=O)C=CC=C2)=C(C)C=C1 Chemical compound CC1=CC(OCC2=C(COCC(NC)=O)C=CC=C2)=C(C)C=C1 TWDQAZDFUMJIKJ-UHFFFAOYSA-N 0.000 description 1
- NTZINMSCSNMXDO-UHFFFAOYSA-N CC1=CC=C(COC2=NC(N)=NC=C2F)C=C1 Chemical compound CC1=CC=C(COC2=NC(N)=NC=C2F)C=C1 NTZINMSCSNMXDO-UHFFFAOYSA-N 0.000 description 1
- NLIPIBUQPMKXHB-UHFFFAOYSA-N CC1=CN(C(F)(F)F)N=C1C(NC(C=CC=C1)=C1C(C=C(C=C1)F)=C1F)=O Chemical compound CC1=CN(C(F)(F)F)N=C1C(NC(C=CC=C1)=C1C(C=C(C=C1)F)=C1F)=O NLIPIBUQPMKXHB-UHFFFAOYSA-N 0.000 description 1
- MJDWAOQTHAKNCL-UHFFFAOYSA-N CC1C2=CC=CC=C2C(C)(C)C1N(C(C1=C(C(F)(F)F)C=CC=C1)=O)F Chemical compound CC1C2=CC=CC=C2C(C)(C)C1N(C(C1=C(C(F)(F)F)C=CC=C1)=O)F MJDWAOQTHAKNCL-UHFFFAOYSA-N 0.000 description 1
- WGEPFMYPGIXEDG-UHFFFAOYSA-N CC1C2=CC=CC=C2C(C)(C)C1NC(C1(NC=CC=C1)Cl)=O Chemical compound CC1C2=CC=CC=C2C(C)(C)C1NC(C1(NC=CC=C1)Cl)=O WGEPFMYPGIXEDG-UHFFFAOYSA-N 0.000 description 1
- ZDVLKIYQTANLQH-UHFFFAOYSA-N CCCC(C)CCCCC1=NC2=NC(N)=NN2C=C1 Chemical compound CCCC(C)CCCCC1=NC2=NC(N)=NN2C=C1 ZDVLKIYQTANLQH-UHFFFAOYSA-N 0.000 description 1
- QSHXABLPRFJMML-UHFFFAOYSA-N CCN(C(C(C=C(C=C1Br)Br)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O)N(CC)C(OC)=O Chemical compound CCN(C(C(C=C(C=C1Br)Br)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O)N(CC)C(OC)=O QSHXABLPRFJMML-UHFFFAOYSA-N 0.000 description 1
- GPCHTZKXTYJAHI-UHFFFAOYSA-N CCN(C)C=NC(C=C(C(F)F)C=C1C)=C1OCCC[Si](C)(C)C Chemical compound CCN(C)C=NC(C=C(C(F)F)C=C1C)=C1OCCC[Si](C)(C)C GPCHTZKXTYJAHI-UHFFFAOYSA-N 0.000 description 1
- ZDBXGLNLWYWCPI-UHFFFAOYSA-N CCN(C)C=NC(C=C1)=C(CCl)C=C1OC1=C(C#N)SN=C1C(C)(C)C Chemical compound CCN(C)C=NC(C=C1)=C(CCl)C=C1OC1=C(C#N)SN=C1C(C)(C)C ZDBXGLNLWYWCPI-UHFFFAOYSA-N 0.000 description 1
- RHDLYSXHSYBACR-UHFFFAOYSA-N CCN(C)C=NC1=C(C)C(OCCC[Si](C)(C)C)=C(C(F)(F)F)C=C1 Chemical compound CCN(C)C=NC1=C(C)C(OCCC[Si](C)(C)C)=C(C(F)(F)F)C=C1 RHDLYSXHSYBACR-UHFFFAOYSA-N 0.000 description 1
- JQQIEMIXUWNANW-UHFFFAOYSA-N CCN(CC1=NC(=CC=C1)Cl)C2=NC(=O)OC2 Chemical compound CCN(CC1=NC(=CC=C1)Cl)C2=NC(=O)OC2 JQQIEMIXUWNANW-UHFFFAOYSA-N 0.000 description 1
- PDBNBOWHVFZSHF-UHFFFAOYSA-N CN(C(OC)=O)NCCC(C(C=C(C=C1Br)Br)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O Chemical compound CN(C(OC)=O)NCCC(C(C=C(C=C1Br)Br)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O PDBNBOWHVFZSHF-UHFFFAOYSA-N 0.000 description 1
- BNQTUTMDWPKROR-UHFFFAOYSA-N CN(C=C1)N=C1C(N(C(F)F)C(C=CC=C1)=C1OC(C(F)F)(F)F)=O Chemical compound CN(C=C1)N=C1C(N(C(F)F)C(C=CC=C1)=C1OC(C(F)F)(F)F)=O BNQTUTMDWPKROR-UHFFFAOYSA-N 0.000 description 1
- FOHXHUSZVZEPTM-UHFFFAOYSA-N CN(CC1=NC(Cl)=CC=C1)C(CO1)=NC1=O Chemical compound CN(CC1=NC(Cl)=CC=C1)C(CO1)=NC1=O FOHXHUSZVZEPTM-UHFFFAOYSA-N 0.000 description 1
- ADGUIGPHEVFMQI-UHFFFAOYSA-N CN(CC1=NC(Cl)=CC=C1F)C(CO1)=CC1=O Chemical compound CN(CC1=NC(Cl)=CC=C1F)C(CO1)=CC1=O ADGUIGPHEVFMQI-UHFFFAOYSA-N 0.000 description 1
- YCLHFYWIKCLUNH-UHFFFAOYSA-N CN1C=C(C(=N1)C(=O)NC2=CC=CC=C2C3=CC=C(C=C3)Cl)C(F)F Chemical compound CN1C=C(C(=N1)C(=O)NC2=CC=CC=C2C3=CC=C(C=C3)Cl)C(F)F YCLHFYWIKCLUNH-UHFFFAOYSA-N 0.000 description 1
- GASVTNCOYNXNGM-UHFFFAOYSA-N CN1N=C(C(NC(C=CC=C2)=C2C(C=CC(Cl)=C2)=C2Cl)=O)C(C(F)F)=C1 Chemical compound CN1N=C(C(NC(C=CC=C2)=C2C(C=CC(Cl)=C2)=C2Cl)=O)C(C(F)F)=C1 GASVTNCOYNXNGM-UHFFFAOYSA-N 0.000 description 1
- KHPGGDKYOLEIGO-UHFFFAOYSA-N CN1N=C(C(NC(C=CC=C2)=C2OC(C(F)F)(F)F)=O)C(C(F)(F)F)=C1 Chemical compound CN1N=C(C(NC(C=CC=C2)=C2OC(C(F)F)(F)F)=O)C(C(F)(F)F)=C1 KHPGGDKYOLEIGO-UHFFFAOYSA-N 0.000 description 1
- BKQAMYHYTOXJJT-ZXVVBBHZSA-N CNC(/C(\C(C=CC=C1)=C1OC1=NC(OC2=CC(CCl)=CC=C2)=CC(F)=N1)=N/OC)=O Chemical compound CNC(/C(\C(C=CC=C1)=C1OC1=NC(OC2=CC(CCl)=CC=C2)=CC(F)=N1)=N/OC)=O BKQAMYHYTOXJJT-ZXVVBBHZSA-N 0.000 description 1
- CPQOAVMMMUXKQW-UHFFFAOYSA-N CNC(C(C=C(CC#N)C=C1)=C1NC(C(C(CN1N=NN=C1C(F)(F)F)=C1)=NN1C1=NC=CC=C1Cl)=O)=O Chemical compound CNC(C(C=C(CC#N)C=C1)=C1NC(C(C(CN1N=NN=C1C(F)(F)F)=C1)=NN1C1=NC=CC=C1Cl)=O)=O CPQOAVMMMUXKQW-UHFFFAOYSA-N 0.000 description 1
- PHHNGOZLJLQNTO-UHFFFAOYSA-N COC(N(CCC(C(C=CC=C1CC#N)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O)N)=O Chemical compound COC(N(CCC(C(C=CC=C1CC#N)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O)N)=O PHHNGOZLJLQNTO-UHFFFAOYSA-N 0.000 description 1
- GXACQSBXJOVAEL-UHFFFAOYSA-N COC(NNCC(C(C=CC=C1CC#N)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O)=O Chemical compound COC(NNCC(C(C=CC=C1CC#N)=C1NC(N(C=C1C2=NC=CC=C2Cl)N=C1Br)=O)=O)=O GXACQSBXJOVAEL-UHFFFAOYSA-N 0.000 description 1
- SZJBGVOMCAGTRL-UHFFFAOYSA-N COCC(C=C1)=C(COC)C(COC)=C1C(C1=NC=C(COCBr)C=C1)=O Chemical compound COCC(C=C1)=C(COC)C(COC)=C1C(C1=NC=C(COCBr)C=C1)=O SZJBGVOMCAGTRL-UHFFFAOYSA-N 0.000 description 1
- YIMFHDVXYWCBEW-YSURURNPSA-N COCC(NC1=O)=NN1C1=C(CO/N=C/CC2=CC(C(F)(F)F)=CC=C2)C=CC=C1 Chemical compound COCC(NC1=O)=NN1C1=C(CO/N=C/CC2=CC(C(F)(F)F)=CC=C2)C=CC=C1 YIMFHDVXYWCBEW-YSURURNPSA-N 0.000 description 1
- FBQRHAVXNBRJJZ-QCGKTTIDSA-N C[C@@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O Chemical compound C[C@@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O FBQRHAVXNBRJJZ-QCGKTTIDSA-N 0.000 description 1
- FBQRHAVXNBRJJZ-RTYYOJRZSA-N C[C@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O Chemical compound C[C@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O FBQRHAVXNBRJJZ-RTYYOJRZSA-N 0.000 description 1
- 239000006009 Calcium phosphide Substances 0.000 description 1
- 241001611011 Caligus Species 0.000 description 1
- 241000712786 Caligus clemensi Species 0.000 description 1
- 241001405819 Caligus elongatus Species 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000005746 Carboxin Substances 0.000 description 1
- 229940123982 Cell wall synthesis inhibitor Drugs 0.000 description 1
- 108700040089 Chitin synthases Proteins 0.000 description 1
- 239000005886 Chlorantraniliprole Substances 0.000 description 1
- 239000005747 Chlorothalonil Substances 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 239000005887 Chromafenozide Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- CEJRFTYXOHGQDM-UHFFFAOYSA-N ClC1=CC=CC(=N1)CN(C1=CC(OC1)=O)C1CC1 Chemical compound ClC1=CC=CC(=N1)CN(C1=CC(OC1)=O)C1CC1 CEJRFTYXOHGQDM-UHFFFAOYSA-N 0.000 description 1
- BDLFKUBJWRIPJE-UHFFFAOYSA-N ClC1=CC=CC(=N1)CN(C1=NC(OC1)=O)CC(F)F Chemical compound ClC1=CC=CC(=N1)CN(C1=NC(OC1)=O)CC(F)F BDLFKUBJWRIPJE-UHFFFAOYSA-N 0.000 description 1
- 241000186650 Clavibacter Species 0.000 description 1
- 239000005654 Clofentezine Substances 0.000 description 1
- 241000896542 Clonostachys rosea f. catenulata Species 0.000 description 1
- 239000005888 Clothianidin Substances 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 239000012027 Collins reagent Substances 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- 241000248757 Cordyceps brongniartii Species 0.000 description 1
- WHPAGCJNPTUGGD-UHFFFAOYSA-N Croconazole Chemical compound ClC1=CC=CC(COC=2C(=CC=CC=2)C(=C)N2C=NC=C2)=C1 WHPAGCJNPTUGGD-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 239000005889 Cyantraniliprole Substances 0.000 description 1
- 239000005754 Cyazofamid Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000005655 Cyflumetofen Substances 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- 239000005758 Cyprodinil Substances 0.000 description 1
- 241001600125 Delftia acidovorans Species 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 108010002156 Depsipeptides Proteins 0.000 description 1
- 244000147058 Derris elliptica Species 0.000 description 1
- URDNHJIVMYZFRT-UHFFFAOYSA-N Diclobutrazol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)CC1=CC=C(Cl)C=C1Cl URDNHJIVMYZFRT-UHFFFAOYSA-N 0.000 description 1
- 239000005759 Diethofencarb Substances 0.000 description 1
- 239000005760 Difenoconazole Substances 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005761 Dimethomorph Substances 0.000 description 1
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 1
- 239000005762 Dimoxystrobin Substances 0.000 description 1
- 241000511317 Diprion pini Species 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 239000005765 Dodemorph Substances 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- AIGRXSNSLVJMEA-UHFFFAOYSA-N EPN Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-UHFFFAOYSA-N 0.000 description 1
- 235000007351 Eleusine Nutrition 0.000 description 1
- 241000209215 Eleusine Species 0.000 description 1
- YUGWDVYLFSETPE-JLHYYAGUSA-N Empenthrin Chemical compound CC\C=C(/C)C(C#C)OC(=O)C1C(C=C(C)C)C1(C)C YUGWDVYLFSETPE-JLHYYAGUSA-N 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- 101000999829 Escherichia coli (strain K12) NH(3)-dependent NAD(+) synthetase Proteins 0.000 description 1
- 239000005895 Esfenvalerate Substances 0.000 description 1
- 239000005961 Ethoprophos Substances 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- 239000005769 Etridiazole Substances 0.000 description 1
- PSMFFFUWSMZAPB-UHFFFAOYSA-N Eukalyptol Natural products C1CC2CCC1(C)COCC2(C)C PSMFFFUWSMZAPB-UHFFFAOYSA-N 0.000 description 1
- 241000086071 Euproctis fraterna Species 0.000 description 1
- RLYRUQAXVIMMHE-UHFFFAOYSA-N FC(C(F)(F)F)(C1=NN(C(F)(F)F)C(CN2C=NC(I)=C2)=C1)F Chemical compound FC(C(F)(F)F)(C1=NN(C(F)(F)F)C(CN2C=NC(I)=C2)=C1)F RLYRUQAXVIMMHE-UHFFFAOYSA-N 0.000 description 1
- QZSVWWVKRXSGKH-UHFFFAOYSA-N FC(C1=CC=CC(OC(C(CC2)CC3)N2C3C2=CC=C(C(F)(F)F)N=N2)=C1OCC1CC1)(F)F Chemical compound FC(C1=CC=CC(OC(C(CC2)CC3)N2C3C2=CC=C(C(F)(F)F)N=N2)=C1OCC1CC1)(F)F QZSVWWVKRXSGKH-UHFFFAOYSA-N 0.000 description 1
- PCYQPADEQGFBKM-UHFFFAOYSA-N FC(C=C1)=CN=C1C1=NC(C2=CC=CC(C3=NC=CC=N3)=N2)=CS1 Chemical compound FC(C=C1)=CN=C1C1=NC(C2=CC=CC(C3=NC=CC=N3)=N2)=CS1 PCYQPADEQGFBKM-UHFFFAOYSA-N 0.000 description 1
- NCLLCVZOKXLYTQ-UHFFFAOYSA-N FC(F)(F)C1C(C=2C=C(Cl)C=C(Cl)C=2)ON=C1C(C=C1C#N)=CC=C1N1C=NC=N1 Chemical compound FC(F)(F)C1C(C=2C=C(Cl)C=C(Cl)C=2)ON=C1C(C=C1C#N)=CC=C1N1C=NC=N1 NCLLCVZOKXLYTQ-UHFFFAOYSA-N 0.000 description 1
- OCXFZSUGGATECL-UHFFFAOYSA-N FC1=C(CON(CCCC2)C2OC(CCCC2)N2OCC(C=CC=C2)=C2F)C=CC=C1 Chemical compound FC1=C(CON(CCCC2)C2OC(CCCC2)N2OCC(C=CC=C2)=C2F)C=CC=C1 OCXFZSUGGATECL-UHFFFAOYSA-N 0.000 description 1
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 description 1
- 239000005772 Famoxadone Substances 0.000 description 1
- 239000005774 Fenamidone Substances 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005656 Fenazaquin Substances 0.000 description 1
- 239000005775 Fenbuconazole Substances 0.000 description 1
- 239000005776 Fenhexamid Substances 0.000 description 1
- 239000005777 Fenpropidin Substances 0.000 description 1
- 239000005778 Fenpropimorph Substances 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 239000005782 Fluopicolide Substances 0.000 description 1
- 239000005784 Fluoxastrobin Substances 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- VEVZCONIUDBCDC-UHFFFAOYSA-N Flurprimidol Chemical compound C=1N=CN=CC=1C(O)(C(C)C)C1=CC=C(OC(F)(F)F)C=C1 VEVZCONIUDBCDC-UHFFFAOYSA-N 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- 239000005787 Flutriafol Substances 0.000 description 1
- 239000005788 Fluxapyroxad Substances 0.000 description 1
- 239000005789 Folpet Substances 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- 239000005948 Formetanate Substances 0.000 description 1
- 239000005959 Fosthiazate Substances 0.000 description 1
- 239000005791 Fuberidazole Substances 0.000 description 1
- ULCWZQJLFZEXCS-KGLIPLIRSA-N Furconazole-cis Chemical compound O1[C@@H](OCC(F)(F)F)CC[C@@]1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 ULCWZQJLFZEXCS-KGLIPLIRSA-N 0.000 description 1
- QTDRLOKFLJJHTG-UHFFFAOYSA-N Furmecyclox Chemical compound C1=C(C)OC(C)=C1C(=O)N(OC)C1CCCCC1 QTDRLOKFLJJHTG-UHFFFAOYSA-N 0.000 description 1
- 239000005903 Gamma-cyhalothrin Substances 0.000 description 1
- 241000896533 Gliocladium Species 0.000 description 1
- 241000235503 Glomus Species 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 108030006517 Glyphosate oxidoreductases Proteins 0.000 description 1
- 108010081348 HRT1 protein Hairy Proteins 0.000 description 1
- 102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 description 1
- 244000286779 Hansenula anomala Species 0.000 description 1
- 235000014683 Hansenula anomala Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000256257 Heliothis Species 0.000 description 1
- 241001523406 Heterorhabditis Species 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- 241000143456 Hirsutella thompsonii Species 0.000 description 1
- 101000589450 Homo sapiens Poly(ADP-ribose) glycohydrolase Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 239000005794 Hymexazol Substances 0.000 description 1
- 239000005795 Imazalil Substances 0.000 description 1
- PPCUNNLZTNMXFO-ACCUITESSA-N Imicyafos Chemical compound CCCSP(=O)(OCC)N1CCN(CC)\C1=N/C#N PPCUNNLZTNMXFO-ACCUITESSA-N 0.000 description 1
- FKWDSATZSMJRLC-UHFFFAOYSA-N Iminoctadine acetate Chemical compound CC([O-])=O.CC([O-])=O.CC([O-])=O.NC([NH3+])=NCCCCCCCC[NH2+]CCCCCCCCN=C(N)[NH3+] FKWDSATZSMJRLC-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 239000005796 Ipconazole Substances 0.000 description 1
- 239000005797 Iprovalicarb Substances 0.000 description 1
- 239000005800 Kresoxim-methyl Substances 0.000 description 1
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 1
- 241000235429 Lagenidium giganteum Species 0.000 description 1
- 241001247233 Lepeophtheirus Species 0.000 description 1
- 241001247234 Lepeophtheirus salmonis Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 241001124557 Lymantriidae Species 0.000 description 1
- 241001660189 Lysobacter antibioticus Species 0.000 description 1
- 239000005802 Mancozeb Substances 0.000 description 1
- 239000005804 Mandipropamid Substances 0.000 description 1
- 239000005805 Mepanipyrim Substances 0.000 description 1
- 239000005806 Meptyldinocap Substances 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 239000005808 Metalaxyl-M Substances 0.000 description 1
- 241001303988 Metarhizium rileyi Species 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- 239000005917 Methoxyfenozide Substances 0.000 description 1
- LISVNGUOWUKZQY-UHFFFAOYSA-N Methyl benzyl sulfoxide Chemical compound CS(=O)CC1=CC=CC=C1 LISVNGUOWUKZQY-UHFFFAOYSA-N 0.000 description 1
- 239000005809 Metiram Substances 0.000 description 1
- 239000005810 Metrafenone Substances 0.000 description 1
- 241001542780 Microsphaeropsis Species 0.000 description 1
- 239000005918 Milbemectin Substances 0.000 description 1
- 241001645777 Muscodor albus Species 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- IXKYFGGIVWTSAU-UHFFFAOYSA-N N#CC(C=C(C=C1)C(C2C(F)(F)F)=NOC2C2=CC=CN=C2Cl)=C1N1N=CN=C1 Chemical compound N#CC(C=C(C=C1)C(C2C(F)(F)F)=NOC2C2=CC=CN=C2Cl)=C1N1N=CN=C1 IXKYFGGIVWTSAU-UHFFFAOYSA-N 0.000 description 1
- GSXBQYOCCGDDKZ-UHFFFAOYSA-N N#CSC1=NN(CC2(C(C=CC(F)=C3)=C3F)OC2C(C=CC=C2)=C2Cl)C=N1 Chemical compound N#CSC1=NN(CC2(C(C=CC(F)=C3)=C3F)OC2C(C=CC=C2)=C2Cl)C=N1 GSXBQYOCCGDDKZ-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
- XFTIKWYXFSNCQF-UHFFFAOYSA-N N,N-dipropylformamide Chemical compound CCCN(C=O)CCC XFTIKWYXFSNCQF-UHFFFAOYSA-N 0.000 description 1
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 description 1
- PLCDAUKKEIGJDB-UHFFFAOYSA-N N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloro-1H-pyridine-2-carboxamide Chemical compound BrC=1C=C(C(=NC=1)CNC(=O)C1(NC=CC(=C1)Cl)Cl)Cl PLCDAUKKEIGJDB-UHFFFAOYSA-N 0.000 description 1
- HCUAZGPNNIIFQO-UHFFFAOYSA-N N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloro-1H-pyridine-2-carboxamide Chemical compound BrC=1C=C(C(=NC=1)C(C)NC(=O)C1(NC=CC(=C1)Cl)Cl)Cl HCUAZGPNNIIFQO-UHFFFAOYSA-N 0.000 description 1
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 1
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical compound CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 description 1
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 description 1
- GOSMTVZEXICJEO-UHFFFAOYSA-N NC(N=C1C(F)(F)F)=NN1C1=C(CF)C(S(CC(F)(F)F)=O)=CC=C1 Chemical compound NC(N=C1C(F)(F)F)=NN1C1=C(CF)C(S(CC(F)(F)F)=O)=CC=C1 GOSMTVZEXICJEO-UHFFFAOYSA-N 0.000 description 1
- FPPPUSYHJHXHNT-UHFFFAOYSA-N NC(N=C1OCC(C=C2)=CC=C2F)=NC=C1F Chemical compound NC(N=C1OCC(C=C2)=CC=C2F)=NC=C1F FPPPUSYHJHXHNT-UHFFFAOYSA-N 0.000 description 1
- CLUAVLPEZADCIC-UHFFFAOYSA-N NC1=NN=C(C(C(CCl)=CC=C2)=C2NC(C(C(Br)=C2)=NN2C2=NC=CC=C2Cl)=O)S1 Chemical compound NC1=NN=C(C(C(CCl)=CC=C2)=C2NC(C(C(Br)=C2)=NN2C2=NC=CC=C2Cl)=O)S1 CLUAVLPEZADCIC-UHFFFAOYSA-N 0.000 description 1
- 241000406465 Neodiprion Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108010019703 Nicotinamidase Proteins 0.000 description 1
- 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 1
- 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 1
- 102000000780 Nicotinate phosphoribosyltransferase Human genes 0.000 description 1
- 108700040046 Nicotinate phosphoribosyltransferases Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- GRGPVGMKELUALN-UHFFFAOYSA-N O=C(C1(C(F)F)NNC=C1)NCC(C=CC(F)=C1)=C1OC(C(C(F)(F)F)F)(F)F Chemical compound O=C(C1(C(F)F)NNC=C1)NCC(C=CC(F)=C1)=C1OC(C(C(F)(F)F)F)(F)F GRGPVGMKELUALN-UHFFFAOYSA-N 0.000 description 1
- WRBUATJSHUUSRU-UHFFFAOYSA-N O=C(CNC(C1=CC=C(CC(C2C(F)(F)F)=NOC2C2=CC(Cl)=CC(Cl)=C2)C=C1)=O)NCC(F)(F)F Chemical compound O=C(CNC(C1=CC=C(CC(C2C(F)(F)F)=NOC2C2=CC(Cl)=CC(Cl)=C2)C=C1)=O)NCC(F)(F)F WRBUATJSHUUSRU-UHFFFAOYSA-N 0.000 description 1
- DUQQPHGXMCYMON-UHFFFAOYSA-N O=C1OCC(N(CC2=NC(Cl)=CC=C2)C2CC2)=N1 Chemical compound O=C1OCC(N(CC2=NC(Cl)=CC=C2)C2CC2)=N1 DUQQPHGXMCYMON-UHFFFAOYSA-N 0.000 description 1
- VEERAVJPMWEQJV-UHFFFAOYSA-N O=C1OCC(N(CC2=NC(Cl)=CC=C2F)C2CC2)=C1 Chemical compound O=C1OCC(N(CC2=NC(Cl)=CC=C2F)C2CC2)=C1 VEERAVJPMWEQJV-UHFFFAOYSA-N 0.000 description 1
- AGNLFKGBQPXJDG-UHFFFAOYSA-N O=C1OCC(N(CCF)CC(C=C2)=NC(Cl)=C2Cl)=C1 Chemical compound O=C1OCC(N(CCF)CC(C=C2)=NC(Cl)=C2Cl)=C1 AGNLFKGBQPXJDG-UHFFFAOYSA-N 0.000 description 1
- UEICSXZODWIRIF-UHFFFAOYSA-N O=C1OCC(N(CCF)CC2=NC(Br)=CC=C2)=C1 Chemical compound O=C1OCC(N(CCF)CC2=NC(Br)=CC=C2)=C1 UEICSXZODWIRIF-UHFFFAOYSA-N 0.000 description 1
- SGXASHZVYAMPET-UHFFFAOYSA-N OB(C(C=CC(Cl)=C1)=C1C(NC1CC1)=O)O Chemical compound OB(C(C=CC(Cl)=C1)=C1C(NC1CC1)=O)O SGXASHZVYAMPET-UHFFFAOYSA-N 0.000 description 1
- WPSMRNZFWZZCBU-UHFFFAOYSA-N OC(C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 Chemical compound OC(C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 WPSMRNZFWZZCBU-UHFFFAOYSA-N 0.000 description 1
- WPSMRNZFWZZCBU-HXUWFJFHSA-N O[C@@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 Chemical compound O[C@@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 WPSMRNZFWZZCBU-HXUWFJFHSA-N 0.000 description 1
- WPSMRNZFWZZCBU-FQEVSTJZSA-N O[C@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 Chemical compound O[C@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 WPSMRNZFWZZCBU-FQEVSTJZSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101000708283 Oryza sativa subsp. indica Protein Rf1, mitochondrial Proteins 0.000 description 1
- 241001147398 Ostrinia nubilalis Species 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 108010004210 PF 1022A Proteins 0.000 description 1
- YJNUXGPXJFAUQJ-LYWANRAQSA-N PF1022A Chemical compound C([C@@H]1C(=O)N(C)[C@H](C(O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](CC=2C=CC=CC=2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O1)=O)CC(C)C)C1=CC=CC=C1 YJNUXGPXJFAUQJ-LYWANRAQSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001310335 Paenibacillus lentimorbus Species 0.000 description 1
- 240000000267 Pandorea jasminoides Species 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 241000887182 Paraphaeosphaeria minitans Species 0.000 description 1
- 239000005813 Penconazole Substances 0.000 description 1
- 239000005814 Pencycuron Substances 0.000 description 1
- 239000005815 Penflufen Substances 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000005816 Penthiopyrad Substances 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000005818 Picoxystrobin Substances 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 239000005923 Pirimicarb Substances 0.000 description 1
- 239000005924 Pirimiphos-methyl Substances 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 102100032347 Poly(ADP-ribose) glycohydrolase Human genes 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 108010035004 Prephenate Dehydrogenase Proteins 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- GGRLUNQHANDPSC-UHFFFAOYSA-N Promacyl Chemical compound CCCC(=O)CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 GGRLUNQHANDPSC-UHFFFAOYSA-N 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 239000005823 Propineb Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000005824 Proquinazid Substances 0.000 description 1
- 239000005825 Prothioconazole Substances 0.000 description 1
- 241001646398 Pseudomonas chlororaphis Species 0.000 description 1
- 241000635201 Pumilus Species 0.000 description 1
- 239000005925 Pymetrozine Substances 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 239000005926 Pyridalyl Substances 0.000 description 1
- 239000005828 Pyrimethanil Substances 0.000 description 1
- 239000005829 Pyriofenone Substances 0.000 description 1
- 239000005831 Quinoxyfen Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
- 229940122208 Ribonuclease inhibitor Drugs 0.000 description 1
- 102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 239000005834 Sedaxane Substances 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 239000005835 Silthiofam Substances 0.000 description 1
- 241001247231 Siphonostomatoida Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 244000148729 Spilanthes acmella Species 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 241001480223 Steinernema carpocapsae Species 0.000 description 1
- 241000509371 Steinernema feltiae Species 0.000 description 1
- 241000295698 Steinernema scapterisci Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 239000005838 Streptomyces K61 (formerly S. griseoviridis) Substances 0.000 description 1
- 241001467541 Streptomyces galbus Species 0.000 description 1
- 241000191251 Streptomyces griseoviridis Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 108010043934 Sucrose synthase Proteins 0.000 description 1
- 108700006291 Sucrose-phosphate synthases Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000005934 Sulfoxaflor Substances 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005938 Teflubenzuron Substances 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- 239000005842 Thiophanate-methyl Substances 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- 239000005845 Tolclofos-methyl Substances 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241001460073 Trichoderma asperellum Species 0.000 description 1
- 239000005857 Trifloxystrobin Substances 0.000 description 1
- 239000005858 Triflumizole Substances 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 239000005859 Triticonazole Substances 0.000 description 1
- 241000243216 Vairimorpha Species 0.000 description 1
- JARYYMUOCXVXNK-UHFFFAOYSA-N Validamycin A Natural products OC1C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)CC1NC1C=C(CO)C(O)C(O)C1O JARYYMUOCXVXNK-UHFFFAOYSA-N 0.000 description 1
- 239000005860 Valifenalate Substances 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 102000016913 Voltage-Gated Sodium Channels Human genes 0.000 description 1
- 108010053752 Voltage-Gated Sodium Channels Proteins 0.000 description 1
- CVQODEWAPZVVBU-UHFFFAOYSA-N XMC Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 description 1
- 241000607757 Xenorhabdus Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 239000006011 Zinc phosphide Substances 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 239000005863 Zoxamide Substances 0.000 description 1
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 1
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 description 1
- FZSVSABTBYGOQH-XFFZJAGNSA-N [(e)-(3,3-dimethyl-1-methylsulfanylbutan-2-ylidene)amino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(C(C)(C)C)\CSC FZSVSABTBYGOQH-XFFZJAGNSA-N 0.000 description 1
- CTJBHIROCMPUKL-WEVVVXLNSA-N [(e)-3-methylsulfonylbutan-2-ylideneamino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(/C)C(C)S(C)(=O)=O CTJBHIROCMPUKL-WEVVVXLNSA-N 0.000 description 1
- BZMIHNKNQJJVRO-LVZFUZTISA-N [(e)-c-(3-chloro-2,6-dimethoxyphenyl)-n-ethoxycarbonimidoyl] benzoate Chemical compound COC=1C=CC(Cl)=C(OC)C=1C(=N/OCC)\OC(=O)C1=CC=CC=C1 BZMIHNKNQJJVRO-LVZFUZTISA-N 0.000 description 1
- KAATUXNTWXVJKI-QPIRBTGLSA-N [(s)-cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-QPIRBTGLSA-N 0.000 description 1
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- MWFQAAWRPDRKDG-KOLCDFICSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1C=C(Cl)Cl MWFQAAWRPDRKDG-KOLCDFICSA-N 0.000 description 1
- APEPLROGLDYWBS-UHFFFAOYSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2,3,3-tetramethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1(C)C APEPLROGLDYWBS-UHFFFAOYSA-N 0.000 description 1
- FMPFURNXXAKYNE-UHFFFAOYSA-N [2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]quinolin-4-yl] methyl carbonate Chemical compound C1=C2C(OC(=O)OC)=C(C)C(CC)=NC2=CC(C)=C1OC1=CC=C(OC(F)(F)F)C=C1 FMPFURNXXAKYNE-UHFFFAOYSA-N 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- 241000192351 [Candida] oleophila Species 0.000 description 1
- OTQSQHBSQXERML-UHFFFAOYSA-N [N-]=[N+]=NC1=CC=C(C(OC(C(C=C2)=CC=C2N=[N+]=[N-])Cl)Cl)C=C1 Chemical compound [N-]=[N+]=NC1=CC=C(C(OC(C(C=C2)=CC=C2N=[N+]=[N-])Cl)Cl)C=C1 OTQSQHBSQXERML-UHFFFAOYSA-N 0.000 description 1
- PVQATPQSBYNMGE-UHFFFAOYSA-N [benzhydryloxy(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)OC(C=1C=CC=CC=1)C1=CC=CC=C1 PVQATPQSBYNMGE-UHFFFAOYSA-N 0.000 description 1
- KWSUZUAUJVMRAE-UHFFFAOYSA-N [diethyl(propan-2-yl)silyl]oxy-diethyl-propan-2-ylsilane Chemical compound CC[Si](CC)(C(C)C)O[Si](CC)(CC)C(C)C KWSUZUAUJVMRAE-UHFFFAOYSA-N 0.000 description 1
- KVLXXFQNLJRDCG-UHFFFAOYSA-N [dimethyl(phenyl)silyl]methoxymethoxymethoxymethyl-dimethyl-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C)(C)COCOCOC[Si](C)(C)C1=CC=CC=C1 KVLXXFQNLJRDCG-UHFFFAOYSA-N 0.000 description 1
- DSLOWNUUMZVCAC-UHFFFAOYSA-N [dimethyl(propan-2-yl)silyl]oxy-dimethyl-propan-2-ylsilane Chemical compound CC(C)[Si](C)(C)O[Si](C)(C)C(C)C DSLOWNUUMZVCAC-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- QDRXWCAVUNHOGA-UHFFFAOYSA-N acequinocyl Chemical group C1=CC=C2C(=O)C(CCCCCCCCCCCC)=C(OC(C)=O)C(=O)C2=C1 QDRXWCAVUNHOGA-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- YLJLLELGHSWIDU-OKZTUQRJSA-N acetic acid;(2s,6r)-4-cyclododecyl-2,6-dimethylmorpholine Chemical compound CC(O)=O.C1[C@@H](C)O[C@@H](C)CN1C1CCCCCCCCCCC1 YLJLLELGHSWIDU-OKZTUQRJSA-N 0.000 description 1
- GDZNYEZGJAFIKA-UHFFFAOYSA-N acetoprole Chemical compound NC1=C(S(C)=O)C(C(=O)C)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl GDZNYEZGJAFIKA-UHFFFAOYSA-N 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- LRZWFURXIMFONG-HRSIRGMGSA-N afidopyropen Chemical compound C([C@@]1(C)[C@H]2[C@]([C@H]3[C@@H](O)C=4C(=O)OC(=CC=4O[C@]3(C)[C@@H](O)C2)C=2C=NC=CC=2)(C)CC[C@@H]1OC(=O)C1CC1)OC(=O)C1CC1 LRZWFURXIMFONG-HRSIRGMGSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- GMAUQNJOSOMMHI-JXAWBTAJSA-N alanycarb Chemical compound CSC(\C)=N/OC(=O)N(C)SN(CCC(=O)OCC)CC1=CC=CC=C1 GMAUQNJOSOMMHI-JXAWBTAJSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- ZCVAOQKBXKSDMS-UHFFFAOYSA-N allethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- PPNXXZIBFHTHDM-UHFFFAOYSA-N aluminium phosphide Chemical compound P#[Al] PPNXXZIBFHTHDM-UHFFFAOYSA-N 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 description 1
- 229950000294 azaconazole Drugs 0.000 description 1
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 125000003725 azepanyl group Chemical group 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- RQVGAIADHNPSME-UHFFFAOYSA-N azinphos-ethyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OCC)OCC)N=NC2=C1 RQVGAIADHNPSME-UHFFFAOYSA-N 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- YFXPPSKYMBTNAV-UHFFFAOYSA-N bensultap Chemical compound C=1C=CC=CC=1S(=O)(=O)SCC(N(C)C)CSS(=O)(=O)C1=CC=CC=C1 YFXPPSKYMBTNAV-UHFFFAOYSA-N 0.000 description 1
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- LJWBIAMZBJWAOW-UHFFFAOYSA-N benzhydryloxysilane Chemical compound C=1C=CC=CC=1C(O[SiH3])C1=CC=CC=C1 LJWBIAMZBJWAOW-UHFFFAOYSA-N 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- 150000008047 benzoylureas Chemical class 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 1
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229950002373 bioresmethrin Drugs 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- IEPBPSSCIZTJIF-UHFFFAOYSA-N bis(2,2,2-trichloroethyl) carbonate Chemical compound ClC(Cl)(Cl)COC(=O)OCC(Cl)(Cl)Cl IEPBPSSCIZTJIF-UHFFFAOYSA-N 0.000 description 1
- UXXXZMDJQLPQPH-UHFFFAOYSA-N bis(2-methylpropyl) carbonate Chemical compound CC(C)COC(=O)OCC(C)C UXXXZMDJQLPQPH-UHFFFAOYSA-N 0.000 description 1
- JKJWYKGYGWOAHT-UHFFFAOYSA-N bis(prop-2-enyl) carbonate Chemical compound C=CCOC(=O)OCC=C JKJWYKGYGWOAHT-UHFFFAOYSA-N 0.000 description 1
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 description 1
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- 229960003369 butacaine Drugs 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- SFNPDDSJBGRXLW-UITAMQMPSA-N butocarboxim Chemical compound CNC(=O)O\N=C(\C)C(C)SC SFNPDDSJBGRXLW-UITAMQMPSA-N 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- MPWIIQYWQOBNKS-UGUYLWEFSA-N callicarpenal Chemical compound C([C@H]([C@]1(C)CC=O)C)C[C@]2(C)[C@@H]1CCC=C2C MPWIIQYWQOBNKS-UGUYLWEFSA-N 0.000 description 1
- MPWIIQYWQOBNKS-UHFFFAOYSA-N callicarpenal Natural products O=CCC1(C)C(C)CCC2(C)C1CCC=C2C MPWIIQYWQOBNKS-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 108010040093 cellulose synthase Proteins 0.000 description 1
- BIWJNBZANLAXMG-YQELWRJZSA-N chloordaan Chemical compound ClC1=C(Cl)[C@@]2(Cl)C3CC(Cl)C(Cl)C3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-YQELWRJZSA-N 0.000 description 1
- XFDJMIHUAHSGKG-UHFFFAOYSA-N chlorethoxyfos Chemical compound CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl XFDJMIHUAHSGKG-UHFFFAOYSA-N 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- 229940089960 chloroacetate Drugs 0.000 description 1
- WBLIXGSTEMXDSM-UHFFFAOYSA-N chloromethane Chemical compound Cl[CH2] WBLIXGSTEMXDSM-UHFFFAOYSA-N 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- HRBKVYFZANMGRE-UHFFFAOYSA-N chlorpyrifos-methyl Chemical group COP(=S)(OC)OC1=NC(Cl)=C(Cl)C=C1Cl HRBKVYFZANMGRE-UHFFFAOYSA-N 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- UOUJSJZBMCDAEU-UHFFFAOYSA-N chromium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Cr+3].[Cr+3] UOUJSJZBMCDAEU-UHFFFAOYSA-N 0.000 description 1
- JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) Chemical compound [Cr+6] JOPOVCBBYLSVDA-UHFFFAOYSA-N 0.000 description 1
- TWLCEYWYILDCDA-UHFFFAOYSA-N chromium(6+) oxygen(2-) pyridine Chemical compound [O-2].[O-2].[O-2].[Cr+6].C1=CC=NC=C1.C1=CC=NC=C1 TWLCEYWYILDCDA-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- UXADOQPNKNTIHB-UHFFFAOYSA-N clofentezine Chemical compound ClC1=CC=CC=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 UXADOQPNKNTIHB-UHFFFAOYSA-N 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- VLXDPFLIRFYIME-BTFPBAQTSA-N copaene Chemical compound C1C=C(C)[C@H]2[C@]3(C)CC[C@@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-BTFPBAQTSA-N 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229940120693 copper naphthenate Drugs 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- SEVNKWFHTNVOLD-UHFFFAOYSA-L copper;3-(4-ethylcyclohexyl)propanoate;3-(3-ethylcyclopentyl)propanoate Chemical compound [Cu+2].CCC1CCC(CCC([O-])=O)C1.CCC1CCC(CCC([O-])=O)CC1 SEVNKWFHTNVOLD-UHFFFAOYSA-L 0.000 description 1
- JOXAXMBQVHFGQT-UHFFFAOYSA-J copper;manganese(2+);n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[Cu+2].[S-]C(=S)NCCNC([S-])=S.[S-]C(=S)NCCNC([S-])=S JOXAXMBQVHFGQT-UHFFFAOYSA-J 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 229960002042 croconazole Drugs 0.000 description 1
- 229910001610 cryolite Inorganic materials 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 description 1
- 125000006841 cyclic skeleton Chemical group 0.000 description 1
- 125000006637 cyclobutyl carbonyl group Chemical group 0.000 description 1
- 125000006640 cycloheptyl carbonyl group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000006641 cyclooctyl carbonyl group Chemical group 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000006638 cyclopentyl carbonyl group Chemical group 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 1
- LSFUGNKKPMBOMG-UHFFFAOYSA-N cycloprothrin Chemical compound ClC1(Cl)CC1(C=1C=CC=CC=1)C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 LSFUGNKKPMBOMG-UHFFFAOYSA-N 0.000 description 1
- APJLTUBHYCOZJI-VZCXRCSSSA-N cyenopyrafen Chemical compound CC1=NN(C)C(\C(OC(=O)C(C)(C)C)=C(/C#N)C=2C=CC(=CC=2)C(C)(C)C)=C1C APJLTUBHYCOZJI-VZCXRCSSSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 description 1
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
- BSBSDQUZDZXGFN-UHFFFAOYSA-N cythioate Chemical compound COP(=S)(OC)OC1=CC=C(S(N)(=O)=O)C=C1 BSBSDQUZDZXGFN-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 229940008203 d-transallethrin Drugs 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- WEBQKRLKWNIYKK-UHFFFAOYSA-N demeton-S-methyl Chemical compound CCSCCSP(=O)(OC)OC WEBQKRLKWNIYKK-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- PIZLBWGMERQCOC-UHFFFAOYSA-N dibenzyl carbonate Chemical compound C=1C=CC=CC=1COC(=O)OCC1=CC=CC=C1 PIZLBWGMERQCOC-UHFFFAOYSA-N 0.000 description 1
- QLVWOKQMDLQXNN-UHFFFAOYSA-N dibutyl carbonate Chemical group CCCCOC(=O)OCCCC QLVWOKQMDLQXNN-UHFFFAOYSA-N 0.000 description 1
- WURGXGVFSMYFCG-UHFFFAOYSA-N dichlofluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=CC=C1 WURGXGVFSMYFCG-UHFFFAOYSA-N 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- 229940120124 dichloroacetate Drugs 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- YEJGPFZQLRMXOI-PKEIRNPWSA-N diclocymet Chemical compound N#CC(C(C)(C)C)C(=O)N[C@H](C)C1=CC=C(Cl)C=C1Cl YEJGPFZQLRMXOI-PKEIRNPWSA-N 0.000 description 1
- 229940004812 dicloran Drugs 0.000 description 1
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-O dicyclohexylazanium Chemical compound C1CCCCC1[NH2+]C1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-O 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001673 diethyltoluamide Drugs 0.000 description 1
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- CJHXCRMKMMBYJQ-UHFFFAOYSA-N dimethirimol Chemical compound CCCCC1=C(C)NC(N(C)C)=NC1=O CJHXCRMKMMBYJQ-UHFFFAOYSA-N 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- DKWOHBPRFZIUQL-UHFFFAOYSA-N dimethyl-methylidene-oxo-$l^{6}-sulfane Chemical compound C[S+](C)([CH2-])=O DKWOHBPRFZIUQL-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- FFHWGQQFANVOHV-UHFFFAOYSA-N dimethyldioxirane Chemical compound CC1(C)OO1 FFHWGQQFANVOHV-UHFFFAOYSA-N 0.000 description 1
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 description 1
- 229950003231 dimpylate Drugs 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 150000004844 dioxiranes Chemical class 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- FPKXBFWMIYHCID-UHFFFAOYSA-N dipymetitrone Chemical compound S1C=2C(=O)N(C)C(=O)C=2SC2=C1C(=O)N(C)C2=O FPKXBFWMIYHCID-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical group CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 description 1
- 108010057988 ecdysone receptor Proteins 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- RDYMFSUJUZBWLH-UHFFFAOYSA-N endosulfan Chemical compound C12COS(=O)OCC2C2(Cl)C(Cl)=C(Cl)C1(Cl)C2(Cl)Cl RDYMFSUJUZBWLH-UHFFFAOYSA-N 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960002125 enilconazole Drugs 0.000 description 1
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 description 1
- 230000000967 entomopathogenic effect Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 230000008686 ergosterol biosynthesis Effects 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- DWRKFAJEBUWTQM-UHFFFAOYSA-N etaconazole Chemical compound O1C(CC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 DWRKFAJEBUWTQM-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HEZNVIYQEUHLNI-UHFFFAOYSA-N ethiofencarb Chemical compound CCSCC1=CC=CC=C1OC(=O)NC HEZNVIYQEUHLNI-UHFFFAOYSA-N 0.000 description 1
- BBXXLROWFHWFQY-UHFFFAOYSA-N ethirimol Chemical compound CCCCC1=C(C)NC(NCC)=NC1=O BBXXLROWFHWFQY-UHFFFAOYSA-N 0.000 description 1
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- IGUYEXXAGBDLLX-UHFFFAOYSA-N ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1C(C(=O)OCC)(C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 IGUYEXXAGBDLLX-UHFFFAOYSA-N 0.000 description 1
- YSPVHAUJXLGZHP-UHFFFAOYSA-N ethyl piperidine-1-carboxylate Chemical compound CCOC(=O)N1CCCCC1 YSPVHAUJXLGZHP-UHFFFAOYSA-N 0.000 description 1
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- DMYHGDXADUDKCQ-UHFFFAOYSA-N fenazaquin Chemical compound C1=CC(C(C)(C)C)=CC=C1CCOC1=NC=NC2=CC=CC=C12 DMYHGDXADUDKCQ-UHFFFAOYSA-N 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 description 1
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 description 1
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 description 1
- NJVOZLGKTAPUTQ-UHFFFAOYSA-M fentin chloride Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 NJVOZLGKTAPUTQ-UHFFFAOYSA-M 0.000 description 1
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 description 1
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 description 1
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- GJEREQYJIQASAW-UHFFFAOYSA-N flufenerim Chemical compound CC(F)C1=NC=NC(NCCC=2C=CC(OC(F)(F)F)=CC=2)=C1Cl GJEREQYJIQASAW-UHFFFAOYSA-N 0.000 description 1
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 description 1
- MBHXIQDIVCJZTD-RVDMUPIBSA-N flufenoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=C(C(F)(F)F)C=C1Cl MBHXIQDIVCJZTD-RVDMUPIBSA-N 0.000 description 1
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 1
- FGIVSGPRGVABAB-UHFFFAOYSA-N fluoren-9-ylmethyl hydrogen carbonate Chemical compound C1=CC=C2C(COC(=O)O)C3=CC=CC=C3C2=C1 FGIVSGPRGVABAB-UHFFFAOYSA-N 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 description 1
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
- RMFNNCGOSPBBAD-MDWZMJQESA-N formetanate Chemical compound CNC(=O)OC1=CC=CC(\N=C\N(C)C)=C1 RMFNNCGOSPBBAD-MDWZMJQESA-N 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 description 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- HAWJXYBZNNRMNO-UHFFFAOYSA-N furathiocarb Chemical compound CCCCOC(=O)N(C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 HAWJXYBZNNRMNO-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 1
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N gamma-hexachlorocyclohexane Natural products ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 description 1
- 125000000232 haloalkynyl group Chemical group 0.000 description 1
- CNKHSLKYRMDDNQ-UHFFFAOYSA-N halofenozide Chemical compound C=1C=CC=CC=1C(=O)N(C(C)(C)C)NC(=O)C1=CC=C(Cl)C=C1 CNKHSLKYRMDDNQ-UHFFFAOYSA-N 0.000 description 1
- 150000005826 halohydrocarbons Chemical class 0.000 description 1
- BKACAEJQMLLGAV-PLNGDYQASA-N heptafluthrin Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1\C=C/C(F)(F)F BKACAEJQMLLGAV-PLNGDYQASA-N 0.000 description 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
- 125000005549 heteroarylene group Chemical group 0.000 description 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- NUKZAGXMHTUAFE-UHFFFAOYSA-N hexanoic acid methyl ester Natural products CCCCCC(=O)OC NUKZAGXMHTUAFE-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- LOBVCQUMXHOALK-UHFFFAOYSA-N hexyl-[hexyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CCCCCC[Si](C)(C)O[Si](C)(C)CCCCCC LOBVCQUMXHOALK-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 description 1
- 229930000073 hydroprene Natural products 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 1
- HICUREFSAIZXFQ-JOWPUVSESA-N i9z29i000j Chemical compound C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\[C@H](OC(=O)C(=N/OC)\C=1C=CC=CC=1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 HICUREFSAIZXFQ-JOWPUVSESA-N 0.000 description 1
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- VPRAQYXPZIFIOH-UHFFFAOYSA-N imiprothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCN1C(=O)N(CC#C)CC1=O VPRAQYXPZIFIOH-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- YFVOXLJXJBQDEF-UHFFFAOYSA-N isocarbophos Chemical compound COP(N)(=S)OC1=CC=CC=C1C(=O)OC(C)C YFVOXLJXJBQDEF-UHFFFAOYSA-N 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- 125000005969 isothiazolinyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 description 1
- UGWALRUNBSBTGI-ZKMZRDRYSA-N kadethrin Chemical compound C(/[C@@H]1C([C@@H]1C(=O)OCC=1C=C(CC=2C=CC=CC=2)OC=1)(C)C)=C1/CCSC1=O UGWALRUNBSBTGI-ZKMZRDRYSA-N 0.000 description 1
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 1
- 239000005910 lambda-Cyhalothrin Substances 0.000 description 1
- 102000035110 latrophilin Human genes 0.000 description 1
- 108091005543 latrophilin Proteins 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229960002809 lindane Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- 150000002697 manganese compounds Chemical class 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 description 1
- CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- 229930002897 methoprene Natural products 0.000 description 1
- 229950003442 methoprene Drugs 0.000 description 1
- TUDYPXFSYJRWDP-UHFFFAOYSA-N methoxy methyl carbonate Chemical compound COOC(=O)OC TUDYPXFSYJRWDP-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- GHDIHPNJQVDFBL-UHFFFAOYSA-N methoxycyclohexane Chemical compound COC1CCCCC1 GHDIHPNJQVDFBL-UHFFFAOYSA-N 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- VNKYTQGIUYNRMY-UHFFFAOYSA-N methoxypropane Chemical compound CCCOC VNKYTQGIUYNRMY-UHFFFAOYSA-N 0.000 description 1
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
- JWAQOELZUOSPMI-UHFFFAOYSA-N methyl 1-(2,2-dimethyl-1,3-dihydroinden-1-yl)imidazole-2-carboxylate Chemical compound COC(=O)C1=NC=CN1C1C(C)(C)CC2=CC=CC=C21 JWAQOELZUOSPMI-UHFFFAOYSA-N 0.000 description 1
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 description 1
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 1
- XMSZANIMCDLNKA-UHFFFAOYSA-N methyl hypofluorite Chemical compound COF XMSZANIMCDLNKA-UHFFFAOYSA-N 0.000 description 1
- WFJRIDQGVSJLLH-UHFFFAOYSA-N methyl n-aminocarbamate Chemical compound COC(=O)NN WFJRIDQGVSJLLH-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 229920000257 metiram Polymers 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 description 1
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 description 1
- 108091040857 miR-604 stem-loop Proteins 0.000 description 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 125000006682 monohaloalkyl group Chemical group 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- PAGDTTPJSICKIZ-UHFFFAOYSA-N n'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethylphenyl]-n-ethyl-n-methylmethanimidamide Chemical compound C1=C(C)C(N=CN(C)CC)=CC(C)=C1OC1=NC(CC=2C=CC(Cl)=CC=2)=NS1 PAGDTTPJSICKIZ-UHFFFAOYSA-N 0.000 description 1
- OYFWLCJAPSAGCG-UHFFFAOYSA-N n'-methylhexane-1,6-diamine Chemical compound CNCCCCCCN OYFWLCJAPSAGCG-UHFFFAOYSA-N 0.000 description 1
- TUCSJFNYZJYLHE-UHFFFAOYSA-N n'-tert-butyl-n'-(3,5-dimethylbenzoyl)-2,7-dimethyl-2,3-dihydro-1-benzofuran-6-carbohydrazide Chemical compound CC1=C2OC(C)CC2=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 TUCSJFNYZJYLHE-UHFFFAOYSA-N 0.000 description 1
- JDEJGVSZUIJWBM-UHFFFAOYSA-N n,n,2-trimethylaniline Chemical compound CN(C)C1=CC=CC=C1C JDEJGVSZUIJWBM-UHFFFAOYSA-N 0.000 description 1
- DLMICMXXVVMDNV-UHFFFAOYSA-N n,n-di(propan-2-yl)propan-1-amine Chemical compound CCCN(C(C)C)C(C)C DLMICMXXVVMDNV-UHFFFAOYSA-N 0.000 description 1
- MXHTZQSKTCCMFG-UHFFFAOYSA-N n,n-dibenzyl-1-phenylmethanamine Chemical compound C=1C=CC=CC=1CN(CC=1C=CC=CC=1)CC1=CC=CC=C1 MXHTZQSKTCCMFG-UHFFFAOYSA-N 0.000 description 1
- NZMAJUHVSZBJHL-UHFFFAOYSA-N n,n-dibutylformamide Chemical compound CCCCN(C=O)CCCC NZMAJUHVSZBJHL-UHFFFAOYSA-N 0.000 description 1
- FRQONEWDWWHIPM-UHFFFAOYSA-N n,n-dicyclohexylcyclohexanamine Chemical compound C1CCCCC1N(C1CCCCC1)C1CCCCC1 FRQONEWDWWHIPM-UHFFFAOYSA-N 0.000 description 1
- KUYQDJOFVBGZID-UHFFFAOYSA-N n,n-diethyl-2-methylbenzamide Chemical compound CCN(CC)C(=O)C1=CC=CC=C1C KUYQDJOFVBGZID-UHFFFAOYSA-N 0.000 description 1
- UXDAWVUDZLBBAM-UHFFFAOYSA-N n,n-diethylbenzeneacetamide Chemical compound CCN(CC)C(=O)CC1=CC=CC=C1 UXDAWVUDZLBBAM-UHFFFAOYSA-N 0.000 description 1
- ULWOJODHECIZAU-UHFFFAOYSA-N n,n-diethylpropan-2-amine Chemical compound CCN(CC)C(C)C ULWOJODHECIZAU-UHFFFAOYSA-N 0.000 description 1
- DIAIBWNEUYXDNL-UHFFFAOYSA-N n,n-dihexylhexan-1-amine Chemical compound CCCCCCN(CCCCCC)CCCCCC DIAIBWNEUYXDNL-UHFFFAOYSA-N 0.000 description 1
- OOHAUGDGCWURIT-UHFFFAOYSA-N n,n-dipentylpentan-1-amine Chemical compound CCCCCN(CCCCC)CCCCC OOHAUGDGCWURIT-UHFFFAOYSA-N 0.000 description 1
- MEWYBGBLQURRNP-UHFFFAOYSA-N n-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide Chemical compound C1C(C)(C)CC(CC)(C)CC1NC(=O)C1=CC=CC(NC=O)=C1O MEWYBGBLQURRNP-UHFFFAOYSA-N 0.000 description 1
- GCIZLUZYQSYVSS-UHFFFAOYSA-N n-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide Chemical compound ClC1=CC=NC(Cl)=C1C(=O)NCC1=NC=C(Br)C=C1Cl GCIZLUZYQSYVSS-UHFFFAOYSA-N 0.000 description 1
- REAVUPQUTRQOII-UHFFFAOYSA-N n-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(CC(NC=2SCCN=2)C=2C(=C(C)C=CC=2)C)=C1 REAVUPQUTRQOII-UHFFFAOYSA-N 0.000 description 1
- RRRNUBCOWJALGN-UHFFFAOYSA-N n-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3-carboxamide Chemical compound N=1C=C(Br)C=C(Cl)C=1C(C)NC(=O)C1=C(Cl)C=CN=C1Cl RRRNUBCOWJALGN-UHFFFAOYSA-N 0.000 description 1
- RIBOWIWISRYMOV-UHFFFAOYSA-N n-[2-(1h-imidazol-2-yl)ethyl]-3-[[[3-[2-(1h-imidazol-2-yl)ethylcarbamoyl]phenyl]-bis(4-methoxyphenyl)methoxy]-bis(4-methoxyphenyl)methyl]benzamide Chemical compound C1=CC(OC)=CC=C1C(C=1C=C(C=CC=1)C(=O)NCCC=1NC=CN=1)(C=1C=CC(OC)=CC=1)OC(C=1C=C(C=CC=1)C(=O)NCCC=1NC=CN=1)(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 RIBOWIWISRYMOV-UHFFFAOYSA-N 0.000 description 1
- YNKFZRGTXAPYFD-UHFFFAOYSA-N n-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
- 229960004313 naftifine Drugs 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910000480 nickel oxide Inorganic materials 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- OGCWVIVNTBZPBW-BHRXDNSCSA-N nicotinic acid mononucleotide Chemical compound O1[C@H](COP(O)([O-])=O)[C@@H](O)[C@@H](O)[C@@H]1[N+]1=CC=CC(C(O)=O)C1 OGCWVIVNTBZPBW-BHRXDNSCSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 101150038594 nodC gene Proteins 0.000 description 1
- UNCVXXVJJXJZII-UHFFFAOYSA-N nodulisporic acid A Natural products C1CC2C(C)(C=CC=C(C)C(O)=O)C(O)CCC2(C)C2(C)C1CC1=C2N2C(C(=C)C)C(=O)C3=C(C(O)C4C(OC(C)(C)C=C44)(C)C)C4=CC1=C32 UNCVXXVJJXJZII-UHFFFAOYSA-N 0.000 description 1
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- YTYGAJLZOJPJGH-UHFFFAOYSA-N noviflumuron Chemical compound FC1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F YTYGAJLZOJPJGH-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003865 nucleic acid synthesis inhibitor Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- JHIPUJPTQJYEQK-ZLHHXESBSA-N orysastrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C(=N\OC)\C(\C)=N\OC JHIPUJPTQJYEQK-ZLHHXESBSA-N 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- 125000005961 oxazepanyl group Chemical group 0.000 description 1
- 125000003551 oxepanyl group Chemical group 0.000 description 1
- 125000003585 oxepinyl group Chemical group 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- HBEQXAKJSGXAIQ-UHFFFAOYSA-N oxopalladium Chemical compound [Pd]=O HBEQXAKJSGXAIQ-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 description 1
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 description 1
- PMCVMORKVPSKHZ-UHFFFAOYSA-N oxydemeton-methyl Chemical compound CCS(=O)CCSP(=O)(OC)OC PMCVMORKVPSKHZ-UHFFFAOYSA-N 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 229910003445 palladium oxide Inorganic materials 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 description 1
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 description 1
- BNIXVQGCZULYKV-UHFFFAOYSA-N pentachloroethane Chemical compound ClC(Cl)C(Cl)(Cl)Cl BNIXVQGCZULYKV-UHFFFAOYSA-N 0.000 description 1
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 238000005897 peptide coupling reaction Methods 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- DLRJIFUOBPOJNS-UHFFFAOYSA-N phenetole Chemical compound CCOC1=CC=CC=C1 DLRJIFUOBPOJNS-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- NIXKBAZVOQAHGC-UHFFFAOYSA-N phenylmethanesulfonic acid Chemical compound OS(=O)(=O)CC1=CC=CC=C1 NIXKBAZVOQAHGC-UHFFFAOYSA-N 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- HOKBIQDJCNTWST-UHFFFAOYSA-N phosphanylidenezinc;zinc Chemical compound [Zn].[Zn]=P.[Zn]=P HOKBIQDJCNTWST-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000000885 phytotoxic effect Effects 0.000 description 1
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- CBLGQEBXWDKYDI-UHFFFAOYSA-N piperazine-1,4-dicarbaldehyde Chemical compound O=CN1CCN(C=O)CC1 CBLGQEBXWDKYDI-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 1
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 125000006684 polyhaloalkyl group Polymers 0.000 description 1
- JPFWJDMDPLEUBD-ITJAGOAWSA-N polyoxorim Polymers O[C@@H]1[C@H](O)[C@@H]([C@H](NC(=O)[C@H]([C@H](O)[C@@H](O)COC(N)=O)N)C(O)=O)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 JPFWJDMDPLEUBD-ITJAGOAWSA-N 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- SMKRKQBMYOFFMU-UHFFFAOYSA-N prallethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC1C(C)=C(CC#C)C(=O)C1 SMKRKQBMYOFFMU-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- WTFXJFJYEJZMFO-UHFFFAOYSA-N propamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCOC1=CC=C(C(N)=N)C=C1 WTFXJFJYEJZMFO-UHFFFAOYSA-N 0.000 description 1
- 229960003761 propamidine Drugs 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 description 1
- YRRBXJLFCBCKNW-UHFFFAOYSA-N prothiocarb Chemical compound CCSC(=O)NCCCN(C)C YRRBXJLFCBCKNW-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- DZVWKNFPXMUIFA-UHFFFAOYSA-N pyflubumide Chemical compound C1=C(CC(C)C)C(C(OC)(C(F)(F)F)C(F)(F)F)=CC=C1N(C(=O)C(C)C)C(=O)C1=C(C)N(C)N=C1C DZVWKNFPXMUIFA-UHFFFAOYSA-N 0.000 description 1
- QHMTXANCGGJZRX-WUXMJOGZSA-N pymetrozine Chemical compound C1C(C)=NNC(=O)N1\N=C\C1=CC=CN=C1 QHMTXANCGGJZRX-WUXMJOGZSA-N 0.000 description 1
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- DDIQWGKUSJOETH-UHFFFAOYSA-N pyrafluprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SCF)=C1NCC1=CN=CC=N1 DDIQWGKUSJOETH-UHFFFAOYSA-N 0.000 description 1
- DWTVBEZBWMDXIY-UHFFFAOYSA-N pyrametostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=C(C)C(C=2C=CC=CC=2)=NN1C DWTVBEZBWMDXIY-UHFFFAOYSA-N 0.000 description 1
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- 229940070846 pyrethrins Drugs 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 description 1
- VTRWMTJQBQJKQH-UHFFFAOYSA-N pyributicarb Chemical compound COC1=CC=CC(N(C)C(=S)OC=2C=C(C=CC=2)C(C)(C)C)=N1 VTRWMTJQBQJKQH-UHFFFAOYSA-N 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 description 1
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- NPRDHMWYZHSAHR-UHFFFAOYSA-N pyridine;trioxochromium Chemical compound O=[Cr](=O)=O.C1=CC=NC=C1.C1=CC=NC=C1 NPRDHMWYZHSAHR-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- YYXSCUSVVALMNW-FOWTUZBSSA-N pyriminostrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(NC=2C(=CC(Cl)=CC=2)Cl)=N1 YYXSCUSVVALMNW-FOWTUZBSSA-N 0.000 description 1
- BAUQXSYUDSNRHL-UHFFFAOYSA-N pyrimorph Chemical compound C1=CC(C(C)(C)C)=CC=C1C(C=1C=NC(Cl)=CC=1)=CC(=O)N1CCOCC1 BAUQXSYUDSNRHL-UHFFFAOYSA-N 0.000 description 1
- NMVCBWZLCXANER-UHFFFAOYSA-N pyriofenone Chemical compound COC1=C(OC)C(OC)=CC(C)=C1C(=O)C1=C(C)C(Cl)=CN=C1OC NMVCBWZLCXANER-UHFFFAOYSA-N 0.000 description 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- QBERHIJABFXGRZ-UHFFFAOYSA-M rhodium;triphenylphosphane;chloride Chemical compound [Cl-].[Rh].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QBERHIJABFXGRZ-UHFFFAOYSA-M 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-HBGVWJBISA-N rotenone Chemical compound O([C@H](CC1=C2O3)C(C)=C)C1=CC=C2C(=O)[C@@H]1[C@H]3COC2=C1C=C(OC)C(OC)=C2 JUVIOZPCNVVQFO-HBGVWJBISA-N 0.000 description 1
- 229910001927 ruthenium tetroxide Inorganic materials 0.000 description 1
- MSHXTAQSSIEBQS-UHFFFAOYSA-N s-[3-carbamoylsulfanyl-2-(dimethylamino)propyl] carbamothioate;hydron;chloride Chemical compound [Cl-].NC(=O)SCC([NH+](C)C)CSC(N)=O MSHXTAQSSIEBQS-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000007330 shade avoidance Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 description 1
- KPRKMFZNFLCZML-UHFFFAOYSA-N silyloxymethoxymethoxysilane Chemical compound [SiH3]OCOCO[SiH3] KPRKMFZNFLCZML-UHFFFAOYSA-N 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000003195 sodium channel blocking agent Substances 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229930185156 spinosyn Natural products 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical compound CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 description 1
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 239000005936 tau-Fluvalinate Substances 0.000 description 1
- INISTDXBRIBGOC-XMMISQBUSA-N tau-fluvalinate Chemical compound N([C@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-XMMISQBUSA-N 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- AWYOMXWDGWUJHS-UHFFFAOYSA-N tebupirimfos Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1 AWYOMXWDGWUJHS-UHFFFAOYSA-N 0.000 description 1
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 description 1
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- XKXIQBVKMABYQJ-UHFFFAOYSA-M tert-butyl carbonate Chemical compound CC(C)(C)OC([O-])=O XKXIQBVKMABYQJ-UHFFFAOYSA-M 0.000 description 1
- URHWNXDZOULUHC-UHFFFAOYSA-N tert-butyl n-[6-[[[(1-methyltetrazol-5-yl)-phenylmethylidene]amino]oxymethyl]pyridin-2-yl]carbamate Chemical compound CN1N=NN=C1C(C=1C=CC=CC=1)=NOCC1=CC=CC(NC(=O)OC(C)(C)C)=N1 URHWNXDZOULUHC-UHFFFAOYSA-N 0.000 description 1
- BIQRTOBZAQMMOX-UHFFFAOYSA-N tert-butyl-(tert-butyl-methoxy-phenylsilyl)oxy-methoxy-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C(C)(C)C)(OC)O[Si](OC)(C(C)(C)C)C1=CC=CC=C1 BIQRTOBZAQMMOX-UHFFFAOYSA-N 0.000 description 1
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 1
- KJTULOVPMGUBJS-UHFFFAOYSA-N tert-butyl-[tert-butyl(diphenyl)silyl]oxy-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 KJTULOVPMGUBJS-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- OUSBBXGWDSZAHN-UHFFFAOYSA-N tetradec-3-en-2-one Chemical compound CCCCCCCCCCC=CC(C)=O OUSBBXGWDSZAHN-UHFFFAOYSA-N 0.000 description 1
- MLGCXEBRWGEOQX-UHFFFAOYSA-N tetradifon Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC(Cl)=C(Cl)C=C1Cl MLGCXEBRWGEOQX-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- BUGOPWGPQGYYGR-UHFFFAOYSA-N thiane 1,1-dioxide Chemical compound O=S1(=O)CCCCC1 BUGOPWGPQGYYGR-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000005302 thiazolylmethyl group Chemical group [H]C1=C([H])N=C(S1)C([H])([H])* 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 description 1
- 125000003777 thiepinyl group Chemical group 0.000 description 1
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 description 1
- DNVLJEWNNDHELH-UHFFFAOYSA-N thiocyclam Chemical compound CN(C)C1CSSSC1 DNVLJEWNNDHELH-UHFFFAOYSA-N 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- OPASCBHCTNRLRM-UHFFFAOYSA-N thiometon Chemical compound CCSCCSP(=S)(OC)OC OPASCBHCTNRLRM-UHFFFAOYSA-N 0.000 description 1
- 125000005505 thiomorpholino group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 1
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 1
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 1
- HYVWIQDYBVKITD-UHFFFAOYSA-N tolylfluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=C(C)C=C1 HYVWIQDYBVKITD-UHFFFAOYSA-N 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- DDVNRFNDOPPVQJ-HQJQHLMTSA-N transfluthrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=CC(F)=C1F DDVNRFNDOPPVQJ-HQJQHLMTSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- LGSAOJLQTXCYHF-UHFFFAOYSA-N tri(propan-2-yl)-tri(propan-2-yl)silyloxysilane Chemical compound CC(C)[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)C(C)C LGSAOJLQTXCYHF-UHFFFAOYSA-N 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- 229940066528 trichloroacetate Drugs 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- WILBTFWIBAOWLN-UHFFFAOYSA-N triethyl(triethylsilyloxy)silane Chemical compound CC[Si](CC)(CC)O[Si](CC)(CC)CC WILBTFWIBAOWLN-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 1
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 description 1
- FKPIQXKEFGLMNA-UHFFFAOYSA-N trimethyl-[2-(2-trimethylsilylethoxy)ethyl]silane Chemical compound C[Si](C)(C)CCOCC[Si](C)(C)C FKPIQXKEFGLMNA-UHFFFAOYSA-N 0.000 description 1
- QWEJGTIVESCYNM-UHFFFAOYSA-N trimethyl-[2-(2-trimethylsilylethoxymethoxymethoxy)ethyl]silane Chemical compound C[Si](C)(C)CCOCOCOCC[Si](C)(C)C QWEJGTIVESCYNM-UHFFFAOYSA-N 0.000 description 1
- DOMWIMKGCFOHBG-UHFFFAOYSA-N trimethyl-[2-[1-[1-(2-trimethylsilylethoxy)ethoxy]ethoxy]ethyl]silane Chemical compound C[Si](C)(C)CCOC(C)OC(C)OCC[Si](C)(C)C DOMWIMKGCFOHBG-UHFFFAOYSA-N 0.000 description 1
- IVZTVZJLMIHPEY-UHFFFAOYSA-N triphenyl(triphenylsilyloxy)silane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)O[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 IVZTVZJLMIHPEY-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- YNWVFADWVLCOPU-MAUPQMMJSA-N uniconazole P Chemical compound C1=NC=NN1/C([C@@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MAUPQMMJSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- JARYYMUOCXVXNK-CSLFJTBJSA-N validamycin A Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-CSLFJTBJSA-N 0.000 description 1
- DBXFMOWZRXXBRN-LWKPJOBUSA-N valifenalate Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(CC(=O)OC)C1=CC=C(Cl)C=C1 DBXFMOWZRXXBRN-LWKPJOBUSA-N 0.000 description 1
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 description 1
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 1
- 229960004740 voriconazole Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 1
- 239000005943 zeta-Cypermethrin Substances 0.000 description 1
- 229940048462 zinc phosphide Drugs 0.000 description 1
- AMHNZOICSMBGDH-UHFFFAOYSA-L zineb Chemical compound [Zn+2].[S-]C(=S)NCCNC([S-])=S AMHNZOICSMBGDH-UHFFFAOYSA-L 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 description 1
- PQHXFGUTAAIHOC-XZZSYSLUSA-N α-(methoxyimino)-n-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1\C=N\OC(C)C1=CC=CC(C(F)(F)F)=C1 PQHXFGUTAAIHOC-XZZSYSLUSA-N 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/60—1,4-Diazines; Hydrogenated 1,4-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/713—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
The invention relates to, inter alia, halogen-substituted compounds of the general formula (I) in which the groups A1-A4, T, n, W, Q, R1, and Z1-Z3 have the meanings specified in the description. The invention further relates to methods for producing the compounds of the formula (I) and to possible intermediates for producing said compounds. The compounds according to the invention are suitable in particular for combating insects, arachnids, and nematodes in the field of agriculture and for combating ectoparasites in the field of veterinary medicine.
Description
Halogen-substituted pyrazol derivatives as pest-control agents The present application relates to novel halogen-substituted compounds, to processes for their preparation and to their use for controlling animal pests, in particular arthropods and especially insects, arachnids and nematodes.
It is known that certain halogen-substituted compounds have herbicidal action (cf. J. Org. Chem. 1997, 62(17), 5908-5919, J. Heterocycl. Chem. 1998, 35(6), 1493-1499, , , US 2006/069132, ).
Furthermore, it is known that certain halogen-substituted compounds have insecticidal action (EP 1 911 751, WO2012/069366, WO2012/080376 & WO2012/107434).
In addition, it is known that certain halogen-substituted compounds have cytokine-inhibitory activities Modern crop protection compositions have to meet many demands, for example in relation to efficacy, persistence and spectrum of their action and possible use. Questions of toxicity, the combinability with other active compounds or formulation auxiliaries play a role, as well as the question of the expense that the synthesis of an active compound requires. Furthermore, resistances may occur. For all these reasons, the search for novel crop protection agents can never be considered as having been concluded, and there is a constant need for novel compounds having properties which, compared to the known compounds, are improved at least in respect of individual aspects.
It was an object of the present invention to provide compounds which widen the spectrum of the pesticides under various aspects and/or improve their activity.
Surprisingly, it has now been found that certain halogen-substituted compounds and their N-oxides and salts have biological properties and are particularly suitable for controlling animal pests, and can therefore be employed particularly well in the agrochemical field and in the animal health sector.
Similar compounds are already known from .
The halogen-substituted compounds according to the invention are defined by the general formula (I) in which R represents hydrogen, optionally substituted C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C - 1 6 3 6 3 6 3 7 cycloalkyl, C -C -alkylcarbonyl, C -C -alkoxycarbonyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )- 1 6 1 6 1 3 1 3 alkyl, or alternatively R represents hydrogen, optionally substituted C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C - 1 6 2 6 3 6 3 7 cycloalkyl, C -C -alkylcarbonyl, C -C -alkoxycarbonyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )- 1 6 1 6 1 3 1 3 alkyl, the chemical groupings A represents CR or nitrogen, A represents CR or nitrogen, A represents CR or nitrogen and A represents CR or nitrogen, but where not more than three of the chemical groupings A to A simultaneously represent nitrogen; 2 3 4 5 R , R , R and R independently of one another represent hydrogen, halogen, cyano, nitro, optionally substituted C -C -alkyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C -C -alkyl, C - 1 6 3 6 1 6 1 6 1 3 1 C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N-C -C -alkylamino or N,N-di-C - 6 1 6 1 6 1 6 1 C -alkylamino; if none of the groupings A and A represents nitrogen, R and R together with the carbon atom to which they are attached may form a 5- or 6-membered ring which contains 0, 1 or 2 nitrogen atoms and/or 0 or 1 oxygen atom and/or 0 or 1 sulphur atom, or if none of the groupings A and A represents nitrogen, R and R together with the carbon atom to which they are attached may form a 6-membered ring which contains 0, 1 or 2 nitrogen atoms; W represents oxygen or sulphur; Q represents hydrogen, formyl, hydroxy, amino or one of the optionally substituted groupings alkyl, alkyloxy, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkylalkyl, arylalkyl, heteroarylalkyl or represents a grouping N-alkylamino, N-alkylcarbonylamino, N,N- dialkylamino; or Q represents an unsaturated 6-membered carbocycle which is optionally mono- or polysubstituted by V or an unsaturated 5- or 6-membered heterocyclic ring which is optionally mono- or polysubstituted by V, or alternatively Q represents an unsaturated 6-membered carbocycle which is optionally polysubstituted by V or an unsaturated 5- or 6-membered heterocyclic ring which is optionally polysubstituted by V, where in both cases V represents halogen, cyano, nitro, optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy, N-alkoxyiminoalkyl, alkylsulphanyl, alkylsulphinyl, alkylsulphonyl, N,N-dialkylamino, T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, 6 N 6 6 (R ) (R ) (R ) n (R ) T1 T2 T3 T4 (R ) (R ) (R ) n T5 T6 T7 where R independently of one another represent halogen, cyano, nitro, amino or optionally substituted C - C -alkyl, C -C -alkyloxy, C -C -alkylcarbonyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C - 6 1 6 1 6 1 6 1 6 1 C -alkylsulphonyl, and n represents the values 0-2; Z represents optionally substituted alkyl and cycloalkyl, and Z represents hydrogen, halogen, cyano, nitro, amino or optionally substituted alkyl, alkylcarbonyl, alkylsulphanyl, alkylsulphinyl, alkylsulphonyl, and Z represents hydrogen or optionally substituted alkyl, cycloalkyl, alkenyl, alkynyl, aryl or hetaryl.
Preference is given to compounds of the formula (I) in which R represents hydrogen, optionally substituted C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C - 1 6 3 6 3 6 3 7 cycloalkyl, C -C -alkylcarbonyl, C -C -alkoxycarbonyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )- 1 6 1 6 1 3 1 3 alkyl, or alternatively R represents hydrogen, optionally substituted C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C - 1 6 2 6 2 6 3 7 cycloalkyl, C -C -alkylcarbonyl, C -C -alkoxycarbonyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )- 1 6 1 6 1 3 1 3 alkyl, the chemical groupings A represents CR or nitrogen, A represents CR or nitrogen, A represents CR or nitrogen and A represents CR or nitrogen, but where not more than three of the chemical groupings A to A simultaneously represent nitrogen; 2 3 4 5 R , R , R and R independently of one another represent hydrogen, halogen, cyano, nitro, optionally substituted C -C -alkyl, C -C -cycloalkyl, C -C -alkoxy, N-alkoxyiminoalkyl, C -C - 1 6 3 6 1 6 1 6 alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N-C -C -alkylamino, N,N-di-C - 1 6 1 6 1 6 1 C alkylamino; if none of the groupings A and A represents nitrogen, R and R together with the carbon atom to which they are attached may form a 5- or 6-membered ring which contains 0, 1 or 2 nitrogen atoms and/or 0 or 1 oxygen atom and/or 0 or 1 sulphur atom, or if none of the groupings A and A represents nitrogen, R and R together with the carbon atom to which they are attached may form a 6-membered ring which contains 0, 1 or 2 nitrogen atoms; W represents oxygen or sulphur; Q represents hydrogen, formyl, hydroxy, amino or one of the optionally substituted groupings C -C - alkyl, C -C -alkenyl, C -C -alkynyl, C -C -cycloalkyl, C -C -heterocycloalkyl, C -C -alkoxy, C - 3 6 3 6 3 6 2 5 1 4 1 C -alkyl-C -C -cycloalkyl, C -C -cycloalkyl-C -C -alkyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )- 6 3 6 3 6 1 6 1 3 1 3 alkyl or represents a grouping N-C -C -alkylamino, N-C -C -alkylcarbonylamino, N,N-di-C -C - 1 4 1 4 1 4 alkylamino; or alternatively Q represents hydrogen, formyl, hydroxy, amino or one of the optionally substituted groupings C -C - alkyl, C -C -alkenyl, C -C -alkynyl, C -C -cycloalkyl, C -C -heterocycloalkyl, C -C -alkoxy, C - 2 6 2 6 3 6 2 5 1 4 1 C -alkyl-C -C -cycloalkyl, C -C -cycloalkyl-C -C -alkyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )- 6 3 6 3 6 1 6 1 3 1 3 alkyl or represents a grouping N-C -C -alkylamino, N-C -C -alkylcarbonylamino, N,N-di-C -C - 1 4 1 4 1 4 alkylamino; or Q represents an unsaturated 6-membered carbocycle which is optionally mono- or polysubstituted by V or an unsaturated 5- or 6-membered heterocyclic ring which is optionally mono- or polysubstituted by V, or alternatively Q represents an unsaturated 6-membered carbocycle which is optionally polysubstituted by V or an unsaturated 5- or 6-membered heterocyclic ring which is optionally polysubstituted by V, where in both cases V independently of one another represent halogen, cyano, nitro, optionally substituted C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C -C - 2 4 2 4 3 6 1 6 1 6 1 3 alkyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N,N-di-(C -C - 1 6 1 6 1 6 1 6 alkyl)amino; T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) (R ) T1 T2 T3 T4 6 (R ) (R ) (R ) n T5 T6 T7 where R independently of one another represent halogen, cyano, nitro, amino or optionally halogen- substituted C -C -alkyl, C -C -alkyloxy, C -C -alkylcarbonyl, C -C -alkylsulphanyl, C -C - 1 6 1 6 1 6 1 6 1 6 alkylsulphinyl, C -C -alkylsulphonyl, and n represents the values 0-1; Z represents optionally substituted C -C -haloalkyl or C -C -cycloalkyl, C -C -halocycloalkyl, and 1 6 3 6 3 6 Z represents hydrogen, halogen, cyano, nitro, amino or optionally substituted C -C -alkyl, C -C - 1 6 1 6 alkylcarbonyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, and 1 6 1 6 1 6 Z represents hydrogen or optionally substituted alkyl, cycloalkyl, alkenyl, alkynyl, aryl or hetaryl.
Preference is furthermore given to compounds of the formula (I) in which R represents hydrogen or represents C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C -cycloalkyl, 1 6 3 6 3 6 3 7 C -C -cycloalkyl-C -C -alkyl, C -C -alkylcarbonyl, C -C -alkoxycarbonyl, aryl-(C -C )-alkyl, 3 7 1 3 1 6 1 6 1 3 heteroaryl-(C -C )-alkyl which are optionally mono- or polysubstituted independently of one another by halogen, cyano, alkoxy and alkoxycarbonyl, the chemical groupings A represents CR or nitrogen, A represents CR or nitrogen, A represents CR or nitrogen and A represents CR or nitrogen, but where not more than three of the chemical groupings A to A simultaneously represent nitrogen; 2 3 4 5 R , R , R and R independently of one another represent hydrogen, halogen, cyano, nitro, optionally substituted C -C -alkyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C -C -alkyl, C - 1 6 3 6 1 6 1 6 1 3 1 C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N-C -C -alkylamino or N,N-di-C - 6 1 6 1 6 1 6 1 C -alkylamino; W represents oxygen or sulphur; Q represents hydrogen, hydroxy, formyl or one of the groupings C -C -alkyl, C -C -alkenyl, C -C - 1 6 3 6 3 6 alkynyl, C -C -cycloalkyl, C -C -heterocycloalkyl, C -C -alkoxy, C -C -alkyl-C -C -cycloalkyl, 3 6 2 5 1 4 1 6 3 6 C -C -cycloalkyl-C -C -alkyl, C -C -hydroxyalkyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )-alkyl, 3 6 1 6 1 6 1 3 1 3 N-C -C -alkylamino, N-C -C -alkylcarbonylamino or N,N-di-C -C -alkylamino which are 1 4 1 4 1 4 optionally mono- or polysubstituted independently of one another by hydroxy, nitro, amino, halogen, alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl; or Q represents aryl substituted by 0 – 4 substituents V or a 5- or 6-membered heteroaromatic substituted by 0 – 4 substituents V, where V independently of one another represent halogen, cyano, nitro, optionally substituted C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C -C - 2 4 2 4 3 6 1 6 1 6 1 3 alkyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N,N-di-(C -C - 1 6 1 6 1 6 1 6 alkyl)amino; T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) (R ) T1 T2 T3 T4 6 (R ) (R ) (R ) n T5 T6 T7 where R independently of one another represent halogen, cyano, nitro, amino or optionally mono- or polyhalogen-substituted C -C -alkyl, C -C -alkyloxy, C -C -alkylcarbonyl, C -C -alkylsulphanyl, 1 6 1 6 1 6 1 6 C -C -alkylsulphinyl, C -C -alkylsulphonyl, and 1 6 1 6 n represents the values 0-1; Z represents optionally substituted C -C -haloalkyl, C -C -cycloalkyl, C -C -halocycloalkyl, and 1 6 3 6 3 6 Z represents hydrogen, halogen, cyano, nitro, amino or optionally mono- or polysubstituted C -C - alkyl, C -C -alkylcarbonyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, and 1 6 1 6 1 6 1 6 Z represents hydrogen or optionally substituted C -C -alkyl, C -C -cycloalkyl, C -C -alkenyl, C -C - 1 6 3 6 2 4 2 4 alkynyl, aryl or hetaryl.
Particular preference is given to compounds of the formula (I) in which R represents hydrogen or represents C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C -cycloalkyl, 1 6 3 6 3 6 3 7 C -C -cycloalkyl-C -C -alkyl, C -C -alkylcarbonyl, C -C -alkoxycarbonyl, aryl-(C -C )-alkyl, 3 7 1 3 1 6 1 6 1 3 heteroaryl-(C -C )-alkyl which are optionally mono- to pentasubstituted independently of one another by halogen, cyano, alkoxy and alkoxycarbonyl, the chemical groupings A represents CR or nitrogen, A represents CR or nitrogen, A represents CR or nitrogen and A represents CR or nitrogen, but where not more than three of the chemical groupings A to A simultaneously represent nitrogen; 2 3 4 5 R , R , R and R independently of one another represent hydrogen, halogen, cyano, nitro, or represent C -C -alkyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C -C -alkyl, C -C - 1 6 3 6 1 6 1 6 1 3 1 6 alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N-C -C -alkylamino or N,N-di-C -C - 1 6 1 6 1 6 1 6 alkylamino which are optionally mono- to pentasubstituted independently of one another by hydroxy, nitro, amino, halogen, alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl; W represents oxygen or sulphur; Q represents hydrogen, hydroxy, formyl or one of the groupings C -C -alkyl, C -C -alkenyl, C -C - 1 6 3 6 3 6 alkynyl, C -C -cycloalkyl, C -C -heterocycloalkyl, C -C -alkoxy, C -C -alkyl-C -C -cycloalkyl, 3 6 2 5 1 4 1 6 3 6 C -C -cycloalkyl-C -C -alkyl, C -C -hydroxyalkyl, aryl-(C -C )-alkyl, heteroaryl-(C -C )-alkyl, 3 6 1 6 1 6 1 3 1 3 N-C -C -alkylamino, N-C -C -alkylcarbonylamino or N,N-di-C -C -alkylamino which are 1 4 1 4 1 4 optionally mono- to pentasubstituted independently of one another by hydroxy, nitro, amino, halogen, alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl; or Q represents aryl substituted by 0 – 4 substituents V or a 5- or 6-membered heteroaromatic substituted by 0 – 4 substituents V, where V independently of one another represents halogen, cyano, nitro, or represents C -C -alkyl, C -C - 1 6 2 4 alkenyl, C -C -alkynyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C -C -alkyl, C - 2 4 3 6 1 6 1 6 1 3 1 C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N,N-di-(C -C -alkyl)amino 6 1 6 1 6 1 6 optionally independently of one another mono- to pentasubstituted by hydroxy, nitro, amino, halogen, alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl; T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) (R ) T1 T2 T3 T4 6 (R ) (R ) (R ) n * * T5 T6 T7 where R independently of one another represent halogen, cyano, nitro, amino or optionally mono- to pentahalogen-substituted C -C -alkyl, C -C -alkyloxy, C -C -alkylcarbonyl, C -C -alkylsulphanyl, 1 6 1 6 1 6 1 6 C -C -alkylsulphinyl, C -C -alkylsulphonyl, and 1 6 1 6 n represents the values 0-1; Z represents C -C -haloalkyl, C -C -cycloalkyl, C -C -halocycloalkyl optionally mono- to 1 6 3 6 3 6 pentasubstituted by hydroxy, nitro, amino, halogen, alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl, and Z represents hydrogen, halogen, cyano, nitro, amino or represents C -C -alkyl, C -C -alkylcarbonyl, 1 6 1 6 C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl optionally independently of one 1 6 1 6 1 6 another mono- to pentasubstituted by hydroxy, nitro, amino, halogen alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl, and Z represents hydrogen or represents C -C -alkyl, C -C -cycloalkyl C -C -alkenyl, C -C -alkynyl, 1 6 3 6 2 4 2 4 aryl or hetaryl optionally independently of one another mono- to pentasubstituted by hydroxy, nitro, amino, alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl.
Especially preferred are compounds of the formula (I) in which R represents hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, methoxymethyl, ethoxymethyl, propoxymethyl, methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, s-butylcarbonyl, t-butylcarbonyl, methoxycarbonyl, ethoxycarbonyl, n- propoxycarbonyl, isopropoxycarbonyl, s-butoxycarbonyl, t-butoxycarbonyl, cyanomethyl, 2- cyanoethyl, benzyl, 4-methoxybenzyl, pyridylmethyl, pyridylmethyl, pyridylmethyl, 4- chloropyridylmethyl; the chemical groupings A represents CR or nitrogen, A represents CR or nitrogen, A represents CR or nitrogen and A represents CR or nitrogen, but where not more than three of the chemical groupings A to A simultaneously represent nitrogen; R and R independently of one another represent hydrogen, methyl, fluorine or chlorine and R and R independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlorodifluoromethyl, trifluoromethyl, 2,2,2- trifluoroethyl, methoxy, ethoxy, n-propoxy, 1-methylethoxy, fluoromethoxy, difluoromethoxy, chlorodifluoromethoxy, dichlorofluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2- difluoroethoxy, pentafluoroethoxy, N-methoxyiminomethyl, 1-(N-methoxyimino)ethyl, methylsulfanyl, trifluoromethylsulphanyl, methylsulphonyl, methylsulphinyl, trifluoromethylsulphonyl, trifluoromethylsulphinyl; W represents oxygen or sulphur; Q represents hydrogen, methyl, ethyl, n-propyl, 1-methylethyl, 1,1-dimethylethyl, 1-methylpropyl, n-butyl, 2-methylpropyl, 2-methylbutyl, hydroxyethyl, 2-hydroxypropyl, cyanomethyl, 2- cyanoethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1-trifluoromethylethyl, 2,2- difluoropropyl, 3,3,3-trifluoropropyl, 2,2-dimethylfluoropropyl, cyclopropyl, 1- cyanocyclopropyl, 1-methoxycarbonylcyclopropyl, 1-(N-methylcarbamoyl)cyclopropyl, 1- carbamoylcyclopropyl, 1-carbamothioylcyclopropyl, 1-(N-cyclopropylcarbamoyl)cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-cyclopropylethyl, bis(cyclopropyl)methyl, 2,2-dimethylcyclopropylmethyl, 2-phenylcyclopropyl, 2,2- dichlorocyclopropyl, transchlorocyclopropyl, cischlorocyclopropyl, 2,2-difluorocyclopropyl, transfluorocyclopropyl, cisfluorocyclopropyl, transhydroxycyclohexyl, 4- trifluoromethylcyclohexyl, propenyl, 2-methylpropenyl, propynyl, 1,1-dimethylbut ynyl, 3-chloropropenyl, 3-fluoropropenyl, 3,3-dichloropropenyl, 3,3-dichloro-1,1- dimethylpropenyl, oxetanyl, thietanyl, 1-oxidothietanyl, 1,1-dioxidothietanyl, isoxazolylmethyl, 1,2,4-triazolylmethyl, 3-methyloxetanylmethyl, benzyl, 2,6- difluorophenylmethyl, 3-fluorophenylmethyl, 2-fluorophenylmethyl, 2,5-difluorophenylmethyl, 1- phenylethyl, 4-chlorophenylethyl, 2-trifluoromethylphenylethyl, 1-pyridinylethyl, pyridin ylmethyl, 5-fluoropyridinylmethyl, (6-chloropyridinyl)methyl, pyrimidinylmethyl, methoxy, 2-ethoxyethyl, 2-methoxyethyl, 2-(methylsulphanyl)ethyl, 1-methyl (ethylsulphanyl)ethyl, 2-methyl(methylsulphanyl)propanyl, methoxycarbonyl, methoxycarbonylmethyl, NH , N-ethylamino, N-allylamino, N,N-dimethylamino, N,N- diethylamino; or Q represents phenyl, naphthyl, pyridazine, pyrazine, pyrimidine, triazine, pyridine, pyrazole, thiazole, isothiazole, oxazole, isoxazole, triazole, imidazole, furan, thiophene, pyrrole, oxadiazole, thiadiazole substituted by 0, 1, 2, 3 or 4 substituents V, where V independently of one another represents fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,2,2,2- tetrafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoroisopropyl, nonafluoro-n- butyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, n-propoxy, 1-methylethoxy, fluoromethoxy, difluoromethoxy, chlorodifluoromethoxy, dichlorofluoromethoxy, trifluoromethoxy, 2,2,2- trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N-methoxyiminomethyl, 1-(N- methoxyimino)ethyl, methylsulphanyl, methylsulphonyl, methylsulphinyl, trifluoromethylsulphonyl, trifluoromethylsulphinyl, trifluoromethylsulphanyl, N,N- dimethylamino; T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) (R ) T1 T2 T3 T4 6 (R ) (R ) (R ) n * * T5 T6 T7 where R independently of one another represent halogen, cyano, nitro, amino, methyl, ethyl, propyl, 1- methylethyl, tert-butyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, trifluoromethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, methylcarbonyl, ethylcarbonyl, trifluoromethylcarbonyl, methylsulphanyl, methylsulphinyl, methylsulphonyl, trifluoromethylsulphonyl, trifluoromethylsulphanyl, trifluoromethylsulphinyl, and n represents the values 0-1; Z represents methyl, ethyl, 1,1-dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1-fluoroethyl, 1-fluoromethylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,2,2,2- tetrafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoroisopropyl, nonafluoro-n- butyl, cyclopropyl, 1-chlorocyclopropyl, 1-fluorocyclopropyl, 1-bromocyclopropyl, 1- cyanocyclopropyl, 1-trifluoromethylcyclopropyl, cyclobutyl and 2,2-difluoro methylcyclopropyl, and Z represents hydrogen, halogen, cyano, nitro, amino, methyl, ethyl, 1,1-dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1-fluoroethyl, 1-fluoromethylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,2,2,2-tetrafluorethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoroisopropyl, nonafluoro-n-butyl, methylsulphanyl, methylsulphinyl, methylsulphonyl, ethylthio, ethylsulphinyl, ethylsulphonyl, trifluoromethylsulphanyl, trifluoromethylsulphinyl, trifluoromethylsulphonyl, chlorodifluoromethylsulphanyl, chlorodifluoromethylsulphinyl, chlorodifluoromethylsulphonyl, dichlorofluoromethylsulphanyl, dichlorofluoromethylsulphinyl, dichlorofluoromethylsulphonyl and Z represents hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1-propenyl, 1-propynyl, 1-butynyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1-fluoroethyl, 1-fluoromethylethyl, 2-fluoroethyl, 2,2- difluoroethyl, 2,2,2-trifluoroethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,5- dichlorophenyl, 3,4-dichlorophenyl, 2,6-dichlorophenyl, 2,6-dichlorotrifluoromethylphenyl, 3- chlorotrifluoromethylpyridinyl.
Especially preferred are compounds of the general formula (I) in which Z represents trifluoromethyl, 1-chlorocyclopropyl, 1-fluorocyclopropyl or pentafluoroethyl, Z represents trifluoromethyl, nitro, methylsulphanyl, methylsulphinyl, methylsulphonyl, fluorine, chlorine, bromine, cyano or iodine, Z represents methyl, ethyl, n-propyl or hydrogen, R represents hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, methoxymethyl, ethoxymethyl, propoxymethyl, methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, s-butylcarbonyl, t-butylcarbonyl, methoxycarbonyl, ethoxycarbonyl, n- propoxycarbonyl, isopropoxycarbonyl, s-butoxycarbonyl, t-butoxycarbonyl, cyanomethyl, 2- cyanoethyl, benzyl, 4-methoxybenzyl, pyridylmethyl, pyridylmethyl, pyridylmethyl, 4- chloropyridylmethyl, 1 2 4 A , A and A each represent CH, where A may alternatively also represent CH or N, A represents CR and R represents fluorine, chlorine, bromine or iodine, where R may alternatively also represent methyl, ethyl, fluorine, chlorine, bromine or iodine, T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) (R ) T1 T2 T3 T4 6 (R ) (R ) (R ) n T5 T6 T7 where R represents hydrogen, methyl, ethyl, 2-methylethyl, 2,2-dimethylethyl, fluorine, chlorine, bromine, iodine, cyano, nitro, trifluoromethyl, amino, or alternatively R represents hydrogen, methyl, ethyl, 2-methylethyl, 2,2-dimethylethyl, fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, amino, W represents oxygen and Q represents hydrogen, methyl, ethyl, n-propyl, 1-methylethyl, 1,1-dimethylethyl, n-butyl, 1- methylpropyl, 2-methylpropyl, 2-methylbutyl, hydroxymethyl, 2-hydroxypropyl, cyanomethyl, 2- cyanoethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1-trifluoromethylethyl, 2,2- difluoropropyl, 3,3,3-trifluoropropyl, 2,2-dimethylfluoropropyl, cyclopropyl, 1- cyanocyclopropyl, 1-methoxycarbonylcyclopropyl, 1-(N-methylcarbamoyl)cyclopropyl, 1-(N- cyclopropylcarbamoyl)cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, 1- cyclopropylethyl, bis(cyclopropyl)methyl, 2,2-dimethylcyclopropylmethyl, 2-phenylcyclopropyl, 2,2-dichlorocyclopropyl, transchlorocyclopropyl, cischlorocyclopropyl, 2,2- difluorocyclopropyl, transfluorocyclopropyl, cisfluorocyclopropyl, trans hydroxycyclohexyl, 4-trifluoromethylcyclohexyl, propenyl, 2-methylpropenyl, propynyl, 1,1-dimethylbutynyl, 3-chloropropenyl, 3,3-dichloropropenyl, 3,3-dichloro-1,1- dimethylpropenyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, oxetanyl, thietanyl, 1-oxidothietanyl, 1,1-dioxidothietanyl, isoxazolylmethyl, 1,2,4-triazol ylmethyl, 3-methyloxetanylmethyl, benzyl, 2,6-difluorophenylmethyl, 3-fluorophenylmethyl, 2-fluorophenylmethyl, 2,5-difluorophenylmethyl, 1-phenylethyl, 4-chlorophenylethyl, 2- trifluormethylphenylethyl, 1-pyridinylethyl, pyridinylmethyl, (6-chloropyridinyl)methyl, 5-fluoropyridinylmethyl, pyrimidinylmethyl, methoxy, 2-ethoxyethyl, 2- (methylsulphanyl)ethyl, 1-methyl(ethylsulphanyl)ethyl, 2-methyl(methylsulphanyl)propan- 2-yl, methoxycarbonyl, methoxycarbonylmethyl, NH , N-ethylamino, N-allylamino, N,N- dimethylamino, N,N-diethylamino; or alternatively Q represents hydrogen, methyl, ethyl, n-propyl, 1-methylethyl, 1,1-dimethylethyl, n-butyl, 1- methylpropyl, 2-methylpropyl, 2-methylbutyl, hydroxyethyl, 2-hydroxypropyl, cyanomethyl, 2- cyanoethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1-trifluoromethylethyl, 2,2- difluoropropyl, 3,3,3-trifluoropropyl, 2,2-dimethylfluoropropyl, cyclopropyl, 1- cyanocyclopropyl, 1-methoxycarbonylcyclopropyl, 1-(N-methylcarbamoyl)cyclopropyl, 1- carbamoylcyclopropyl, 1-carbamothioylcyclopropyl, 1-(N-cyclopropylcarbamoyl)cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-cyclopropylethyl, bis(cyclopropyl)methyl, 2,2-dimethylcyclopropylmethyl, 2-phenylcyclopropyl, 2,2- dichlorocyclopropyl, transchlorocyclopropyl, cischlorocyclopropyl, 2,2- difluorocyclopropyl, transfluorocyclopropyl, cisfluorocyclopropyl, trans hydroxycyclohexyl, 4-trifluoromethylcyclohexyl, propenyl, 2-methylpropenyl, propynyl, 1,1-dimethylbutynyl, 3-chloropropenyl, 3-fluoropropenyl, 3,3-dichloropropenyl, 3,3- dichloro-1,1-dimethylpropenyl, oxetanyl, thietanyl, 1-oxidothietanyl, 1,1- dioxidothietanyl, isoxazolylmethyl, 1,2,4-triazolylmethyl, 3-methyloxetanylmethyl, benzyl, 2,6-difluorophenylmethyl, 3-fluorophenylmethyl, 2-fluorophenylmethyl, 2,5- difluorophenylmethyl, 1-phenylethyl, 4-chlorophenylethyl, 2-trifluormethylphenylethyl, 1- pyridinylethyl, pyridinylmethyl, (6-chloropyridinyl)methyl, 5-fluoropyridinylmethyl, pyrimidinylmethyl, methoxy, 2-ethoxyethyl, 2-methoxyethyl, 2-(methylsulphanyl)ethyl, 1- methyl(ethylsulphanyl)ethyl, 2-methyl(methylsulphanyl)propanyl, methoxycarbonyl, methoxycarbonylmethyl, NH , N-ethylamino, N-allylamino, N,N-dimethylamino, N,N- diethylamino; Q represents phenyl, naphthyl, pyridazine, pyrazine, pyrimidine, triazine, pyridine, pyrazole, thiazole, isothiazole, oxazole, isoxazole, triazole, imidazole, furan, thiophene, pyrrole, oxadiazole, thiadiazole substituted by 0, 1, 2 or 3 substituents V, where V independently of one another represents fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,2,2,2- tetrafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoroisopropyl, nonafluoro-n- butyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, n-propoxy, 1-methylethoxy, fluoromethoxy, difluoromethoxy, chlorodifluoromethoxy, dichlorofluoromethoxy, trifluoromethoxy, 2,2,2- trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N-methoxyiminomethyl, 1-(N- methoxyimino)ethyl, methylsulphanyl, methylsulphonyl, methylsulphinyl, trifluoromethylsulphonyl, trifluoromethylsulphinyl, trifluoromethylsulphanyl, N,N- dimethylamino.
Very especially preferred are furthermore the compounds in each case defined by one of the general 1 1 3 formulae I(a), I(b), I(c), I(d), I(e), I(f), I(g) in which the radicals A -A , n, W, Q, R and Z -Z have the general, preferred or particularly preferred meanings described above.
N 2 A (R ) (R ) (Ia (Ib (R ) (R ) (Ic (Id A N 2 (R ) (R ) (If) 3 N N (R ) Especially preferred are all compounds of the general formula (Ic), where the preferred ranges for the 1 2 3 4 1 6 1 2 3 radicals A , A , A , A , Q, R , R , W, Z , Z and Z apply correspondingly to the above preferred ranges for the compounds of the general formula (I).
Very particular preference is given to compounds of the general formula (Ia) in which Z represents 2 3 1 6a 6b 6c 1 CF2CF3, Z represents CF3, Z represents CH3, the radicals R , R , R and R represent hydrogen, A , 2 4 3 A , A represent C-H, A represents C-Cl, W represents oxygen and Q represents 1-cyanocyclopropyl or cyclopropyl.
Very particular preference is alternatively given to compounds of the general formula (Ia) in which Z 2 3 1 6a 6b 6c represents CF CF , Z represents CF , Z represents CH , the radicals R , R , R and R 2 3 3 3 1 4 2 3 represent hydrogen, A , A represent C-H, A represents N, A represents C-Cl, W represents oxygen and Q represents 1-cyanocyclopropyl or cyclopropyl.
Very particular preference is furthermore given to compounds of the general formula (Ib) in which Z 2 3 1 6a 6b represents CF CF , Z represents CF , Z represents CH , the radicals R , R and R represent 2 3 3 3 1 2 4 3 hydrogen, A , A , A represent C-H, A represents C-Cl, W represents oxygen and Q represents 1- cyanocyclopropyl or cyclopropyl.
Very particular preference is alternatively given to compounds of the general formula (Ib) in which Z 2 3 1 6a 6b 6c represents CF CF , Z represents CF , Z represents CH , the radicals R , R , R and R 2 3 3 3 1 4 2 3 represent hydrogen, A , A represent C-H, A represents N, A represents C-Cl, W represents oxygen and Q represents 1-cyanocyclopropyl or cyclopropyl.
Very particular preference is furthermore given to compounds of the general formula (Ic) in which Z represents CF CF , Z represents CF , Z represents methyl, ethyl, phenyl, 4-NO -phenyl, 3- 2 3 3 2 1 6a 6b chloropyridinyl , the radicals R , R represent hydrogen or methyl, R represents hydrogen, methyl 1 4 2 3 or CF , A , A represent C-H, A represents C-H or C-F, A represents C-H or C-Cl , W represents oxygen and Q represents one of the radicals 1-cyanocyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyridyl, 2,2,2-trifluoroethyl, methylsulphonyl, thietanyl, 1- carbamoylcyclopropyl.
Very particular preference is alternatively given to compounds of the general formula (Ic) in which Z represents CF CF , Z represents CF , Z represents methyl, ethyl, phenyl, 4-NO -phenyl, 3- 2 3 3 2 1 6a 6b chloropyridinyl , the radicals R , R represent hydrogen or methyl, R represents hydrogen, methyl 1 4 2 3 or CF , A , A represent C-H, A represents N, A represents C-H or C-Cl, W represents oxygen and Q represents one of the radicals 1-cyanocyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyridyl, 2,2,2-trifluoroethyl, methylsulphonyl, thietanyl, 1- carbamoylcyclopropyl.
Very particular preference is furthermore given to compounds of the general formula (Id) in which Z 2 3 1 6a 6b represents CF CF , Z represents CF , Z represents CH , the radicals R , R and R represent 2 3 3 3 1 2 4 3 hydrogen, A , A , A represent C-H, A represents C-Cl, W represents oxygen and Q represents 1- cyanocyclopropyl or cyclopropyl.
Very particular preference is alternatively given to compounds of the general formula (Id) in which Z 2 3 1 6a 6b 6c represents CF CF , Z represents CF , Z represents CH , the radicals R , R , R and R 2 3 3 3 1 4 2 3 represent hydrogen, A , A represent C-H, A represents N, A represents C-Cl, W represents oxygen and Q represents 1-cyanocyclopropyl or cyclopropyl.
Very particular preference is furthermore given to compounds of the general formula (Ie) in which Z 2 3 1 6a 6b represents CF CF , Z represents CF , Z represents CH , the radicals R , R and R represent 2 3 3 3 1 2 4 3 hydrogen, A , A , A represent C-H, A represents C-Cl, W represents oxygen and Q represents one of the radicals 1-cyanocyclopropyl, 2-thienylmethyl, 6-chloropyridinyl, 1-carbamothioylcyclopropyl or cyclopropyl.
Very particular preference is alternatively given to compounds of the general formula (Ie) in which Z 2 3 1 6a 6b represents CF CF , Z represents CF , Z represents CH , the radicals R , R and R represent 2 3 3 3 1 4 2 3 hydrogen, A , A represent C-H, A represents N, A represents C-Cl, W represents oxygen and Q represents one of the radicals 1-cyanocyclopropyl, 2-thienylmethyl, 6-chloropyridinyl, 1- carbamothioylcyclopropyl or cyclopropyl.
Most preference is given to the compounds of the general formula (Ic) in which Z represents CF CF , Z represents CF , Z represents methyl, ethyl, phenyl, 4-NO -phenyl, 3-chloropyridinyl , the radicals 1 6a 6b 1 4 2 R , R represent hydrogen or methyl, R represents hydrogen, methyl or CF , A , A represent C-H, A represents C-H or C-F, A represents C-H or C-Cl, W represents oxygen and Q represents one of the radicals 1-cyanocyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid yl, 2,2,2-trifluoroethyl, methylsulphonyl, thietanyl, 1-carbamoylcyclopropyl.
Most preference is alternatively given to the compounds of the general formula (Ic) in which Z represents CF CF , Z represents CF , Z represents methyl, ethyl, phenyl, 4-NO -phenyl, 3- 2 3 3 2 1 6a 6b chloropyridinyl , the radicals R , R represent hydrogen or methyl, R represents hydrogen, methyl 1 4 2 3 or CF , A , A represent C-H, A represents N, A represents C-H or C-Cl, W represents oxygen and Q represents one of the radicals 1-cyanocyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyridyl, 2,2,2-trifluoroethyl, methylsulphonyl, thietanyl, 1- carbamoylcyclopropyl.
According to the invention, "alkyl" - on its own or as part of a chemical group – represents straight- chain or branched hydrocarbons preferably having 1 to 6 carbon atoms such as, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3- methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1- methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,2-dimethylpropyl, 1,3-dimethylbutyl, 1,4-dimethylbutyl, 2,3-dimethylbutyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2- trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl and 2-ethylbutyl. Preference is furthermore given to alkyl groups having 1 to 4 carbon atoms such as, inter alia, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl. The alkyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "alkenyl" - on its own or as part of a chemical group – represents straight- chain or branched hydrocarbons preferably having 2 to 6 carbon atoms and at least one double bond such as, for example, vinyl, 2-propenyl, 2-butenyl, 3-butenyl, 1-methylpropenyl, 2-methyl propenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methylbutenyl, 2-methylbutenyl, 3-methyl butenyl, 1-methylbutenyl, 2-methylbutenyl, 3-methylbutenyl, 1,1-dimethylpropenyl, 1,2- dimethylpropenyl, 1-ethylpropenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl pentenyl, 2-methylpentenyl, 3-methylpentenyl, 4-methylpentenyl, 3-methylpentenyl, 4- methylpentenyl, 1-methylpentenyl, 2-methylpentenyl, 3-methylpentenyl, 4-methyl pentenyl, 1,1-dimethylbutenyl, 1,1-dimethylbutenyl, 1,2-dimethylbutenyl, 1,2-dimethyl butenyl, 1,3-dimethylbutenyl, 2,2-dimethylbutenyl, 2,3-dimethylbutenyl, 2,3-dimethyl butenyl, 1-ethylbutenyl, 1-ethylbutenyl, 2-ethylbutenyl, 2-ethylbutenyl, 1,1,2-trimethyl propenyl, 1-ethylmethylpropenyl and 1-ethylmethylpropenyl. Preference is furthermore given to alkenyl groups having 2 to 4 carbon atoms such as, inter alia, 2-propenyl, 2-butenyl or 1- methylpropenyl. The alkenyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "alkynyl" - on its own or as part of a chemical group – represents straight- chain or branched hydrocarbons preferably having 2 to 6 carbon atoms and at least one triple bond such as, for example, 2-propynyl, 2-butynyl, 3-butynyl, 1-methylpropynyl, 2-pentynyl, 3-pentynyl, 4- pentynyl, 1-methylbutynyl, 2-methylbutynyl, 1-methylbutynyl, 1,1-dimethylpropynyl, 1- ethylpropynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methylpentynyl, 1-methyl pentynyl, 1-methylpentynyl, 2-methylpentynyl, 2-methylpentynyl, 3-methylpentynyl, 4- methylpentynyl, 1,1-dimethylbutynyl, 1,2-dimethylbutynyl, 2,2-dimethylbutynyl, 1-ethyl butynyl, 2-ethylbutynyl, 1-ethylmethylpropynyl and 2,5-hexadiynyl. Preference is furthermore given to alkynyl groups having 2 to 4 carbon atoms such as, inter alia, ethynyl, 2-propynyl or 2-butynyl- 2-propenyl. The alkynyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "cycloalkyl" - on its own or as part of a chemical group - represents mono-, bi- or tricyclic hydrocarbons preferably having 3 to 10 carbons such as, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl or adamantyl. Preference is furthermore given to cycloalkyl groups having 3, 4, 5, 6 or 7 carbon atoms such as, inter alia, cyclopropyl or cyclobutyl. The cycloalkyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "alkylcycloalkyl" represents mono-, bi- or tricyclic alkylcycloalkyl preferably having 4 to 10 or 4 to 7 carbon atoms such as, for example, ethylcyclopropyl, isopropylcyclobutyl, 3-methylcyclopentyl and 4-methylcyclohexyl. Preference is furthermore given to alkylcycloalkyl groups having 4, 5 or 7 carbon atoms such as, inter alia, ethylcyclopropyl or 4- methylcyclohexyl. The alkylcycloalkyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "cycloalkylalkyl" represents mono-, bi- or tricyclic cycloalkylalkyl preferably having 4 to 10 or 4 to 7 carbon atoms such as, for example, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl and cyclopentylethyl. Preference is furthermore given to cycloalkylalkyl groups having 4, 5 or 7 carbon atoms such as, inter alia, cyclopropylmethyl or cyclobutylmethyl. The cycloalkylalkyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "halogen" represents fluorine, chlorine, bromine or iodine, in particular fluorine, chlorine or bromine.
The halogen-substituted chemical groups according to the invention such as, for example, haloalkyl, halocycloalkyl, haloalkyloxy, haloalkylsulphanyl, haloalkylsulphinyl or haloalkylsulphonyl are mono- or polysubstituted by halogen up to the maximum possible number of substituents. In the case of polysubstitution by halogen, the halogen atoms can be identical or different, and can all be attached to one or to a plurality of carbon atoms. Here, halogen represents in particular fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine and particularly preferably fluorine.
According to the invention, "halocycloalkyl" represents mono-, bi- or tricyclic halocycloalkyl having preferably 3 to 10 carbon atoms such as, inter alia, 1-fluorocyclopropyl, 2-fluorocyclopropyl or 1- fluorocyclobutyl. Preference is furthermore given to halocycloalkyl having 3, 5 or 7 carbon atoms. The halocycloalkyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "haloalkyl" "haloalkenyl" or "haloalkynyl" represents halogen-substituted alkyl, alkenyl or alkynyl groups having preferably 1 to 9 identical or different halogen atoms such as, for example, monohaloalkyl such as CH CH Cl, CH CH F, CHClCH , CHFCH , CH Cl, CH F; 2 2 2 2 3 3 2 2 perhaloalkyl such as CCl or CF or CF CF ; polyhaloalkyl such as CHF , CH F, CH CHFCl, CHCl , 3 3 2 3 2 2 2 2 CF CF H, CH CF . This applies correspondingly to haloalkenyl and other halogen-substituted radicals. 2 2 2 3 Haloalkoxy is, for example, OCF , OCHF , OCH F, OCF CF , OCH CF and OCH CH Cl. 3 2 2 2 3 2 3 2 2 Further examples for haloalkyl groups are trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2- difluoroethyl, pentafluoroethyl and pentafluoro-t-butyl. Preference is given to haloalkyl groups having 1 to 4 carbon atoms and 1 to 9, preferably 1 to 5, identical or different halogen atoms selected from the group consisting of fluorine, chlorine and bromine. Particular preference is given to haloalkyl groups having 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms selected from the group consisting of fluorine and chlorine such as, inter alia, difluoromethyl, trifluoromethyl or 2,2- difluoroethyl.
According to the invention, "hydroxyalkyl" represents a straight-chain or branched alcohol preferably having 1 to 6 carbon atoms such as, for example, methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, s-butanol and t-butanol. Preference is furthermore given to hydroxyalkyl groups having 1 to 4 carbon atoms. The hydroxyalkyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "alkoxy" represents a straight-chain or branched O-alkyl preferably having 1 to 6 carbon atoms such as, for example, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, s-butoxy and t-butoxy. Preference is furthermore given to alkoxy groups having 1 to 4 carbon atoms.
The alkoxy groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "haloalkoxy" represents halogen-substituted straight-chain or branched O- alkyl preferably having 1 to 6 carbon atoms such as, inter alia, difluoromethoxy, trifluoromethoxy, 2,2- difluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2,2,2-trifluoroethoxy and 2-chloro-1,1,2-trifluoroethoxy.
Preference is furthermore given to haloalkoxy groups having 1 to 4 carbon atoms. The haloalkoxy groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "alkylsulphanyl" represents straight-chain or branched S-alkyl preferably having 1 to 6 carbon atoms such as, for example, methylthio, ethylthio, n-propylthio, isopropylthio, n- butylthio, isobutylthio, s-butylthio and t-butylthio. Preference is furthermore given to alkylsulphanyl groups having 1 to 4 carbon atoms. The alkylsulphanyl groups according to the invention may be substituted by one or more identical or different radicals.
Examples of haloalkylsulphanylalkyl groups, i.e. halogen-substituted alkylsulphanyl groups, are inter alia difluoromethylthio, trifluoromethylthio, trichloromethylthio, chlorodifluoromethylthio, 1- fluoroethylthio, 2-fluoroethylthio, 2,2-difluoroethylthio, 1,1,2,2-tetrafluoroethylthio, 2,2,2- trifluoroethylthio or 2-chloro-1,1,2-trifluoroethylthio.
According to the invention, "alkylsulphinyl" represents straight-chain or branched alkylsulphinyl preferably having 1 to 6 carbon atoms such as, for example, methylsulphinyl, ethylsulphinyl, n- propylsulphinyl, isopropylsulphinyl, n-butylsulphinyl, isobutylsulphinyl, s-butylsulphinyl and t- butylsulphinyl. Preference is furthermore given to alkylsulphinyl groups having 1 to 4 carbon atoms.
The alkylsulphinyl groups according to the invention may be substituted by one or more identical or different radicals.
Examples of haloalkylsulphinyl groups, i.e. halogen-substituted alkylsulphinyl groups, are inter alia difluoromethylsulphinyl, trifluoromethylsulphinyl, trichloromethylsulphinyl, chlorodifluoromethylsulphinyl, 1-fluoroethylsulphinyl, 2-fluoroethylsulphinyl, 2,2- difluoroethylsulphinyl, 1,1,2,2-tetrafluoroethylsulphinyl, 2,2,2-trifluoroethylsulphinyl and 2-chloro- 1,1,2-trifluoroethylsulphinyl.
According to the invention, "alkylsulphonyl" represents straight-chain or branched alkylsulphonyl preferably having 1 to 6 carbon atoms such as, for example, methylsulphonyl, ethylsulphonyl, n- propylsulphonyl, isopropylsulphonyl, n-butylsulphonyl, isobutylsulphonyl, s-butylsulphonyl and t- butylsulphonyl. Preference is furthermore given to alkylsulphonyl groups having 1 to 4 carbon atoms.
The alkylsulphonyl groups according to the invention may be substituted by one or more identical or different radicals.
Examples of haloalkylsulphonyl groups, i.e. halogen-substituted alkylsulphonyl groups, are inter alia difluoromethylsulphonyl, trifluoromethylsulphonyl, trichloromethylsulphonyl, chlorodifluoromethylsulphonyl, 1-fluoroethylsulphonyl, 2-fluoroethylsulphonyl, 2,2- difluoroethylsulphonyl, 1,1,2,2-tetrafluoroethylsulphonyl, 2,2,2-trifluoroethylsulphonyl and 2-chloro- 1,1,2-trifluoroethylsulphonyl.
According to the invention, "alkylcarbonyl" represents straight-chain or branched alkyl-C(=O) preferably having 2 to 7 carbon atoms such as methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, s-butylcarbonyl and t-butylcarbonyl. Preference is furthermore given to alkylcarbonyl groups having 1 to 4 carbon atoms. The alkylcarbonyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "cycloalkylcarbonyl" represents straight-chain or branched cycloalkylcarbonyl preferably having 3 to 10 carbon atoms in the cycloalkyl moiety such as, for example, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, cycloheptylcarbonyl, cyclooctylcarbonyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octylcarbonyl and adamantylcarbonyl. Preference is furthermore given to cycloalkylcarbonyl having 3, 5 or 7 carbon atoms in the cycloalkyl moiety. The cycloalkylcarbonyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "alkoxycarbonyl" - alone or as a constituent of a chemical group - represents straight-chain or branched alkoxycarbonyl, preferably having 1 to 6 carbon atoms or having 1 to 4 carbon atoms in the alkoxy moiety such as, for example, methoxycarbonyl, ethoxycarbonyl, n- propoxycarbonyl, isopropoxycarbonyl, s-butoxycarbonyl and t-butoxycarbonyl. The alkoxycarbonyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "alkylaminocarbonyl" represents straight-chain or branched alkylaminocarbonyl having preferably 1 to 6 carbon atoms or 1 to 4 carbon atoms in the alkyl moiety, such as, for example, methylaminocarbonyl, ethylaminocarbonyl, n-propylaminocarbonyl, isopropylaminocarbonyl, s-butylaminocarbonyl and t-butylaminocarbonyl. The alkylaminocarbonyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "N,N-dialkylaminocarbonyl" represents straight-chain or branched N,N- dialkylaminocarbonyl having preferably 1 to 6 carbon atoms or 1 to 4 carbon atoms in the alkyl moiety, such as, for example, N,N-dimethylaminocarbonyl, N,N-diethylaminocarbonyl, N,N-di(n- propylamino)carbonyl, N,N-di(isopropylamino)carbonyl and N,N-di-(s-butylamino)carbonyl. The N,N- dialkylaminocarbonyl groups according to the invention may be substituted by one or more identical or different radicals.
According to the invention, "aryl" represents a mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring carbon atoms such as, for example, phenyl, naphthyl, anthryl, phenanthrenyl, preferably phenyl. Furthermore, aryl also represents polycyclic systems such as tetrahydronaphtyl, indenyl, indanyl, fluorenyl, biphenylyl, where the bonding site is on the aromatic system. The aryl groups according to the invention may be substituted by one or more identical or different radicals.
Examples for substituted aryls are the arylalkyl groups which may likewise be substituted by one or more identical or different radicals in the alkyl and/or aryl moiety. Examples for such arylalkyl groups are inter alia benzyl and 1-phenylethyl.
According to the invention, "heterocycle", "heterocyclic ring" or "heterocyclic ring system" represents a carbocyclic ring system having at least one ring in which at least one carbon atom is replaced by a heteroatom, preferably by a heteroatom from the group consisting of N, O, S, P, B, Si, Se, and which is saturated, unsaturated or heteroaromatic and may be unsubstituted or substituted by a substituent Z, where the point of attachment is located at a ring atom. Unless defined differently, the heterocyclic ring contains preferably 3 to 9 ring atoms, especially 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3, heteroatoms in the heterocyclic ring, preferably from the group consisting of N, O, and S, although no two oxygen atoms should be directly adjacent. The heterocyclic rings usually contain not more than 4 nitrogen atoms and/or not more than 2 oxygen atoms and/or not more than 2 sulphur atoms. If the heterocyclyl radical or the heterocyclic ring is optionally substituted, it can be fused to other carbocyclic or heterocyclic rings. In the case of optionally substituted heterocyclyl, the invention also embraces polycyclic systems such as, for example, 8-azabicyclo[3.2.1]octanyl or 1- azabicyclo[2.2.1]heptyl. In the case of optionally substituted heterocyclyl, the invention also embraces spirocyclic systems such as, for example, 1-oxaazaspiro[2.3]hexyl.
Heterocyclyl groups according to the invention are, for example, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dihydropyranyl, tetrahydropyranyl, dioxanyl, pyrrolinyl, pyrrolidinyl, imidazolinyl, imidazolidinyl, thiazolidinyl, oxazolidinyl, dioxolanyl, dioxolyl, pyrazolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxetanyl, oxiranyl, azetidinyl, aziridinyl, oxazetidinyl, oxaziridinyl, oxazepanyl, oxazinanyl, azepanyl, oxopyrrolidinyl, dioxopyrrolidinyl, oxomorpholinyl, oxopiperazinyl and oxepanyl.
Heteroarylene, i.e. heteroaromatic systems, has a particular meaning. According to the invention, the term heteroaryl represents heteroaromatic compounds, i.e. completely unsaturated aromatic heterocyclic compounds which fall under the above definition of heterocycles. Preference is given to 5- to 7- membered rings having 1 to 3, preferably 1 or 2, identical or different heteroatoms from the group above. Heteroaryl groups according to the invention are, for example, furyl, thienyl, pyrazolyl, imidazolyl, 1,2,3- and 1,2,4-triazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,3-, 1,3,4-, 1,2,4- and 1,2,5- oxadiazolyl, azepinyl, pyrrolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-, 1,2,4- and 1,2,3- triazinyl, 1,2,4-, 1,3,2-, 1,3,6- and 1,2,6-oxazinyl, oxepinyl, thiepinyl, 1,2,4-triazolonyl and 1,2,4- diazepinyl. The heteroaryl groups according to the invention may also be substituted by one or more identical or different radicals.
Substituted groups such as a substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, phenyl, benzyl, heterocyclyl and heteroaryl radical are, for example, a substituted radical derived from the unsubstituted base structure, where the substituents are, for example, one or more, preferably 1, 2 or 3, radicals from the group of halogen, alkoxy, alkylsulphanyl, hydroxyl, amino, nitro, carboxyl or a group equivalent to the carboxyl group, cyano, isocyano, azido, alkoxycarbonyl, alkylcarbonyl, formyl, carbamoyl, mono- and N,N-dialkylaminocarbonyl, substituted amino such as acylamino, mono- and N,N-dialkylamino, trialkylsilyl and optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl, where each of the latter cyclic groups may also be bonded via heteroatoms or divalent functional groups such as in the alkyl radicals mentioned, and alkylsulphinyl, including both enantiomers of the alkylsulphonyl group, alkylsulphonyl, alkylphosphinyl, alkylphosphonyl and, in the case of cyclic radicals (= "cyclic skeleton"), also alkyl, haloalkyl, alkylsulphanylalkyl, alkoxyalkyl, optionally substituted mono- and N,N-dialkylaminoalkyl and hydroxyalkyl.
The term "substituted groups", such as substituted alkyl etc., includes, as substituents, in addition to the saturated hydrocarbonaceous radicals mentioned, corresponding unsaturated aliphatic and aromatic radicals such as optionally substituted alkenyl, alkynyl, alkenyloxy, alkynyloxy, alkenylthio, alkynylthio, alkenyloxycarbonyl, alkynyloxycarbonyl, alkenylcarbonyl, alkynylcarbonyl, mono- and N,N-dialkenylaminocarbonyl, mono- and dialkynylaminocarbonyl, mono- and N,N-dialkenylamino, mono- and N,N-dialkynylamino, trialkenylsilyl, trialkynylsilyl, optionally substituted cycloalkenyl, optionally substituted cycloalkynyl, phenyl, phenoxy etc. In the case of substituted cylic radicals with aliphatic components in the ring, cyclic systems with those substituents bonded to the ring by a double bond are also included, for example those having an alkylidene group such as methylidene or ethylidene, or an oxo group, imino group and a substituted imino group.
When two or more radicals form one or more rings, these may be carbocyclic, heterocyclic, saturated, partly saturated, unsaturated, for example also aromatic and further substituted.
The substituents mentioned by way of example ("first substituent level") may, if they contain hydrocarbon-containing moieties, optionally be further substituted therein ("second substituent level"), for example by one of the substituents as defined for the first substituent level. Corresponding further substituent levels are possible. The term "substituted radical" preferably embraces just one or two substituent levels.
Preferred substituents for the substituent levels are, for example, amino, hydroxy, halogen, nitro, cyano, isocyano, mercapto, isothiocyanato, carboxyl, carboxamide, SF , aminosulphonyl, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, N-monoalkylamino, N,N- dialkylamino, N-alkanoylamino, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy, cycloalkenyloxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkanoyl, alkenylcarbonyl, alkynylcarbonyl, arylcarbonyl, alkylsulphanyl, cycloalkylsulphanyl, alkenylthio, cycloalkenylthio, alkynylthio, alkylsulphenyl and alkylsulphinyl, where both enantiomers of the alkylsulphinyl group are included, alkylsulphonyl, N-monoalkylaminosulphonyl, N,N-dialkylaminosulphonyl, alkylphosphinyl, alkylphosphonyl, where in the case of alkylphosphinyl and alkylphosphonyl both enantiomers are included, N-alkylaminocarbonyl, N,N-dialkylaminocarbonyl, N-alkanoylaminocarbonyl, N-alkanoyl-N- alkylaminocarbonyl, aryl, aryloxy, benzyl, benzyloxy, benzylthio, arylthio, arylamino, benzylamino, heterocyclyl and trialkylsilyl.
Substituents composed of a plurality of substituent levels are preferably alkoxyalkyl, alkylsulphanylalkyl, alkylsulphanylalkoxy, alkoxyalkoxy, phenethyl, benzyloxy, haloalkyl, halocycloalkyl, haloalkoxy, haloalkylsulphanyl, haloalkylsulphinyl, haloalkylsulphonyl, haloalkanoyl, haloalkylcarbonyl, haloalkoxycarbonyl, haloalkoxyalkoxy, haloalkoxyalkylsulphanyl, haloalkoxyalkanoyl, haloalkoxyalkyl.
In the case of radicals having carbon atoms, preference is given to those having 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, especially 1 or 2 carbon atoms. Preference is generally given to substituents from the group of halogen, e.g. fluorine and chlorine, (C -C )-alkyl, preferably methyl or ethyl, (C -C )-haloalkyl, preferably trifluoromethyl, (C -C )-alkoxy, preferably methoxy or ethoxy, (C - 1 4 1 4 1 C )-haloalkoxy, nitro and cyano. Particular preference is given here to the substituents methyl, methoxy, fluorine and chlorine.
Substituted amino such as mono- or disubstituted amino means a radical from the group of the substituted amino radicals which are N-substituted, for example, by one or two identical or different radicals from the group consisting of alkyl, hydroxy, amino, alkoxy, acyl and aryl; preferably N-mono- and N,N-dialkylamino, (for example methylamino, ethylamino, N,N-dimethylamino, N,N-diethylamino, N,N-di-n-propylamino, N,N-diisopropylamino or N,N-dibutylamino), N-mono- or N,N- dialkoxyalkylamino groups (for example N-methoxymethylamino, N-methoxyethylamino, N,N- di(methoxymethyl)amino or N,N-di(methoxyethyl)amino), N-mono- and N,N-diarylamino, such as optionally substituted anilines, acylamino, N,N-diacylamino, N-alkyl-N-arylamino, N-alkyl-N-acylamino and also saturated N-heterocycles; preference is given here to alkyl radicals having 1 to 4 carbon atoms; here, aryl is preferably phenyl or substituted phenyl; for acyl, the definition given further below applies, preferably (C -C )-alkanoyl. The same applies to substituted hydroxylamino or hydrazino.
According to the invention, the term "cyclic amino groups" embraces heteroaromatic or aliphatic ring systems having one or more nitrogen atoms. The heterocycles are saturated or unsaturated, consist of one or more optionally fused ring systems and optionally contain further heteroatoms such as, for example, one or two nitrogen, oxygen and/or sulphur atoms. Furthermore, the term also includes groups having a spiro ring or a bridged ring system. The number of atoms which form the cyclic amino group is not limited, and in the case of a one-ring system, for example, can consist of 3 to 8 ring atoms, and in the case of a two-ring system of 7 to 11 atoms.
Examples of cyclic amino groups having saturated and unsaturated monocyclic groups having a nitrogen atom as heteroatom which may be mentioned are 1-azetidinyl, pyrrolidino, 2-pyrrolidinyl, 1-pyrrolyl, piperidino, 1,4-dihydropyrazinyl, 1,2,5,6-tetrahydropyrazinyl, 1,4-dihydropyridinyl, 1,2,5,6- tetrahydropyridinyl, homopiperidinyl; examples of cyclic amino groups having saturated and unsaturated monocyclic groups having two or more nitrogen atoms as heteroatoms which may be mentioned are 1-imidazolidinyl, 1-imidazolyl, 1-pyrazolyl, 1-triazolyl, 1-tetrazolyl, 1-piperazinyl, 1- homopiperazinyl, 1,2-dihydropiperazinyl, 1,2-dihydropyrimidinyl, perhydropyrimidinyl, 1,4- diazacycloheptanyl; examples of cyclic amino groups having saturated and unsaturated monocyclic groups having one or two oxygen atoms and one to three nitrogen atoms as heteroatoms, such as, for example, oxazolidinyl, 2,3-dihydroisoxazolyl, isoxazolyl, 1,2,3-oxadiazinyl, morpholino, examples of cyclic amino groups having saturated and unsaturated monocyclic groups having one to three nitrogen atoms and one to two sulphur atoms as heteroatoms which may be mentioned are thiazolidinyl, isothiazolinyl, thiomorpholino, or dioxothiomorpholino; examples of cyclic amino groups having saturated and unsaturated fused cyclic groups which may be mentioned are indolyl, 1,2-dihydrobenzimidazolyl, perhydropyrrolo[1,2-a]pyrazinyl; examples of cyclic amino groups having spirocyclic groups which may be mentioned are 2-azaspiro[4,5]decanyl; examples of cyclic amino groups having bridged heterocyclic groups which may be mentioned are 2- azabicyclo[2.2.1]heptanyl.
Substituted amino also includes quaternary ammonium compounds (salts) with four organic substituents on the nitrogen atom.
Optionally substituted phenyl is preferably phenyl which is unsubstituted or mono- or polysubstituted, preferably up to trisubstituted, by identical or different radicals from the group of halogen, (C -C )-alkyl, (C -C )-alkoxy, (C -C )-alkoxy-(C -C )-alkoxy, (C -C )-alkoxy-(C -C )-alkyl, (C -C )-haloalkyl, (C - 1 4 1 4 1 4 1 4 1 4 1 4 1 C )-haloalkoxy, (C -C )-alkylsulphanyl, (C -C )-haloalkylsulphanyl, cyano, isocyano and nitro, for 4 1 4 1 4 example o-, m- and p-tolyl, dimethylphenyls, 2-, 3- and 4-chlorophenyl, 2-, 3- and 4-fluorophenyl, 2-, 3- and 4-trifluoromethyl- and -trichloromethylphenyl, 2,4-, 3,5-, 2,5- and 2,3-dichlorophenyl, o-, m- and p- methoxyphenyl.
Optionally substituted cycloalkyl is preferably cycloalkyl, which is unsubstituted or mono- or polysubstituted, preferably up to trisubstituted, by identical or different radicals from the group of halogen, cyano, (C -C )-alkyl, (C -C )-alkoxy, (C -C )-alkoxy-(C -C )-alkoxy, (C -C )-alkoxy-(C -C )- 1 4 1 4 1 4 1 4 1 4 1 4 alkyl, (C -C )-haloalkyl and (C -C )-haloalkoxy, especially by one or two (C -C )-alkyl radicals. 1 4 1 4 1 4 Optionally substituted heterocyclyl is preferably heterocyclyl which is unsubstituted or mono- or polysubstituted, preferably up to trisubstituted, by identical or different radicals from the group of halogen, cyano, (C -C )-alkyl, (C -C )-alkoxy, (C -C )-alkoxy-(C -C )-alkoxy, (C -C )-alkoxy-(C -C )- 1 4 1 4 1 4 1 4 1 4 1 4 alkyl, (C -C )-haloalkyl, (C -C )-haloalkoxy, nitro and oxo, especially mono- or polysubstituted by 1 4 1 4 radicals from the group of halogen, (C -C )-alkyl, (C -C )-alkoxy, (C -C )-haloalkyl and oxo, most 1 4 1 4 1 4 preferably substituted by one or two (C -C )-alkyl radicals.
Examples of alkyl-substituted heteroaryl groups are furylmethyl, thienylmethyl, pyrazolylmethyl, imidazolylmethyl, 1,2,3- and 1,2,4-triazolylmethyl, isoxazolylmethyl, thiazolylmethyl, isothiazolylmethyl, 1,2,3-, 1,3,4-, 1,2,4- and 1,2,5-oxadiazolylmethyl, azepinylmethyl, pyrrolylmethyl, pyridylmethyl, pyridazinylmethyl, pyrimidinylmethyl, pyrazinylmethyl, 1,3,5-, 1,2,4- and 1,2,3- triazinylmethyl, 1,2,4-, 1,3,2-, 1,3,6- and 1,2,6-oxazinylmethyl, oxepinylmethyl, thiepinylmethyl and 1,2,4-diazepinylmethyl.
Salts which are suitable according to the invention of the compounds according to the invention, for example salts with bases or acid addition salts, are all customary non-toxic salts, preferably agriculturally and/or physiologically acceptable salts. For example salts with bases or acid addition salts.
Preference is given to salts with inorganic bases such as, for example, alkali metal salts (e.g. sodium, potassium or caesium salts), alkaline earth metal salts (e.g. calcium or magnesium salts), ammonium salts or salts with organic bases, in particular with organic amines, such as, for example, triethylammonium, dicyclohexylammonium, N,N’-dibenzylethylenediammonium, pyridinium, picolinium or ethanolammonium salts, salts with inorganic acids (e.g. hydrochlorides, hydrobromides, dihydrosulphates, trihydrosulphates or phosphates), salts with organic carboxylic acids or organic sulphoacids (e.g. formates, acetates, trifluoroacetates, maleates, tartrates, methanesulphonates, benzenesulphonates or 4-toluenesulphonates). It is known that t-amines such as some of the compounds according to the invention are capable of forming N-oxides, which also represent salts according to the invention.
The compounds according to the invention may, depending on the nature of the substituents, be in the form of geometric and/or optically active isomers or corresponding isomer mixtures in different compositions. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Accordingly, the invention encompasses both pure stereoisomers and any mixture of these isomers.
If appropriate, the compounds according to the invention may be present in various polymorphic forms or as a mixture of different polymorphic forms. Both the pure polymorphs and the polymorph mixtures are provided by the invention and can be used in accordance with the invention.
The compounds of the general formula (I) can be mixed or applied jointly with other insecticidal, nematicidal, acaricidal or antimicrobial active compounds. In these mixtures or joint applications, synergistic effects occur, i.e. the observed effect of these mixture or joint applications is higher than the total of the effects of the individual active compounds in these applications. Examples of such mixing or combination partners are: (1) Acetylcholinesterase (AChE) inhibitors such as, for example, carbamates, for example alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb; or organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chloropyrifos, chloropyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl)salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and vamidothion. (2) GABA-gated chloride channel antagonists such as, for example, cyclodiene organochlorines, e.g. chlordane and endosulfan; or phenylpyrazoles (fiproles), e.g. ethiprole and fipronil. (3) Sodium channel modulators/voltage-dependent sodium channel blockers such as, for example, pyrethroids, e.g. acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta- cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans-isomers], deltamethrin, empenthrin [(EZ)-(1R)- isomers], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin [(1R)-trans-isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R)-isomers)], tralomethrin and transfluthrin; or DDT; or methoxychlor. (4) Nicotinergic acetylcholine receptor (nAChR) agonists such as, for example, neonicotinoids, e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; or nicotine; or sulfoxaflor. (5) Nicotinergic acetylcholine receptor (nAChR) allosteric activators such as, for example, spinosyns, e.g. spinetoram and spinosad. (6) Chloride channel activators such as, for example, avermectins/milbemycins, for example abamectin, emamectin benzoate, lepimectin and milbemectin. (7) Juvenile hormone imitators such as, for example, juvenile hormone analogues, e.g. hydroprene, kinoprene and methoprene; or fenoxycarb; or pyriproxyfen. (8) Active compounds with unknown or nonspecific mechanisms of action such as, for example, alkyl halides, e.g. methyl bromide and other alkyl halides; or chloropicrin; or sulphuryl fluoride; or borax; or tartar emetic. (9) Selective antifeedants, for example pymetrozine; or flonicamid. (10) Mite growth inhibitors, for example clofentezine, hexythiazox and diflovidazin; or etoxazole. (11) Microbial disruptors of the insect gut membrane, e.g. Bacillus thuringiensis subspecies israelensis, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis and B.t. plant proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34 Ab1/35Ab1; or Bacillus sphaericus. (12) Oxidative phosphorylation inhibitors, ATP disruptors, for example diafenthiuron; or organotin compounds, e.g. azocyclotin, cyhexatin and fenbutatin oxide; or propargite; or tetradifon. (13) Oxidative phosphorylation decouplers acting by interrupting the H proton gradient such as, for example, chlorfenapyr, DNOC and sulfluramid. (14) Nicotinergic acetylcholine receptor antagonists such as, for example, bensultap, cartap hydrochloride, thiocyclam, and thiosultap-sodium. (15) Chitin biosynthesis inhibitors, type 0, such as, for example, bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron. (16) Chitin biosynthesis inhibitors, type 1, such as, for example, buprofezin. (17) Moulting disruptors, dipteran, such as, for example, cyromazine. (18) Ecdysone receptor agonists such as, for example, chromafenozide, halofenozide, methoxyfenozide and tebufenozide. (19) Octopaminergic agonists, such as, for example, amitraz. (20) Complex-III electron transport inhibitors such as, for example, hydramethylnone or acequinocyl or fluacrypyrim. (21) Complex-I electron transport inhibitors, for example METI acaricides, e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad; or rotenone (Derris). (22) Voltage-gated sodium channel blockers, for example indoxacarb or metaflumizone. (23) Inhibitors of acetyl-CoA carboxylase such as, for example, tetronic and tetramic acid derivatives, e.g. spirodiclofen, spiromesifen and spirotetramat. (24) Complex-IV electron transport inhibitors such as, for example, phosphines, e.g. aluminium phosphide, calcium phosphide, phosphine and zinc phosphide; or cyanide. (25) Complex-II electron transport inhibitors, such as, for example, cyenopyrafen and cyflumetofen. (28) Ryanodine receptor effectors such as, for example, diamides, e.g. chlorantraniliprole, cyantraniliprole and flubendiamide.
Further active compounds having an unknown mechanism of action, such as, for example, amidoflumet, azadirachtin, benclothiaz, benzoximate, bifenazate, bromopropylate, chinomethionat, cryolite, dicofol, diflovidazin, fluensulphone, flufenerim, flufiprole, fluopyram, fufenozide, imidaclothiz, iprodione, meperfluthrin, pyridalyl, pyrifluquinazon, tetramethylfluthrin and iodomethane; and additionally preparations based on Bacillus firmus (particularly strain CNCM I-1582, for example VOTiVO™, BioNem), and the following known active compounds: 3-bromo-N-{2-bromochlor[(1-cyclopropylethyl)carbamoyl]phenyl}(3-chloropyridinyl)-1H- pyrazolecarboxamide (known from ), 4-{[(6-bromopyridyl)methyl](2- fluoroethyl)amino}furan-2(5H)-one (known from ), 4-{[(6-fluoropyridyl)methyl](2,2- difluoroethyl)amino}furan-2(5H)-one (known from ), 4-{[(2-chloro-1,3-thiazol yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (known from ), 4-{[(6-chloropyrid yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (known from ), flupyradifurone, 4- {[(6-chlorofluoropyridyl)methyl](methyl)amino}furan-2(5H)-one (known from ), 4-{[(5,6-dichloropyridyl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (known from ), 4-{[(6-chlorofluoropyridyl)methyl](cyclopropyl)amino}furan-2(5H)-one (known from ), 4-{[(6-chloropyridyl)methyl](cyclopropyl)amino}furan-2(5H)-one (known from EP A 0 539 588), 4-{[(6-chloropyridyl)methyl](methyl)amino}furan-2(5H)-one (known from EP A 0 539 588), {[1-(6-chloropyridinyl)ethyl](methyl)oxido-λ -sulphanylidene}cyanamide (known from WO2007/149134) and its diastereomers {[(1R)(6-chloropyridinyl)ethyl](methyl)oxido-λ - sulphanylidene}cyanamide (A) and {[(1S)(6-chloropyridinyl)ethyl](methyl)oxido-λ - sulphanylidene}cyanamide (B) (likewise known from ) and also diastereomers [(R)- methyl(oxido){(1R)[6-(trifluoromethyl)pyridinyl]ethyl}-λ -sulphanylidene]cyanamide (A1) and [(S)-methyl(oxido){(1S)[6-(trifluoromethyl)pyridinyl]ethyl}-λ -sulphanylidene]cyanamide (A2), identified as diastereomer group A (known from , ), [(R)- methyl(oxido){(1S)[6-(trifluoromethyl)pyridinyl]ethyl}-λ -sulphanylidene]cyanamide (B1) and [(S)- methyl(oxido){(1R)[6-(trifluoromethyl)pyridinyl]ethyl}-λ -sulphanylidene]cyanamide (B2), identified as diastereomer group B (likewise known from , ) and 11-(4- chloro-2,6-dimethylphenyl)hydroxy-1,4-dioxaazadispiro[4.2.4.2]tetradecenone (known from ), 3-(4'-fluoro-2,4-dimethylbiphenylyl)hydroxyoxaazaspiro[4.5]dec enone (known from ), 1-{2-fluoromethyl[(2,2,2- trifluoroethyl)sulphinyl]phenyl}(trifluoromethyl)-1H-1,2,4-triazolamine (known from ), afidopyropen (known from ), 2-cyano(difluoromethoxy)-N,N- dimethylbenzolsulphonamide (known from ), 2-cyano(difluoromethoxy)-N- methylbenzolsulphonamide (known from ), 2-cyano(difluoromethoxy)-N- ethylbenzenesulphonamide (known from ), 4-(difluoromethoxy)-N-ethyl-N-methyl-1,2- benzothiazolamine-1,1-dioxide (known from ), N-[1-(2,3-dimethylphenyl)(3,5- dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazolamine (known from ), {1'-[(2E)(4- chlorophenyl)propenyl]fluorospiro[indol-3,4'-piperidine]-1(2H)-yl}(2-chloropyridin yl)methanone (known from ), 3-(2,5-dimethylphenyl)hydroxymethoxy-1,8- diazaspiro[4.5]decenone (known from ), 3-(2,5-dimethylphenyl)methoxy oxo-1,8-diazaspiro[4.5]decenyl ethyl carbonate (known from ), 4-(butyn yloxy)(3,5-dimethylpiperidinyl)fluoropyrimidine (known from ), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile (known from ), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl)malononitrile (known from ), 8-[2-(cyclopropylmethoxy)(trifluoromethyl)phenoxy][6- (trifluoromethyl)pyridazinyl]azabicyclo[3.2.1]octane (known from ), flometoquin, PF1364 (CAS Reg. No. 12047762) (known from JP 2010/018586), 5-[5-(3,5-dichlorophenyl) (trifluoromethyl)-4,5-dihydro-1,2-oxazolyl](1H-1,2,4-triazolyl)benzonitrile (known from ), 5-[5-(2-chloropyridinyl)(trifluoromethyl)-4,5-dihydro-1,2-oxazolyl](1H- 1,2,4-triazolyl)benzonitrile (known from ), 4-[5-(3,5-dichlorophenyl) (trifluoromethyl)-4,5-dihydro-1,2-oxazolyl]methyl-N-{2-oxo[(2,2,2- trifluoroethyl)amino]ethyl}benzamide (known from ), 4-{[(6-chloropyridin yl)methyl](cyclopropyl)amino}-1,3-oxazol-2(5H)-one, 4-{[(6-chloropyridinyl)methyl](2,2- difluoroethyl)amino}-1,3-oxazol-2(5H)-one, 4-{[(6-chloropyridinyl)methyl](ethyl)amino}-1,3-oxazol- 2(5H)-one, 4-{[(6-chloropyridinyl)methyl](methyl)amino}-1,3-oxazol-2(5H)-one (all known from ), pyflubumide (known from ), methyl 2-[2-({[3-bromo(3- chloropyridinyl)-1H-pyrazolyl]carbonyl}amino)chloromethylbenzoyl] methylhydrazinecarboxylate (known from ), methyl 2-[2-({[3-bromo(3-chloropyridin- 2-yl)-1H-pyrazolyl]carbonyl}amino)cyanomethylbenzoyl]ethylhydrazinecarboxylate (known from ), methyl 2-[2-({[3-bromo(3-chloropyridinyl)-1H-pyrazol yl]carbonyl}amino)cyanomethylbenzoyl]methylhydrazinecarboxylate (known from ), methyl 2-[3,5-dibromo({[3-bromo(3-chloropyridinyl)-1H-pyrazol yl]carbonyl}amino)benzoyl]-1,2-diethylhydrazinecarboxylate (known from ), methyl 2- [3,5-dibromo({[3-bromo(3-chloropyridinyl)-1H-pyrazolyl]carbonyl}amino)benzoyl] ethylhydrazinecarboxylate (known from ), (5RS,7RS;5RS,7SR)(6-chloro pyridylmethyl)-1,2,3,5,6,7-hexahydromethylnitropropoxyimidazo[1,2-a]pyridine (known from ), 2-{6-[2-(5-fluoropyridinyl)-1,3-thiazolyl]pyridinyl}pyrimidine (known from ), 2-{6-[2-(pyridinyl)-1,3-thiazolyl]pyridinyl}pyrimidine (known from ), 1-(3-chloropyridinyl)-N-[4-cyanomethyl(methylcarbamoyl)phenyl]{[5- (trifluoromethyl)-1H-tetrazolyl]methyl}-1H-pyrazolecarboxamide (known from ), 1-(3-chloropyridinyl)-N-[4-cyanomethyl(methylcarbamoyl)phenyl]{[5-(trifluoromethyl)-2H- tetrazolyl]methyl}-1H-pyrazolecarboxamide (known from ), N-[2-(tert- butylcarbamoyl)cyanomethylphenyl](3-chloropyridinyl){[5-(trifluoromethyl)-1H-tetrazol yl]methyl}-1H-pyrazolecarboxamide (known from ), N-[2-(tert-butylcarbamoyl) cyanomethylphenyl](3-chloropyridinyl){[5-(trifluoromethyl)-2H-tetrazolyl]methyl}-1H- pyrazolecarboxamide (known from ), (1E)-N-[(6-chloropyridinyl)methyl]-N'- cyano-N-(2,2-difluoroethyl)ethanimideamide (known from ), N-[2-(5-amino-1,3,4- thiadiazolyl)chloromethylphenyl]bromo(3-chloropyridinyl)-1H-pyrazolecarboxamide (known from CN 102057925), methyl 2-[3,5-dibromo({[3-bromo(3-chloropyridinyl)-1H-pyrazol- -yl]carbonyl}amino)benzoyl]ethylmethylhydrazinecarboxylate (known from ), heptafluthrin, pyriminostrobin, flufenoxystrobin and 3-chloro-N -(2-cyanopropanyl)-N -[4- (1,1,1,2,3,3,3-heptafluoropropanyl)methylphenyl]phthalamide (known from WO2012/034472).
Antimicrobially active compounds: (1) Ergosterol biosynthesis inhibitors, for example aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidin, fenpropimorph, fluquinconazole, flurprimidol, flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole, imazalil, imazalil sulphate, imibenconazole, ipconazole, metconazole, myclobutanil, naftifin, nuarimol, oxpoconazole, paclobutrazole, pefurazoate, penconazole, piperalin, prochloraz, propiconazole, prothioconazole, pyributicarb, pyrifenox, quinconazole, simeconazole, spiroxamine, tebuconazole, terbinafine, tetraconazole, triadimefon, triadimenol, tridemorph, triflumizole, triforine, triticonazole, uniconazole, uniconazole-p, viniconazole, voriconazole, 1-(4-chlorophenyl)(1H-1,2,4- triazolyl)cycloheptanol, methyl 1-(2,2-dimethyl-2,3-dihydro-1H-indenyl)-1H-imidazole carboxylate, N'-{5-(difluoromethyl)methyl[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N- methylimidoformamide, N-ethyl-N-methyl-N'-{2-methyl(trifluoromethyl)[3- (trimethylsilyl)propoxy]phenyl}imidoformamide and O-[1-(4-methoxyphenoxy)-3,3-dimethylbutan yl] 1H-imidazolecarbothioate. (2) Respiration inhibitors (respiratory chain inhibitors), for example bixafen, boscalid, carboxin, diflumetorim, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, furmecyclox, isopyrazam mixture of the syn-epimeric racemate 1RS,4SR,9RS and of the anti-epimeric racemate 1RS,4SR,9SR, isopyrazam (anti-epimeric racemate), isopyrazam (anti-epimeric enantiomer 1R,4S,9S), isopyrazam (anti-epimeric enantiomer 1S,4R,9R), isopyrazam (syn-epimeric racemate 1RS,4SR,9RS), isopyrazam (syn-epimeric enantiomer 1R,4S,9R), isopyrazam (syn-epimeric enantiomer 1S,4R,9S), mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, thifluzamide, 1-methyl-N-[2-(1,1,2,2- tetrafluoroethoxy)phenyl](trifluoromethyl)-1H-pyrazolecarboxamide, 3-(difluoromethyl) methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazolecarboxamide, 3-(difluoromethyl)-N-[4- fluoro(1,1,2,3,3,3-hexafluoropropoxy)phenyl]methyl-1H-pyrazolecarboxamide and N-[1-(2,4- dichlorophenyl)methoxypropanyl](difluoromethyl)methyl-1H-pyrazolecarboxamide. (3) Respiration inhibitors (respiratory chain inhibitors) acting on complex III of the respiratory chain, for example ametoctradin, amisulbrom, azoxystrobin, cyazofamid, dimoxystrobin, enestroburin, famoxadone, fenamidone, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, trifloxystrobin, (2E)(2- {[6-(3-chloromethylphenoxy)fluoropyrimidinyl]oxy}phenyl)(methoxyimino)-N- methylethanamide, (2E)(methoxyimino)-N-methyl(2-{[({(1E)[3- (trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide, (2E)(methoxyimino)-N- methyl{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}ethanamide, (2E){2- [({[(1E)(3-{[(E)fluorophenylethenyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl} (methoxyimino)-N-methylethanamide, (2E){2-[({[(2E,3E)(2,6-dichlorophenyl)buten ylidene]amino}oxy)methyl]phenyl}(methoxyimino)-N-methylethanamide, 2-chloro-N-(1,1,3- trimethyl-2,3-dihydro-1H-indenyl)pyridinecarboxamide, 5-methoxymethyl(2-{[({(1E)[3- (trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazolone, methyl (2E){2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}sulphanyl)methyl]phenyl} methoxypropenoate, N-(3-ethyl-3,5,5-trimethylcyclohexyl)(formylamino)hydroxybenzamide, 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}methoxy-N-methylacetamide and (2R){2-[(2,5- dimethylphenoxy)methyl]phenyl}methoxy-N-methylacetamide. (4) Mitosis and cell division inhibitors, for example benomyl, carbendazim, chlorfenazole, diethofencarb, ethaboxam, fluopicolide, fuberidazole, pencycuron, thiabendazole, thiophanate-methyl, thiophanate, zoxamide, 5-chloro(4-methylpiperidinyl)(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5- a]pyrimidine and 3-chloro(6-chloropyridinyl)methyl(2,4,6-trifluorophenyl)pyridazine. (5) Compounds with multisite activity, for example Bordeaux mixture, captafol, captan, chlorothalonil, copper formulations such as copper hydroxide, copper naphthenate, copper oxide, copper oxychloride, copper sulphate, dichlofluanid, dithianon, dodine, dodine free base, ferbam, fluorofolpet, folpet, guazatine, guazatine acetate, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, metiram zinc, oxine-copper, propamidine, propineb, sulphur and sulphur preparations, for example calcium polysulphide, thiram, tolylfluanid, zineb and ziram. (6) Resistance inductors, for example acibenzolar-S-methyl, isotianil, probenazole and tiadinil. (7) Amino acid and protein biosynthesis inhibitors, for example andoprim, blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim and pyrimethanil. (8) ATP production inhibitors, for example fentin acetate, fentin chloride, fentin hydroxide and silthiofam. (9) Cell wall synthesis inhibitors, for example benthiavalicarb, dimethomorph, flumorph, iprovalicarb, mandipropamid, polyoxins, polyoxorim, validamycin A and valifenalate. (10) Lipid and membrane synthesis inhibitors, for example biphenyl, chloroneb, dicloran, edifenphos, etridiazole, iodocarb, iprobenfos, isoprothiolane, propamocarb, propamocarb hydrochloride, prothiocarb, pyrazophos, quintozene, tecnazene and tolclofos-methyl. (11) Melanin biosynthesis inhibitors, for example carpropamid, diclocymet, fenoxanil, phthalide, pyroquilon and tricyclazole. (12) Nucleic acid synthesis inhibitors, for example benalaxyl, benalaxyl-M (kiralaxyl), bupirimate, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazol, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl, oxolinic acid, (13) Signal transduction inhibitors, for example chlozolinate, fenpiclonil, fludioxonil, iprodione, procymidone, quinoxyfen and vinclozolin. (14) Decouplers, for example binapacryl, dinocap, ferimzone, fluazinam and meptyldinocap. (15) Further compounds, for example benthiazole, bethoxazin, capsimycin, carvone, chinomethionat, chlazafenone, cufraneb, cyflufenamid, cymoxanil, cyprosulfamide, dazomet, debacarb, dichlorophen, diclomezine, difenzoquat, difenzoquat methylsulphate, diphenylamine, ecomat, fenpyrazamine, flumetover, fluoromide, flusulfamide, flutianil, fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene, irumamycin, methasulfocarb, methyl isothiocyanate, metrafenon, mildiomycin, natamycin, nickel dimethyldithiocarbamate, nitrothal-isopropyl, octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and salts thereof, phenothrin, phosphoric acid and salts thereof, propamocarb- fosetylate, propanosine-sodium, proquinazid, pyrrolnitrin, tebufloquin, tecloftalam, tolnifanid, triazoxide, trichlamide, zarilamide, 1-(4-{4-[(5R)(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazolyl]- 1,3-thiazolyl}piperidinyl)[5-methyl(trifluoromethyl)-1H-pyrazolyl]ethanone, 1-(4-{4- [(5S)(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazolyl]-1,3-thiazolyl}piperidinyl)[5-methyl- 3-(trifluoromethyl)-1H-pyrazolyl]ethanone, 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol- 3-yl]-1,3-thiazolyl}piperidinyl)[5-methyl(trifluoromethyl)-1H-pyrazolyl]ethanone, 1-(4- methoxyphenoxy)-3,3-dimethylbutanyl-1H-imidazolecarboxylate, 2,3,5,6-tetrachloro (methylsulphonyl)pyridine, 2,3-dibutylchlorothieno[2,3-d]pyrimidin-4(3H)-one, 2-[5-methyl (trifluoromethyl)-1H-pyrazolyl](4-{4-[(5R)phenyl-4,5-dihydro-1,2-oxazolyl]-1,3-thiazol yl}piperidinyl)ethanone, 2-[5-methyl(trifluoromethyl)-1H-pyrazolyl](4-{4-[(5S)phenyl- 4,5-dihydro-1,2-oxazolyl]-1,3-thiazolyl}piperidinyl)ethanone, 2-[5-methyl(trifluoromethyl)- 1H-pyrazolyl]{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazolyl)-1,3-thiazolyl]piperidin yl}ethanone, 2-butoxyiodopropyl-4H-chromenone, 2-chloro[2-chloro(2,6-difluoro methoxyphenyl)methyl-1H-imidazolyl]pyridine, 2-phenylphenol and salts thereof, 3,4,5- trichloropyridine-2,6-dicarbonitrile, 3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidinyl]pyridine, 3- chloro(4-chlorophenyl)(2,6-difluorophenyl)methylpyridazine, 4-(4-chlorophenyl)(2,6- difluorophenyl)-3,6-dimethylpyridazine, 5-amino-1,3,4-thiadiazolethiol, 5-chloro-N'-phenyl-N'- (propynyl)thiophenesulphonohydrazide, 5-methyloctyl[1,2,4]triazolo[1,5-a]pyrimidine amine, ethyl (2Z)aminocyanophenylpropenoate, N-(4-chlorobenzyl)[3-methoxy(prop- 2-ynyloxy)phenyl]propanamide, N-[(4-chlorophenyl)(cyano)methyl][3-methoxy(propyn yloxy)phenyl]propanamide, N-[(5-bromochloropyridinyl)methyl]-2,4-dichloropyridine carboxamide, N-[1-(5-bromochloropyridinyl)ethyl]-2,4-dichloropyridinecarboxamide, N-[1-(5- bromochloropyridinyl)ethyl]fluoroiodopyridinecarboxamide, N-{(E)- [(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}phenylacetamide, N- {(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl} phenylacetamide, N-methyl(1-{[5-methyl(trifluoromethyl)-1H-pyrazolyl]acetyl}piperidin yl)-N-(1,2,3,4-tetrahydronaphthalenyl)-1,3-thiazolecarboxamide, N-methyl(1-{[5-methyl (trifluoromethyl)-1H-pyrazolyl]acetyl}piperidinyl)-N-[(1R)-1,2,3,4-tetrahydronaphthalenyl]- 1,3-thiazolecarboxamide, N-methyl(1-{[5-methyl(trifluoromethyl)-1H-pyrazol yl]acetyl}piperidinyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalenyl]-1,3-thiazolecarboxamide, pentyl {6-[({[(1-methyl-1H-tetrazolyl)(phenyl)methylidene]amino}oxy)methyl]pyridinyl}carbamate, phenazinecarboxylic acid, quinolinol and quinolinol sulphate (2:1), (16) Further antimicrobially active compounds: (16.1) benthiazole, (16.2) bethoxazine, (16.3) capsimycin, (16.4) carvone, (16.5) chinomethionat, (16.6) pyriofenone (chlazafenone), (16.7) cufraneb, (16.8) cyflufenamid, (16.9) cymoxanil, (16.10) cyprosulfamide, (16.11) dazomet, (16.12) debacarb, (16.13) dichlorophen, (16.14) diclomezine, (16.15) difenzoquat, (16.16) difenzoquat methylsulphate, (16.17) diphenylamine, (16.18) EcoMate, (16.19) fenpyrazamine, (16.20) flumetover, (16.21) fluoroimide, (16.22) flusulfamide, (16.23) flutianil, (16.24) fosetyl-aluminium, (16.25) fosetyl-calcium, (16.26) fosetyl-sodium, (16.27) hexachlorobenzene, (16.28) irumamycin, (16.29) methasulfocarb, (16.30) methyl isothiocyanate, (16.31) metrafenone, (16.32) mildiomycin, (16.33) natamycin, (16.34) nickel dimethyldithiocarbamate, (16.35) nitrothal-isopropyl, (16.37) oxamocarb, (16.38) oxyfenthiin, (16.39) pentachlorophenol and salts, (16.40) phenothrin, (16.41) phosphoric acid and its salts, (16.42) propamocarb-fosetylate, (16.43) propanosine-sodium, (16.44) pyrimorph, (16.45) (2E)(4-tert- butylphenyl)(2-chloropyridinyl)(morpholinyl)propenone, (16.46) (2Z)(4-tert- butylphenyl)(2-chloropyridinyl)(morpholinyl)propenone, (16.47) pyrrolnitrin, (16.48) tebufloquin, (16.49) tecloftalam, (16.50) tolnifanide, (16.51) triazoxide, (16.52) trichlamide, (16.53) zarilamid, (16.54) (3S,6S,7R,8R)benzyl[({3-[(isobutyryloxy)methoxy]methoxypyridin yl}carbonyl)amino]methyl-4,9-dioxo-1,5-dioxonanyl 2-methylpropanoate, (16.55) 1-(4-{4-[(5R)- -(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazolyl]-1,3-thiazolyl}piperidinyl)[5-methyl (trifluoromethyl)-1H-pyrazolyl]ethanone, (16.56) 1-(4-{4-[(5S)(2,6-difluorophenyl)-4,5-dihydro- 1,2-oxazolyl]-1,3-thiazolyl}piperidinyl)[5-methyl(trifluoromethyl)-1H-pyrazol yl]ethanone, (16.57) 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazolyl]-1,3-thiazol yl}piperidinyl)[5-methyl(trifluoromethyl)-1H-pyrazolyl]ethanone, (16.58) 1-(4- methoxyphenoxy)-3,3-dimethylbutanyl 1H-imidazolecarboxylate, (16.59) 2,3,5,6-tetrachloro (methylsulphonyl)pyridine, (16.60) 2,3-dibutylchlorothieno[2,3-d]pyrimidin-4(3H)-one, (16.61) 2,6- dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone, (16.62) 2-[5-methyl (trifluoromethyl)-1H-pyrazolyl](4-{4-[(5R)phenyl-4,5-dihydro-1,2-oxazolyl]-1,3-thiazol yl}piperidinyl)ethanone, (16.63) 2-[5-methyl(trifluoromethyl)-1H-pyrazolyl](4-{4-[(5S) phenyl-4,5-dihydro-1,2-oxazolyl]-1,3-thiazolyl}piperidinyl)ethanone, (16.64) 2-[5-methyl (trifluoromethyl)-1H-pyrazolyl]{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazolyl)-1,3-thiazol yl]piperidinyl}ethanone, (16.65) 2-butoxyiodopropyl-4H-chromenone, (16.66) 2-chloro [2-chloro(2,6-difluoromethoxyphenyl)methyl-1H-imidazolyl]pyridine, (16.67) 2- phenylphenol and salts, (16.68) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolinyl)quinoline, (16.69) 3,4,5-trichloropyridine-2,6-dicarbonitrile, (16.70) 3-chloro(4-chlorophenyl)(2,6- difluorophenyl)methylpyridazine, (16.71) 4-(4-chlorophenyl)(2,6-difluorophenyl)-3,6- dimethylpyridazine, (16.72) 5-amino-1,3,4-thiadiazolethiol, (16.73) 5-chloro-N'-phenyl-N'-(prop ynyl)thiophenesulphonohydrazide, (16.74) 5-fluoro[(4-fluorobenzyl)oxy]pyrimidineamine, (16.75) 5-fluoro[(4-methylbenzyl)oxy]pyrimidineamine, (16.76) 5-methyl octyl[1,2,4]triazolo[1,5-a]pyrimidineamine, (16.77) ethyl (2Z)aminocyanophenylacrylate, (16.78) N'-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazolyl]oxy}-2,5-dimethylphenyl)-N-ethyl-N- methylimidoformamide, (16.79) N-(4-chlorobenzyl)[3-methoxy(propyn yloxy)phenyl]propanamide, (16.80) N-[(4-chlorophenyl)(cyano)methyl][3-methoxy(propyn yloxy)phenyl]propanamide, (16.81) N-[(5-bromochloropyridinyl)methyl]-2,4- dichloronicotinamide, (16.82) N-[1-(5-bromochloropyridinyl)ethyl]-2,4-dichloronicotinamide, (16.83) N-[1-(5-bromochloropyridinyl)ethyl]fluoroiodonicotinamide, (16.84) N-{(E)- [(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}phenylacetamide, (16.85) N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl} phenylacetamide, (16.86) N'-{4-[(3-tert-butylcyano-1,2-thiazolyl)oxy]chloromethylphenyl}- N-ethyl-N-methylimidoformamide, (16.87) N-methyl(1-{[5-methyl(trifluoromethyl)-1H-pyrazol- 1-yl]acetyl}piperidinyl)-N-(1,2,3,4-tetrahydronaphthalenyl)-1,3-thiazolecarboxamide, (16.88) N-methyl(1-{[5-methyl(trifluoromethyl)-1H-pyrazolyl]acetyl}piperidinyl)-N-[(1R)-1,2,3,4- tetrahydronaphthalenyl]-1,3-thiazolecarboxamide, (16.89) N-methyl(1-{[5-methyl (trifluoromethyl)-1H-pyrazolyl]acetyl}piperidinyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalenyl]- 1,3-thiazolecarboxamide, (16.90) pentyl {6-[({[(1-methyl-1H-tetrazol yl)(phenyl)methylene]amino}oxy)methyl]pyridinyl}carbamate, (16.91) phenazinecarboxylic acid, (16.92) quinolinol, (16.93) quinolinol sulphate (2:1), (16.94) tert-butyl {6-[({[(1-methyl-1H- tetrazolyl)(phenyl)methylene]amino}oxy)methyl]pyridinyl}carbamate, (16.95) 1-methyl (trifluoromethyl)-N-[2'-(trifluoromethyl)biphenylyl]-1H-pyrazolecarboxamide, (16.96) N-(4'- chlorobiphenylyl)(difluoromethyl)methyl-1H-pyrazolecarboxamide, (16.97) N-(2',4'- dichlorobiphenylyl)(difluoromethyl)methyl-1H-pyrazolecarboxamide, (16.98) 3- (difluoromethyl)methyl-N-[4'-(trifluoromethyl)biphenylyl]-1H-pyrazolecarboxamide, (16.99) N-(2',5'-difluorobiphenylyl)methyl(trifluoromethyl)-1H-pyrazolecarboxamide, (16.100) 3- (difluoromethyl)methyl-N-[4'-(propynyl)biphenylyl]-1H-pyrazolecarboxamide, (16.101) 5-fluoro-1,3-dimethyl-N-[4'-(propynyl)biphenylyl]-1H-pyrazolecarboxamide, (16.102) 2- chloro-N-[4'-(propynyl)biphenylyl]nicotinamide, (16.103) 3-(difluoromethyl)-N-[4'-(3,3- dimethylbutynyl)biphenylyl]methyl-1H-pyrazolecarboxamide, (16.104) N-[4'-(3,3- dimethylbutynyl)biphenylyl]fluoro-1,3-dimethyl-1H-pyrazolecarboxamide, (16.105) 3- (difluoromethyl)-N-(4'-ethynylbiphenylyl)methyl-1H-pyrazolecarboxamide, (16.106) N-(4'- ethynylbiphenylyl)fluoro-1,3-dimethyl-1H-pyrazolecarboxamide, (16.107) 2-chloro-N-(4'- ethynylbiphenylyl)nicotinamide, (16.108) 2-chloro-N-[4'-(3,3-dimethylbutynyl)biphenyl yl]nicotinamide, (16.109) 4-(difluoromethyl)methyl-N-[4'-(trifluoromethyl)biphenylyl]-1,3- thiazolecarboxamide, (16.110) 5-fluoro-N-[4'-(3-hydroxymethylbutynyl)biphenylyl]-1,3- dimethyl-1H-pyrazolecarboxamide, (16.111) 2-chloro-N-[4'-(3-hydroxymethylbutyn yl)biphenylyl]nicotinamide, (16.112) 3-(difluoromethyl)-N-[4'-(3-methoxymethylbutyn yl)biphenylyl]methyl-1H-pyrazolecarboxamide, (16.113) 5-fluoro-N-[4'-(3-methoxy methylbutynyl)biphenylyl]-1,3-dimethyl-1H-pyrazolecarboxamide, (16.114) 2-chloro-N-[4'- (3-methoxymethylbutynyl)biphenylyl]nicotinamide, (16.115) (5-bromomethoxy methylpyridinyl)(2,3,4-trimethoxymethylphenyl)methanone, (16.116) N-[2-(4-{[3-(4- chlorophenyl)propynyl]oxy}methoxyphenyl)ethyl]-N2-(methylsulphonyl)valinamide, (16.117) 4-oxo[(2-phenylethyl)amino]butanoic acid, (16.118) butynyl {6-[({[(Z)-(1-methyl-1H-tetrazol- -yl)(phenyl)methylene]amino}oxy)methyl]pyridinyl}carbamate, (16.119) 4-amino fluoropyrimidinol (mesomeric form: 4-aminofluoropyrimidin-2(1H)-one), (16.120) propyl 3,4,5- trihydroxybenzoate, (16.121) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-indenyl)-1H-pyrazole- 4-carboxamide, (16.122) 1,3-dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indenyl]-1H- pyrazolecarboxamide, (16.123) 1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-indenyl]- 1H-pyrazolecarboxamide, (16.124) [3-(4-chlorofluorophenyl)(2,4-difluorophenyl)-1,2-oxazol- 4-yl](pyridinyl)methanol, (16.125) (S)-[3-(4-chlorofluorophenyl)(2,4-difluorophenyl)-1,2- oxazolyl](pyridinyl)methanol, (16.126) (R)-[3-(4-chlorofluorophenyl)(2,4-difluorophenyl)- 1,2-oxazolyl](pyridinyl)methanol, (16.127) 2-{[3-(2-chlorophenyl)(2,4-difluorophenyl)oxiran- 2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazolethione, (16.128) 1-{[3-(2-chlorophenyl)(2,4- difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazolyl thiocyanate, (16.129) 5-(allylsulphanyl) {[3-(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazole, (16.130) 2-[1-(2,4- dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (16.131) 2-{[rel(2R,3S)(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-2,4-dihydro-3H-1,2,4- triazolethione, (16.132) 2-{[rel(2R,3R)(2-chlorophenyl)(2,4-difluorophenyl)oxiran yl]methyl}-2,4-dihydro-3H-1,2,4-triazolethione, (16.133) 1-{[rel(2R,3S)(2-chlorophenyl)(2,4- difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazolyl thiocyanate, (16.134) 1-{[rel(2R,3R)(2- chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazolyl thiocyanate, (16.135) 5- (allylsulphanyl){[rel(2R,3S)(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H- 1,2,4-triazole, (16.136) 5-(allylsulphanyl){[rel(2R,3R)(2-chlorophenyl)(2,4- difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazole, (16.137) 2-[(2S,4S,5S)(2,4-dichlorophenyl) hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (16.138) 2-[(2R,4S,5S) (2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (16.139) 2-[(2R,4R,5R)(2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H- 1,2,4-triazolethione, (16.140) 2-[(2S,4R,5R)(2,4-dichlorophenyl)hydroxy-2,6,6- trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (16.141) 2-[(2S,4S,5R)(2,4- dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (16.142) 2-[(2R,4S,5R)(2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4- triazolethione, (16.143) 2-[(2R,4R,5S)(2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptan yl]-2,4-dihydro-3H-1,2,4-triazolethione, (16.144) 2-[(2S,4R,5S)(2,4-dichlorophenyl)hydroxy- 2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (16.145) 2-fluoro (trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-indenyl)benzamide, (16.146) 2-(6- benzylpyridinyl)quinazoline, (16.147) 2-[6-(3-fluoromethoxyphenyl)methylpyridin yl]quinazoline, (16.148) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolinyl)quinoline, (16.149) abscisic acid.
The active compounds according to the invention can furthermore be combined with microorganisms.
The microorganisms, given good plant tolerance, favourable homeotherm toxicity and good environmental compatibility, are suitable for protecting plants and plant organs, for increasing harvest yields, for improving the quality of the harvested material and for controlling animal pests, especially insects, arachnids, helminths, nematodes and molluscs, which are encountered in agriculture, in horticulture, in animal husbandry, in forests, in gardens and leisure facilities, in the protection of stored products and of materials, and in the hygiene sector. They can preferably be used as crop protection compositions. They are active against normally sensitive and resistant species and against all or some stages of development. The abovementioned microorganisms include: microorganisms from the group of the bacteria, for example Bacillus agri, Bacillus aizawai, Bacillus albolactis, Bacillus amyloliquefaciens, in particular the strain B. amyloliquefaciens IN937a, or strain FZB42, Bacillus cereus, in particular spores of B. cereus CNCM I-1562, Bacillus coagulans, Bacillus endoparasiticus, Bacillus endorhythmos, Bacillus firmus, in particular spores of B. firmus CNCM I- 1582, Bacillus kurstaki, Bacillus lacticola, Bacillus lactimorbus, Bacillus lactis, Bacillus laterosporus, Bacillus lentimorbus, Bacillus licheniformis, Bacillus medusa, Bacillus megaterium, Bacillus metiens, Bacillus natto, Bacillus nigrificans, Bacillus popillae, Bacillus pumilus, in particular the strain B. pumilus GB34, Bacillus siamensis, Bacillus sphaericus, Bacillus subtilis, in particular the strain B. subtilis GB03, or the strain B. subtilis var. amyloliquefaciens FZB24, Bacillus thuringiensis, in particular B. thuringiensis var. israelensis or B. thuringiensis ssp. aizawai strain ABTS-1857 or B. thuringiensis ssp kurstaki strain HD-1, B. thuringiensis var. san diego, B. thuringiensis var. tenebrinos, Bacillus uniflagellatus, Delftia acidovorans, in particular strain RAY209, Lysobacter antibioticus, in particular strain 13-1, Metarhizium anisopliae, Pseudomonas chlororaphis, in particular strain MA342, Pseudomonas proradix, Streptomyces galbus, in particular strain K61, Streptomyces griseoviridis; microorganisms from the group of the fungi, for example Ampelomyces quisqualis, in particular strain AQ10, Aureobasidium pullulans, in particular blastospores of strain DSM14940 or blastospores of strain DSM14941 or mixtures thereof, Beauveria bassiana, in particular strain ATCC74040, Beauveria brongniartii, Candida oleophila, in particular strain O, Coniothyrium minitans, in particular strain CON/M/91-8, Dilophosphora alopecuri, Gliocladium catenulatum, in particular strain J1446; Hirsutella thompsonii, Lagenidium giganteum, Lecanicillium lecanii (previously known as Verticillium lecanii), in particular conidia of strain KV01, Metarhizium anisopliae, in particular strain F52, Metschnikovia fructicola, in particular strain NRRL Y-30752, Microsphaeropsis ochracea, Muscodor albus, in particular strain QST20799, Nomuraea rileyi, Paecilomyces lilacinus, in particular spores of strain P. lilacinus 251, Penicillium bilaii, in particular strain ATCC22348, Pichia anomala, in particular strain WRL-076, Pseudozyma flocculosa, in particular strain PF-A22 UL, Pytium oligandrum DV74, Trichoderma asperellum, in particular strain ICC012, Trichoderma harzianum, insbesondere T. harzianum T39, Verticillium lecanii, in particular the strains DAOM198499 and DAOM216596; insecticidal microorganisms from the group of the protozoa, for example Nosema locustae, Vairimorpha; insecticidal microorganisms from the group of the viruses, for example Gypsy moth (Lymantria dispar) nuclear polyhedrosis virus (NPV), Tussock moth (Lymantriidae) NPV, Heliothis NPV, Pine sawfly (Neodiprion) NPV, Codling moth (Cydia pomonella) granulosis virus (GV); microorganisms from the group of the entomopathogenic nematodes, for example Steinernema scapterisci, Steinernema feltiae (Neoaplectana carpocapsae), Heterorhabditis heliothidis, Xenorhabdus luminescence.
The active compounds identified here by their common names are known and are described, for example, in the pesticide handbook ("The Pesticide Manual" 14th Ed., British Crop Protection Council 2006) or can be found on the Internet (e.g. http://www.alanwood.net/pesticides).
All mixing partners mentioned in classes (1) to (16) can, if they are capable on the basis of their functional groups, optionally form salts with suitable bases or acids.
Finally, it has been found that the novel compounds of the formula (I), whilst being well tolerated by plants, with favourable homeotherm toxicity and good environmental compatibility, are suitable in particular for controlling animal pests, especially arthropods, insects, arachnids, helminths, nematodes and molluscs, which are encountered in agriculture, in forests, in the protection of stored products and materials and in the hygiene sector, or in the animal health sector. The compounds according to the invention can likewise be used in the animal health sector, for example for controlling endo- and/or ectoparasites.
The compounds according to the invention can be used as agents for controlling animal pests, preferably as crop protection agents. They are active against normally sensitive and resistant species and against all or some stages of development.
The compounds according to the invention can be converted into generally known formulations. In general, such formulations comprise from 0.01 to 98% by weight of active compound, preferably from 0.5 to 90% by weight.
The compounds according to the invention can be present in their commercially available formulations and in the use forms, prepared from these formulations, as a mixture with other active compounds or synergists. Synergists are compounds which enhance the action of the active compounds, without any need for the synergist added to be active itself.
The active compound content of the use forms prepared from the commercially available formulations may vary within wide limits. The active compound concentration of the application forms may be from 0.00000001 to 95% by weight of active compound, preferably from 0.00001 to 1% by weight.
The compounds are employed in a customary manner appropriate for the use forms.
All plants and plant parts can be treated in accordance with the invention. Plants in this context are understood to include all plants and plant populations, such as desired and unwanted wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant varieties which can or cannot be protected by varietal property rights. Plant parts are to be understood as meaning all above-ground and below-ground parts and organs of plants, such as shoot, leaf, flower and root, examples which may be mentioned being leaves, needles, stems, trunks, flowers, fruit-bodies, fruits and seeds and also roots, tubers and rhizomes. The plant parts also include harvested material and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, slips and seed.
The treatment according to the invention of the plants and plant parts with the active compounds is effected directly or by allowing them to act on the surroundings, habitat or storage space thereof by the customary treatment methods, for example by dipping, spraying, evaporating, fogging, scattering, painting on, injecting, and, in the case of propagation material, especially in the case of seeds, also by applying one or more coats.
As already mentioned above, it is possible to treat all plants and their parts according to the invention. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and also parts thereof, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering methods, if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated. The terms "parts" and "parts of plants" or "plant parts" have been elucidated above.
More preferably, plants of the plant cultivars which are each commercially available or in use are treated in accordance with the invention. Plant cultivars are to be understood as meaning plants having new properties ("traits") and which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They may be cultivars, biotypes and genotypes.
In the animal health sector, i.e. in the field of veterinary medicine, the active compounds according to the present invention act against animal parasites, especially ectoparasites or, in a further embodiment, also endoparasites. The term "endoparasites" includes especially helminths such as cestodes, nematodes or trematodes, and protozoa such as coccidia. Ectoparasites are typically and preferably arthropods, especially insects such as flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice, fleas and the like; or acaricides such as ticks, for example hard ticks or soft ticks, or mites such as scab mites, harvest mites, bird mites and the like, and also aquatic ectoparasites such as copepods.
These parasites include: From the order of the Anoplurida, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phthirus spp. and Solenopotes spp.; specific examples are: Linognathus setosus, Linognathus vituli, Linognathus ovillus, Linognathus oviformis, Linognathus pedalis, Linognathus stenopsis, Haematopinus asini macrocephalus, Haematopinus eurysternus, Haematopinus suis, Pediculus humanus capitis, Pediculus humanus corporis, Phylloera vastatrix, Phthirus pubis, Solenopotes capillatus; From the order of the Mallophagida and the suborders Amblycerina and Ischnocerina, for example, Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp.; specific examples are: Bovicola bovis, Bovicola ovis, Bovicola limbata, Damalina bovis, Trichodectes canis, Felicola subrostratus, Bovicola caprae, Lepikentron ovis, Werneckiella equi; From the order of the Diptera and the suborders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Odagmia spp., Wilhelmia spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp., Melophagus spp., Rhinoestrus spp., Tipula spp.; specific examples are: Aedes aegypti, Aedes albopictus, Aedes taeniorhynchus, Anopheles gambiae, Anopheles maculipennis, Calliphora erythrocephala, Chrysozona pluvialis, Culex quinquefasciatus, Culex pipiens, Culex tarsalis, Fannia canicularis, Sarcophaga carnaria, Stomoxys calcitrans, Tipula paludosa, Lucilia cuprina, Lucilia sericata, Simulium reptans, Phlebotomus papatasi, Phlebotomus longipalpis, Odagmia ornata, Wilhelmia equina, Boophthora erythrocephala, Tabanus bromius, Tabanus spodopterus, Tabanus atratus, Tabanus sudeticus, Hybomitra ciurea, Chrysops caecutiens, Chrysops relictus, Haematopota pluvialis, Haematopota italica, Musca autumnalis, Musca domestica, Haematobia irritans irritans, Haematobia irritans exigua, Haematobia stimulans, Hydrotaea irritans, Hydrotaea albipuncta, Chrysomya chloropyga, Chrysomya bezziana, Oestrus ovis, Hypoderma bovis, Hypoderma lineatum, Przhevalskiana silenus, Dermatobia hominis, Melophagus ovinus, Lipoptena capreoli, Lipoptena cervi, Hippobosca variegata, Hippobosca equina, Gasterophilus intestinalis, Gasterophilus haemorroidalis, Gasterophilus inermis, Gasterophilus nasalis, Gasterophilus nigricornis, Gasterophilus pecorum, Braula coeca; From the order of the Siphonapterida, for example Pulex spp., Ctenocephalides spp., Tunga spp., Xenopsylla spp., Ceratophyllus spp.; specific examples are: Ctenocephalides canis, Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsylla cheopis; From the order of the Heteropterida, for example, Cimex spp., Triatoma spp., Rhodnius spp. and Panstrongylus spp.
From the order of the Blattarida, for example Blatta orientalis, Periplaneta americana, Blattela germanica and Supella spp. (e.g. Suppella longipalpa); From the subclass of the Acari (Acarina) and the orders of the Meta- and Mesostigmata, for example, Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Rhipicephalus (Boophilus) spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Dermanyssus spp., Rhipicephalus spp. (the original genus of multihost ticks), Ornithonyssus spp., Pneumonyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp., Varroa spp., Acarapis spp.; specific examples are: Argas persicus, Argas reflexus, Ornithodorus moubata, Otobius megnini, Rhipicephalus (Boophilus) microplus, Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) annulatus, Rhipicephalus (Boophilus) calceratus, Hyalomma anatolicum, Hyalomma aegypticum, Hyalomma marginatum, Hyalomma transiens, Rhipicephalus evertsi, Ixodes ricinus, Ixodes hexagonus, Ixodes canisuga, Ixodes pilosus, Ixodes rubicundus, Ixodes scapularis, Ixodes holocyclus, Haemaphysalis concinna, Haemaphysalis punctata, Haemaphysalis cinnabarina, Haemaphysalis otophila, Haemaphysalis leachi, Haemaphysalis longicorni, Dermacentor marginatus, Dermacentor reticulatus, Dermacentor pictus, Dermacentor albipictus, Dermacentor andersoni, Dermacentor variabilis, Hyalomma mauritanicum, Rhipicephalus sanguineus, Rhipicephalus bursa, Rhipicephalus appendiculatus, Rhipicephalus capensis, Rhipicephalus turanicus, Rhipicephalus zambeziensis, Amblyomma americanum, Amblyomma variegatum, Amblyomma maculatum, Amblyomma hebraeum, Amblyomma cajennense, Dermanyssus gallinae, Ornithonyssus bursa, Ornithonyssus sylviarum, Varroa jacobsoni; From the order of the Actinedida (Prostigmata) und Acaridida (Astigmata), for example, Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp., Laminosioptes spp.; specific examples are: Cheyletiella yasguri, Cheyletiella blakei, Demodex canis, Demodex bovis, Demodex ovis, Demodex caprae, Demodex equi, Demodex caballi, Demodex suis, Neotrombicula autumnalis, Neotrombicula desaleri, Neoschongastia xerothermobia, Trombicula akamushi, Otodectes cynotis, Notoedres cati, Sarcoptis canis, Sarcoptes bovis, Sarcoptes ovis, Sarcoptes rupicaprae (=S. caprae), Sarcoptes equi, Sarcoptes suis, Psoroptes ovis, Psoroptes cuniculi, Psoroptes equi, Chorioptes bovis, Psoergates ovis, Pneumonyssoidic mange, Pneumonyssoides caninum, Acarapis woodi.
From the subclass of the copepods with the order of the Siphonostomatoida in particular the genera Lepeophtheirus and Caligus; the species Lepeophtheirus salmonis, Caligus elongatus and Caligus clemensi may be mentioned by way of example and with particular preference.
The active compounds according to the invention are also suitable for controlling arthropods, helminths and protozoa which attack animals. The animals include agricultural livestock, for example cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese, cultured fish, honey bees. The animals also include domestic animals - also referred to as companion animals - for example dogs, cats, caged birds, aquarium fish, and what are known as test animals, for example hamsters, guinea pigs, rats and mice.
The control of these arthropods – or, in a further embodiment, also helminths and/or protozoa – should reduce cases of death and improve the performance (for meat, milk, wool, hides, eggs, honey etc.) and the health of the host animal, and so the use of the active compounds according to the invention enables more economically viable and easier animal husbandry.
For example, it is desirable to prevent or to interrupt the uptake of blood from the host by the parasites (if relevant). Control of the parasites can also contribute to preventing the transmission of infectious substances.
The term "control" as used herein with regard to the field of animal health means that the active compounds act by reducing the occurrence of the parasite in question in an animal infested with such parasites to a harmless level. More specifically, "control" as used herein means that the active compound kills the parasite in question, retards its growth or inhibits its proliferation.
In general, the active compounds according to the invention can be employed directly when they are used for the treatment of animals. They are preferably employed in the form of pharmaceutical compositions which may comprise the pharmaceutically acceptable excipients and/or auxiliaries known in the prior art.
In the sector of animal health and in animal husbandry, the active compounds are employed (administered) in a known manner, by enteral administration in the form of, for example, tablets, capsules, potions, drenches, granules, pastes, boluses, the feed-through process and suppositories, by parenteral administration, for example by injection (intramuscular, subcutaneous, intravenous, intraperitoneal inter alia), implants, by nasal administration, by dermal administration in the form, for example, of dipping or bathing, spraying, pouring on and spotting on, washing and powdering, and also with the aid of moulded articles containing the active compound, such as collars, earmarks, tailmarks, limb bands, halters, marking devices, etc. The active compounds can be formulated as a shampoo or as suitable formulations applicable in aerosols or unpressurized sprays, for example pump sprays and atomizer sprays, In the case of employment for livestock, poultry, domestic pets, etc., the active compounds according to the invention can be employed as formulations (for example powders, wettable powders ["WP"], emulsions, emulsifiable concentrates ["EC"], free-flowing compositions, homogeneous solutions and suspension concentrates ["SC"]), which contain the active compounds in an amount of 1 to 80% by weight, directly or after dilution (e.g. 100- to 10 000-fold dilution ), or they can be used as a chemical bath.
In the case of use in the animal health sector, the active compounds according to the invention can be used in combination with suitable synergists, repellents or other active compounds, for example acaricides, insecticides, anthelmintics, anti-protozoal agents, in order to widen the activity spectrum.
Potential mixing components for compounds of the formula (I) according to the invention for applications in animal health may be one or more compounds of the groups of active compounds already listed on pages 29 (from line 33 onwards) to page 41 (line 17). Here, the following selection or additionally the following active compounds is/are particularly suitable for use in mixtures for applications in the animal health sector: From the group of the acetylcholinesterase (AChE) inhibitors: from the group of the carbamates, bendiocarb, carbaryl, methomyl, promacyl and propoxur may be mentioned here as being particularly preferred for applications against ectoparasites; or from the group of the organophosphates, azamethiphos, chlorfenvinphos, chlorpyrifos, coumaphos, cythioate, diazinon (dimpylate), dichlorvos (DDVP), dicrotophos, dimethoate, ethion (diethion), famphur (famophos), fenitrothion, fenthion (MPP), heptenophos, malathion, naled, phosmet (PMP, phtalofos) phoxim, propetamphos, temephos, tetrachlorvinphos (CVMP) and triclorfon/metrifonate may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the GABA-gated chloride channel antagonists: from the group of the organochlorines, endosulphan (alpha-) and lindane may be mentioned here as being particularly preferred for applications against ectoparasites; or from the group of the fiproles (phenylpyrazoles), for example acetoprole, ethiprole, fipronil, pyrafluprole, pyriprole and rizazole, fipronil and pyriprole may be mentioned here as being particularly preferred for applications against ectoparasites; or from the group of the arylisoxazolines, arylpyrrolines, arylpyrrolidines, for example fluralaner (known from WO2009/2024541, Ex. 11-1; but also compounds from WO2012007426, WO2012042006, WO2012042007, WO2012107533, WO2012120135, WO2012165186, WO2012155676, WO2012017359, WO2012127347, WO2012038851, WO2012120399, WO2012156400, WO2012163959, WO2011161130, WO2011073444, WO2011092287, WO2011075591, WO2011157748, , , , ), afoxolaner (e.g. in WO2011149749) and structurally related arylpyrrolines (known, for example, from WO2009/072621, WO 2010020522, WO 2009112275, WO 2009097992, WO 2009072621, JP 2008133273, JP 2007091708), or arylpyrrolidines (e.g. in WO2012004326, WO2012035011, WO2012045700, WO 2010090344, WO 2010043315, WO 2008128711, JP 2008110971), afoxolaner and fluaralaner may be mentioned here as being particularly preferred for applications against ectoparasites, or from the group of the so-called metadiamides (known, for example, from WO2012020483, WO2012020484, WO2012077221, WO2012069366, WO2012175474, WO2011095462, WO2011113756, WO2011093415, WO2005073165).
From the group of the sodium channel modulators / voltage-gated sodium channel blockers: from the group of the pyrethroids the type I pyrethroids allethrin, bioallethrin, permethrin, phenothrin, resmethrin, tetramethrin and the type II pyrethroids (alphacyanopyrethroids) alpha-cypermethrin, cyfluthrin (beta-), cyhalothrin (lambda-), cypermethrin (alpha-, zeta-), deltamethrin, fenvalerate, flucythrinate, flumethrin, fluvalinate (tau-), and the ester-free pyrethroids etofenprox and silafluofen may be mentioned here as being particularly preferred for applications against ectoparasites. Active compounds from this class are very particularly suitable as mixing components, since they have a longer-lasting contact-repelling action and therefore add this component to the activity spectrum.
From the group of the nicotinergic acetylcholine receptor agonists, chlothianidin, dinotefuran, imidacloprid, nitenpyram, and thiacloprid, or nicotine or flupyradifurone, may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the allosteric acetylcholine receptor modulators (agonists), spinosad and spinetoram may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the chloride channel activators, doramectin, eprinomectin, ivermectin, milbemycin oxime, moxidectin, selamectin and nodulisporic acid A may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the juvenile hormone analogues, for example hydroprene (S-), kinoprene, methoprene (S-); or fenoxycarb; pyriproxyfen; methoprene (S-) and pyriproxyfen may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the mite growth inhibitors, etoxazole may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the Slo and latrophilin receptor agonists such as cyclic depsipeptides, for example emodepside and its precursor PF1022A (known from EP 382173, compound I), emodepside may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the chitin biosynthesis inhibitors, type 0, such as benzoylureas, diflubenzuron, fluazuron, lufenuron and triflumuron may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the moulting disruptors, cyromazine and dicyclanil may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the octopaminergic agonists, amitraz, cymiazole and demiditraz may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the complex I electron transport inhibitors, such as from the group of the METI acaricides, fenpyroximate, pyrimidifen and tolfenpyrad may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the blockers of the voltage-gated sodium channel, indoxacarb and metaflumizone may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the inhibitors of acetyl-CoA carboxylase, such as tetronic acid derivatives or tetramic acid derivatives, spirodiclofen and spiromesifen and also spirotetramat may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the ryanodine receptor effectors, flubendiamide, Rynaxypyr and Cyazypyr may be mentioned here as being particularly preferred for applications against ectoparasites.
From the group of the effectors having an unknown mechanism of action, particular mention may be made of 1-(3-chloropyridinyl)-N-[4-cyanomethyl(methylcarbamoyl)phenyl]{[5- (trifluoromethyl)-2H-tetrazolyl]methyl}-1H-pyrazolecarboxamide (known from WO2010/069502).
From the group of the synergists that can be used to further enhance the activity, MGK264 (N- octylbicycloheptenecarboxamide), piperonyl butoxide (PBO) and verbutin may be mentioned here as being particularly preferred for applications against ectoparasites.
In addition to these groups, it is also possible to use short-term repellents in mixtures or a combined application. Examples are DEET (N,N-diethylmethylbenzamide), icaridin (1-piperidinecarboxylic acid), (1S, 20S)methylpiperidinylcyclohexenecarboxamide (SS220), indalone (butyl 3,4- dihydro-2, 2-dimethyloxo-2H-pyrancarboxylate), dihydronepetalactones, nootkatone, IR3535 (3- [N-butyl-N-acetyl]-aminopropionic acid ethyl ester), 2-ethylhexane-1,3-diol, (1R,2R,5R)(2- hydroxypropanyl)methyl-cyclohexanol, dimethyl benzene-1,2-dicarboxylate, dodecanoic acid, undecanone, N,N-diethylphenylacetamide and essential oils or other plant ingredients of known repellent action such as, for example, borneol, callicarpenal, 1,8-cineol (eucalyptol), carvacrol, b- citronellol, a-copaene, coumarin (or its synthetic derivatives known from US20120329832). Icaridin, indalone and IR3535 (3-[N-butyl-N-acetyl]-aminopropionic acid ethyl ester) are particularly preferred for use against ectoparasites.
From the groups (I-1) to (I-25) mentioned above, the following groups are preferred as mixing components: (I-2), (I-3), (I-4), (I-5), (I-6), (I-17), (I-25).
Very particularly preferred examples of insecticidally or acaricidally active compounds, synergists or repellents as mixing components for the compounds of the formula (I) according to the invention are afoxolaner, allethrin, amitraz, bioallethrin, chlothianidin, cyfluthrin (beta-), cyhalothrin (lambda-), cymiazole, cypermethrin (alpha-, zeta-), cyphenothrin, deltamethrin, demiditraz, dinotefuran, doramectin, eprinomectin, etofenprox, fenvalerate, fipronil, fluazuron, flucythrinate, flumethrin, fluralaner, fluvalinate (tau-), icaridin, imidacloprid, ivermectin, MGK264, milbemycin oxime, moxidectin, nitenpyram, permethrin, phenothrin, piperonyl butoxide, pyriprole, resmethrin, selamectin, silafluofen, spinetoram, spinosad, tetramethrin, thiacloprid.
It has also been found that the compounds according to the invention have strong insecticidal action against insects which destroy industrial materials. Industrial materials in the present context are understood to mean inanimate materials, such as preferably plastics, adhesives, sizes, papers and cards, leather, wood, processed wood products and coating compositions.
In addition, the compounds according to the invention can be used as antifouling compositions, alone or in combinations with other active compounds.
The active compounds are also suitable for controlling animal pests in the domestic sector, in the hygiene sector and in the protection of stored products, especially insects, arachnids and mites, which are found in enclosed spaces, for example homes, factory halls, offices, vehicle cabins and the like. They can be used to control these pests alone or in combination with other active compounds and auxiliaries in domestic insecticide products. They are effective against sensitive and resistant species, and against all developmental stages.
Plants are to be understood to mean all plant species, plant cultivars and plant populations such as wanted and unwanted wild plants or crop plants. Crop plants to be treated according to the invention are plants which occur naturally or those which have been obtained by conventional breeding and optimization methods or by biotechnological and recombinant methods or by combining the methods mentioned above. The term crop plant does, of course, also include transgenic plants.
Plant cultivars are to be understood as meaning plants having new properties (traits) and which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques or a combination thereof. They can be cultivars, varieties, bio- or genotypes.
Plant parts are understood to mean all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, in particular leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. The term plant parts also includes harvested material and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, slips and seeds or seed.
In a preferred embodiment, naturally occurring plant species and plant cultivars, or those obtained by conventional breeding and optimization methods (e.g. crossing or protoplast fusion), and also plant parts thereof, are treated.
In a further embodiment according to the invention, transgenic plants obtained by genetic engineering methods, if appropriate in combination with conventional methods, and parts thereof are treated.
The treatment method according to the invention is preferably employed for genetically modified organisms such as, for example, plants or plant parts.
Genetically modified plants, so-called transgenic plants, are plants in which a heterologous gene has been stably integrated into the genome.
The expression "heterologous gene" essentially means a gene which is provided or assembled outside the plant and when introduced in the nuclear, chloroplastic or mitochondrial genome gives the transformed plant new or improved agronomic or other properties by expressing a protein or polypeptide of interest or by downregulating or silencing another gene/other genes which is/are present in the plant (using for example, antisense technology, cosuppression technology or RNA interference [RNAi] technology). A heterologous gene that is present in the genome is also called a transgene. A transgene that is defined by its particular location in the plant genome is called a transformation or transgenic event.
Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, vegetation period, diet), the treatment according to the invention may also result in superadditive ("synergistic") effects. For example, the following effects which exceed the effects actually to be expected are possible: reduced application rates and/or widened spectrum of activity and/or increased efficacy of the active compounds and compositions which can be used in accordance with the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salinity, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, bigger fruits, greater plant height, greener leaf colour, earlier flowering, higher quality and/or a higher nutritional value of the harvested products, higher sugar concentration within the fruits, better storage stability and/or processability of the harvested products.
At certain application rates, the active compound combinations according to the invention may also have a strengthening effect on plants. Accordingly, they are also suitable for mobilizing the defence system of the plant against attack by unwanted phytopathogenic fungi and/or microorganisms and/or viruses. This may optionally be one of the reasons for the enhanced activity of the combinations according to the invention, for example against fungi. Plant-strengthening (resistance-inducing) substances are also to be understood as meaning, in the present context, those substances or combinations of substances which are capable of stimulating the defence system of plants in such a way that, when subsequently inoculated with unwanted phytopathogenic fungi and/or microorganisms and/or viruses, the treated plants display a substantial degree of resistance to these unwanted phytopathogenic fungi and/or microorganisms and/or viruses. In the present case, unwanted phytopathogenic fungi and/or microorganisms and/or viruses are understood as meaning phytopathogenic fungi, bacteria and viruses. The substances according to the invention can therefore be used for protection of plants from attack by the pathogens mentioned within a certain period of time after treatment. The period of time within which protection is effected generally extends from 1 to 10 days, preferably 1 to 7 days, after the treatment of the plants with the active compounds.
Plants which are furthermore preferably treated according to the invention are resistant against one or more biotic stress factors, i.e. said plants have a better defence against animal and microbial pests, such as nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and/or viroids.
In addition to the plants and plant cultivars mentioned above, is is also possible to treat those according to the invention which are resistant to one or more abiotic stress factors.
Abiotic stress conditions may include, for example, drought, cold temperature exposure, heat exposure, osmotic stress, waterlogging, increased soil salinity, increased exposure to minerals, exposure to ozone, exposure to strong light, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients or shade avoidance.
Plants and plant cultivars which may also be treated according to the invention are those plants characterized by enhanced yield characteristics. Enhanced yield in these plants may be the result of, for example, improved plant physiology, improved plant growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation. Yield can also be affected by improved plant architecture (under stress and non-stress conditions), including early flowering, flowering control for hybrid seed production, seedling vigour, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, seed number per pod or ear, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance. Further yield traits include seed composition, such as carbohydrate content, protein content, oil content and oil composition, nutritional value, reduction in antinutritional compounds, improved processability and better storage stability.
Plants that may be treated according to the invention are hybrid plants that already express the characteristic of heterosis or hybrid vigor which results in generally higher yield, vigor, health and resistance towards biotic and abiotic stresses. Such plants are typically made by crossing an inbred male- sterile parent line (the female parent) with another inbred male-fertile parent line (the male parent).
Hybrid seed is typically harvested from the male-sterile plants and sold to growers. Male-sterile plants can sometimes (e.g. in maize) be produced by detasseling, (i.e. the mechanical removal of the male reproductive organs or male flowers) but, more typically, male sterility is the result of genetic determinants in the plant genome. In that case, and especially when seed is the desired product to be harvested from the hybrid plants, it is typically useful to ensure that male fertility in hybrid plants, which contain the genetic determinants responsible for male sterility, is fully restored. This can be accomplished by ensuring that the male parents have appropriate fertility restorer genes which are capable of restoring the male fertility in hybrid plants that contain the genetic determinants responsible for male sterility. Genetic determinants for male sterility may be located in the cytoplasm. Examples of cytoplasmic male sterility (CMS) were for instance described for Brassica species. However, genetic determinants for male sterility can also be located in the nuclear genome. Male-sterile plants can also be obtained by plant biotechnology methods such as genetic engineering. A particularly useful means of obtaining male-sterile plants is described in WO 89/10396, in which, for example, a ribonuclease such as a barnase is selectively expressed in the tapetum cells in the stamens. Fertility can then be restored by expression in the tapetum cells of a ribonuclease inhibitor such as barstar.
Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may be treated according to the invention are herbicide-tolerant plants, i.e. plants made tolerant to one or more given herbicides. Such plants can be obtained either by genetic transformation, or by selection of plants containing a mutation imparting such herbicide tolerance.
Herbicide-tolerant plants are for example glyphosate-tolerant plants, i.e. plants made tolerant to the herbicide glyphosate or salts thereof. Thus, for example, glyphosate-tolerant plants can be obtained by transforming the plant with a gene encoding the enzyme 5-enolpyruvylshikimatephosphate synthase (EPSPS). Examples of such EPSPS genes are the AroA gene (mutant CT7) of the bacterium Salmonella typhimurium, the CP4 gene of the bacterium Agrobacterium sp., the genes encoding a petunia EPSPS, a tomato EPSPS, or an Eleusine EPSPS. It can also be a mutated EPSPS. Glyphosate-tolerant plants can also be obtained by expressing a gene that encodes a glyphosate oxidoreductase enzyme. Glyphosate- tolerant plants can also be obtained by expressing a gene that encodes a glyphosate acetyl transferase enzyme. Glyphosate-tolerant plants can also be obtained by selecting plants naturally-occurring mutations of the above-mentioned genes.
Other herbicide resistant plants are for example plants that have been made tolerant to herbicides inhibiting the enzyme glutamine synthase, such as bialaphos, phosphinothricin or glufosinate. Such plants can be obtained by expressing an enzyme detoxifying the herbicide or a mutant of the glutamine synthase enzyme that is resistant to inhibition. One such efficient detoxifying enzyme is, for example, an enzyme encoding a phosphinothricin acetyltransferase (such as the bar or pat protein from Streptomyces species for example). Plants expressing an exogenous phosphinothricin acetyltransferase have been described.
Further herbicide-tolerant plants are also plants that have been made tolerant to the herbicides inhibiting the enzyme hydroxyphenylpyruvate dioxygenase (HPPD). Hydroxyphenylpyruvate dioxygenases are enzymes that catalyse the reaction in which para-hydroxyphenylpyruvate (HPP) is converted to homogentisate. Plants tolerant to HPPD inhibitors can be transformed with a gene encoding a naturally- occurring resistant HPPD enzyme, or a gene encoding a mutated HPPD enzyme. Tolerance to HPPD inhibitors can also be obtained by transforming plants with genes encoding certain enzymes enabling the formation of homogentisate despite the inhibition of the native HPPD enzyme by the HPPD inhibitor.
Tolerance of plants to HPPD inhibitors can also be improved by transforming plants with a gene encoding a prephenate dehydrogenase enzyme in addition to a gene encoding an HPPD-tolerant enzyme.
Further herbicide-resistant plants are plants that have been made tolerant to acetolactate synthase (ALS) inhibitors. The known ALS inhibitors include, for example, sulphonylurea, imidazolinone, triazolopyrimidines, pyrimidinyl oxy(thio)benzoates and/or sulphonylaminocarbonyltriazolinone herbicides. Different mutations in the ALS enzyme (also known as acetohydroxy acid synthase, AHAS) are known to confer tolerance to different herbicides and groups of herbicides. The production of sulphonylurea-tolerant plants and imidazolinone-tolerant plants has been described in the international publication . Further sulphonylurea- and imidazolinone-tolerant plants have also been described, for example in .
Other plants tolerant to imidazolinone and/or sulphonylurea can be obtained by induced mutagenesis, selection in cell cultures in the presence of the herbicide or mutation breeding.
Plants or plant varieties (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are insect-resistant transgenic plants, i.e. plants made resistant to attack by certain target insects. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such insect resistance.
The term "insect-resistant transgenic plant", as used herein, includes any plant containing at least one transgene comprising a coding sequence encoding: 1) an insecticidal crystal protein from Bacillus thuringiensis or an insecticidal portion thereof, such as the insecticidal crystal proteins compiled online at: http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/, or insecticidal portions thereof, e.g., proteins of the Cry protein classes Cry1Ab, Cry1Ac, Cry1F, Cry2Ab, Cry3Ae, or Cry3Bb or insecticidal portions thereof; or 2) a crystal protein from Bacillus thuringiensis or a portion thereof which is insecticidal in the presence of a second other crystal protein from Bacillus thuringiensis or a portion thereof, such as the binary toxin made up of the Cry34 and Cry35 crystal proteins; or 3) a hybrid insecticidal protein comprising parts of two different insecticidal crystal proteins from Bacillus thuringiensis, such as a hybrid of the proteins of 1) above or a hybrid of the proteins of 2) above, e.g., the Cry1A.105 protein produced by maize event MON98034 (); or 4) a protein of any one of points 1) to 3) above wherein some, particularly 1 to 10, amino acids have been replaced by another amino acid to obtain a higher insecticidal activity to a target insect species, and/or to expand the range of target insect species affected, and/or because of changes induced into the encoding DNA during cloning or transformation, such as the Cry3Bb1 protein in maize events MON863 or MON88017, or the Cry3A protein in maize event MIR 604; ) an insecticidal secreted protein from Bacillus thuringiensis or Bacillus cereus, or an insecticidal portion thereof, such as the vegetative insecticidal proteins (VIP) listed at: http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/vip.html, for example proteins from the VIP3Aa protein class; or 6) a secreted protein from Bacillus thuringiensis or Bacillus cereus which is insecticidal in the presence of a second secreted protein from Bacillus thuringiensis or B. cereus, such as the binary toxin made up of the VIP1A and VIP2A proteins; 7) a hybrid insecticidal protein comprising parts from different secreted proteins from Bacillus thuringiensis oder Bacillus cereus, such as a hybrid of the proteins in 1) above or a hybrid of the proteins in 2) above; or 8) a protein of any one of points 1) to 3) above wherein some, particularly 1 to 10, amino acids have been replaced by another amino acid to obtain a higher insecticidal activity to a target insect species, and/or to expand the range of target insect species affected, and/or because of changes induced into the encoding DNA during cloning or transformation (while still encoding an insecticidal protein), such as the VIP3Aa protein in cotton event COT 102.
Of course, an insect-resistant transgenic plant, as used herein, also includes any plant comprising a combination of genes encoding the proteins of any one of the above classes 1 to 8. In one embodiment, an insect-resistant plant contains more than one transgene encoding a protein of any one of the above classes 1 to 8, to expand the range of target insect species affected, or to delay insect resistance development to the plants by using different proteins insecticidal to the same target insect species but having a different mode of action, such as binding to different receptor binding sites in the insect.
Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are tolerant to abiotic stress factors. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such stress resistance. Particularly useful stress tolerant plants include: a. plants which contain a transgene capable of reducing the expression and/or the activity of the poly(ADP-ribose) polymerase (PARP) gene in the plant cells or plants; b. plants which contain a stress tolerance enhancing transgene capable of reducing the expression and/or the activity of the PARG encoding genes of the plants or plants cells; c. plants which contain a stress tolerance-enhancing transgene coding for a plant-functional enzyme of the nicotinamide adenine dinucleotide salvage biosynthesis pathway, including nicotinamidase, nicotinate phosphoribosyltransferase, nicotinic acid mononucleotide adenyltransferase, nicotinamide adenine dinucleotide synthetase or nicotinamide phosphoribosyltransferase.
Plants or plant varieties (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention show altered quantity, quality and/or storage stability of the harvested product and/or altered properties of specific ingredients of the harvested product such as, for example: 1) transgenic plants which synthesize a modified starch, which in its physical-chemical characteristics, in particular the amylose content or the amylose/amylopectin ratio, the degree of branching, the average chain length, the side chain distribution, the viscosity behaviour, the gelling strength, the starch grain size and/or the starch grain morphology, is changed in comparison with the synthesised starch in wild type plant cells or plants, so that this modified starch is better suited for special applications; 2) transgenic plants which synthesize non starch carbohydrate polymers or which synthesize non starch carbohydrate polymers with altered properties in comparison to wild type plants without genetic modification. Examples are plants which produce polyfructose, especially of the inulin and levan type, plants which produce alpha-1,4-glucans, plants which produce alpha-1,6-branched alpha-1,4-glucans, and plants producing alternan; 3) transgenic plants which produce hyaluronan.
Plants or plant varieties (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are plants, such as cotton plants, with altered fibre characteristics. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such altered fiber characteristics and include: a) plants, such as cotton plants, containing an altered form of cellulose synthase genes; b) plants, such as cotton plants, containing an altered form of rsw2 or rsw3 homologous nucleic acids; c) plants, such as cotton plants, with increased expression of sucrose phosphate synthase; d) plants, such as cotton plants, with increased expression of sucrose synthase; e) plants, such as cotton plants, wherein the timing of the plasmodesmatal gating at the basis of the fibre cell is altered, for example through downregulation of fibre-selective -1,3-glucanase; f) plants, such as cotton plants, having fibers with altered reactivity, e.g. through the expression of N-acetylglucosaminetransferase gene including nodC, and chitin synthase genes.
Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are plants, such as oilseed rape or related Brassica plants, with altered oil composition characteristics. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such altered oil characteristics and include: a) plants, such as oilseed rape plants, which produce oil having a high oleic acid content; b) plants, such as oilseed rape plants, which produce oil having a low linolenic acid content; c) plants, such as oilseed rape plants, producing oil having a low level of saturated fatty acids.
Particularly useful transgenic plants which may be treated according to the invention are plants which comprise one or more genes which encode one or more toxins and are the transgenic plants available under the following trade names: YIELD GARD (for example maize, cotton, soya beans), KnockOut (for example maize), BiteGard (for example maize), BT-Xtra (for example maize), StarLink (for example maize), Bollgard (cotton), Nucotn (cotton), Nucotn 33B (cotton), NatureGard (for example maize), Protecta and NewLeaf (potato). Examples of herbicide-tolerant plants which may be mentioned are maize varieties, cotton varieties and soyabean varieties which are available under the following trade names: Roundup Ready (tolerance to glyphosate, for example maize, cotton, soya beans), Liberty Link (tolerance to phosphinothricin, for example oilseed rape), IMI (tolerance to imidazolinone) and SCS (tolerance to sulphonylurea, for example maize). Herbicide-resistant plants (plants bred in a conventional manner for herbicide tolerance) which may be mentioned include the cultivars sold under the name Clearfield (for example maize).
Particularly useful transgenic plants which may be treated according to the invention are plants containing transformation events, or a combination of transformation events, and that are listed for example in the databases for various national or regional regulatory agencies (see for example http://gmoinfo.jrc.it/gmp_browse.aspx and http://www.agbios.com/dbase.php).
Treatment according to the invention of the plants and plant parts with the active compound combinations is carried out directly or by allowing the compounds to act on their surroundings, environment or storage space by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats.
The mixtures according to the invention are particularly suitable for the treatment of seed. Here, particular mention may be made of the combinations according to the invention mentioned above as preferred or particularly preferred. Thus, most of the damage to crop plants which is caused by pests occurs as early as when the seed is infested during storage and after the seed is introduced into the soil, and during and immediately after germination of the plants. This phase is particularly critical since the roots and shoots of the growing plant are particularly sensitive and even minor damage can lead to the death of the whole plant. Protecting the seed and the germinating plant by the use of suitable compositions is therefore of particularly great interest.
The control of pests by treating the seed of plants has been known for a long time and is the subject of continuous improvements. However, the treatment of seed entails a series of problems which cannot always be solved in a satisfactory manner. Thus, it is desirable to develop methods for protecting the seed and the germinating plant which dispense with the additional application of crop protection compositions after sowing or after emergence of the plants. It is furthermore desirable to optimize the amount of active compound employed in such a way as to provide optimum protection for the seed and the germinating plant from attack by pests, but without damaging the plant itself by the active compound employed. In particular, methods for the treatment of seed should also take into consideration the intrinsic insecticidal properties of transgenic plants in order to achieve optimum protection of the seed and also the germinating plant with a minimum of crop protection compositions being employed.
The present invention therefore in particular also relates to a method for the protection of seed and germinating plants, from attack by pests, by treating the seed with a composition according to the invention. The invention likewise relates to the use of the compositions according to the invention for the treatment of seed for protecting the seed and the resuling plant from pests. The invention further relates to seed which has been treated with a composition according to the invention for protection from pests.
One of the advantages of the present invention is that the particular systemic properties of the compositions according to the invention mean that treatment of the seed with these compositions not only protects the seed itself, but also the resulting plants after emergence, from pests. In this way, the immediate treatment of the crop at the time of sowing or shortly thereafter can be dispensed with.
A further advantage is the synergistically increased insecticidal activity of the compositions according to the invention in comparison with the individual insecticidally active compound, which exceeds the expected activity of the two active compounds when applied individually. Also advantageous is the synergictic enhancement of the fungicidal activity of the compositions according to the invention compared with the individual fungicidally active compound, which exceeds the expected activity of the active compound applied individually. This makes possible an optimization of the amount of active compounds employed.
Furthermore, it must be considered as advantageous that the mixtures according to the invention can also be employed in particular in transgenic seed, the plants arising from this seed being capable of expressing a protein directed against pests. By treating such seed with the compositions according to the invention, certain pests can be controlled merely by the expression of the, for example, insecticidal protein, and additionally damage to the seed may be averted by the compositions according to the invention.
The compositions according to the invention are suitable for protecting seed of any plant variety as already mentioned above which is employed in agriculture, in the greenhouse, in forests or in horticulture. In particular, this takes the form of seed of maize, peanut, canola, oilseed rape, poppy, soya, cotton, beet (for example sugar beet and fodder beet), rice, millet, wheat, barley, oats, rye, sunflower, tobacco, potatoes or vegetables (for example tomatoes, cabbage species). The compositions according to the invention are likewise suitable for treating the seed of fruit plants and vegetables as already mentioned above. The treatment of the seed of maize, soya, cotton, wheat and canola or oilseed rape is of particular importance.
As already mentioned above, the treatment of transgenic seed with a composition according to the invention is also of particular significance. This takes the form of seed of plants which, as a rule, comprise at least one heterologous gene which governs the expression of a polypeptide with in particular insecticidal properties. In this context, the heterologous genes in transgenic seed may be derived from microorganisms such as Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus or Gliocladium. The present invention is particularly suitable for the treatment of transgenic seed which comprises at least one heterologous gene originating from Bacillus sp. and whose gene product shows activity against the European corn borer and/or the corn root worm. The gene involved is more preferably a heterologous gene which originates from Bacillus thuringiensis.
Within the context of the present invention, the composition according to the invention is applied to the seed either alone or in a suitable formulation. Preferably, the seed is treated in a state in which it is stable enough to avoid damage during treatment. In general, the seed can be treated at any time between harvest and sowing. The seed usually used has been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits.
When treating the seed, it generally has to be ensured that the amount of the composition according to the invention applied to the seed and/or the amount of further additives is selected such that the germination of the seed is not impaired, or that the resulting plant is not damaged. This must be ensured particularly in the case of active compounds which can exhibit phytotoxic effects at certain application rates.
In addition, the compounds according to the invention can be used to control a multitude of different pests, including, for example, harmful sucking insects, biting insects and other pests which are plant parasites, stored material pests, pests which destroy industrial material, and hygiene pests including parasites in the animal health sector, and for the control thereof, for example the elimination and eradication thereof. The present invention thus also includes a method for controlling pests.
In the animal health sector, i.e. in the field of veterinary medicine, the active compounds according to the present invention act against animal parasites, especially ectoparasites or endoparasites. The term "endoparasites" includes especially helminths such as cestodes, nematodes or trematodes, and protozoa such as coccidia. Ectoparasites are typically and preferably arthropods, especially insects such as flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice, fleas and the like; or acaricides such as ticks, for example hard ticks or soft ticks, or mites such as scab mites, harvest mites, bird mites and the like.
These parasites include: From the order of the Anoplurida, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phthirus spp., Solenopotes spp.; specific examples are: Linognathus setosus, Linognathus vituli, Linognathus ovillus, Linognathus oviformis, Linognathus pedalis, Linognathus stenopsis, Haematopinus asini macrocephalus, Haematopinus eurysternus, Haematopinus suis, Pediculus humanus capitis, Pediculus humanus corporis, Phylloera vastatrix, Phthirus pubis, Solenopotes capillatus; From the order of the Mallophagida and the suborders Amblycerina and Ischnocerina, for example, Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp., Felicola spp.; specific examples are: Bovicola bovis, Bovicola ovis, Bovicola limbata, Damalina bovis, Trichodectes canis, Felicola subrostratus, Bovicola caprae, Lepikentron ovis, Werneckiella equi; From the order of the Diptera and the suborders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Odagmia spp., Wilhelmia spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp., Melophagus spp., Rhinoestrus spp., Tipula spp.; specific examples are: Aedes aegypti, Aedes albopictus, Aedes taeniorhynchus, Anopheles gambiae, Anopheles maculipennis, Calliphora erythrocephala, Chrysozona pluvialis, Culex quinquefasciatus, Culex pipiens, Culex tarsalis, Fannia canicularis, Sarcophaga carnaria, Stomoxys calcitrans, Tipula paludosa, Lucilia cuprina, Lucilia sericata, Simulium reptans, Phlebotomus papatasi, Phlebotomus longipalpis, Odagmia ornata, Wilhelmia equina, Boophthora erythrocephala, Tabanus bromius, Tabanus spodopterus, Tabanus atratus, Tabanus sudeticus, Hybomitra ciurea, Chrysops caecutiens, Chrysops relictus, Haematopota pluvialis, Haematopota italica, Musca autumnalis, Musca domestica, Haematobia irritans irritans, Haematobia irritans exigua, Haematobia stimulans, Hydrotaea irritans, Hydrotaea albipuncta, Chrysomya chloropyga, Chrysomya bezziana, Oestrus ovis, Hypoderma bovis, Hypoderma lineatum, Przhevalskiana silenus, Dermatobia hominis, Melophagus ovinus, Lipoptena capreoli, Lipoptena cervi, Hippobosca variegata, Hippobosca equina, Gasterophilus intestinalis, Gasterophilus haemorroidalis, Gasterophilus inermis, Gasterophilus nasalis, Gasterophilus nigricornis, Gasterophilus pecorum, Braula coeca; From the order of the Siphonapterida, for example Pulex spp., Ctenocephalides spp., Tunga spp., Xenopsylla spp., Ceratophyllus spp.; specific examples are: Ctenocephalides canis, Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsylla cheopis; From the order of the Heteropterida, for example, Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp.
From the order of the Blattarida, for example Blatta orientalis, Periplaneta americana, Blattela germanica, Supella spp. (e.g. Suppella longipalpa); From the subclass of the Acari (Acarina) and the orders of the Meta- and Mesostigmata, for example, Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Rhipicephalus (Boophilus) spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Dermanyssus spp., Rhipicephalus spp. (the original genus of multihost ticks), Ornithonyssus spp., Pneumonyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp., Varroa spp., Acarapis spp.; specific examples are: Argas persicus, Argas reflexus, Ornithodorus moubata, Otobius megnini, Rhipicephalus (Boophilus) microplus, Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) annulatus, Rhipicephalus (Boophilus) calceratus, Hyalomma anatolicum, Hyalomma aegypticum, Hyalomma marginatum, Hyalomma transiens, Rhipicephalus evertsi, Ixodes ricinus, Ixodes hexagonus, Ixodes canisuga, Ixodes pilosus, Ixodes rubicundus, Ixodes scapularis, Ixodes holocyclus, Haemaphysalis concinna, Haemaphysalis punctata, Haemaphysalis cinnabarina, Haemaphysalis otophila, Haemaphysalis leachi, Haemaphysalis longicorni, Dermacentor marginatus, Dermacentor reticulatus, Dermacentor pictus, Dermacentor albipictus, Dermacentor andersoni, Dermacentor variabilis, Hyalomma mauritanicum, Rhipicephalus sanguineus, Rhipicephalus bursa, Rhipicephalus appendiculatus, Rhipicephalus capensis, Rhipicephalus turanicus, Rhipicephalus zambeziensis, Amblyomma americanum, Amblyomma variegatum, Amblyomma maculatum, Amblyomma hebraeum, Amblyomma cajennense, Dermanyssus gallinae, Ornithonyssus bursa, Ornithonyssus sylviarum, Varroa jacobsoni; From the order of the Actinedida (Prostigmata) and Acaridida (Astigmata), for example, Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp., Laminosioptes spp.; specific examples are: Cheyletiella yasguri, Cheyletiella blakei, Demodex canis, Demodex bovis, Demodex ovis, Demodex caprae, Demodex equi, Demodex caballi, Demodex suis, Neotrombicula autumnalis, Neotrombicula desaleri, Neoschongastia xerothermobia, Trombicula akamushi, Otodectes cynotis, Notoedres cati, Sarcoptis canis, Sarcoptes bovis, Sarcoptes ovis, Sarcoptes rupicaprae (=S. caprae), Sarcoptes equi, Sarcoptes suis, Psoroptes ovis, Psoroptes cuniculi, Psoroptes equi, Chorioptes bovis, Psoergates ovis, Pneumonyssoidic mange, Pneumonyssoides caninum, Acarapis woodi.
The active compounds according to the invention are also suitable for controlling arthropods, helminths and protozoa which attack animals. The animals include agricultural livestock, for example cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese, cultured fish, honey bees. The animals also include domestic animals - also referred to as companion animals - for example dogs, cats, caged birds, aquarium fish, and what are known as test animals, for example hamsters, guinea pigs, rats and mice.
The control of these arthropods, helminths and/or protozoa should reduce cases of death and improve the performance (for meat, milk, wool, hides, eggs, honey etc.) and the health of the host animal, and so the use of the active compounds according to the invention enables more economically viable and easier animal husbandry.
For example, it is desirable to prevent or to interrupt the uptake of blood from the host by the parasites (if relevant). Control of the parasites can also contribute to preventing the transmission of infectious substances.
The term "control" as used herein with regard to the field of animal health means that the active compounds act by reducing the occurrence of the parasite in question in an animal infested with such parasites to a harmless level. More specifically, "control" as used herein means that the active compound kills the parasite in question, retards its growth or inhibits its proliferation.
In general, the active compounds according to the invention can be employed directly when they are used for the treatment of animals. They are preferably employed in the form of pharmaceutical compositions which may comprise pharmaceutically acceptable excipients and/or auxiliaries known in the prior art.
In the sector of animal health and in animal husbandry, the active compounds are employed (administered) in a known manner, by enteral administration in the form of, for example, tablets, capsules, potions, drenches, granules, pastes, boluses, the feed-through process and suppositories, by parenteral administration, for example by injection (intramuscular, subcutaneous, intravenous, intraperitoneal inter alia), implants, by nasal administration, by dermal administration in the form, for example, of dipping or bathing, spraying, pouring on and spotting on, washing and powdering, and also with the aid of moulded articles containing the active compound, such as collars, earmarks, tailmarks, limb bands, halters, marking devices, etc. The active compounds can be formulated as a shampoo or as suitable formulations applicable in aerosols or unpressurized sprays, for example pump sprays and atomizer sprays, In the case of employment for livestock, poultry, domestic pets, etc., the active compounds according to the invention can be employed as formulations (for example powders, wettable powders ["WP"], emulsions, emulsifiable concentrates ["EC"], free-flowing compositions, homogeneous solutions and suspension concentrates ["SC"]), which contain the active compounds in an amount of 1 to 80% by weight, directly or after dilution (e.g. 100- to 10 000-fold dilution ), or they can be used as a chemical bath.
In the case of use in the animal health sector, the active compounds according to the invention can be used in combination with suitable synergists or other active compounds, for example acaricides, insecticides, anthelmintics, anti-protozoal agents.
The compounds according to the invention can be prepared by customary methods known to those skilled in the art.
Reaction Scheme 1 shows the general Preparation Process A for the compounds (I-1) according to the invention.
Reaction Scheme 1 W Q Q 1 2 1 Z Z E 1 Z Z A A A E E 3 3 3 E E 3 E E Z 3 2 Z 3 2 (I-1) 1 1 3 The radicals A -A , Q, W, R and Z -Z have the meanings described above. The five-membered cycles of E1-E3, carbon and nitrogen represent the 5-membered heterocycles defined under T. X represents a halogen. U represents bromine, iodine or triflate if M represents a boronic acid, boronic ester or trifluoroboronate. U represents a boronic acid, boronic ester or trifluoroboronate if M represents bromine, iodine or triflate.
Compounds according to the invention of the general structure (I-1) can be prepared by processes known from the literature using palladium-catalysed reactions from the reaction partners 4 and 5 [WO2005-040110; WO2009-089508]. The compounds of the general structure 5 are either commercially available or can be prepared by processes known to the person skilled in the art. The compounds of the general structure 4 can be prepared by processes known from the literature either by nucleophilic substitution at the aromatic ring (X = chlorine or fluorine) [WO2007-107470; Tetrahedron Letters 2003, 44, 7629-7632] or by a transition metal-catalysed reaction (X = bromine or iodine) [WO2012-003405; WO2009-158371] from the appropriate starting materials 2 and 3.
Alternatively, the compounds (I-a) according to the invention can be prepared by the general Preparation Process B (Reaction Scheme 2).
Reaction Scheme 2 1 2 O Z Z A Alkyl Alkyl 1 2 A 3 E E 6 N 2 3 E E R1 A 3 E E 3 3 2 (I-1) 1 1 3 The radicals A -A , Q, R and Z -Z have the meanings described above. The five-membered cycles of E1-E3, carbon and nitrogen represent the 5-membered heterocycles defined under T. U represents bromine, iodine or triflate if M represents a boronic acid, boronic ester or trifluoroboronate. U represents a boronic acid, boronic ester or trifluoroboronate if M represents bromine, iodine or triflate.
Compounds according to the invention of the general structure (I-1) can be prepared analogously to peptide coupling methods known from the literature from starting materials 8 and 9 [WO2010-051926; WO2010-133312]. Compounds of the general structure 8 can be prepared analogously to processes known from the literature by ester cleavage from compounds of the general structure 7 [WO2010- 051926; WO2010-133312]. Compounds of the general structure 7 can be prepared analogously to processes known from the literature by palladium-catalysed reactions [WO2005-040110; WO2009- 089508].
Compounds according to the invention of the general structure (I-2) can be synthesized by the Preparation Process C shown in Reaction Scheme 3.
Reaction Scheme 3 N 2 A 3 3 E E (I-1) (I-2) 1 1 3 The radicals A -A , Q, R and Z -Z have the meanings described above. The five-membered cycles of E1-E3, carbon and nitrogen represent the 5-membered heterocycles defined under T.
Compounds according to the invention of the general structure (I-2) can be prepared analogously to processes known from the literature from compounds of the general structure (I-1) [WO2012-056372; WO2003-066050].
Compounds according to the invention of the general structure (I-1a) can be synthesized by the Preparation Process D shown in Reaction Scheme 4.
Reaction Scheme 4 1 1 3 2 The radicals A -A , Q, W, R , Z and Z have the meanings described above. Z represents radicals such as fluorine, chlorine, bromine, iodine, cyano, methylsulphanyl, hydroxy and other radicals which can be prepared via the diazonium salt of 4b [Chemical Reviews 1988, 88, 5, 765-792]. The five-membered cycles of E1-E3, carbon and nitrogen represent the 5-membered heterocycles defined under T. X represents a halogen. U represents bromine, iodine or triflate and M represents a boronic acid, boronic ester or trifluoroboronate.
Compounds according to the invention of the general structure (I-1a) can be prepared by processes known from the literature using palladium-catalysed reactions from the reaction partners 4c and 5 [WO2005-040110; WO2009-089508]. The compounds of the general structure 5 are either commercially available or can be prepared by processes known to the person skilled in the art. The compounds of the general structure 4c can be prepared by processes known from the literature from the compounds of the general structure 4b [Chemical Reviews 1988, 88, 5, 765-792]. Compounds of the general structure 4b can be prepared from compounds of the general structure 4a by processes known from the literature [WO2008-008375; Journal of Heterocyclic Chemistry 2002, 39(5), 1055-1059]. The compounds of the general structure 4a can be prepared by processes known from the literature either by nucleophilic substitution at the aromatic ring (X = chlorine or fluorine) [WO2007-107470; Tetrahedron Letters 2003, 44, 7629-7632] or by a transition metal-catalysed reaction (X = bromine or iodine) [WO2012-003405; WO2009-158371] from the appropriate starting materials 2a and 3.
The compounds of the general structure 5 are either commercially available or can be prepared by processes known to the person skilled in the art or analogously to these processes [WO2012004217; WO2009-130475; WO2008-107125; WO2003-099805; WO2012-0225061; WO2009-010488].
The compounds of the general structure 2/2a are either commercially available or can be prepared by processes known to the person skilled in the art or analogously to these processes [WO2010-051926; WO2011-131615; WO2006-018725; WO2012-065932; WO2007077961; US2012-0115903; WO2010- 017902; WO2010-127856; Tetrahedron Letters 2011, 44, 8451-8457].
The compounds of the general structure 3 are either commercially available or can be prepared by processes known to the person skilled in the art or analogously to these processes.
Oxidizing agents for the oxidation of alcoholic groups are known (cf., for example, oxidizing agents in Organic Synthesis by Oxidation with Metal Compounds, Mijs, de Jonge, Plenum Verlag, New York, 1986; Manganese Compounds as Oxidizing Agents in Organic Chemistry, Arndt, Open Court Publishing Company, La Salle, IL, 1981; The Oxidation of Organic Compounds by Permanganate Ion and Hexavalent Chromium, Lee, Open Court Publishing Company, La Salle, IL, 1980). An oxidation can be carried out, for example, in the presence of permanganates (for example potassium permanganate), metal oxides (for example manganese dioxide, chromium oxides which are used, for example, in dipyridinechromium(VI) oxide as Collins reagent (cf. J. C. Collins et al., Tetrahedron Lett. 30, 3363-3366, 1968)). Likewise in the presence of pyridinium chlorochromate (for example Corey’s reagent) (cf. also R. O. Hutchins et al., Tetrahedron Lett. 48, 4167-4170, 1977; D. Landini et al.
Synthesis 134-136, 1979) or ruthenium tetroxide (cf. S.-I. Murahashi, N. Komiya Ruthenium-catalyzed Oxidation of Alkenes, Alcohols, Amines, Amides, β-Lactams, Phenols and Hydrocarbons, in: Modern Oxidation Methods, Baeckvall, Jan-Erling (Eds.), Wiley-VCH-Verlag GmbH & Co. KGaA, 2004).
Likewise suitable are ultrasound-induced oxidation reactions and the use of potassium permanganate (cf.
J. Yamawaki et al., Chem. Lett. 3, 379-380, 1983).
All known suitable acidic or basic reaction auxiliaries can be used according to the procedures described in the literature to deblock/remove the protective group SG. When protective groups of the carbamate type are used for amino groups, preference is given to using acidic reaction auxiliaries. When the t- butylcarbamate protective group (BOC group) is employed, for example, mixtures of mineral acids such as hydrochloric acid, hydrobromic acid, nitric acid, sulphuric acid, phosphoric acid or organic acids such as benzoic acid, formic acid, acetic acid, trifluoroacetic acid, methanesulphonic acid, benzenesulphonic acid or toluenesulphonic acid and a suitable diluent such as water and/or an organic solvent such as tetrahydrofuran, dioxane, dichloromethane, chloroform, ethyl acetate, ethanol or methanol are used.
Preference is given to mixtures of hydrochloric acid or acetic acid with water and/or an organic solvent such as ethyl acetate.
It is known that certain reactions and preparation processes can be carried out particularly efficiently in the presence of diluents or solvents and basic or acidic reaction auxiliaries. It is also possible to use mixtures of the diluents or solvents. The diluents or solvents are advantageously employed in such an amount that the reaction mixture remains readily stirrable during the entire process.
Suitable diluents or solvents for carrying out the processes according to the invention are, in principle, all organic solvents which are inert under the specific reaction conditions. Examples include: halohydrocarbons (for example chlorohydrocarbons such as tetrachloroethylene, tetrachloroethane, dichloropropane, methylene chloride, dichlorobutane, chloroform, carbon tetrachloride, trichloroethane, trichloroethylene, pentachloroethane, difluorobenzene, 1,2-dichloroethane, chlorobenzene, bromobenzene, dichlorobenzene, chlorotoluene, trichlorobenzene), alcohols (for example methanol, ethanol, isopropanol, butanol), ethers (for example ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenetole, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, dioxane, dichlorodiethyl ether and polyethers of ethylene oxide and/or propylene oxide), amines (for example trimethyl-, triethyl-, tripropyl-, tributylamine, N-methylmorpholine, pyridine and tetramethylenediamine), nitrohydrocarbons (for example nitromethane, nitroethane, nitropropane, nitrobenzene, chloronitrobenzene, o-nitrotoluene); nitriles (for example acetonitrile, propionitrile, butyronitrile, isobutyronitrile, benzonitrile, m-chlorobenzonitrile), tetrahydrothiophene dioxide, dimethyl sulphoxide, tetramethylene sulphoxide, dipropyl sulphoxide, benzyl methyl sulphoxide, diisobutyl sulphoxide, dibutyl sulphoxide, diisoamyl sulphoxide, sulphones (for example dimethyl, diethyl, dipropyl, dibutyl, diphenyl, dihexyl, methyl ethyl, ethyl propyl, ethyl isobutyl and pentamethylene sulphone), aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane and technical hydrocarbons), and also what are called "white spirits" with components having boiling points in the range from, for example, 40°C to 250°C, cymene, petroleum fractions within a boiling range from 70°C to 190°C, cyclohexane, methylcyclohexane, petroleum ether, ligroin, octane, benzene, toluene, chlorobenzene, bromobenzene, nitrobenzene, xylene, esters (for example methyl, ethyl, butyl and isobutyl acetate, dimethyl, dibutyl and ethylene carbonate); amides (for example hexamethylphosphoric triamide, formamide, N-methylformamide, N,N- dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N- methylcaprolactam, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidine, octylpyrrolidone, octylcaprolactam, 1,3-dimethylimidazolinedione, N-formylpiperidine, N , N ’-diformylpiperazine) and ketones (for example acetone, acetophenone, methyl ethyl ketone, methyl butyl ketone).
The basic reaction auxiliaries used to perform the process according to the invention may be all suitable acid binders. Examples include: alkaline earth metal or alkali metal compounds (e.g. hydroxides, hydrides, oxides and carbonates of lithium, sodium, potassium, magnesium, calcium and barium), amidine bases or guanidine bases (e.g. 7-methyl-1,5,7-triazabicyclo[4.4.0]decene (MTBD); diazabicyclo[4.3.0]nonene (DBN), diazabicyclo[2.2.2]octane (DABCO), 1,8- diazabicyclo[5.4.0]undecene (DBU), cyclohexyltetrabutylguanidine (CyTBG), cyclohexyltetramethylguanidine (CyTMG), N,N,N,N-tetramethyl-1,8-naphthalenediamine, pentamethylpiperidine) and amines, especially tertiary amines (e.g. triethylamine, trimethylamine, tribenzylamine, triisopropylamine, tributylamine, tricyclohexylamine, triamylamine, trihexylamine, N,N-dimethylaniline, N,N-dimethyltoluidine, N,N-dimethyl-p-aminopyridine, N-methylpyrrolidine, N- methylpiperidine, N-methylimidazole, N-methylpyrazole, N-methylmorpholine, N- methylhexamethylenediamine, pyridine, 4-pyrrolidinopyridine, 4-dimethylaminopyridine, quinoline, α- picoline, β-picoline, isoquinoline, pyrimidine, acridine, N,N,N`,N`-tetramethylenediamine, N,N,N`,N`- tetraethylenediamine, quinoxaline, N-propyldiisopropylamine, N-ethyldiisopropylamine, N,N`- dimethylcyclohexylamine, 2,6-lutidine, 2,4-lutidine or triethyldiamine).
The acidic reaction auxiliaries used to perform the process according to the invention include all mineral acids (e.g. hydrohalic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid or hydriodic acid, and also sulphuric acid, phosphoric acid, phosphorous acid, nitric acid), Lewis acids (e.g. aluminium(III) chloride, boron trifluoride or its etherate, titanium(IV) chloride, tin(IV) chloride) and organic acids (e.g. formic acid, acetic acid, propionic acid, malonic acid, lactic acid, oxalic acid, fumaric acid, adipic acid, stearic acid, tartaric acid, oleic acid, methanesulphonic acid, benzoic acid, benzenesulphonic acid or para-toluenesulphonic acid).
If protective groups are intended in the reactions schemes, all generally known protective groups may be used. In particular those described by Greene T. W., Wuts P. G. W. in Protective Groups in Organic Synthesis; John Wiley & Sons, Inc. 1999, "Protection for the hydroxyl group including 1,2- and 1,3- diols".
Also suitable are protective groups of the substituted methyl ether type (for example methoxymethyl ether (MOM), methylthiomethyl ether (MTM), (phenyldimethylsilyl)methoxymethyl ether (SNOM-OR), benzyloxymethyl ether (BOM-OR) para-methoxybenzyloxymethyl ether (PMBM-OR), para-nitrobenzyloxymethyl ether, ortho- nitrobenzyloxymethyl ether (NBOM-OR), (4-methoxyphenoxy)methyl ether (p-AOM-OR), guaiacolmethyl ether (GUM-OR), t-butoxymethyl ether, 4-pentyloxymethyl ether (POM-OR), silyloxymethyl ether, 2-methoxyethoxymethyl ether (MEM-OR), 2,2,2-trichloroethoxymethyl ether, bis(2-chloroethoxy)methyl ether, 2-(trimethylsilyl)ethoxymethyl ether (SEM-OR), methoxymethyl ether (MM-OR)); of the substituted ethyl ether type (for example 1-ethoxyethyl ether (EE-OR), 1-(2-chloroethoxy)ethyl ether (CEE-OR), 1-[2-(trimethylsilyl)ethoxy]ethyl ether (SEE-OR), 1-methylmethoxyethyl ether (MIP-OR), 1-methylbenzyloxyethyl ether (MBE-OR), 1-methylbenzyloxyfluoroethyl ether (MIP-OR), 1-methylphenoxyethyl ether, 2,2,2-trichloroethyl ether, 1,1-dianisyl-2,2,2-trichloroethyl ether (DATE-OR), 1,1,1,3,3,3-hexafluorophenylisopropyl ether (HIP-OR), 2-trimethylsilylethyl ether, 2-(benzylthio)ethyl ether, 2-(phenylselenyl)ethyl ether), an ether (for example tetrahydropyranyl ether (THP-OR), 3-bromotetrahydropyranyl ether (3-BrTHP-OR), tetrahydrothiopyranyl ether, 1- methoxycyclohexyl ether, 2- and 4-picolyl ether, 3-methylpicolyl-N-oxido ether, 2-quinolinylmethyl ether (Qm-OR), 1-pyrenylmethyl ether, diphenylmethyl ether (DPM-OR), para, para’-dinitrobenzhydryl ether (DNB-OR), 5-dibenzosuberyl ether, triphenylmethyl ether (Tr-OR), alpha-naphthyldiphenylmethyl ether, para-methoxyphenyldiphenylmethyl ether (MMTrOR), di(para-methoxyphenyl)phenylmethyl ether (DMTr-OR), tri(para-methoxyphenyl)phenylmethyl ether (TMTr-OR), 4-(4’- bromophenacyloxy)phenyldiphenylmethyl ether, 4,4’,4’’-tris(4,5-dichlorophthalimidophenyl)methyl ether (CPTr-OR), 4,4’,4’’-tris(benzoyloxyphenyl)methyl ether (TBTr-OR), 4,4’-dimethoxy-3’’-[N- (imidazolylmethyl)]trityl ether (IDTr-OR), 4,4’-dimethoxy-3’’-[N-(imidazolylethyl)carbamoyl]trityl ether (IETr-OR), 1,1-bis(4-methoxyphenyl)-1’-pyrenylmethyl ether (Bmpm-OR), 9-anthryl ether, 9-(9- phenyl)xanthenyl ether (Pixyl-OR), 9-(9-phenyloxo)anthryl (tritylone ether), 4- methoxytetrahydropyranyl ether (MTHP-OR), 4-methoxytetrahydrothiopyranyl ether, 4- methoxytetrahydrothiopyranyl S,S-dioxide, 1-[(2-chloromethyl)phenyl]methoxypiperidinyl ether (CTMP-OR), 1-(2-fluorophenyl)methoxypiperidinyl ether (Fpmp-OR), 1,4-dioxanyl ether, tetrahydrofuranyl ether, tetrahydrothiofuranyl ether, 2,3,3a,4,5,6,7,7a-octahydro-7,8,8-trimethyl- 4,7-methanebenzofuranyl ether (MBF-OR), t-butyl ether, allyl ether, propargyl ether, para- chlorophenyl ether, para-methoxyphenyl ether, para-nitrophenyl ether, para-2,4-dinitrophenyl ether (DNP-OR), 2,3,5,6-tetrafluoro(trifluoromethyl)phenyl ether, benzyl ether (Bn-OR)); of the substituted benzyl ether type (for example para-methoxybenzyl ether (MPM-OR), 3,4- dimethoxybenzyl ether (DMPM-OR), ortho-nitrobenzyl ether, para-nitrobenzyl ether, para-halobenzyl ether, 2,6-dichlorobenzyl ether, para-aminoacylbenzyl ether (PAB-OR), para-azidobenzyl ether (Azb- OR), 4-azidochlorobenzyl ether, 2-trifluoromethylbenzyl ether, para-(methylsulphinyl)benzyl ether (Msib-OR)); of the silyl ether type (for example trimethylsilyl ether (TMS-OR), triethylsilyl ether (TES-OR), triisopropylsilyl ether (TIPS-OR), dimethylisopropylsilyl ether (IPDMS-OR), diethylisopropylsilyl ether (DEIPS-OR), dimethylhexylsilyl ether (TDS-OR), t-butyldimethylsilyl ether (TBDMS-OR), t- butyldiphenylsilyl ether (TBDPS-OR), tribenzylsilyl ether, tri-para-xylylsilyl ether, triphenylsilyl ether (TPS-OR), diphenylmethylsilyl ether (DPMS-OR), di-t-butylmethylsilyl ether (DTBMS-OR), tris(trimethylsilyl)silyl ether (sisyl ether), di-t-butylmethylsilyl ether (DTBMS-OR), tris(trimethylsilyl)silyl ether (sisyl ether), (2-hydroxystyryl)dimethylsilyl ether (HSDMS-OR), (2- hydroxystyryl)diisopropylsilyl ether (HSDIS-OR), t-butylmethoxyphenylsilyl ether (TBMPS-OR), t- butoxydiphenylsilyl ether (DPTBOS-OR)); of the ester type (for example formate ester, benzoylformate ester, acetate ester (Ac-OR), chloroacetate ester, dichloroacetate ester, trichloroacetate ester, trifluoroacetate ester, (TFA-OR), methoxyacetate ester, triphenylmethoxyacetate ester, phenoxyacetate ester, para-chlorophenoxyacetate ester, phenylacetate ester, diphenylacetate ester (DPA-OR), nicotinate ester, 3-phenylpropionate ester, 4- pentoate ester, 4-oxopentoate ester (levulinate) (Lev-OR) 4,4-(ethylenedithio)pentanoate ester (LevS- OR), 5-[3-bis(4-methoxyphenyl)hydroxymethoxyphenoxy]levulinate ester, pivaloate ester (Pv-OR), 1- adamantanoate ester, crotonate ester, 4-methoxycrotonate ester, benzoate ester (Bz-OR), para- phenylbenzoate ester, 2,4,6-trimethylbenzoate ester (mesitoate), 4-(methylthiomethoxy)butyrate ester (MTMB-OR), 2-(methylthiomethoxymethyl)benzoate ester (MTMT-OR), of the ester type (for example methyl carbonate, methoxymethyl carbonate, 9-fluorenylmethyl carbonate (Fmoc-OR), ethyl carbonate, 2,2,2-trichloroethyl carbonate (Troc-OR), 1,1-dimethyl-2,2,2-trichloroethyl carbonate (TCBOC-OR), 2-(trimethylsilyl)ethyl carbonate (TMS-OR), 2-(phenylsulphonyl)ethyl carbonate (Ps-OR), 2-(triphenylphosphonio)ethyl carbonate (Peoc-OR), t-butyl carbonate (Boc-OR), isobutyl carbonate, vinyl carbonate, allyl carbonate (Alloc-OR), para-nitrophenyl carbonate, benzyl carbonate (Z-OR), para-methoxybenzyl carbonate, 3,4-dimethoxybenzyl carbonate, ortho-nitrobenzyl carbonate, para-nitrobenzyl carbonate, 2-dansylethyl carbonate (Dnseoc-OR), 2-(4-nitrophenyl)ethyl carbonate (Npeoc-OR), 2-(2,4-dinitrophenyl)ethyl carbonate (Dnpeoc)), and of the sulphate type (for example allylsulphonate (Als-OR), methanesulphonate (Ms-OR), benzylsulphonate, tosylate (Ts-OR), 2-[(4-nitrophenyl)ethyl]sulphonate (Npes-OR)).
Suitable catalysts for carrying out a catalytic hydrogenation in the process according to the invention are all customary hydrogenation catalysts such as, for example, platinum catalysts (for example platinum plate, platinum sponge, platinum black, colloidal platinum, platinum oxide, platinum wire), palladium catalysts (for example palladium sponge, palladium black, palladium oxide, palladium/carbon, colloidal palladium, palladium/barium sulphate, palladium/barium carbonate, palladium hydroxide, nickel catalysts (for example reduced nickel, nickel oxide, Raney nickel), ruthenium catalysts, cobalt catalysts (for example reduced cobalt, Raney cobalt), copper catalysts (for example reduced copper, Raney copper, Ullmann copper). Preference is given to using noble metal catalysts (for example platinum and palladium or ruthenium catalysts), which may be applied to a suitable support (for example carbon or silicon), rhodium catalysts (for example tris(triphenylphosphine)rhodium(I) chloride in the presence of triphenylphosphine). Furthermore, it is possible to use "chiral hydrogenation catalysts" (for example those comprising chiral diphosphine ligands such as (2S,3S)-(-)-2,3-bis(diphenylphosphino)butane [(S,S)-chiraphos] or (R)-(+)-2,2’- or (S)-(-)-2,2’-bis(diphenylphosphino)-1,1’-binaphthalene [R(+)- BINAP or S(-)-BINAP] ), whereby the proportion of an isomer in the isomer mixture is increased or the formation of another isomer is virtually completely suppressed.
Salts of the compounds according to the invention are prepared by standard methods. Representative acid addition salts are, for example, those formed by reaction with inorganic acids, such as, for example, sulphuric acid, hydrochloric acid, hydrobromic acid, phosphoric acid, or organic carboxylic acids such as acetic acid, trifluoroacetic acid, citric acid, succinic acid, butyric acid, lactic acid, formic acid, fumaric acid, maleic acid, malonic acid, camphoric acid, oxalic acid, phthalic acid, propionic acid, glycolic acid, glutaric acid, stearic acid, salicylic acid, sorbic acid, tartaric acid, cinnamic acid, valeric acid, picric acid, benzoic acid or organic sulphonic acids such as methanesulphonic acid and 4- toluenesulphonic acid.
Also representative are salts of compounds according to the invention formed from organic bases such as, for example, pyridine or triethylamine, or those formed from inorganic bases such as, for example, hydrides, hydroxides or carbonates of sodium, lithium, calcium, magnesium or barium, provided the compounds of the general formula (I) have a structural element suitable for this salt formation.
Synthesis methods for preparing heterocyclic N-oxides and t-amines are known. They can be obtained using peroxy acids (for example peracetic acid and meta-chloroperbenzoic acid (MCPBA), hydrogen peroxide), alkyl hydroperoxides (for example t-butyl hydroperoxide), sodium perborate and dioxiranes (for example dimethyldioxirane). These methods have been described, for example, by T. L. Gilchrist, in Comprehensive Organic Synthesis, Vol. 7, pp. 748-750, 1992, S. V. Ley, (Ed.), Pergamon Press; M.
Tisler, B. Stanovnik, in Comprehensive Heterocyclic Chemistry, Vol. 3, pp. 18-20, 1984, A. J. Boulton, A. McKillop, (Eds.), Pergamon Press; M. R. Grimmett, B. R. T. Keene in Advances in Heterocyclic Chemistry, Vol. 43, pp. 149-163, 1988, A. R. Katritzky, (Ed.), Academic Press; M. Tisler, B. Stanovnik, in Advances in Heterocyclic Chemistry, Vol. 9, pp. 285-291, 1968, A. R. Katritzky, A. J. Boulton (Eds.), Academic Press; G. W. H. Cheeseman, E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, Vol. 22, pp. 390-392, 1978, A. R. Katritzky, A. J. Boulton, (Eds.), Academic Press.
Experimental part Preparation Process A Example (Ic-1) 2-Chloro-N-cyclopropyl[2'-methyl-5'-(pentafluoroethyl)-4'-(trifluoromethyl)-2'H-1,3'- bipyrazolyl]benzamide 2.00 g (6.99 mmol) of 5-fluoromethyl(pentafluoroethyl)(trifluoromethyl)-1H-pyrazole, 1.03 g (6.99 mmol) of 4-bromo-1H-pyrazole and 1.93 g of potassium carbonate are suspended in 50 ml of tetrahydrofuran p.a. The reaction mixture is heated under reflux for 16 h. The cooled reaction mixture is filtered and the solvent is removed under reduced pressure. The residue is purified by column chromatography on silica gel.
This gives 0.69 g of 4-bromo-2'-methyl-5'-(pentafluoroethyl)-4'-(trifluoromethyl)-2'H-1,3'-bipyrazole as a colourless solid.
H-NMR (400 MHz, d -acetonitrile): δ = 8.00 (s, 1H), 7.91 (s, 1H), 3.71 (s, 3H). a) + HPLC-MS : logP = 4.14, mass (m/z) = 413 [M+H] . 10.5 ml of isopropyl alcohol are added to 150 mg (0.36 mmol) of 4-bromo-2'-methyl-5'- (pentafluoroethyl)-4'-(trifluoromethyl)-2'H-1,3'-bipyrazole, 87 mg (0.36 mmol) of [4-chloro (cyclopropylcarbamoyl)phenyl]boronic acid, 21 mg (0.01 mmol) of tetrakis(triphenylphosphine)palladium and 1.1 ml of a 1M aqueous sodium bicarbonate solution, and the mixture is heated under reflux for 3 h. The reaction mixture is concentrated to dryness and the residue is taken up in ethyl acetate. The organic phase is washed twice with water, dried over sodium sulphate, filtered and concentrated to dryness. The crude product is purified by column chromatography on silica gel.
This gives 71 mg of 2-chloro-N-cyclopropyl[2'-methyl-5'-(pentafluoroethyl)-4'-(trifluoromethyl)-2'H- 1,3'-bipyrazolyl]benzamide as a colourless solid.
H-NMR (400 MHz, d -acetonitrile): δ = 8.26 (s, 1H), 8.24 (s, 1H), 7.67 (d, 1H), 7.65 (dd, 1H), 7.48 (d, 1H), 6.95 (s, 1H), 3.75 (s, 3H), 2.82-2.87 (m, 1H), 0.75-0.80 (m, 2H). 0.57-0.62 (m, 2H). a) + HPLC-MS : logP = 3.79, mass (m/z) = 528 [M+H] .
Preparation Process B Example (Ib1) N-Benzylchloro{1-[1-methyl(pentafluoroethyl)(trifluoromethyl)-1H-pyrazol- -yl]-1H-imidazolyl}benzamide 500 mg (1.74 mmol) of 5-fluoromethyl(pentafluoroethyl)(trifluoromethyl)-1H-pyrazole, 339 mg (1.74 mmol) of 4-iodo-1H-imidazole and 483 mg (3.49 mmol) of potassium carbonate are suspended in 20 ml of tetrahydrofuran p.a. The reaction mixture is heated under reflux until the reaction has gone to completion. The cooled reaction mixture is filtered and the solvent is removed under reduced pressure.
The residue is purified by column chromatography on silica gel.
This gives 370 mg of 5-(4-iodo-1H-imidazolyl)methyl(pentafluoroethyl)(trifluoromethyl)- 1H-pyrazole as a colourless solid.
H-NMR (400 MHz, d -acetonitrile): δ = 7.68 (d, 1H), 7.43 (d, 1H), 3.68 (s, 3H) ppm. a) + HPLC-MS : logP = 3.47, mass (m/z) = 461 [M+H] . ml of isopropyl alcohol are added to 250 mg (0.54 mmol) of 5-(4-iodo-1H-imidazolyl)methyl- 3-(pentafluoroethyl)(trifluoromethyl)-1H-pyrazole, 161 mg (0.54 mmol) of methyl 2-chloro (4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)benzoate, 31 mg (0.02 mmol) of tetrakis(triphenylphosphine)palladium and 1.66 mL of a 1M aqueous sodium bicarbonate solution, and the mixture is heated under reflux for 3 h. The reaction mixture is concentrated to dryness and the residue is taken up in ethyl acetate. The organic phase is washed twice with water, dried over sodium sulphate, filtered and concentrated to dryness. The crude product is purified by column chromatography on silica gel.
This gives 160 mg of methyl 2-chloro{1-[1-methyl(pentafluoroethyl)(trifluoromethyl)-1H- pyrazolyl]-1H-imidazolyl}benzoate as a colourless solid.
H-NMR (400 MHz, d -acetonitrile): δ = 8.28 (d, 1H), 7.95 (dd, 1H), 7.83 (d, 1H), 7.71 (d, 1H), 7.55 (d, 1H), 3.91 (s, 3H), 3.73 (s, 3H) ppm. a) + HPLC-MS : logP = 4.26, mass (m/z) = 503 [M+H] . 150 mg (0.29 mmol) of methyl 2-chloro{1-[1-methyl(pentafluoroethyl)(trifluoromethyl)-1H- pyrazolyl]-1H-imidazolyl}benzoate are dissolved in 6.3 ml of tetrahydrofuran p.a., and the mixture is cooled with ice. 8.54 mg of lithium hydroxide, dissolved in 0.7 ml of water, are added dropwise to the reaction solution. After 10 minutes, the ice cooling is removed and the reaction mixture is stirred at room temperature for another 18 h. The reaction mixture is acidified with 1M hydrochloric acid and the product is extracted with ethyl acetate. The organic phase is washed with saturated sodium chloride solution, dried over sodium sulphate, filtered and concentrated under reduced pressure.
This gives 127 mg of 2-chloro{1-[1-methyl(pentafluoroethyl)(trifluoromethyl)-1H-pyrazol yl]-1H-imidazolyl}benzoic acid as a colourless solid.
H-NMR (400 MHz, d -acetonitrile): δ = 8.31 (d, 1H), 7.96 (dd, 1H), 7.83 (d, 1H), 7.72 (d, 1H), 7.55 (d, 1H), 3.73 (s, 3H) ppm. a) + HPLC-MS : logP = 3.30, mass (m/z) = 489 [M+H] . 127 mg (0.26 mmol) of 2-chloro{1-[1-methyl(pentafluoroethyl)(trifluoromethyl)-1H-pyrazol yl]-1H-imidazolyl}benzoic acid, 42 mg (0.39 mmol) of benzylamine and 67 mg (0.52 mmol) of N,N- diethylisopropylamine are dissolved in a mixture of 4.6 ml of dichloromethane and 0.4 ml of N,N- dimethylformamide. 53 mg (0.39 mmol) of N-hydroxybenzotriazole and 60 mg (0.31 mmol) of N-ethyl- N´-(3-dimethylaminopropyl)carbodiimide hydrochloride are added. The reaction mixture is stirred at room temperature for 16 h. The reaction solution is diluted with ethyl acetate and then washed successively with 1M hydrochloric acid, 1M aqueous sodium hydroxide solution and saturated sodium chloride solution. The crude product is purified by column chromatography on silica gel.
This gives 77 mg of N-benzylchloro{1-[1-methyl(pentafluoroethyl)(trifluoromethyl)-1H- pyrazolyl]-1H-imidazolyl}benzamide as a colourless solid.
H-NMR (400 MHz, d -acetonitrile): δ = 7.94 (d, 1H), 7.88 (dd, 1H), 7.82 (d, 1H), 7.71 (d, 1H), 7.49 (d, 1H), 7.25-7.43 (m, 5H), 4.56 (d, 2H), 3.73 (s, 3H) ppm. a) + HPLC-MS : logP = 4.00, mass (m/z) = 578 [M+H] .
Note regarding the determination of the logP values and mass detection: The determination of the given logP values was carried out in accordance with EEC Directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on a reversed-phase column (C18). Agilent 1100 LC system; 50*4.6 Zorbax Eclipse Plus C18 1.8 micron; mobile phase A: acetonitrile (0.1% formic acid); mobile phase B: water (0.09% formic acid); linear gradient from 10% acetonitrile to 95% acetonitrile in 4.25 min, then 95% acetonitrile for a further 1.25 min; oven temperature 55°C; flow rate: 2.0 ml/min.
Mass detection is carried out via an Agilend MSD system.
The compounds listed in Tables 1 & 2 were prepared using the Preparation Processes A to C described above.
BCS 13-3006 Foreign Countries THS/mr 201420 Table 1 Z R1 1 (Ia) Z 6c 6b 6a 6b 6c R R R Mass 1 2 3 1 *) Ex. No Z Z Z R A A A A W Q logP 4 3 2 1 ***) [m/z] Ia-1 CF CF CF CH H H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.99 552.0 2 3 3 3 Ia-2 CF CF CF CH H H H H C-H C-Cl C-H C-H O cyclopropyl 4.08 527.0 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 Table 2 Z Z R1 1 (Ib) Z 6b 6a 6b R R Mass 1 2 3 1 *) Ex. No Z Z Z R A A A A W Q logP 4 3 2 1 ***) [m/z] Ib-2 CF CF CF CH H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.38 553.1 2 3 3 3 Ib-3 CF CF CF CH H H H C-H C-Cl C-H C-H O cyclopropyl 3.43 528.0 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 Table 3 Z R1 Z 6b (Ic) 6a 6b R R Retention Mass 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 time ***) [m/z] Ic-2 CF CF CF CH H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.72 553.1 2 3 3 3 Ic-3 CF CF CF CH H H H C-H C-Cl C-H C-H O benzyl 4.39 578.0 2 3 3 3 Ic-4 CF CF CF CH H H CF C-H C-Cl C-H C-H O cyclopropyl 4.51 596.0 2 3 3 3 3 Ic-5 CF2CF3 CF3 CH3 H CH3 CF3 C-H C-Cl C-H C-H O cyclopropyl 4.60 610.0 Ic-6 CF CF CF phenyl H H H C-H C-Cl C-H C-H O cyclopropyl 4.54 590.1 2 3 3 Ic-7 CF CF CF phenyl H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 4.43 615.1 2 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6a 6b R R Retention Mass 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 time ***) [m/z] Ic-8 CF CF CF 4-NO - H H H C-H C-Cl C-H C-H O cyclopropyl 2 3 3 2 phenyl 4.54 635.1 Ic-9 CF2CF3 CF3 CH3 H CH3 CH3 C-H C-Cl C-H C-H O cyclopropyl 4.02 556.0 Ic-10 CF CF CF CH H H H C-H C-Cl C-H C-H O 2-thienylmethyl 4.40 584.0 2 3 3 3 Ic-11 CF CF CF CH H H H C-H C-Cl C-H C-H O 1-carbamothioyl- 2 3 3 3 cyclopropyl 3.59 587.0 Ic-12 CF CF CF CH H H CH C-H C-Cl C-H C-H O cyclopropyl 3.97 542.0 2 3 3 3 3 Ic-13 CF2CF3 CF3 CH3 H CH3 H C-H C-Cl C-H C-H O cyclopropyl 3.88 542.1 Ic-14 CF CF CF 3- H H H C-H C-Cl C-H C-H O cyclopropyl 2 3 3 chloropyrid inyl 4.28 625.0 Ic-15 CF CF CF 3- H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2 3 3 chloropyrid inyl 4.15 650.0 Ic-16 CF CF CF CH CH H H H C-H C-Cl C-H C-H O cyclopropyl 4.14 542.0 2 3 3 2 3 BCS 13-3006 Foreign Countries THS/mr 201420 6a 6b R R Retention Mass 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 time ***) [m/z] Ic-17 CF CF CF CH H H H C-H C-H C-H C-H O benzyl 4.31 544.0 2 3 3 3 Ic-18 CF CF CF CH H H H C-H C-H C-H C-H O cyclopropyl 3.66 494.1 2 3 3 3 Ic-19 CF CF CF CH H H H C-H C-H C-H C-H O 1-cyanocyclopropyl 3.61 519.1 2 3 3 3 Ic-20 CF CF CF CH H H H C-H C-H C-H C-H O 2-thienylmethyl 4.20 550.1 2 3 3 3 Ic-21 CF CF CF CH CH H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 4.04 567.1 2 3 3 2 3 Ic-22 CF CF CF CH H H H C-H C-Cl C-H C-H O pyridyl 2.38 565.0 2 3 3 3 Ic-23 CF CF CF CH H H H C-H C-Cl C-H C-H O 2,2,2-trifluoroethyl 4.17 570.0 2 3 3 3 Ic-24 CF2CF3 CF3 CH3 H H H C-H C-Cl C-F C-H O cyclopropyl 3.90 546.0 Ic-25 CF CF CF CH H H H C-H C-Cl C-H C-H O 4-chlorophenyl 4.93 598.0 2 3 3 3 Ic-26 CF CF CF CH H H H C-H C-Cl C-H C-H O methylsulphonyl 3.58 566.0 2 3 3 3 Ic-27 CF CF CF CH H H H C-H C-Cl C-F C-H O 1-cyanocyclopropyl 3.87 571.0 2 3 3 3 Ic-28 CF CF CF CH H H H C-H C-Cl C-H C-H O thietanyl 4.09 560.0 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6a 6b R R Retention Mass 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 time ***) [m/z] Ic-29 CF CF CF CH H H H C-H C-Cl C-H C-H O 1-carbamoyl- 2 3 3 3 cyclopropyl 3.07 571.0 Ic-30 CF3 CN Me H H H C-H C-Cl C-H C-H O cyclopropyl 2.97 435 CF CF CF Me H H H C-H C-Cl C-H C-H O 2-oxo[(2,2,2- 3.65 627 2 3 3 Ic-31 trifluoroethyl)amino] ethyl Ic-32 CF CF CF Me H H H C-H C-Cl C-H C-H O 1-(CF )cyclopropyl 4.29 596 2 3 3 3 Ic-33 CF CF CF Me H H H C-F C-H C-H C-H O cyclopropyl 1.19 512 2 3 3 Ic-34 CF2CF3 CF3 Me H H H C-H C-Br C-H C-H O 1-cyanocyclopropyl 3.74 597 Ic-35 CF CF CF Me H H H C-H C-H C-H C-H O H 3.1 454 2 3 3 Ic-36 CF CF CF Me H H H C-H C-F C-H C-H O 1-cyanocyclopropyl 3.69 537 2 3 3 Ic-37 CF CF CF Me H H H C-H C-F C-H C-H O cyclopropyl 3.79 512 2 3 3 Ic-38 CF CF CF Me H H H C-H C-H C-F C-H O 1-cyanocyclopropyl 2.62 537 2 3 3 Ic-39 CF CF CF Me H H H C-H C-H C-F C-H O cyclopropyl 2.62 512 2 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6a 6b R R Retention Mass 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 time ***) [m/z] Ic-40 CF CF CF Me H H H C-F C-H C-H C-H O 1-cyanocyclopropyl 1.16 537 2 3 3 Ic-41 CF CF CF Me H H H C-H C-H C-H C-F O cyclopropyl 2.61 512 2 3 3 Ic-42 CF CF CF Me H H H C-H C-H C-H C-F O 1-cyanocyclopropyl 2.61 537 2 3 3 Ic-43 CF CF CF Me H H H C-H C-H C-Cl C-H O 1-cyanocyclopropyl 1.23 553 2 3 3 Ic-44 CF CF CF Me H H H C-H C-H C-Cl C-H O cyclopropyl 1.25 528 2 3 3 Ic-45 CF CF CF Me H H H C-H C-H C-H C-Cl O 1-cyanocyclopropyl 1.22 553 2 3 3 Ic-46 CF CF CF Me H H H C-H C-H C-H C-Cl O cyclopropyl 1.28 528 2 3 3 Ic-47 CF2CF3 CF3 Me H H H C-H C-F C-F C-H O 1-cyanocyclopropyl 1.24 555 Ic-48 CF CF CF Me H H H C-H C-F C-H C-Cl O 1-cyanocyclopropyl 1.24 569 2 3 3 Ic-49 CF CF CF Me H H H C-H C-F C-H C-Cl O cyclopropyl 1.31 546 2 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) CF (E/Z)- Me H H H C-H C-Cl C-H C-H O cyclopropyl 2.47 453 Ic-50 (hydroxyimino) methyl CF (E/Z)- Me H H H C-H C-Cl C-H C-H O cyclopropyl 3.15 467 Ic-51 (methoxyimino) methyl Ic-52 CF formyl Me H H H C-H C-Cl C-H C-H O cyclopropyl 2.67 438 Ic-53 CF CN Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2.92 460 Ic-54 CF CF CF Me H H H C-H C-H C-Me C-H O cyclopropyl 1.22 508 2 3 3 Ic-55 CF CF CF Me H H H C-H C-F C-F C-H O cyclopropyl 1.26 530 2 3 3 Ic-56 CF CF CF Me H H H C-H C-H C-Me C-H O 1-cyanocyclopropyl 1.21 533 2 3 3 Ic-57 CF CF CF Me H H H C-H C-H C-H C-Me O cyclopropyl 1.21 508 2 3 3 Ic-58 CF CF CF Me H H H C-H C-H C-H C-Me O 1-cyanocyclopropyl 1.2 533 2 3 3 Ic-59 CF CF CF Me H H H C-H C-H C-CF C-H O cyclopropyl 1.27 562 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-60 CF CF CF Me H H H C-H C-H C-CF C-H O 1-cyanocyclopropyl 1.26 587 2 3 3 3 Ic-61 CF2CF3 CF3 Me H H H C-H C-H C-F C-F O cyclopropyl 1.25 530 Ic-62 CF CF CF Me H H H C-H C-H C-OMe C-H O cyclopropyl 1.18 524 2 3 3 Ic-63 CF CF CF Me H H H C-H C-H C-OMe C-H O 1-cyanocyclopropyl 1.17 549 2 3 3 Ic-64 CF CF CF Me H H H C-H C-H C-F C-F O 1-cyanocyclopropyl 1.24 553 2 3 3 Ic-65 CF CF CF Me H H H C-H C-NO C-H C-H O 1-cyanocyclopropyl 3.48 564 2 3 3 2 Ic-66 CF CF CF Me H H H C-H C-NO C-H C-H O cyclopropyl 3.53 539 2 3 3 2 Ic-67 CF CF CF Me H H H C-H C-OMe C-H C-H O 1-cyanocyclopropyl 3.77 549 2 3 3 Ic-68 CF CF CF Me H H H C-H C-OMe C-H C-H O cyclopropyl 3.86 524 2 3 3 Ic-69 CF CH OH Me H H H C-H C-Cl C-H C-H O cyclopropyl 2.15 439 Ic-70 CF CF CF Me H H H C-H C-H N C-H O cyclopropyl 1.08 495 2 3 3 Ic-71 CF2CF3 CF3 Me H H H C-H C-H N C-H O 1-cyanocyclopropyl 1.06 520 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-72 CF CF CF Me H H H C-H N C-H C-F O cyclopropyl 1.24 513 2 3 3 Ic-73 CF2CF3 CF3 Me H H H C-H N C-H C-F O 1-cyanocyclopropyl 1.2 536 Ic-74 CF CF CF Me H H H C-H C-H C-OCF C-H O cyclopropyl 1.29 578 2 3 3 3 Ic-75 CF CF CF Me H H H C-H C-H C-OCF C-H O 1-cyanocyclopropyl 1.27 603 2 3 3 3 Ic-76 CF CF CF Me H H H C-H N C-H C-H O 1-cyanocyclopropyl 1.19 520 2 3 3 Ic-77 CF CF CF Me H H H C-H C-Cl C-H C-H O 2-fluoroethyl 3.67 534 2 3 3 Ic-78 CF CF CF Me H H H C-H C-Cl C-H C-H O 2,2-difluoroethyl 3.86 552 2 3 3 Ic-79 CF CF CF Me H H H C-H C-Cl C-H C-H O 2-methylcyclopropyl 4.15 542 2 3 3 Ic-80 CF CF CF Me H H H C-H C-Cl C-H C-H O 2,2-difluoropropyl 4.05 566 2 3 3 Ic-81 CF CF CF Me H H H C-H C-Cl C-H C-H O 2-fluorocyclopropyl 3.8 546 2 3 3 Ic-83 CF CF CF Me H H H C-H C-Cl N C-H O 1-cyanocyclopropyl 3.58 554 2 3 3 Ic-84 CF2CF3 CF3 Me H H H C-H C-Me N C-H O cyclopropyl 1.07 509 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-85 CF CF CF Me H H H C-H C-Me N C-H O 1-cyanocyclopropyl 3.26 534 2 3 3 Ic-86 CF2CF3 CF3 Me H H H C-H C-OMe N C-H O cyclopropyl 1.2 525 Ic-87 CF CF CF Me H H H C-H C-OMe N C-H O 1-cyanocyclopropyl 1.19 550 2 3 3 Ic-88 CF CF CF Me H H H C-H N C-Cl C-H O cyclopropyl 4.18 529 2 3 3 Ic-89 CF CF CF Me H H H C-H N C-Cl C-H O 1-cyanocyclopropyl 4.06 554 2 3 3 Ic-90 CF CF CF Me H H H C-H C-Cl C-Me C-H O cyclopropyl 1.22 542 2 3 3 Ic-91 CF CF CF Me H H H C-H C-Cl C-Me C-H O 1-cyanocyclopropyl 1.21 567 2 3 3 Ic-92 CF CF CF Me H H H C-H C-Cl C-H C-F O cyclopropyl 1.21 546 2 3 3 Ic-93 CF CF CF Me H H H C-H C-Cl C-H C-F O 1-cyanocyclopropyl 1.2 571 2 3 3 Ic-94 CF CF CF Me H H H C-H C-Cl C-Cl C-H O cyclopropyl 1.28 562 2 3 3 Ic-95 CF CF CF Me H H H C-H C-Cl C-Cl C-H O 1-cyanocyclopropyl 1.23 587 2 3 3 Ic-96 CF2CF3 CF3 Me Me H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 4.1 567 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) CF CF CF Me Me H H C-H C-Cl C-H C-H O 1-(methylcarbamoyl) 3.58 599 2 3 3 Ic-97 cyclopropyl CF (E/Z)- Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2.42 478 Ic-98 (hydroxyimino) methyl CF (E/Z)- Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.09 492 Ic-99 (methoxyimino) methyl CF3 cyclopropyl- Me H H H C-H C-Cl C-H C-H O cyclopropyl 2.31 493 Ic-100 carbamoyl CF cyclopropyl- Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2.32 518 Ic-101 carbamoyl Ic-102 CF formyl Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2.61 463 Ic-103 CF CH F Me H H H C-H C-Cl C-H C-H O cyclopropyl 2.89 442 Ic-104 CF CH OH Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2.13 465 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-105 CF CF CF Me H H H N C-H C-H C-H O 1-cyanocyclopropyl 1.21 520 2 3 3 Ic-106 CF2CF3 CF3 Me H H H C-F C-Cl C-H C-H O cyclopropyl 1.2 546 Ic-107 CF CF CF Me H H H C-F C-Cl C-H C-H O 1-cyanocyclopropyl 1.17 571 2 3 3 CF CF CF Me H H H C-H C-Cl C-H C-H O 3-(methylsulphanyl) 4.28 588 2 3 3 Ic-108 cyclobutyl Ic-109 CF CF CF Me H H H C-H C-Cl C-H C-H O propynyl 3.69 526 2 3 3 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O 1,1,1- 4.23 584 Ic-110 trifluoropropanyl Ic-111 CF CF CF Me H H H C-H C-Cl C-H C-H O buta-2,3-dienyl 4.04 540 2 3 3 CF CF CF Me H H H C-H C-Cl C-H C-H O 3-chloropropen 4.13 562 2 3 3 Ic-112 Ic-113 CF CF CF Me H H H C-H C-Cl C-H C-H O isopropyl 4.01 530 2 3 3 Ic-114 CF3 CH2Cl Me H H H C-H C-Cl C-H C-H O cyclopropyl 3.12 458 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-115 CF CH F Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2.89 467 Ic-116 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O 1-oxidothietanyl 3.03 576 Ic-117 CF CF CF Me H H H C-H C-Cl C-H C-H O 1,1-dioxidothietanyl 3.37 592 2 3 3 CF CF CF Me H H H C-H C-(E/Z)- C-H C-H O cyclopropyl 3.99 551 2 3 3 Ic-118 (methoxyimino) methyl CF CF CF Me H H H C-H C-Cl C-H C-H O 2-(methylsulphanyl) 4.52 588 2 3 3 Ic-119 cyclobutyl CF CF CF Me H H H C-H C-Cl C-H C-H O 2-[(methylsulphanyl) 4.56 602 2 3 3 Ic-120 methyl]cyclobutyl Ic-121 CF CF formyl Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.09 513 CF CF CF Me H H H C-H C-Cl C-H C-H O 3-(methylsulphonyl) 3.24 620 2 3 3 Ic-122 cyclobutyl CF CF CF Me H H H C-H C-Cl C-H C-H O 2-[(methylsulphinyl) 3.09 618 2 3 3 Ic-123 methyl]cyclobutyl BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) CF CF CF Me H H H C-H C-Cl C-H C-H O (1S,2R) 3.47 620 2 3 3 Ic-124 (methylsulphonyl) cyclobutyl CF CF CF Me H H H C-H C-Cl C-H C-H O 2-(methylsulphinyl) 3.17 604 2 3 3 Ic-125 cyclobutyl Ic-126 CF CF Me H H H C-H C-Cl C-H C-H O cyclopropyl 3.42 478 Ic-127 CF CF Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.3 503 Ic-128 CF CF CF Me H H H C-H C-Cl C-H C-H O 3-cyanothietanyl 4.38 585 2 3 3 Ic-129 CF CF CF Me H H H C-H C-Me C-H C-H O 1-cyanocyclopropyl 3.73 533 2 3 3 Ic-130 CF CF CF Me H H H C-H C-Me C-H C-H O cyclopropyl 3.76 508 2 3 3 Ic-131 CF CF CF Me H H H C-H C-Me C-H C-H O 4-fluorophenyl 4.57 562 2 3 3 Ic-132 CF CF CF Me H H H C-H C-Cl C-H C-H S cyclopropyl 4.34 544 2 3 3 Ic-133 CF3 CHF2 Me H H H C-H C-Cl C-H C-H O cyclopropyl 3.01 460 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-134 CF S(O)Me Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 2.16 497 Ic-135 CF3 CF3 Me H H H C-H C-Cl C-H C-H O phenyl 4.1 514 Ic-136 CF CF CF Me H H H C-H C-Cl C-H C-H O phenyl 1.30 564 2 3 3 Ic-137 CF CF CF Me H H H C-H C-Cl C-H C-H O 3-methylbutanyl 1.30 558 2 3 3 CF CF CF Me H H H C-H C-Cl C-H C-H O 2-(dimethylamino) 0.89 559 2 3 3 Ic-138 ethyl Ic-139 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O 2-methoxyethyl 1.19 546 Ic-140 CF CF CF Me H H H C-H C-Cl C-H C-H O pyridinyl 1.25 565 2 3 3 Ic-141 CF CF CF Me H H H C-H C-Cl C-H C-H O cyclopentyl 1.26 556 2 3 3 Ic-142 CF CF CF Me H H H C-H C-Cl C-H C-H O isobutyl 1.25 544 2 3 3 Ic-143 CF CF CF Me H H H C-H C-Cl C-H C-H O cyclobutyl 1.27 542 2 3 3 Ic-144 CF CF CF Me H H H C-H C-Cl C-H C-H O 1H-tetrazolyl 1.16 556 2 3 3 Ic-145 CF CF CF Me H H H C-H C-Cl C-H C-H O 1,2-oxazolyl 1.22 555 2 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) CF CF CF Me H H H C-H C-Cl C-H C-H O 1H-imidazol 0.89 568 2 3 3 Ic-146 ylmethyl Ic-147 CF CF CF Me H H H C-H C-Cl C-H C-H O cyanomethyl 1.13 527 2 3 3 CF CF CF Me H H H C-H C-Cl C-H C-H O 5-methyl-1,2-oxazol- 1.27 569 2 3 3 Ic-148 3-yl Ic-149 CF CF CF Me H H H C-H C-Cl C-H C-H O pyridinyl 1.20 565 2 3 3 Ic-150 CF CF CF Me H H H C-H C-Cl C-H C-H O 1H-pyrazolyl 1.19 554 2 3 3 Ic-151 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O 3-chloropropyl 1.23 564 Ic-152 CF CF CF Me H H H C-H C-Cl C-H C-H O methyl 1.17 502 2 3 3 Ic-153 CF CF CF Me H H H C-H C-Cl C-H C-H O cyclopropylmethyl 1.23 542 2 3 3 CF CF CF Me H H H C-H C-Cl C-H C-H O 1-amino 1.10 559 2 3 3 Ic-154 oxopropanyl Ic-155 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O methoxy 1.16 518 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-156 CF CF CF Me H H H C-H C-Cl C-H C-H O 2-aminooxoethyl 1.08 545 2 3 3 Ic-157 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O 1H-pyrazolylmethyl 1.13 568 CF CF CF Me H H H C-H C-Cl C-H C-H O 5-methyl-1,3,4- 1.13 570 2 3 3 Ic-158 oxadiazolyl CF CF CF Me H H H C-H C-Cl C-H C-H O 1-methyl-1H- 3.73 568 2 3 3 Ic-159 pyrazolyl CF CF CF Me H H H C-H C-Cl C-H C-H O 4-methyl-1,3-oxazol- 1.19 569 2 3 3 Ic-160 2-yl CF CF CF Me H H H C-H C-Cl C-H C-H O 1-cyclopropyl- 1.27 570 2 3 3 Ic-161 propanyl CF CF CF Me H H H C-H C-Cl C-H C-H O 5-hydroxy-1H- 1.15 570 2 3 3 Ic-162 pyrazolyl CF CF CF Me H H H C-H C-Cl C-H C-H O 1-methyl-1H- 1.14 568 2 3 3 Ic-163 pyrazolyl BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) CF CF CF Me H H H C-H C-Cl C-H C-H O (3R)- 1.18 558 2 3 3 Ic-164 tetrahydrofuranyl CF CF CF Me H H H C-H C-Cl C-H C-H O 1-methoxypropan 1.21 560 2 3 3 Ic-165 CF CF CF Me H H H C-H C-Cl C-H C-H O 1-methyl-1H- 1.13 568 2 3 3 Ic-166 pyrazolyl CF CF CF Me H H H C-H C-Cl C-H C-H O 2-(methylsulphanyl) 1.19 562 2 3 3 Ic-167 ethyl Ic-168 CF CF Me H H H C-H C-Cl C-H C-H O 2-fluoroethyl 3.24 484 Ic-169 CF CF Me H H H C-H C-Cl C-H C-H O 2,2,2-trifluoroethyl 3.71 520 Ic-170 CF CF Me H H H C-H C-Cl C-H C-H O 2,2-difluoroethyl 3.43 502 CF CF CF Me H H H C-H C-H C-O- O cyclopropyl 2.77 574 2 3 3 Ic-171 CF - BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) CF CF CF Me H H H C-H C-H C-O- O 1-cyanocyclopropyl 2.73 599 2 3 3 Ic-172 CF - CF CF CF Me H H H C-H C-F C- C-H O cyclopropyl 2.4 591 2 3 3 Ic-173 sulphamoyl Ic-174 CF CF CF Me H H H C-F C-F C-H C-H O cyclopropyl 2.56 530 2 3 3 Ic-175 CF CF CF Me H H H C-F C-F C-H C-H O 1-cyanocyclopropyl 2.55 555 2 3 3 Ic-176 CF CF CF Me H H H C-H C-Cl C-H C-H O 1-ethoxycyclopropyl 4.08 572 2 3 3 Ic-177 CF CF Me H H H C-H C-Cl C-H C-H O 2-fluorocyclopropyl 3.41 496 Ic-178 CF CF CF Me H H H N C-H N C-H O cyclopropyl 1.17 496 2 3 3 Ic-179 CF CF CF Me H H H N C-H N C-H O 1-cyanocyclopropyl 1.15 521 2 3 3 CF CF CF Me H H H C-H C-Cl C-H C-H O (1R,2R) 3.99 572 2 3 3 Ic-180 ethoxycyclopropyl Ic-181 CF CF CF Me H H H C-H C-Cl C-H C-H O 2-(CF )cyclopropyl 4.26 596 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-182 CF CF CF Me H H H C-H C-SMe C-H C-H O cyclopropyl 3.81 540 2 3 3 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O (1S,2S,3S)ethoxy- 4.34 586 Ic-183 3-methylcyclopropyl CF CF CF Me H H H C-H C-Cl C-H C-H O 2,2- 4.34 596 2 3 3 Ic-184 dichlorocyclopropyl CF CF CF Me H H H C-H C- C-H C-H O cyclopropyl 3.99 629 2 3 3 Ic-185 diethylsulphamoyl CF CF CF Me H H H C-H C-Cl C-H C-H O (1S,2S) 3.73 572 2 3 3 Ic-186 ethoxycyclopropyl CF CF CF Me H H H C-H C-Cl C-H C-H O 1- 3.83 558 2 3 3 Ic-187 methoxycyclopropyl CF CF CF Me H H H C-H C-Cl C-H C-H O 1,1'-bi(cyclopropyl)- 4.43 568 2 3 3 Ic-188 1-yl Ic-189 CF2CF3 CF3 Me H H H C-H C-S(O)Me C-H C-H O cyclopropyl 3.19 556 Ic-190 CF CF CF Me H H H C-H C-S(O) Me C-H C-H O cyclopropyl 3.35 572 2 3 3 2 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-191 CF CF CF Me H H amino C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.3 568 2 3 3 Ic-192 CF2CF3 CF3 Me H H amino C-H C-Cl C-H C-H O cyclopropyl 3.35 543 Ic-193 CF CF CF Me H H H C-H C-Cl C-H C-H O butynyl 3.97 540 2 3 3 Ic-194 CF CF SMe Me H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.56 531 CF CF CF Me H H H C-H C-Cl C- C-H O cyclopropyl 3.31 607 2 3 3 Ic-195 sulphamoyl Ic-196 CF2CF3 CF3 Me H H H C-H C-CF3 C-H C-H O cyclopropyl 3.96 562 CF CF CF Me Et H H C-H C- C-H C-H O ethyl 4.39 629 2 3 3 Ic-197 cyclopropyl- sulphamoyl Ic-198 CF CF CF Me H H H C-H C-Cl C-H C-H O pentynyl 4.27 554 2 3 3 Ic-199 CF CF CF Me Me H H C-H C-Cl C-H C-H O cyclopropyl 2.72 542 2 3 3 Ic-200 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O 1-methylcyclopropyl 4.12 542 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-201 CF CF CF Me H H H C-H C-F C-F C-F O cyclopropyl 4.09 548 2 3 3 Ic-202 CF2CF3 CF3 Me H H H C-H C-F C-F C-F O 1-cyanocyclopropyl 4.03 573 Ic-203 CF CF CF Me H H H C-H C-CF C-H C-H O 1-cyanocyclopropyl 3.88 587 2 3 3 3 Ic-204 CF CF CF Me nPr H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 4.56 595 2 3 3 Ic-205 CF CF CF Me propionyl H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 4.63 609 2 3 3 Ic-206 CF CF CF Me allyl H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 4.44 593 2 3 3 Ic-207 CF CF CF Me H H H C-H C-Cl C-H C-H O 1-cyclopropylethyl 4.4 556 2 3 3 Ic-208 CF CF CF Me Et H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 4.33 581 2 3 3 Ic-209 CF CF CF Me H H H C-H C-Cl C-H C-H O 4-fluorophenyl 4.53 582 2 3 3 CF CF CF Me H H H C-H C-Cl C-H C-H O 1-cyclobutylcyclo- 4.77 582 2 3 3 Ic-210 propyl Ic-211 CF CF CF Me Et H H C-H C-Cl C-H C-H O cyclopropyl 1.35 556 2 3 3 Ic-212 CF CF CF Me H H H C-H C-Cl C-H N O cyclopropyl 1.09 494 2 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 6 6b R R Retention Mass a **) time 1 2 3 1 *) Z Z Z R A A A A W Q logP 4 3 2 1 [m/z] ***) Ic-213 CF CF CF Me H H H C-H C-Cl C-H N O 1-cyanocyclopropyl 1.09 519 2 3 3 Ic-214 CF2CF3 CF3 Me H H H C-H C-Cl C-H C-H O pyrazinyl 1.24 566 BCS 13-3006 Foreign Countries THS/mr 201420 Table 4 Z Z R1 1 (Id) Z 6b 6a 6a 6b R R Mass 1 2 3 1 *) Ex. No Z Z Z R A A A A W Q logP 4 3 2 1 ***) [m/z] Id-1 CF CF CF CH H H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.87 553.1 2 3 3 3 Id-2 CF CF CF CH H H H C-H C-Cl C-H C-H O cyclopropyl 3.97 528.0 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 Table 5 Z Z R1 1 (Ie) Z 6a R Mass 1 2 3 1 *) Ex. No Z Z Z R A A A A W Q logP 4 3 2 1 ***) [m/z] Ie-1 CF CF CF CH H H C-H C-Cl C-H C-H O 1-cyanocyclopropyl 3.62 554.0 2 3 3 3 Ie-2 CF CF CF CH H H C-H C-Cl C-H C-H O cyclopropyl 3.72 529.0 2 3 3 3 Ie-3 CF CF CF CH H H C-H C-H C-H C-H O cyclopropyl 3.50 495.1 2 3 3 3 Ie-4 CF2CF3 CF3 CH3 H H C-H C-H C-H C-H O 2-thienylmethyl 4.05 551.1 Ie-5 CF CF CF CH H H C-H C-H C-H C-H O 6-chloropyridinyl 4.24 566.1 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 Ie-6 CF CF CF CH H H C-H C-H C-H C-H O 1- 2 3 3 3 carbamothioylcyclop ropyl 3.29 554.1 Ie-7 CF CF CF CH H H C-H C-H C-H C-H O 1-cyanocyclopropyl 3.46 520.1 2 3 3 3 BCS 13-3006 Foreign Countries THS/mr 201420 The stated mass is the peak of the isotope pattern of the [M+H] ion of the highest intensity; if the [M- H] ion was detected, the stated mass is marked with .
The stated mass is the peak of the isotope pattern of the [M-H] ion of the highest intensity. If the mass was determined by a GCMS (see below for methods) measurement, the stated mass is marked with .
Note regarding the determination of the logP values and mass detection: The determination of the given logP values was carried out in accordance with EEC Directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on a reversed-phase column (C18). Agilent 1100 LC system; 50*4.6 Zorbax Eclipse Plus C18 1.8 micron; mobile phase A: acetonitrile (0.1% formic acid); mobile phase B: water (0.09% formic acid); linear gradient from 10% acetonitrile to 95% acetonitrile in 4.25 min, then 95% acetonitrile for a further 1.25 min; oven temperature 55°C; flow rate: 2.0 ml/min.
Mass detection is carried out via an Agilend MSD system.
Note regarding the determination of the retention times. Measurement of retention times and associated mass spectroscopy was carried out using the following methods: Instrument: Micromass Quattro Premier with Waters UPLC Acquity; column: Thermo Hypersil GOLD 1.9 µ 50 x 1 mm; mobile phase A: 1 l of water + 0.5 ml of 50% strength formic acid, mobile phase B: 1 l of acetonitrile + 0.5 ml of 50% strength formic acid; gradient: 0.0 min 97% A → 0.5 min 97% A → 3.2 min 5% A → 4.0 min 5% A; oven: 50°C; flow rate: 0.3 ml/min; UV detection: 210 nm.
Instrument: Waters ACQUITY SQD UPLC System; column: Waters Acquity UPLC HSS T3 1.8 µ 50 x 1 mm; mobile phase A: 1 l of water + 0.25 ml of 99% strength formic acid, mobile phase B: 1 l of acetonitrile + 0.25 ml of 99% strength formic acid; gradient: 0.0 min 90% A → 1.2 min 5% A → 2.0 min 5% A; oven: 50°C; flow rate: 0.40 ml/min; UV detection: 208 – 400 nm.
MS instrument: Waters SQD; HPLC instrument: Waters UPLC; column: Zorbax SB-Aq (Agilent), 50 mm x 2.1 mm, 1.8 µm; mobile phase A: water + 0.025% formic acid, mobile phase B: acetonitrile (ULC) + 0.025% formic acid; gradient: 0.0 min 98%A - 0.9 min 25%A – 1.0 min 5%A - 1.4 min 5%A – 1.41 min 98%A – 1.5 min 98%A; oven: 40°C; flow rate: 0.600 ml/min; UV detection: DAD; 210 nm.
Instrument: Waters ACQUITY SQD UPLC System; column: Waters Acquity UPLC HSS T3 1.8 µ 50 x 1 mm; mobile phase A: 1 l of water + 0.25 ml of 99% strength formic acid, mobile phase B: 1 l of acetonitrile + 0.25 ml of 99% strength formic acid; gradient: 0.0 min 95% A → 6.0 min 5% A → 7.5 min 5% A; oven: 50°C; flow rate: 0.35 ml/min; UV detection: 210 – 400 nm.
BCS 13-3006 Foreign Countries THS/mr 201420 NMR data of selected examples NMR peak list method The 1H NMR data of selected examples are stated in the form of 1H NMR peak lists. For each signal peak, first the δ value in ppm and then the signal intensity in round brackets are listed. The δ value – signal intensity number pairs for different signal peaks are listed with separation from one another by semicolons.
The peak list for one example therefore takes the form of: δ (intensity ); δ (intensity );……..; δ (intensity );……; δ (intensity ) 1 1 2 2 i i n n The intensity of sharp signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal intensities. In the case of broad signals, several peaks or the middle of the signal and their relative intensities may be shown in comparison to the most intense signal in the spectrum.
For calibration of the chemical shift of the 1H NMR spectra we use tetramethylsilane and/or the chemical shift of the solvent, particularly in the case of spectra measured in DMSO. Therefore, the tetramethylsilane peak may but need not occur in NMR peak lists.
The lists of the 1H NMR peaks are similar to the conventional 1H NMR printouts and thus usually contain all peaks listed in a conventional NMR interpretation.
In addition, like conventional 1H NMR printouts, they may show solvent signals, signals of stereoisomers of the target compounds, which likewise form part of the subject-matter of the invention, and/or peaks of impurities.
In the reporting of compound signals in the delta range of solvents and/or water, our lists of 1H NMR peaks show the usual solvent peaks, for example peaks of DMSO in DMSO-D and the peak of water, which usually have a high intensity on average.
The peaks of stereoisomers of the target compounds and/or peaks of impurities usually have a lower intensity on average than the peaks of the target compounds (for example with a purity of > 90%).
Such stereoisomers and/or impurities may be typical of the particular preparation process. Their peaks can thus help in this case to identify reproduction of our preparation process with reference to "by- product fingerprints".
BCS 13-3006 Foreign Countries THS/mr 201420 An expert calculating the peaks of the target compounds by known methods (MestreC, ACD simulation, but also with empirically evaluated expected values) can, if required, isolate the peaks of the target compounds, optionally using additional intensity filters. This isolation would be similar to the relevant peak picking in conventional 1H NMR interpretation.
Further details of 1H NMR peak lists can be found in Research Disclosure Database Number 564025.
Example Ia-1: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.676(2.1); 7.671(3.1); 7.659(1.8); 7.653(1.0); 7.638(2.0); 7.633(1.6); 7.618(1.0); 7.462(3.1); 7.442(2.2); 7.349(1.5); 7.344(2.3); 7.340(1.3); 6.998(1.3); 6.992(1.8); 6.985(1.3); 6.813(1.7); 6.809(1.8); 6.806(1.7); 6.801(1.4); 3.690(11.5); 2.469(0.4); 2.464(0.6); 2.459(0.4); 2.163(185.6); 2.120(0.5); 2.114(0.7); 2.108(0.9); 2.101(0.6); 1.972(1.3); 1.965(8.3); 1.958(13.7); 1.953(59.4); 1.946(104.0); 1.940(134.9); 1.934(91.2); 1.928(46.0); 1.781(0.3); 1.775(0.6); 1.769(0.8); 1.763(0.5); 1.589(1.2); 1.575(3.1); 1.568(2.9); 1.554(1.7); 1.437(16.0); 1.357(1.6); 1.343(2.9); 1.336(3.2); 1.322(1.5); 1.317(0.4); 1.135(0.8); 0.146(0.4); 0.008(4.0); 0.000(103.9); -0.009(3.2); -0.149(0.4) Example Ia-2: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.632(3.0); 7.627(4.1); 7.609(2.3); 7.603(1.4); 7.588(2.5); 7.583(1.9); 7.429(3.8); 7.408(3.0); 7.335(2.0); 7.330(3.3); 7.325(1.9); 6.991(1.8); 6.985(2.7); 6.978(1.8); 6.922(0.9); 6.802(2.3); 6.798(2.4); 6.795(2.2); 6.791(1.9); 4.068(0.5); 4.050(0.5); 3.803(0.5); 3.687(16.0); 2.863(0.7); 2.854(1.0); 2.845(1.5); 2.836(1.5); 2.827(1.0); 2.818(0.7); 2.641(0.8); 2.462(0.4); 2.160(73.5); 2.113(0.4); 2.107(0.5); 2.101(0.3); 1.972(2.6); 1.964(5.0); 1.958(7.4); 1.952(31.4); 1.946(54.8); 1.940(70.8); 1.934(47.6); 1.928(24.2); 1.768(0.4); 1.437(2.8); 1.320(0.5); 1.299(0.6); 1.221(0.6); 1.203(1.4); 1.186(0.6); 1.134(10.8); 0.788(0.9); 0.775(2.6); 0.770(3.2); 0.757(3.6); 0.752(2.4); 0.740(1.2); 0.606(1.1); 0.595(3.0); 0.588(3.0); 0.585(2.7); 0.579(2.6); 0.567(0.9); 0.008(3.1); 0.000(69.8); -0.009(2.3); -0.150(0.3) Example Ib-1: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.942(3.4); 7.936(3.9); 7.892(2.3); 7.886(1.9); 7.871(2.5); 7.865(2.1); 7.818(3.6); 7.815(3.6); 7.708(4.8); 7.705(4.3); 7.509(3.9); 7.488(3.5); 7.424(1.4); 7.420(1.9); 7.403(4.5); 7.387(3.5); 7.382(1.4); 7.369(4.8); 7.365(2.3); 7.350(2.0); 7.304(1.3); 7.286(1.6); 7.268(0.6); 4.566(5.2); 4.551(5.0); 4.085(0.4); 4.068(1.1); 4.050(1.1); 4.032(0.4); 3.730(16.0); 2.467(0.4); 2.463(0.5); 2.458(0.3); 2.164(93.1); 2.133(0.4); 2.120(0.4); 2.113(0.5); 2.107(0.6); 2.101(0.5); 1.972(5.7); 1.964(7.5); 1.958(11.7); 1.952(44.6); 1.946(77.0); 1.940(99.3); 1.934(68.5); 1.928(35.2); 1.775(0.5); 1.768(0.6); 1.762(0.4); 1.437(0.4); 1.271(0.4); 1.221(1.3); 1.204(2.6); 1.186(1.3); 0.000(5.1) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ib-2: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.921(8.4); 7.903(2.6); 7.897(1.6); 7.819(3.5); 7.709(4.4); 7.706(3.9); 7.587(1.1); 7.571(0.4); 7.518(2.4); 7.515(1.6); 7.499(1.5); 7.496(2.2); 5.447(0.8); 3.731(16.0); 2.139(49.6); 2.119(0.6); 2.113(0.8); 2.107(1.0); 2.101(0.7); 2.095(0.3); 1.964(10.0); 1.958(15.9); 1.952(65.9); 1.946(114.1); 1.940(147.1); 1.934(100.3); 1.927(51.2); 1.915(1.0); 1.780(0.5); 1.774(0.7); 1.768(0.9); 1.762(0.6); 1.756(0.4); 1.589(1.7); 1.575(4.4); 1.568(4.1); 1.555(2.2); 1.514(0.4); 1.367(2.4); 1.354(4.2); 1.347(4.5); 1.341(1.8); 1.332(1.8); 1.294(0.5); 1.285(2.1); 1.271(1.1); 1.262(0.5); 0.008(0.8); 0.000(21.6); -0.009(0.7) Example Ib-3: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.875(1.0); 7.871(3.0); 7.851(1.1); 7.846(0.7); 7.813(1.2); 7.810(1.2); 7.692(1.7); 7.689(1.6); 7.480(1.1); 7.478(0.9); 7.460(0.8); 7.458(0.9); 5.447(16.0); 4.085(0.5); 4.067(1.4); 4.050(1.4); 4.032(0.5); 3.729(5.6); 2.856(0.4); 2.848(0.6); 2.838(0.6); 2.830(0.4); 2.142(4.0); 1.971(6.7); 1.964(1.0); 1.958(1.5); 1.952(6.2); 1.946(11.0); 1.940(14.3); 1.934(9.8); 1.927(5.0); 1.437(0.6); 1.372(1.0); 1.277(1.2); 1.221(1.8); 1.203(3.6); 1.186(1.8); 1.135(2.6); 1.099(0.3); 0.778(0.9); 0.772(1.2); 0.760(1.3); 0.754(0.9); 0.742(0.4); 0.610(0.4); 0.600(1.0); 0.598(1.0); 0.592(1.1); 0.588(0.9); 0.583(0.9); 0.008(1.0); 0.000(23.8); -0.009(0.9) Example Ic-1: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.261(5.7); 8.235(5.4); 7.699(3.4); 7.693(4.3); 7.664(2.4); 7.658(1.7); 7.643(2.8); 7.637(2.3); 7.491(4.2); 7.470(3.2); 6.953(0.8); 5.448(1.2); 4.086(0.5); 4.068(1.4); 4.050(1.4); 4.032(0.5); 3.749(16.0); 2.873(0.7); 2.863(1.0); 2.854(1.5); 2.845(1.5); 2.836(1.0); 2.827(0.7); 2.170(41.6); 2.120(0.4); 2.114(0.4); 2.108(0.5); 2.102(0.3); 1.972(6.7); 1.965(3.6); 1.959(5.6); 1.953(25.2); 1.947(44.3); 1.940(57.9); 1.934(39.8); 1.928(20.4); 1.769(0.3); 1.437(5.6); 1.372(3.6); 1.340(0.5); 1.285(0.8); 1.277(3.9); 1.222(1.7); 1.204(3.3); 1.186(1.6); 0.798(0.8); 0.785(2.5); 0.780(3.2); 0.767(3.4); 0.762(2.4); 0.750(1.1); 0.614(1.1); 0.603(2.7); 0.596(2.8); 0.592(2.4); 0.587(2.5); 0.574(0.8); 0.146(0.4); 0.008(3.5); 0.000(89.6); -0.009(3.3); -0.150(0.4) Example Ic-2: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.270(2.7); 8.246(2.5); 7.749(1.6); 7.743(2.1); 7.714(1.1); 7.708(0.8); 7.693(1.3); 7.687(1.1); 7.570(0.6); 7.524(2.0); 7.504(1.6); 6.878(0.3); 6.872(0.7); 3.751(7.9); 2.612(0.7); 2.138(33.6); 2.107(0.4); 1.972(1.6); 1.964(3.4); 1.958(5.2); 1.952(23.5); 1.946(41.4); 1.940(54.4); 1.934(37.3); 1.927(19.0); 1.768(0.3); 1.602(0.9); 1.588(2.0); 1.581(2.0); 1.568(1.1); 1.550(0.4); 1.543(0.4); 1.437(16.0); 1.372(1.2); 1.363(1.2); 1.349(2.0); 1.342(2.2); 1.328(0.9); 1.312(0.4); 1.305(0.5); 1.285(0.4); 1.277(1.4); 1.222(0.4); 1.204(0.8); 1.186(0.4); 1.135(9.5); 0.146(0.3); 0.015(0.4); BCS 13-3006 Foreign Countries THS/mr 201420 0.008(2.8); 0.000(79.4); -0.009(2.6); -0.149(0.3) Example Ic-3: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.271(5.6); 8.248(5.2); 7.763(3.4); 7.758(3.9); 7.687(1.9); 7.682(1.7); 7.666(2.4); 7.661(2.2); 7.521(3.9); 7.500(3.1); 7.423(1.9); 7.406(4.3); 7.388(3.0); 7.383(1.1); 7.370(4.6); 7.351(2.3); 7.305(1.3); 7.287(1.6); 7.269(0.6); 4.570(5.3); 4.555(5.1); 4.050(0.3); 3.750(16.0); 2.462(0.4); 2.155(71.7); 2.120(0.4); 2.113(0.4); 2.107(0.6); 2.101(0.4); 1.972(1.9); 1.964(6.1); 1.958(9.3); 1.952(39.2); 1.946(68.5); 1.940(89.0); 1.934(61.3); 1.927(31.5); 1.774(0.4); 1.768(0.5); 1.762(0.4); 1.437(1.5); 1.270(0.4); 1.221(0.4); 1.204(0.8); 1.186(0.4); 0.000(4.2) Example Ic-4: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.171(3.2); 7.551(0.9); 7.531(7.5); 7.528(5.7); 7.524(4.9); 7.519(1.3); 7.504(0.6); 7.498(0.5); 6.937(0.8); 4.068(0.9); 4.050(0.9); 3.881(0.4); 3.790(15.9); 3.714(0.7); 2.864(0.7); 2.854(1.0); 2.846(1.5); 2.836(1.6); 2.828(1.0); 2.818(0.7); 2.467(0.4); 2.462(0.6); 2.458(0.4); 2.230(1.3); 2.138(154.8); 2.119(1.8); 2.113(2.3); 2.107(3.0); 2.101(2.0); 2.095(1.0); 1.972(6.5); 1.964(29.3); 1.958(46.1); 1.952(191.8); 1.946(333.8); 1.940(431.2); 1.933(293.7); 1.927(149.0); 1.915(1.9); 1.780(1.0); 1.774(1.8); 1.768(2.5); 1.762(1.6); 1.756(0.8); 1.437(16.0); 1.270(0.9); 1.222(1.1); 1.204(2.3); 1.186(1.0); 1.135(1.3); 0.793(0.8); 0.780(2.4); 0.775(3.2); 0.762(3.4); 0.757(2.4); 0.745(1.2); 0.599(1.1); 0.587(2.6); 0.581(2.7); 0.577(2.4); 0.572(2.5); 0.559(0.8); 0.146(1.1); 0.008(10.1); 0.000(267.4); -0.009(8.5); -0.150(1.1) Example Ic-5: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.562(1.8); 7.560(1.5); 7.542(2.1); 7.540(2.3); 7.444(0.5); 7.439(0.6); 7.428(6.0); 7.420(1.6); 7.416(0.9); 7.414(0.8); 7.412(1.0); 7.408(1.9); 7.402(1.5); 7.399(1.4); 7.397(1.0); 7.394(1.3); 7.389(0.4); 7.375(0.6); 7.361(0.8); 7.356(0.7); 7.343(0.6); 7.339(0.7); 6.961(0.7); 4.086(0.4); 4.068(1.3); 4.050(1.3); 4.032(0.4); 3.921(0.5); 3.815(0.4); 3.756(13.3); 3.402(0.5); 2.858(0.6); 2.849(0.8); 2.840(1.3); 2.831(1.3); 2.825(0.9); 2.822(1.0); 2.816(0.8); 2.813(0.7); 2.807(0.5); 2.798(0.3); 2.633(1.0); 2.472(0.5); 2.467(0.7); 2.462(0.9); 2.458(0.6); 2.453(0.3); 2.153(129.0); 2.121(18.1); 2.114(1.5); 2.107(1.4); 2.101(0.9); 2.095(0.5); 1.972(7.3); 1.964(15.2); 1.958(24.6); 1.952(98.5); 1.946(171.1); 1.940(219.8); 1.934(149.3); 1.928(75.1); 1.915(0.9); 1.781(0.5); 1.775(0.9); 1.768(1.3); 1.762(0.8); 1.756(0.4); 1.437(1.2); 1.285(0.4); 1.270(1.0); 1.222(1.6); 1.204(3.3); 1.186(1.6); 1.135(16.0); 0.789(0.7); 0.777(2.2); 0.772(2.7); 0.759(3.5); 0.754(2.5); 0.744(1.7); 0.742(1.6); 0.727(0.5); 0.602(0.9); 0.592(2.2); 0.590(2.2); 0.585(2.7); 0.581(2.2); 0.575(3.0); 0.567(1.3); 0.563(1.6); 0.558(1.0); 0.146(0.6); 0.008(5.9); 0.000(143.6); -0.009(4.7); -0.150(0.6) Example Ic-6: H-NMR(400.0 MHz, acetonitrile-d ): BCS 13-3006 Foreign Countries THS/mr 201420 δ= 8.131(8.4); 7.586(2.0); 7.580(2.4); 7.549(1.2); 7.544(0.9); 7.528(1.6); 7.523(1.3); 7.481(0.9); 7.475(0.4); 7.468(0.9); 7.464(1.7); 7.457(2.1); 7.453(1.0); 7.440(3.5); 7.438(3.1); 7.426(0.5); 7.420(2.4); 7.341(0.3); 7.334(2.3); 7.331(2.4); 7.326(1.2); 7.319(0.6); 7.313(1.9); 7.309(1.3); 6.954(0.6); 2.853(0.4); 2.843(0.6); 2.834(0.9); 2.825(0.9); 2.816(0.6); 2.807(0.5); 2.524(0.4); 2.471(0.6); 2.467(0.7); 2.462(0.6); 2.200(267.1); 2.115(0.4); 2.108(0.4); 2.102(0.3); 1.972(1.9); 1.965(5.2); 1.959(8.2); 1.953(33.9); 1.947(58.8); 1.941(76.0); 1.935(52.0); 1.929(26.6); 1.776(0.3); 1.770(0.4); 1.437(16.0); 1.222(0.4); 1.204(0.7); 1.186(0.3); 0.785(0.5); 0.772(1.5); 0.767(1.9); 0.754(2.0); 0.749(1.4); 0.737(0.7); 0.594(0.7); 0.583(1.7); 0.577(1.8); 0.573(1.6); 0.567(1.6); 0.555(0.5); 0.008(1.8); 0.000(40.5); -0.009(1.4) Example Ic-7: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.140(16.0); 7.637(4.5); 7.632(5.2); 7.599(4.2); 7.594(3.6); 7.578(3.8); 7.573(3.1); 7.501(0.6); 7.493(0.5); 7.484(2.0); 7.474(5.7); 7.470(2.7); 7.466(3.8); 7.462(3.0); 7.458(4.9); 7.453(5.1); 7.445(1.9); 7.443(2.4); 7.439(5.5); 7.427(0.9); 7.422(1.6); 7.417(1.2); 7.343(0.7); 7.336(5.2); 7.332(5.3); 7.328(2.6); 7.320(1.4); 7.315(4.1); 7.311(2.9); 4.068(0.7); 4.050(0.6); 2.472(1.3); 2.467(2.5); 2.462(3.4); 2.458(2.4); 2.453(1.2); 2.243(0.4); 2.151(557.2); 2.126(1.5); 2.120(3.4); 2.113(4.7); 2.107(5.6); 2.101(3.9); 2.095(2.0); 2.083(0.4); 1.971(8.0); 1.964(62.9); 1.958(99.0); 1.952(403.2); 1.946(705.3); 1.940(916.1); 1.934(628.4); 1.927(319.6); 1.915(4.5); 1.792(0.4); 1.781(2.2); 1.774(3.9); 1.768(5.2); 1.762(3.6); 1.756(1.8); 1.588(2.1); 1.574(5.3); 1.567(5.3); 1.553(2.9); 1.512(0.3); 1.437(11.9); 1.382(0.3); 1.372(0.3); 1.342(3.0); 1.328(5.3); 1.321(5.7); 1.307(2.2); 1.292(0.5); 1.277(0.9); 1.271(1.1); 1.221(0.8); 1.204(1.6); 1.193(0.3); 1.186(0.8); 1.135(0.7); 0.146(1.8); 0.008(18.4); 0.000(481.6); -0.009(16.9); -0.150(1.9) Example Ic-8: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.261(0.9); 8.254(6.6); 8.249(2.2); 8.236(2.3); 8.231(6.8); 8.224(0.7); 8.181(7.5); 8.174(6.7); 7.626(4.0); 7.621(4.9); 7.588(2.6); 7.583(1.9); 7.567(3.2); 7.562(2.6); 7.502(0.5); 7.494(0.9); 7.487(7.0); 7.482(2.5); 7.469(2.3); 7.464(7.1); 7.460(5.7); 7.439(3.6); 6.925(1.2); 4.068(0.7); 4.050(0.7); 2.865(0.3); 2.856(0.9); 2.846(1.3); 2.838(1.8); 2.828(1.9); 2.819(1.2); 2.810(0.9); 2.473(0.9); 2.468(1.6); 2.464(2.2); 2.459(1.6); 2.454(0.8); 2.338(0.6); 2.165(463.3); 2.133(1.1); 2.120(1.3); 2.114(2.0); 2.108(2.5); 2.101(1.7); 2.095(0.9); 1.972(6.9); 1.964(31.0); 1.958(47.6); 1.952(185.3); 1.946(318.3); 1.940(409.5); 1.934(278.7); 1.928(141.8); 1.781(1.0); 1.775(1.8); 1.769(2.3); 1.762(1.6); 1.756(0.7); 1.437(16.0); 1.269(0.7); 1.221(0.9); 1.204(1.9); 1.189(0.6); 1.186(0.9); 1.135(0.5); 0.788(1.0); 0.775(2.9); 0.770(3.9); 0.757(4.0); 0.752(2.9); 0.740(1.3); 0.597(1.4); 0.586(3.5); 0.580(3.5); 0.576(3.1); 0.570(3.1); 0.558(0.9); 0.146(0.8); 0.008(8.3); 0.000(190.9); -0.009(6.5); -0.150(0.9) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ic-9: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.531(2.2); 7.525(0.9); 7.513(1.2); 7.508(3.1); 7.394(9.0); 7.389(2.8); 7.377(2.3); 7.371(1.1); 6.917(0.8); 5.447(0.7); 4.086(0.4); 4.068(1.4); 4.050(1.4); 4.032(0.5); 3.692(16.0); 2.860(0.7); 2.852(1.0); 2.842(1.5); 2.833(1.5); 2.824(1.0); 2.815(0.7); 2.467(0.6); 2.462(0.8); 2.458(0.6); 2.255(21.6); 2.143(284.1); 2.113(23.4); 2.107(3.9); 2.101(2.1); 2.095(1.1); 1.972(9.9); 1.964(35.5); 1.958(54.3); 1.952(218.8); 1.946(374.8); 1.940(483.1); 1.934(328.2); 1.927(166.5); 1.915(2.0); 1.780(1.1); 1.774(2.1); 1.768(2.8); 1.762(1.8); 1.756(0.9); 1.437(1.8); 1.317(0.4); 1.301(0.4); 1.286(0.4); 1.271(0.9); 1.222(1.6); 1.204(3.3); 1.186(1.5); 1.135(1.3); 0.789(0.8); 0.777(2.4); 0.772(3.1); 0.759(3.2); 0.754(2.3); 0.742(1.1); 0.610(1.1); 0.600(2.7); 0.593(2.8); 0.589(2.4); 0.584(2.4); 0.571(0.7); 0.146(1.0); 0.008(10.6); 0.000(242.0); -0.009(7.6); -0.149(1.1) Example Ic-10: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.259(3.5); 8.238(3.2); 7.732(2.4); 7.727(2.4); 7.685(1.4); 7.680(1.0); 7.665(1.7); 7.659(1.3); 7.513(2.4); 7.492(1.8); 7.393(0.5); 7.324(1.4); 7.321(1.4); 7.311(1.5); 7.308(1.4); 7.072(1.3); 7.066(1.4); 6.992(1.4); 6.983(1.3); 6.979(1.3); 6.970(0.9); 4.729(3.3); 4.714(3.2); 4.067(0.5); 4.050(0.5); 3.747(10.0); 2.147(15.6); 2.144(17.9); 1.971(2.8); 1.964(2.8); 1.958(5.5); 1.952(16.6); 1.946(26.8); 1.940(32.1); 1.934(21.4); 1.927(10.4); 1.437(16.0); 1.221(0.6); 1.204(1.3); 1.186(0.6); 0.000(12.6); -0.008(0.4) Example Ic-11: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.285(3.7); 8.254(3.5); 8.092(0.3); 7.813(2.3); 7.807(2.5); 7.709(1.2); 7.703(1.1); 7.688(1.5); 7.682(1.4); 7.522(3.0); 7.501(2.1); 5.447(16.0); 4.085(0.5); 4.068(1.6); 4.050(1.6); 4.032(0.6); 3.755(9.9); 2.152(17.8); 1.981(1.3); 1.972(9.8); 1.961(4.0); 1.959(3.9); 1.952(13.4); 1.946(22.0); 1.940(28.1); 1.934(19.2); 1.928(9.8); 1.437(2.3); 1.393(1.2); 1.383(3.0); 1.374(2.9); 1.363(1.0); 1.221(1.9); 1.204(3.7); 1.186(1.8); 0.008(0.6); 0.000(11.7); -0.008(0.4) Example Ic-12: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.997(3.9); 7.540(4.7); 7.535(3.2); 7.524(3.2); 7.519(2.0); 7.504(4.1); 7.498(0.7); 7.488(0.4); 7.481(1.2); 6.918(0.7); 5.447(0.8); 4.068(0.5); 4.050(0.5); 3.753(12.5); 2.865(0.5); 2.856(0.8); 2.847(1.2); 2.837(1.2); 2.828(0.8); 2.819(0.5); 2.625(0.8); 2.432(16.0); 2.349(1.8); 2.152(76.1); 1.972(2.6); 1.964(3.1); 1.958(5.1); 1.953(18.8); 1.946(32.0); 1.940(40.4); 1.934(27.5); 1.928(13.8); 1.437(0.5); 1.277(10.6); 1.222(0.6); 1.204(1.2); 1.186(0.6); 1.135(6.6); 0.792(0.7); 0.779(1.9); 0.774(2.5); 0.762(2.6); 0.756(1.9); 0.744(0.8); 0.607(0.9); 0.596(2.3); 0.590(2.3); 0.586(2.1); 0.580(2.0); 0.568(0.6); 0.008(0.9); 0.000(16.2); -0.009(0.5) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ic-13: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.034(5.1); 7.558(2.8); 7.554(4.1); 7.553(4.3); 7.530(4.2); 7.525(3.7); 7.518(4.7); 7.516(4.3); 7.498(1.0); 7.496(1.0); 6.936(0.9); 5.448(0.8); 4.068(0.6); 4.050(0.6); 3.692(16.0); 2.869(0.8); 2.860(1.0); 2.851(1.5); 2.842(1.6); 2.833(1.0); 2.824(0.8); 2.465(0.4); 2.350(1.7); 2.285(19.5); 2.257(0.3); 2.241(0.5); 2.160(348.0); 2.120(1.2); 2.114(1.1); 2.108(1.3); 2.101(0.9); 2.096(0.5); 1.972(4.3); 1.965(13.8); 1.959(22.0); 1.953(85.5); 1.947(147.8); 1.940(189.1); 1.934(128.4); 1.928(64.8); 1.781(0.4); 1.775(0.8); 1.769(1.1); 1.763(0.8); 1.757(0.4); 1.575(1.1); 1.558(1.1); 1.437(7.5); 1.315(0.6); 1.276(10.1); 1.222(0.8); 1.204(1.6); 1.186(0.8); 0.795(0.9); 0.782(2.4); 0.777(3.1); 0.764(3.3); 0.759(2.4); 0.747(1.1); 0.616(1.1); 0.605(2.8); 0.599(2.9); 0.595(2.6); 0.590(2.5); 0.577(0.8); 0.484(0.4); 0.146(0.4); 0.008(4.4); 0.000(79.8); -0.009(2.6); -0.150(0.3) Example Ic-14: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.420(3.9); 8.416(4.1); 8.408(4.0); 8.404(3.9); 8.253(8.7); 8.079(0.5); 8.068(4.0); 8.065(4.0); 8.048(4.4); 8.044(4.1); 7.992(0.6); 7.981(10.8); 7.620(0.4); 7.588(6.7); 7.583(9.0); 7.573(4.6); 7.565(4.3); 7.553(7.1); 7.548(2.7); 7.533(5.0); 7.527(4.0); 7.473(0.6); 7.445(7.8); 7.424(5.3); 7.299(0.5); 7.272(0.6); 7.234(1.0); 7.229(0.5); 7.216(0.6); 7.211(1.0); 7.076(0.5); 7.053(0.5); 6.885(1.7); 6.837(4.2); 6.832(1.5); 6.820(1.4); 6.812(0.8); 4.086(2.3); 4.068(6.9); 4.050(6.9); 4.032(2.3); 3.654(0.4); 3.629(1.1); 3.604(1.1); 3.579(0.4); 2.865(0.5); 2.855(1.4); 2.846(1.9); 2.837(2.8); 2.828(2.9); 2.819(2.0); 2.810(1.6); 2.803(0.9); 2.793(0.8); 2.785(0.5); 2.775(0.4); 2.624(0.3); 2.472(0.5); 2.467(0.9); 2.463(1.2); 2.458(0.8); 2.441(0.4); 2.264(0.4); 2.247(0.7); 2.228(0.6); 2.219(0.5); 2.146(384.3); 2.119(1.7); 2.113(2.8); 2.107(3.1); 2.101(2.1); 2.095(1.1); 2.064(0.4); 1.972(33.4); 1.964(28.1); 1.958(47.1); 1.952(213.3); 1.946(375.9); 1.940(492.1); 1.934(333.9); 1.927(168.7); 1.915(2.4); 1.780(1.1); 1.774(2.1); 1.768(2.8); 1.762(1.9); 1.756(0.9); 1.270(7.9); 1.233(0.3); 1.221(8.2); 1.204(16.0); 1.186(7.9); 1.135(3.7); 0.897(0.4); 0.882(1.2); 0.864(0.6); 0.789(1.6); 0.776(4.6); 0.771(6.0); 0.758(6.4); 0.752(5.2); 0.746(1.9); 0.741(2.2); 0.734(1.7); 0.728(1.2); 0.716(0.6); 0.598(2.1); 0.587(5.2); 0.581(5.3); 0.577(4.9); 0.572(4.9); 0.559(2.3); 0.547(1.2); 0.535(0.4); 0.146(0.9); 0.008(8.3); 0.000(214.0); -0.009(7.2); -0.150(0.9) Example Ic-15: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.419(4.5); 8.416(4.7); 8.408(4.8); 8.404(4.7); 8.271(10.2); 8.115(0.4); 8.101(0.5); 8.071(4.5); 8.067(4.4); 8.050(5.0); 8.047(4.7); 7.994(12.7); 7.639(8.7); 7.634(11.6); 7.604(4.6); 7.598(3.4); 7.586(5.8); 7.583(6.2); 7.577(6.5); 7.575(6.0); 7.566(4.7); 7.554(4.5); 7.532(1.1); 7.490(0.5); 7.477(8.8); 7.456(6.4); 7.265(2.3); 7.260(1.3); 7.247(1.4); 7.242(2.6); 7.078(0.4); 7.074(0.4); 7.060(0.4); 6.925(0.6); 6.921(0.5); 6.902(1.6); 6.895(3.2); 6.882(3.4); 6.877(8.8); 5.448(0.6); 4.553(0.6); 4.540(0.6); 4.528(0.5); 4.086(2.2); 4.068(6.8); 4.050(6.9); 4.032(2.3); 3.304(0.4); 3.293(0.3); 2.731(14.4); 2.470(1.0); 2.465(1.4); 2.460(1.0); 2.456(0.5); 2.184(70.6); 2.120(2.5); BCS 13-3006 Foreign Countries THS/mr 201420 2.114(2.7); 2.108(2.9); 2.101(2.2); 2.095(1.5); 1.972(31.3); 1.964(16.3); 1.958(27.5); 1.952(124.2); 1.946(219.0); 1.940(287.2); 1.934(196.8); 1.928(101.3); 1.809(0.4); 1.781(0.9); 1.775(1.4); 1.769(1.8); 1.762(1.3); 1.756(0.8); 1.590(3.6); 1.576(9.3); 1.569(9.2); 1.561(2.7); 1.555(5.0); 1.547(4.9); 1.540(4.6); 1.526(2.4); 1.515(0.6); 1.486(0.4); 1.437(0.8); 1.387(0.6); 1.365(0.5); 1.347(4.9); 1.333(9.1); 1.326(10.6); 1.312(7.9); 1.304(4.9); 1.290(2.1); 1.272(0.9); 1.246(0.3); 1.221(8.1); 1.204(16.0); 1.186(7.9); 1.134(0.5); 0.146(1.1); 0.008(10.1); 0.000(253.8); -0.009(9.0); -0.150(1.1) Example Ic-16: H-NMR(400.0 MHz, DMSO-d ): δ= 8.865(5.8); 8.584(6.2); 8.544(2.1); 8.533(2.2); 7.765(2.2); 7.756(3.5); 7.751(6.0); 7.551(3.1); 7.543(0.6); 7.537(0.6); 7.529(2.5); 4.113(1.2); 4.095(3.5); 4.077(3.6); 4.058(2.1); 4.039(3.4); 4.021(3.5); 4.003(1.2); 3.930(2.5); 3.324(5.6); 2.863(0.6); 2.854(0.9); 2.845(1.3); 2.836(1.2); 2.827(0.9); 2.817(0.6); 2.505(29.1); 2.503(29.9); 1.991(12.2); 1.989(14.3); 1.398(4.3); 1.332(4.4); 1.314(8.9); 1.297(5.5); 1.279(0.6); 1.196(3.2); 1.193(3.8); 1.178(6.2); 1.176(7.5); 1.160(3.3); 1.158(3.8); 1.072(13.8); 1.070(16.0); 0.734(0.8); 0.717(3.1); 0.704(3.0); 0.699(2.5); 0.688(0.9); 0.563(1.0); 0.553(3.2); 0.545(3.2); 0.537(2.6); 0.524(0.7); 0.008(1.3); 0.002(18.6); 0.000(21.9); - 0.009(0.7) Example Ic-17: H-NMR(400.0 MHz, DMSO-d ): δ= 9.123(0.9); 9.108(1.7); 9.093(0.9); 8.781(6.3); 8.538(7.0); 8.204(3.6); 7.878(1.8); 7.859(2.0); 7.836(1.8); 7.816(2.0); 7.569(1.9); 7.550(3.4); 7.531(1.6); 7.348(13.8); 7.337(9.0); 7.322(0.5); 7.315(0.6); 7.271(0.9); 7.263(1.1); 7.259(1.2); 7.250(1.5); 7.244(0.7); 7.238(0.8); 7.228(0.4); 4.532(4.6); 4.517(4.5); 4.057(0.8); 4.039(2.3); 4.021(2.3); 4.003(0.9); 3.826(16.0); 3.328(19.3); 2.512(13.5); 2.507(26.7); 2.503(34.6); 2.498(24.7); 2.494(11.9); 1.990(10.1); 1.194(2.6); 1.176(5.3); 1.158(2.6); 0.008(0.4); 0.000(8.7) Example Ic-18: H-NMR(400.0 MHz, DMSO-d ): δ= 8.774(6.3); 8.527(7.1); 8.500(1.8); 8.490(1.8); 8.087(3.6); 7.844(1.7); 7.825(2.0); 7.736(1.7); 7.717(2.1); 7.533(2.0); 7.513(3.5); 7.494(1.5); 3.877(1.2); 3.825(16.0); 3.325(29.1); 2.887(0.6); 2.877(0.9); 2.868(1.4); 2.859(1.4); 2.850(0.9); 2.841(0.7); 2.525(0.8); 2.511(16.4); 2.507(32.9); 2.503(43.5); 2.498(31.6); 2.494(15.5); 1.989(0.5); 0.745(0.8); 0.732(2.3); 0.727(3.3); 0.715(3.0); 0.709(2.6); 0.698(1.1); 0.606(1.2); 0.595(3.4); 0.588(2.9); 0.585(2.9); 0.579(2.5); 0.567(0.8); 0.008(0.3); 0.000(9.3); -0.008(0.4) Example Ic-19: H-NMR(400.0 MHz, DMSO-d ): δ= 9.391(3.4); 8.796(5.8); 8.543(6.2); 8.542(6.3); 8.316(0.3); 8.138(2.2); 8.134(3.5); 8.130(2.0); 7.914(1.6); 7.910(1.2); 7.897(1.4); 7.893(1.7); 7.891(1.3); 7.764(1.7); 7.744(1.9); 7.582(1.9); BCS 13-3006 Foreign Countries THS/mr 201420 7.563(3.2); 7.543(1.4); 4.057(1.2); 4.039(3.6); 4.021(3.6); 4.003(1.2); 3.877(2.3); 3.829(14.6); 3.326(22.8); 2.526(0.7); 2.512(14.0); 2.508(28.4); 2.503(37.4); 2.499(26.7); 2.494(12.6); 1.990(16.0); 1.613(1.5); 1.599(3.5); 1.592(3.7); 1.579(1.7); 1.323(1.8); 1.309(3.5); 1.303(3.7); 1.288(1.4); 1.194(4.3); 1.176(8.4); 1.158(4.1); 0.008(0.3); 0.000(9.4) Example Ic-20: H-NMR(400.0 MHz, DMSO-d ): δ= 9.218(0.9); 9.203(1.8); 9.188(0.9); 8.780(6.2); 8.531(6.8); 8.178(3.6); 7.877(1.8); 7.857(2.0); 7.810(1.8); 7.791(2.1); 7.566(1.9); 7.546(3.3); 7.527(1.5); 7.403(2.4); 7.400(2.5); 7.391(2.7); 7.388(2.5); 7.052(2.1); 7.044(2.7); 6.983(2.4); 6.975(2.2); 6.971(2.4); 6.962(1.9); 4.679(4.4); 4.664(4.4); 4.056(0.4); 4.039(1.4); 4.021(1.4); 4.003(0.5); 3.874(0.4); 3.825(16.0); 3.325(27.3); 2.671(0.3); 2.507(39.1); 2.503(49.7); 2.498(36.2); 1.989(6.1); 1.193(1.6); 1.175(3.1); 1.158(1.5); 0.008(0.4); 0.000(8.3) Example Ic-21: H-NMR(400.0 MHz, DMSO-d ): δ= 9.452(3.6); 8.886(4.9); 8.595(5.5); 7.831(0.9); 7.825(2.4); 7.819(3.4); 7.814(3.7); 7.808(2.8); 7.803(1.1); 7.601(3.3); 7.590(0.8); 7.578(2.8); 4.113(0.9); 4.095(2.9); 4.077(2.9); 4.057(2.1); 4.039(3.7); 4.021(3.8); 4.004(1.3); 3.929(0.7); 3.324(4.7); 2.525(0.4); 2.512(7.4); 2.508(14.8); 2.503(19.5); 2.499(14.0); 2.494(6.7); 1.990(16.0); 1.623(1.3); 1.609(3.0); 1.602(3.2); 1.589(1.4); 1.398(5.5); 1.334(4.2); 1.316(8.9); 1.297(4.8); 1.290(1.7); 1.276(3.0); 1.269(3.2); 1.255(1.2); 1.194(4.3); 1.176(8.3); 1.158(4.1); 1.071(4.4); 0.008(0.7); 0.000(19.1); -0.009(0.7) Example Ic-22: H-NMR(400.0 MHz, acetonitrile-d ): δ= 9.201(0.8); 8.295(5.7); 8.273(5.2); 7.897(3.5); 7.891(3.6); 7.766(2.4); 7.760(2.2); 7.745(2.7); 7.739(2.6); 7.586(4.0); 7.565(3.2); 4.086(0.7); 4.068(2.3); 4.050(2.3); 4.032(0.8); 3.935(0.6); 3.756(16.0); 3.391(0.4); 3.376(0.9); 2.468(0.5); 2.463(0.7); 2.459(0.5); 2.181(101.9); 2.120(0.5); 2.114(0.6); 2.108(0.7); 2.102(0.6); 1.972(10.5); 1.965(6.5); 1.959(10.4); 1.953(46.5); 1.947(81.4); 1.941(106.1); 1.934(71.9); 1.928(36.5); 1.915(0.6); 1.775(0.5); 1.769(0.6); 1.763(0.4); 1.566(0.4); 1.559(0.5); 1.552(1.1); 1.545(0.5); 1.537(0.4); 1.340(0.5); 1.310(0.4); 1.285(0.9); 1.271(1.8); 1.222(2.7); 1.204(5.3); 1.186(2.6); 0.882(0.4); 0.080(1.2); 0.008(2.1); 0.000(57.3); -0.009(1.7) Example Ic-23: H-NMR(400.0 MHz, DMSO-d ): δ= 9.248(1.0); 9.232(2.2); 9.216(1.0); 8.844(6.3); 8.581(7.1); 7.833(1.8); 7.827(2.1); 7.812(2.1); 7.807(2.7); 7.776(4.6); 7.771(3.6); 7.608(4.5); 7.587(3.8); 4.144(0.5); 4.128(0.7); 4.120(1.8); 4.104(1.8); 4.096(1.9); 4.080(1.8); 4.072(0.7); 4.056(1.4); 4.039(2.4); 4.021(2.4); 4.003(0.9); 3.823(16.0); 3.321(6.5); 2.891(0.7); 2.732(0.6); 2.524(0.8); 2.511(17.4); 2.507(35.0); 2.502(45.7); 2.498(32.5); 2.493(15.4); 1.989(10.6); 1.193(2.8); 1.175(5.5); 1.158(2.7); 0.008(1.0); 0.000(28.3); - BCS 13-3006 Foreign Countries THS/mr 201420 0.009(0.9) Example Ic-24: H-NMR(400.0 MHz, DMSO-d ): δ= 8.886(5.3); 8.644(2.1); 8.631(7.2); 7.913(1.6); 7.908(1.7); 7.887(1.7); 7.882(1.7); 7.652(2.9); 7.650(2.9); 4.056(1.2); 4.038(3.7); 4.021(3.7); 4.003(1.3); 3.839(0.7); 3.825(13.8); 3.321(6.3); 2.868(0.5); 2.858(0.8); 2.850(1.2); 2.840(1.2); 2.831(0.8); 2.822(0.6); 2.506(30.6); 2.502(39.4); 2.498(28.8); 1.989(16.0); 1.236(0.5); 1.193(4.2); 1.175(8.3); 1.158(4.1); 0.748(0.8); 0.735(2.3); 0.730(3.0); 0.718(2.9); 0.712(2.4); 0.701(1.0); 0.567(1.0); 0.556(3.0); 0.550(2.9); 0.546(2.7); 0.540(2.5); 0.528(0.7); 0.000(12.1); -0.008(0.5) Example Ic-25: H-NMR(400.0 MHz, DMSO-d ): δ= 10.722(3.2); 8.860(4.7); 8.619(5.0); 7.997(2.8); 7.992(3.1); 7.866(1.4); 7.860(1.4); 7.844(1.7); 7.839(1.7); 7.784(3.9); 7.761(4.5); 7.650(3.0); 7.629(2.5); 7.443(4.5); 7.421(4.1); 3.828(13.0); 3.320(41.4); 2.670(1.1); 2.541(0.6); 2.501(168.7); 2.498(131.8); 2.328(1.1); 1.398(16.0); 0.000(2.0) Example Ic-26: H-NMR(400.0 MHz, DMSO-d ): δ= 8.814(4.6); 8.537(4.5); 7.953(2.0); 7.786(1.6); 7.710(0.8); 7.690(0.9); 7.495(1.5); 7.475(1.3); 4.056(0.4); 4.038(1.3); 4.020(1.3); 4.002(0.5); 3.822(13.1); 3.323(38.8); 3.074(2.3); 2.891(16.0); 2.732(13.2); 2.731(12.5); 2.675(0.4); 2.671(0.6); 2.666(0.4); 2.524(1.4); 2.511(32.4); 2.507(65.4); 2.502(85.2); 2.497(59.7); 2.493(27.6); 2.333(0.4); 2.329(0.5); 2.324(0.4); 1.989(5.8); 1.236(0.4); 1.193(1.6); 1.175(3.2); 1.157(1.6); 0.008(0.6); 0.000(16.0); -0.009(0.5) Example Ic-27: H-NMR(400.0 MHz, DMSO-d ): δ= 9.558(4.5); 8.902(6.2); 8.639(6.9); 7.981(1.9); 7.976(2.0); 7.955(1.9); 7.950(1.9); 7.716(3.2); 7.714(3.2); 4.056(0.9); 4.039(2.7); 4.021(2.7); 4.003(1.0); 3.824(16.0); 3.773(0.6); 3.322(9.6); 2.525(0.7); 2.511(17.1); 2.507(35.1); 2.502(46.3); 2.498(33.3); 2.494(16.1); 1.989(11.8); 1.638(1.6); 1.624(3.9); 1.617(4.1); 1.603(1.8); 1.298(1.9); 1.284(3.8); 1.278(4.1); 1.263(1.5); 1.193(3.1); 1.175(6.2); 1.158(3.1); 0.000(0.9) Example Ic-28: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.273(5.4); 8.246(5.0); 7.731(3.3); 7.725(4.0); 7.690(2.1); 7.684(1.6); 7.669(2.5); 7.663(2.0); 7.514(3.9); 7.494(3.1); 7.462(0.6); 7.446(0.6); 5.447(0.5); 5.337(0.8); 5.316(1.6); 5.295(1.7); .274(0.9); 4.068(0.9); 4.050(0.9); 3.752(16.0); 3.546(2.2); 3.542(1.3); 3.522(4.0); 3.503(1.7); 3.500(2.8); 3.375(2.9); 3.372(1.6); 3.355(4.1); 3.352(3.7); 3.335(1.3); 3.331(2.2); 2.463(0.4); 2.151(108.1); 2.120(0.5); 2.114(0.8); 2.107(0.9); 2.101(0.6); 2.095(0.3); 1.972(4.8); 1.964(8.9); 1.958(14.9); 1.952(64.2); 1.946(112.1); 1.940(145.5); 1.934(99.3); 1.928(50.3); 1.915(0.8); 1.781(0.4); BCS 13-3006 Foreign Countries THS/mr 201420 1.775(0.6); 1.768(0.8); 1.762(0.6); 1.437(2.7); 1.222(1.1); 1.204(2.2); 1.186(1.1); 0.146(1.4); 0.008(14.3); 0.000(296.2); -0.009(10.2); -0.150(1.4) Example Ic-29: H-NMR(400.0 MHz, DMSO-d ): δ= 9.025(4.4); 8.775(6.2); 8.541(6.8); 8.012(3.7); 8.007(3.7); 7.782(1.9); 7.776(1.7); 7.761(2.3); 7.755(2.1); 7.557(4.1); 7.536(3.4); 7.325(1.7); 7.072(1.7); 3.821(16.0); 3.327(34.7); 2.507(39.2); 2.502(48.5); 2.498(35.1); 2.075(0.6); 1.358(1.6); 1.348(3.9); 1.339(4.3); 1.330(1.7); 1.006(1.8); 0.996(4.1); 0.987(4.0); 0.977(1.5); 0.008(2.2); 0.000(44.4); -0.008(2.1) Example Ic-30: H-NMR(400.0 MHz, DMSO-d ): δ= 9.860(0.8); 8.997(5.9); 8.658(6.0); 8.568(1.8); 8.557(1.8); 7.836(6.8); 7.815(2.3); 7.810(1.6); 7.575(2.8); 7.555(2.5); 7.239(0.4); 7.217(0.4); 6.724(0.5); 6.716(0.4); 4.065(16.0); 3.325(110.7); 2.871(0.5); 2.861(0.7); 2.852(1.1); 2.842(1.2); 2.833(0.7); 2.824(0.6); 2.675(0.5); 2.671(0.7); 2.666(0.6); 2.541(0.5); 2.510(42.7); 2.506(86.2); 2.502(114.9); 2.497(84.6); 2.493(42.7); 2.333(0.5); 2.328(0.7); 2.324(0.6); 0.739(0.8); 0.726(2.2); 0.721(3.0); 0.709(2.8); 0.703(2.3); 0.692(1.1); 0.679(0.3); 0.674(0.4); 0.662(0.4); 0.656(0.3); 0.565(1.0); 0.555(3.0); 0.548(2.7); 0.545(2.6); 0.539(2.5); 0.527(0.8); 0.503(0.4); 0.497(0.4); 0.492(0.4); 0.487(0.4); 0.008(1.2); 0.000(32.1); - 0.008(1.5) Example Ic-31: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.268(5.6); 8.248(5.0); 7.812(3.6); 7.806(3.9); 7.713(1.9); 7.707(1.7); 7.692(2.4); 7.686(2.2); 7.541(4.1); 7.520(3.2); 7.296(0.7); 7.069(0.5); 4.068(0.7); 4.051(7.3); 4.036(6.9); 3.988(0.8); 3.972(0.9); 3.964(2.5); 3.948(2.5); 3.941(2.6); 3.924(2.5); 3.917(0.9); 3.900(0.9); 3.753(16.0); 2.143(19.9); 2.113(0.4); 2.107(0.5); 2.086(0.4); 1.972(3.0); 1.964(4.0); 1.958(6.4); 1.952(30.1); 1.946(53.3); 1.940(70.0); 1.934(47.9); 1.927(24.6); 1.915(0.5); 1.768(0.6); 1.437(0.5); 1.271(1.2); 1.221(0.8); 1.204(1.5); 1.186(0.7); 0.008(0.7); 0.000(23.0); -0.009(0.8) Example Ic-32: H-NMR(601.6 MHz, acetonitrile-d ): δ= 8.2654(5.3); 8.2647(5.7); 8.241(5.2); 7.690(8.1); 7.687(3.9); 7.679(3.4); 7.676(1.9); 7.514(3.6); 7.509(1.1); 7.503(0.9); 7.499(3.0); 7.463(1.5); 3.750(16.0); 2.136(109.3); 2.059(0.6); 2.055(1.0); 2.051(1.5); 2.047(1.0); 2.043(0.5); 1.965(5.7); 1.956(15.3); 1.952(19.2); 1.948(105.0); 1.944(179.4); 1.940(265.5); 1.936(186.2); 1.932(95.2); 1.834(0.6); 1.830(1.0); 1.826(1.5); 1.821(1.0); 1.817(0.5); 1.396(1.5); 1.386(3.7); 1.382(4.0); 1.373(2.1); 1.270(0.3); 1.252(1.0); 1.242(3.2); 1.231(0.7); 0.005(2.1); 0.000(72.1); -0.006(3.0) Example Ic-34: H-NMR(400.0 MHz, acetonitrile-d ): BCS 13-3006 Foreign Countries THS/mr 201420 δ= 8.273(5.5); 8.254(5.0); 7.704(3.5); 7.699(3.9); 7.693(2.6); 7.673(4.6); 7.628(3.0); 7.622(2.5); 7.607(1.7); 7.601(1.7); 7.587(1.2); 3.750(16.0); 3.696(0.5); 2.463(0.4); 2.154(180.4); 2.120(0.5); 2.114(0.7); 2.108(1.0); 2.101(0.7); 2.095(0.3); 1.964(5.4); 1.958(12.6); 1.953(67.6); 1.946(121.1); 1.940(161.6); 1.934(110.1); 1.928(56.0); 1.915(0.6); 1.781(0.3); 1.775(0.6); 1.769(0.9); 1.763(0.6); 1.603(1.6); 1.589(4.0); 1.582(3.9); 1.569(2.1); 1.371(2.2); 1.358(3.9); 1.351(4.0); 1.336(1.7); 1.270(0.4); 1.135(2.3); 0.146(1.5); 0.008(11.8); 0.000(330.0); -0.009(11.1); -0.150(1.4) Example Ic-35: H-NMR(400.0 MHz, DMSO-d ): δ= 8.776(6.1); 8.537(6.7); 8.193(3.6); 8.040(1.6); 7.859(1.7); 7.840(1.9); 7.807(1.8); 7.787(2.0); 7.627(0.6); 7.624(0.5); 7.616(0.4); 7.598(0.5); 7.575(0.4); 7.566(0.4); 7.557(0.3); 7.548(0.4); 7.541(2.0); 7.522(3.4); 7.502(1.6); 7.467(1.6); 4.056(1.0); 4.038(3.0); 4.020(3.0); 4.002(1.0); 3.831(16.0); 3.325(59.5); 2.676(0.4); 2.671(0.6); 2.667(0.4); 2.542(0.4); 2.525(1.6); 2.511(34.4); 2.507(69.7); 2.502(91.5); 2.498(65.4); 2.494(31.3); 2.334(0.4); 2.329(0.6); 2.325(0.4); 1.989(13.1); 1.193(3.5); 1.175(7.0); 1.157(3.4); 0.000(3.4) Example Ic-36: H-NMR(400.0 MHz, DMSO-d ): δ= 9.360(3.6); 8.798(6.0); 8.547(6.6); 7.935(1.5); 7.930(2.0); 7.919(1.6); 7.913(2.6); 7.905(0.9); 7.899(1.3); 7.890(1.2); 7.884(1.0); 7.878(1.1); 7.872(0.8); 7.430(1.7); 7.408(1.9); 7.405(2.0); 7.383(1.5); 4.056(0.9); 4.038(2.9); 4.020(2.9); 4.002(1.0); 3.930(1.4); 3.821(16.0); 3.325(85.1); 2.676(0.5); 2.671(0.6); 2.667(0.5); 2.541(0.4); 2.524(2.0); 2.511(38.5); 2.507(75.2); 2.502(96.7); 2.498(68.6); 2.493(32.4); 2.333(0.4); 2.329(0.6); 2.324(0.4); 1.989(12.5); 1.612(1.6); 1.598(4.1); 1.591(4.2); 1.577(1.9); 1.300(2.0); 1.287(4.1); 1.280(4.3); 1.266(1.6); 1.193(3.4); 1.175(6.8); 1.157(3.4); 1.069(9.3); 0.008(2.0); 0.000(47.1); -0.009(1.7) Example Ic-37: H-NMR(400.0 MHz, DMSO-d ): δ= 8.773(4.0); 8.530(4.5); 8.480(1.1); 8.470(1.1); 7.853(0.9); 7.847(1.4); 7.837(1.5); 7.831(1.8); 7.826(1.1); 7.817(0.8); 7.811(0.6); 7.805(0.7); 7.799(0.5); 7.371(1.1); 7.350(1.2); 7.347(1.2); 7.325(1.0); 4.038(0.7); 4.020(0.7); 3.930(2.7); 3.820(10.3); 3.740(0.3); 3.325(20.2); 2.877(0.4); 2.868(0.6); 2.859(0.9); 2.849(0.9); 2.840(0.5); 2.831(0.4); 2.524(0.6); 2.511(12.1); 2.507(23.8); 2.502(30.9); 2.498(22.0); 2.493(10.3); 1.989(3.0); 1.193(0.8); 1.175(1.6); 1.158(0.8); 1.069(16.0); 0.735(0.6); 0.722(1.6); 0.717(2.2); 0.705(2.1); 0.699(1.7); 0.688(0.7); 0.572(0.8); 0.561(2.3); 0.555(2.0); 0.551(1.8); 0.545(1.8); 0.533(0.5); 0.000(7.0) Example Ic-50: H-NMR(400.0 MHz, acetonitrile-d ): δ= 9.117(4.9); 8.273(5.8); 8.211(5.5); 8.164(0.9); 8.144(0.9); 7.921(4.1); 7.698(3.0); 7.693(3.8); 7.678(0.4); 7.664(2.4); 7.659(1.9); 7.643(2.3); 7.637(1.9); 7.610(0.5); 7.605(0.4); 7.487(3.6); BCS 13-3006 Foreign Countries THS/mr 201420 7.477(0.8); 7.467(2.8); 7.456(0.5); 7.393(0.6); 6.914(1.2); 5.447(1.0); 3.893(0.3); 3.860(2.7); 3.785(16.0); 2.875(0.7); 2.866(1.0); 2.857(1.5); 2.848(1.5); 2.839(1.0); 2.830(0.7); 2.139(99.1); 2.114(1.1); 2.108(1.2); 2.102(0.7); 1.964(5.8); 1.958(12.0); 1.952(50.9); 1.946(90.3); 1.940(118.8); 1.934(83.1); 1.928(43.5); 1.775(0.5); 1.768(0.7); 1.762(0.5); 1.135(1.1); 0.800(0.8); 0.787(2.8); 0.782(3.6); 0.770(3.7); 0.765(2.9); 0.753(1.3); 0.617(1.1); 0.606(3.2); 0.600(3.4); 0.591(3.0); 0.579(0.9); 0.008(2.0); 0.000(45.8) Example Ic-51: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.292(3.8); 8.214(3.7); 8.186(0.7); 8.122(0.6); 7.925(3.0); 7.693(2.2); 7.688(2.8); 7.659(1.5); 7.654(1.1); 7.638(1.6); 7.633(1.5); 7.483(2.7); 7.463(2.1); 7.385(0.6); 6.911(0.9); 3.859(2.0); 3.798(11.7); 3.760(16.0); 3.514(2.7); 2.872(0.5); 2.863(0.7); 2.854(1.2); 2.845(1.2); 2.835(0.8); 2.827(0.5); 2.463(0.4); 2.228(0.4); 2.145(185.3); 2.114(1.8); 2.108(2.0); 2.101(1.4); 2.095(0.8); 1.964(12.8); 1.958(26.5); 1.952(118.4); 1.946(212.5); 1.940(281.9); 1.934(199.0); 1.928(105.1); 1.781(0.6); 1.775(1.2); 1.769(1.5); 1.762(1.2); 1.756(0.5); 1.271(0.6); 0.798(0.6); 0.781(2.6); 0.769(2.6); 0.764(2.2); 0.751(1.0); 0.611(0.8); 0.599(2.4); 0.593(2.6); 0.583(2.1); 0.571(0.6); 0.146(0.4); 0.008(3.2); 0.000(82.9); -0.149(0.4) Example Ic-52: H-NMR(400.0 MHz, acetonitrile-d ): δ= 9.797(4.1); 8.403(5.2); 8.297(0.4); 8.285(4.9); 7.720(3.0); 7.715(3.6); 7.683(1.9); 7.678(1.5); 7.663(2.4); 7.657(1.9); 7.617(0.3); 7.613(0.4); 7.520(0.4); 7.513(0.4); 7.501(3.4); 7.480(2.7); 6.943(0.9); 3.892(16.0); 3.777(0.4); 2.876(0.6); 2.867(0.9); 2.858(1.3); 2.849(1.3); 2.840(0.9); 2.831(0.6); 2.464(0.4); 2.155(193.5); 2.120(0.6); 2.114(0.8); 2.107(0.9); 2.101(0.7); 2.095(0.4); 1.964(7.5); 1.958(15.2); 1.952(61.4); 1.946(107.2); 1.940(139.4); 1.934(95.6); 1.928(48.9); 1.781(0.4); 1.775(0.6); 1.768(0.8); 1.762(0.6); 0.801(0.7); 0.787(2.2); 0.783(2.9); 0.770(2.9); 0.765(2.3); 0.753(1.0); 0.616(1.0); 0.604(2.7); 0.599(2.8); 0.595(2.5); 0.589(2.4); 0.577(0.7); 0.146(0.3); 0.008(4.0); 0.000(75.6); -0.009(3.5); -0.150(0.4) Example Ic-53: H-NMR(400.0 MHz, DMSO-d ): δ= 9.477(3.7); 9.018(5.8); 8.669(5.9); 8.316(0.3); 7.892(7.5); 7.889(3.1); 7.875(2.4); 7.869(1.5); 7.627(2.6); 7.622(1.2); 7.608(1.1); 7.604(2.3); 4.063(16.0); 3.323(62.1); 2.675(0.5); 2.671(0.6); 2.666(0.5); 2.541(0.5); 2.506(74.2); 2.502(94.3); 2.497(67.8); 2.333(0.5); 2.329(0.6); 2.324(0.5); 1.989(0.3); 1.630(1.3); 1.616(3.5); 1.609(3.6); 1.596(1.5); 1.289(1.6); 1.276(3.4); 1.269(3.6); 1.255(1.3); 0.000(0.5) Example Ic-65: H-NMR(400.0 MHz, DMSO-d6): δ= 9.527(1.6); 9.038(2.1); 8.736(2.3); 8.235(1.2); 8.214(1.5); 8.068(0.8); 8.063(0.8); 8.047(0.6); BCS 13-3006 Foreign Countries THS/mr 201420 8.042(0.7); 7.976(1.4); 7.971(1.3); 4.056(0.4); 4.038(1.2); 4.021(1.2); 4.003(0.4); 3.931(2.2); 3.838(5.5); 3.326(12.2); 2.511(6.4); 2.507(12.7); 2.503(16.5); 2.498(11.9); 2.494(5.8); 1.989(5.0); 1.630(0.5); 1.616(1.3); 1.609(1.4); 1.596(0.6); 1.398(1.7); 1.292(0.6); 1.279(1.3); 1.272(1.4); 1.257(0.5); 1.193(1.4); 1.176(2.7); 1.158(1.3); 1.069(16.0); 0.008(0.6); 0.000(16.4); -0.009(0.6) Example Ic-66: H-NMR(400.0 MHz, DMSO-d ): δ= 9.005(2.0); 8.718(2.2); 8.683(0.7); 8.673(0.7); 8.158(1.2); 8.137(1.5); 8.005(0.8); 8.000(0.8); 7.984(0.6); 7.979(0.7); 7.922(1.4); 7.917(1.2); 4.038(0.9); 4.020(0.9); 3.930(2.2); 3.836(5.1); 3.325(22.5); 2.807(0.5); 2.797(0.5); 2.524(0.5); 2.511(10.2); 2.507(20.8); 2.502(27.4); 2.498(19.6); 2.493(9.3); 1.989(3.8); 1.193(1.0); 1.175(2.1); 1.157(1.0); 1.069(16.0); 0.733(0.8); 0.727(1.1); 0.715(1.1); 0.709(0.9); 0.698(0.4); 0.563(0.4); 0.553(1.1); 0.547(1.0); 0.543(0.9); 0.537(0.9); 0.008(1.0); 0.000(26.7); -0.009(1.0) Example Ic-67: H-NMR(400.0 MHz, DMSO-d ): δ= 8.969(3.4); 8.714(5.1); 8.475(5.5); 7.928(3.2); 7.922(3.5); 7.835(1.6); 7.829(1.4); 7.814(1.7); 7.808(1.6); 7.222(2.8); 7.201(2.6); 4.056(0.5); 4.038(1.6); 4.021(1.7); 4.003(0.6); 3.889(16.0); 3.820(13.5); 3.326(23.9); 2.525(0.7); 2.511(13.3); 2.507(26.5); 2.503(34.6); 2.498(24.8); 2.494(11.9); 1.989(6.9); 1.583(1.3); 1.568(3.4); 1.561(3.5); 1.548(1.5); 1.398(4.0); 1.292(1.6); 1.278(3.4); 1.271(3.6); 1.257(1.3); 1.193(1.9); 1.176(3.7); 1.158(1.8); 1.070(0.9); 0.008(1.3); 0.000(35.8); - 0.009(1.3) Example Ic-68: H-NMR(400.0 MHz, DMSO-d ): δ= 8.691(5.5); 8.455(5.4); 8.152(2.6); 7.861(4.6); 7.771(2.3); 7.750(2.4); 7.183(2.8); 7.161(2.6); 4.055(0.8); 4.038(2.2); 4.021(2.2); 4.002(0.8); 3.931(1.7); 3.868(16.0); 3.818(15.8); 3.326(30.3); 2.850(1.6); 2.844(1.6); 2.672(0.4); 2.503(62.6); 2.329(0.4); 1.989(8.5); 1.398(4.8); 1.192(2.3); 1.175(4.5); 1.157(2.2); 1.069(10.3); 0.708(4.3); 0.692(4.3); 0.550(5.3); 0.000(26.4); -0.001(26.4) Example Ic-69: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.284(5.9); 8.223(5.4); 7.704(3.2); 7.699(4.0); 7.667(2.1); 7.662(1.6); 7.647(2.4); 7.641(2.0); 7.488(3.8); 7.467(3.0); 6.920(0.8); 6.835(0.4); 4.414(4.5); 4.400(4.6); 4.085(0.9); 4.068(2.7); 4.050(2.8); 4.032(0.9); 3.807(16.0); 3.288(0.8); 3.276(1.2); 3.262(0.5); 2.875(0.7); 2.865(1.0); 2.857(1.5); 2.847(1.5); 2.838(1.0); 2.829(0.7); 2.145(49.0); 2.113(0.3); 2.107(0.4); 1.972(12.3); 1.964(2.3); 1.958(5.1); 1.952(26.0); 1.946(46.8); 1.940(62.5); 1.934(42.9); 1.927(22.0); 1.768(0.4); 1.437(7.1); 1.269(0.4); 1.221(3.2); 1.204(6.3); 1.186(3.1); 1.135(0.6); 0.799(0.8); 0.787(2.4); 0.782(3.2); 0.769(3.3); 0.764(2.5); 0.752(1.2); 0.615(1.1); 0.604(2.8); 0.598(2.9); 0.594(2.6); BCS 13-3006 Foreign Countries THS/mr 201420 0.588(2.5); 0.576(0.8); 0.146(0.9); 0.008(8.0); 0.000(197.8); -0.009(8.4); -0.150(0.9) Example Ic-77: H-NMR(400.0 MHz, DMSO-d ): δ= 8.831(6.1); 8.793(1.0); 8.778(2.0); 8.765(1.0); 8.575(6.6); 8.317(0.5); 7.795(1.4); 7.790(2.5); 7.779(3.7); 7.774(7.8); 7.576(3.4); 7.570(0.9); 7.560(0.8); 7.554(2.8); 4.619(1.5); 4.606(3.0); 4.594(1.6); 4.500(1.5); 4.488(3.0); 4.475(1.6); 4.056(0.6); 4.038(1.7); 4.020(1.7); 4.002(0.6); 3.823(16.0); 3.611(0.8); 3.598(1.9); 3.585(1.9); 3.572(0.7); 3.544(0.8); 3.531(2.0); 3.518(1.9); 3.505(0.7); 3.324(44.7); 2.675(0.3); 2.671(0.4); 2.667(0.3); 2.506(55.0); 2.502(68.1); 2.498(49.4); 2.329(0.4); 2.324(0.3); 1.989(7.1); 1.193(1.9); 1.175(3.7); 1.157(1.8); 0.146(0.3); 0.008(3.2); 0.000(71.0); -0.008(3.5); -0.150(0.4) Example Ic-78: H-NMR(400.0 MHz, DMSO-d ): δ= 8.967(1.0); 8.952(2.0); 8.937(1.0); 8.830(6.2); 8.570(6.7); 7.815(1.6); 7.809(2.2); 7.794(1.5); 7.788(3.8); 7.783(5.0); 7.778(2.8); 7.592(3.8); 7.572(3.2); 6.278(0.4); 6.268(0.8); 6.259(0.4); 6.139(0.8); 6.129(1.7); 6.119(0.8); 5.999(0.4); 5.990(0.9); 5.980(0.4); 4.038(0.4); 4.020(0.4); 3.822(16.0); 3.733(0.6); 3.723(0.8); 3.718(0.8); 3.708(0.7); 3.693(1.4); 3.684(1.6); 3.679(1.6); 3.669(1.4); 3.654(0.7); 3.644(0.8); 3.640(0.9); 3.629(0.7); 3.325(36.0); 2.525(0.8); 2.511(17.4); 2.507(35.4); 2.502(46.5); 2.498(33.5); 2.493(16.2); 1.989(1.7); 1.398(1.4); 1.193(0.5); 1.175(0.9); 1.157(0.4); 0.008(2.2); 0.000(58.2); -0.009(2.2) Example Ic-79: H-NMR(400.0 MHz, DMSO-d ): δ= 8.839(0.4); 8.822(6.1); 8.604(0.4); 8.575(6.8); 8.507(2.0); 8.496(2.0); 7.767(1.3); 7.762(2.7); 7.754(3.9); 7.748(5.4); 7.745(4.3); 7.740(1.2); 7.545(4.0); 7.536(0.7); 7.532(0.6); 7.523(3.3); 4.056(0.6); 4.038(1.7); 4.020(1.8); 4.002(0.6); 3.838(0.9); 3.820(16.0); 3.324(57.4); 2.675(0.4); 2.671(0.5); 2.667(0.4); 2.566(0.4); 2.556(1.1); 2.547(1.5); 2.537(1.6); 2.525(1.7); 2.511(28.1); 2.506(57.0); 2.502(75.0); 2.497(53.8); 2.493(25.8); 2.333(0.4); 2.329(0.5); 2.324(0.3); 1.989(7.5); 1.193(2.0); 1.175(4.0); 1.157(2.0); 1.065(8.3); 1.050(10.9); 0.951(0.5); 0.943(0.6); 0.936(0.7); 0.929(1.0); 0.921(0.8); 0.914(1.0); 0.906(0.8); 0.899(0.6); 0.890(0.5); 0.723(0.9); 0.711(1.4); 0.700(1.8); 0.689(1.2); 0.678(0.8); 0.538(0.5); 0.519(1.1); 0.505(1.5); 0.501(1.2); 0.492(1.1); 0.487(1.5); 0.473(0.7); 0.146(0.4); 0.015(0.4); 0.008(3.2); 0.000(91.2); -0.009(3.4); -0.150(0.4) Example Ic-80: H-NMR(400.0 MHz, DMSO-d ): δ= 8.999(1.0); 8.984(2.0); 8.968(1.0); 8.839(6.1); 8.582(6.8); 7.812(1.6); 7.806(2.0); 7.791(1.8); 7.786(2.8); 7.770(4.5); 7.765(3.1); 7.590(4.1); 7.569(3.4); 4.056(1.0); 4.038(2.9); 4.021(2.9); 4.003(1.1); 3.824(16.0); 3.754(1.0); 3.738(1.0); 3.720(2.1); 3.704(2.1); 3.686(1.1); 3.670(1.0); 3.325(21.8); 2.507(27.1); 2.502(34.9); 2.498(25.0); 1.989(12.4); 1.731(3.5); 1.683(7.8); 1.636(3.9); BCS 13-3006 Foreign Countries THS/mr 201420 1.193(3.3); 1.175(6.5); 1.158(3.2); 0.008(2.0); 0.000(47.1); -0.009(1.8) Example Ic-81: H-NMR(400.0 MHz, DMSO-d ): δ= 8.815(6.0); 8.603(1.7); 8.598(1.8); 8.569(6.6); 8.316(0.7); 7.789(8.6); 7.770(2.8); 7.764(1.8); 7.569(2.9); 7.548(2.4); 4.832(0.7); 4.829(0.7); 4.824(0.8); 4.822(0.7); 4.815(0.8); 4.807(0.7); 4.673(0.7); 4.668(0.8); 4.659(0.8); 4.656(0.8); 4.651(0.7); 4.038(0.6); 4.020(0.6); 3.838(0.5); 3.820(16.0); 3.324(38.9); 3.300(0.5); 3.249(0.3); 3.238(0.6); 3.226(0.6); 3.224(0.6); 3.213(0.8); 3.199(0.8); 3.188(0.6); 3.174(0.6); 3.163(0.3); 2.675(0.4); 2.671(0.5); 2.667(0.3); 2.506(55.1); 2.502(70.3); 2.497(51.1); 2.333(0.3); 2.329(0.4); 2.324(0.3); 1.989(2.6); 1.472(0.4); 1.464(0.5); 1.453(0.6); 1.445(0.8); 1.439(0.6); 1.428(0.5); 1.420(0.6); 1.412(0.6); 1.404(0.7); 1.398(2.2); 1.393(0.8); 1.387(0.8); 1.379(0.6); 1.368(0.5); 1.359(0.5); 1.193(0.7); 1.175(1.4); 1.157(0.7); 1.051(0.5); 1.034(0.9); 1.020(1.1); 1.004(1.0); 1.001(1.0); 0.990(0.8); 0.987(0.8); 0.970(0.5); 0.146(0.4); 0.008(3.7); 0.000(84.3); -0.008(4.3); -0.150(0.4) Example Ic-96: H-NMR(400.0 MHz, DMSO-d ): δ= 8.837(3.3); 8.798(0.9); 8.580(3.5); 8.530(0.9); 7.927(0.6); 7.856(0.3); 7.834(1.2); 7.829(1.3); 7.808(1.9); 7.802(2.7); 7.678(0.5); 7.657(0.4); 7.627(1.9); 7.606(1.6); 3.821(16.0); 3.327(74.0); 3.126(2.5); 2.867(10.1); 2.672(0.4); 2.511(22.7); 2.507(45.9); 2.503(60.9); 2.498(44.5); 2.494(21.8); 2.329(0.4); 1.705(2.0); 1.701(2.2); 1.478(1.1); 1.398(8.9); 0.000(5.3) Example Ic-98: H-NMR(400.0 MHz, acetonitrile-d ): δ= 19.976(0.4); 9.362(1.6); 8.419(0.4); 8.291(5.3); 8.225(5.3); 8.177(0.9); 8.163(0.9); 7.923(4.0); 7.751(3.6); 7.745(3.6); 7.714(2.7); 7.694(3.0); 7.688(3.2); 7.656(1.4); 7.634(1.0); 7.618(0.7); 7.588(0.9); 7.572(0.6); 7.551(0.5); 7.534(0.5); 7.520(3.4); 7.500(2.7); 7.487(0.6); 7.394(0.6); 7.202(0.8); 7.183(1.3); 7.161(0.6); 6.136(0.5); 5.985(1.5); 5.886(0.4); 4.192(1.0); 4.085(0.9); 4.068(2.6); 4.050(2.7); 4.032(1.0); 3.894(1.1); 3.862(2.8); 3.809(0.5); 3.785(16.0); 2.889(0.4); 2.567(0.5); 2.550(0.5); 2.530(0.4); 2.468(3.2); 2.464(4.1); 2.459(2.7); 2.348(0.5); 2.243(1.1); 2.161(1572.6); 2.139(30.6); 2.120(5.8); 2.114(6.6); 2.108(7.6); 2.102(5.3); 2.096(3.0); 1.972(19.3); 1.965(45.5); 1.953(475.0); 1.947(832.2); 1.941(1075.4); 1.934(736.8); 1.928(381.7); 1.781(2.7); 1.775(4.8); 1.769(6.3); 1.763(4.3); 1.757(2.3); 1.602(1.9); 1.588(5.2); 1.582(5.7); 1.568(2.7); 1.528(0.5); 1.407(0.4); 1.367(2.6); 1.354(5.3); 1.346(5.4); 1.332(1.9); 1.272(0.6); 1.249(0.5); 1.234(0.4); 1.222(3.1); 1.204(6.2); 1.186(3.0); 1.034(0.4); 0.984(0.5); 0.965(1.0); 0.948(0.5); 0.146(3.7); 0.000(819.7); -0.009(37.8); -0.028(5.4); -0.075(0.4); -0.092(0.4); -0.150(4.0) Example Ic-99: H-NMR(400.0 MHz, acetonitrile-d3): δ= 8.307(3.6); 8.225(3.4); 8.197(0.5); 8.137(0.6); 7.930(2.6); 7.757(0.4); 7.752(0.5); 7.741(2.2); BCS 13-3006 Foreign Countries THS/mr 201420 7.735(2.8); 7.726(0.6); 7.723(0.4); 7.709(1.6); 7.703(1.1); 7.699(0.5); 7.688(1.6); 7.682(1.3); 7.678(0.4); 7.608(0.4); 7.585(0.9); 7.571(0.6); 7.550(0.3); 7.515(2.5); 7.494(2.0); 7.391(0.4); 3.861(1.8); 3.800(10.5); 3.760(16.0); 3.513(2.7); 2.146(62.9); 2.120(0.4); 2.114(0.6); 2.108(0.7); 2.101(0.5); 1.972(0.7); 1.964(3.7); 1.958(8.9); 1.952(42.4); 1.946(76.1); 1.940(100.5); 1.934(68.4); 1.928(34.8); 1.775(0.4); 1.769(0.6); 1.762(0.4); 1.603(1.2); 1.589(3.1); 1.582(3.4); 1.569(1.6); 1.400(0.3); 1.360(1.6); 1.346(3.3); 1.339(2.9); 1.325(1.4); 0.932(0.3); 0.913(0.8); 0.894(0.5); 0.891(0.5); 0.146(0.4); 0.008(3.8); 0.000(100.3); -0.009(3.6); -0.150(0.4) Example Ic-100: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.253(5.9); 8.244(5.4); 8.156(0.7); 8.143(0.7); 7.691(4.5); 7.686(4.2); 7.676(1.1); 7.671(0.6); 7.658(2.4); 7.652(1.8); 7.637(2.3); 7.631(1.9); 7.528(1.3); 7.507(1.0); 7.493(3.5); 7.472(2.7); 7.236(0.5); 7.213(0.5); 6.924(1.3); 6.836(1.7); 6.831(0.7); 6.818(0.6); 6.811(0.3); 6.732(1.0); 4.067(0.7); 4.050(0.7); 3.803(16.0); 2.875(0.7); 2.866(1.1); 2.858(1.6); 2.848(1.6); 2.840(1.2); 2.830(0.9); 2.820(0.5); 2.802(0.4); 2.793(0.4); 2.671(0.7); 2.662(1.1); 2.653(1.5); 2.644(1.4); 2.635(1.0); 2.626(0.7); 2.253(0.4); 2.154(253.3); 2.120(1.3); 2.114(1.3); 2.108(1.5); 2.101(1.1); 2.095(0.6); 1.972(4.5); 1.964(7.7); 1.952(84.3); 1.946(147.1); 1.940(189.4); 1.934(130.4); 1.928(66.1); 1.780(0.4); 1.775(0.8); 1.769(1.1); 1.762(0.7); 1.756(0.3); 1.437(1.5); 1.372(0.3); 1.340(1.1); 1.285(1.7); 1.271(2.6); 1.243(0.7); 1.222(0.9); 1.204(1.7); 1.186(0.8); 0.881(0.4); 0.801(0.8); 0.788(2.7); 0.784(3.5); 0.771(3.7); 0.764(3.2); 0.754(1.7); 0.747(1.1); 0.734(0.8); 0.659(1.2); 0.646(3.3); 0.642(3.5); 0.629(3.5); 0.624(2.7); 0.616(1.9); 0.605(4.3); 0.599(4.3); 0.590(3.7); 0.577(1.1); 0.562(0.7); 0.556(0.7); 0.547(0.6); 0.314(1.3); 0.302(3.1); 0.296(3.2); 0.292(3.1); 0.288(2.9); 0.275(0.9); 0.146(1.3); 0.000(277.3); -0.008(13.9); -0.150(1.4) Example Ic-101: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.270(5.6); 8.254(5.4); 7.756(0.6); 7.750(0.9); 7.741(3.2); 7.736(4.3); 7.715(0.6); 7.708(2.3); 7.702(1.6); 7.687(2.4); 7.682(2.0); 7.641(1.3); 7.570(0.7); 7.549(0.5); 7.525(3.5); 7.504(2.8); 6.754(0.9); 3.807(16.0); 2.672(0.6); 2.664(1.0); 2.655(1.4); 2.645(1.4); 2.637(1.0); 2.627(0.6); 2.166(149.2); 2.120(0.4); 2.114(0.6); 2.108(0.7); 2.102(0.5); 1.972(1.7); 1.965(3.3); 1.959(8.1); 1.953(40.0); 1.947(71.9); 1.941(95.7); 1.934(66.1); 1.928(34.6); 1.775(0.4); 1.769(0.6); 1.763(0.4); 1.605(1.6); 1.590(4.2); 1.584(4.8); 1.570(2.2); 1.563(0.6); 1.365(2.3); 1.352(4.6); 1.345(4.8); 1.330(1.8); 1.285(0.4); 1.270(0.7); 1.221(0.4); 1.204(0.6); 1.186(0.3); 0.661(0.8); 0.648(2.5); 0.643(3.1); 0.630(3.2); 0.626(2.5); 0.613(0.9); 0.317(0.9); 0.304(2.7); 0.299(2.9); 0.295(2.7); 0.290(2.7); 0.277(0.8); 0.146(0.6); 0.008(5.4); 0.000(133.8); -0.009(6.5); -0.150(0.6) Example Ic-102: H-NMR(400.0 MHz, acetonitrile-d3): δ= 9.802(3.8); 8.415(5.3); 8.296(5.1); 7.771(2.9); 7.765(3.5); 7.734(1.9); 7.728(1.4); 7.713(2.2); BCS 13-3006 Foreign Countries THS/mr 201420 7.707(1.8); 7.585(1.3); 7.534(3.4); 7.513(2.7); 4.068(0.4); 4.050(0.4); 3.895(16.0); 3.794(1.7); 3.758(1.9); 3.412(1.8); 2.146(110.9); 2.142(147.6); 2.120(1.0); 2.114(1.1); 2.108(1.3); 2.101(0.9); 2.095(0.5); 1.972(2.7); 1.964(7.2); 1.958(16.7); 1.952(78.0); 1.946(137.5); 1.940(181.3); 1.934(123.5); 1.928(63.0); 1.781(0.5); 1.775(0.8); 1.769(1.0); 1.762(0.7); 1.756(0.4); 1.606(1.4); 1.592(3.7); 1.585(3.6); 1.571(1.9); 1.437(0.8); 1.365(1.9); 1.352(3.6); 1.345(3.8); 1.330(1.4); 1.285(0.3); 1.270(0.6); 1.221(0.4); 1.204(0.9); 1.186(0.4); 1.135(0.8); 0.146(0.6); 0.008(6.7); 0.000(144.1); - 0.009(5.4); -0.150(0.7) Example Ic-103: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.255(5.8); 8.224(6.0); 7.711(3.5); 7.706(4.3); 7.694(0.3); 7.675(2.2); 7.669(1.6); 7.654(2.5); 7.649(2.1); 7.492(4.0); 7.471(3.2); 6.929(0.9); 5.325(5.1); 5.203(5.1); 4.085(0.5); 4.067(1.4); 4.050(1.4); 4.032(0.5); 3.832(16.0); 2.874(0.7); 2.865(1.0); 2.856(1.6); 2.846(1.6); 2.838(1.1); 2.828(0.8); 2.153(53.1); 2.120(0.4); 2.114(0.5); 2.108(0.5); 2.102(0.4); 1.972(6.0); 1.965(2.3); 1.958(5.7); 1.953(27.9); 1.947(50.1); 1.941(66.5); 1.934(45.6); 1.928(23.4); 1.775(0.3); 1.769(0.4); 1.285(0.4); 1.271(1.2); 1.221(1.7); 1.204(3.2); 1.186(1.6); 0.800(0.9); 0.787(2.8); 0.782(3.6); 0.770(3.7); 0.764(2.7); 0.752(1.2); 0.615(1.2); 0.604(3.1); 0.598(3.3); 0.593(2.9); 0.588(2.9); 0.576(0.9); 0.008(1.2); 0.000(31.7); -0.008(1.3) Example Ic-104: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.303(5.5); 8.236(5.2); 7.756(3.3); 7.750(4.0); 7.718(2.1); 7.713(1.7); 7.698(2.4); 7.692(2.1); 7.637(1.2); 7.521(3.7); 7.500(3.1); 7.447(0.5); 7.236(0.3); 6.869(0.3); 4.416(4.5); 4.403(4.6); 4.085(1.2); 4.068(3.7); 4.050(3.7); 4.032(1.3); 3.809(16.0); 3.325(0.8); 3.316(1.0); 2.445(0.4); 2.162(75.4); 2.114(0.4); 2.108(0.5); 2.102(0.4); 1.972(16.3); 1.965(2.8); 1.959(6.0); 1.953(30.6); 1.947(55.3); 1.941(73.7); 1.934(50.7); 1.928(26.1); 1.775(0.3); 1.769(0.5); 1.763(0.3); 1.603(1.6); 1.589(4.1); 1.582(4.1); 1.568(2.2); 1.528(0.4); 1.478(0.4); 1.372(4.7); 1.364(2.5); 1.350(4.2); 1.343(5.6); 1.340(6.8); 1.329(1.8); 1.311(0.4); 1.304(0.4); 1.285(6.8); 1.277(5.8); 1.269(1.5); 1.221(4.5); 1.204(8.7); 1.186(4.4); 0.008(1.3); 0.000(36.4); -0.009(1.4) Example Ic-108: H-NMR(400.0 MHz, DMSO-d ): δ= 8.904(1.1); 8.886(1.2); 8.840(3.8); 8.591(4.1); 7.788(4.8); 7.783(2.1); 7.771(1.9); 7.765(1.4); 7.572(1.9); 7.566(0.8); 7.554(0.5); 7.549(1.7); 4.578(0.4); 4.559(0.7); 4.540(0.7); 4.522(0.4); 4.056(0.8); 4.039(2.4); 4.021(2.5); 4.003(0.9); 3.825(9.8); 3.426(0.4); 3.417(0.6); 3.407(0.7); 3.397(0.6); 3.386(0.4); 3.332(14.8); 2.525(0.3); 2.512(6.4); 2.508(12.7); 2.503(16.4); 2.499(11.7); 2.494(5.6); 2.457(0.5); 2.451(0.3); 2.436(0.8); 2.431(0.8); 2.424(0.9); 2.419(0.8); 2.411(0.8); 2.406(1.1); 2.386(0.7); 2.287(0.7); 2.277(0.8); 2.267(0.9); 2.256(1.1); 2.244(0.7); 2.234(0.6); 2.224(0.5); 2.042(16.0); 2.032(1.9); 1.990(10.4); 1.236(1.2); 1.193(2.8); 1.176(5.5); 1.158(2.7); BCS 13-3006 Foreign Countries THS/mr 201420 0.000(3.8) Example Ic-109: H-NMR(400.0 MHz, DMSO-d ): δ= 8.998(0.7); 8.984(1.2); 8.970(0.6); 8.840(3.3); 8.583(3.5); 8.317(0.6); 7.801(1.0); 7.796(1.2); 7.781(1.0); 7.775(2.0); 7.768(2.8); 7.764(1.6); 7.578(2.1); 7.557(1.7); 4.065(2.0); 4.059(2.1); 4.051(2.1); 4.045(1.9); 3.823(8.9); 3.328(186.6); 3.185(1.1); 3.179(2.2); 3.173(1.0); 2.675(1.3); 2.671(1.6); 2.666(1.2); 2.506(205.9); 2.502(250.6); 2.497(178.5); 2.333(1.3); 2.329(1.6); 2.324(1.2); 1.989(0.4); 1.398(16.0); 1.235(1.1); 0.000(6.2) Example Ic-110: H-NMR(400.0 MHz, DMSO-d ): δ= 9.134(1.1); 9.112(1.1); 8.847(3.3); 8.585(3.6); 8.317(0.5); 7.829(0.9); 7.823(1.0); 7.808(1.1); 7.802(1.3); 7.751(2.2); 7.746(1.9); 7.603(2.2); 7.582(1.9); 4.804(0.5); 4.784(0.5); 3.821(8.5); 3.328(134.0); 2.676(0.8); 2.671(1.1); 2.667(0.8); 2.541(0.5); 2.524(2.9); 2.511(65.4); 2.507(132.6); 2.502(173.7); 2.498(124.3); 2.494(59.5); 2.333(0.8); 2.329(1.1); 2.324(0.8); 1.398(16.0); 1.343(4.1); 1.326(4.0); 1.236(1.2); 0.000(6.7) Example Ic-111: H-NMR(400.0 MHz, DMSO-d ): δ= 8.813(5.9); 8.761(1.0); 8.746(2.0); 8.732(1.0); 8.562(6.5); 7.788(1.5); 7.783(2.4); 7.770(3.6); 7.765(9.2); 7.568(3.3); 7.563(1.1); 7.551(1.0); 7.545(2.7); 5.333(0.4); 5.317(1.5); 5.301(2.4); .285(1.6); 5.269(0.5); 4.954(1.9); 4.946(4.2); 4.938(3.5); 4.930(3.8); 4.922(1.8); 4.038(0.6); 4.020(0.6); 3.885(0.9); 3.877(1.8); 3.870(2.4); 3.862(3.2); 3.855(2.4); 3.848(1.8); 3.839(1.1); 3.825(16.0); 3.330(47.7); 2.891(0.5); 2.732(0.5); 2.672(0.3); 2.511(21.8); 2.507(43.0); 2.503(55.5); 2.498(39.6); 2.494(18.8); 2.329(0.3); 1.989(2.5); 1.236(2.7); 1.193(0.7); 1.175(1.4); 1.157(0.7); 0.000(1.6) Example Ic-112: H-NMR(400.0 MHz, DMSO-d ): δ= 8.835(4.0); 8.829(3.3); 8.809(0.5); 8.795(0.6); 8.781(1.1); 8.766(0.6); 8.590(3.8); 8.579(3.2); 7.813(2.6); 7.808(3.8); 7.796(2.7); 7.790(1.4); 7.775(2.8); 7.769(2.1); 7.576(4.2); 7.556(3.6); 6.503(0.6); 6.499(1.3); 6.495(0.6); 6.470(0.7); 6.466(1.5); 6.462(0.8); 6.458(0.6); 6.453(1.1); 6.449(0.5); 6.440(0.6); 6.436(1.2); 6.431(0.6); 6.071(0.6); 6.056(1.3); 6.040(0.7); 6.022(1.5); 6.006(1.6); 5.989(1.2); 5.973(0.5); 4.055(1.0); 4.050(0.9); 4.037(1.8); 4.026(0.9); 4.021(1.2); 3.934(1.0); 3.931(1.1); 3.920(1.9); 3.916(1.9); 3.905(1.1); 3.901(1.0); 3.824(16.0); 3.329(94.9); 2.676(0.4); 2.671(0.6); 2.667(0.4); 2.525(1.5); 2.511(36.2); 2.507(72.1); 2.502(93.4); 2.498(65.7); 2.493(30.4); 2.334(0.5); 2.329(0.6); 2.325(0.4); 1.989(2.3); 1.235(2.9); 1.193(0.6); 1.175(1.2); 1.157(0.6); 0.000(5.2) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ic-113: H-NMR(400.0 MHz, DMSO-d ): δ= 8.834(4.9); 8.580(5.4); 8.383(1.5); 8.364(1.5); 7.770(1.4); 7.765(1.7); 7.750(1.5); 7.744(2.3); 7.727(3.7); 7.722(2.6); 7.551(3.4); 7.530(2.8); 4.074(0.6); 4.056(1.1); 4.038(1.6); 4.020(1.1); 4.002(0.4); 3.822(12.9); 3.329(78.9); 2.676(0.4); 2.671(0.6); 2.667(0.4); 2.524(1.5); 2.511(36.1); 2.507(71.1); 2.502(91.6); 2.498(65.5); 2.494(31.3); 2.334(0.4); 2.329(0.6); 2.325(0.4); 1.989(3.3); 1.236(1.7); 1.193(1.0); 1.171(16.0); 1.154(15.8); 1.068(0.5); 0.000(3.6) Example Ic-114: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.262(11.5); 7.714(3.0); 7.709(3.7); 7.678(2.0); 7.673(1.5); 7.658(2.3); 7.652(1.9); 7.498(3.5); 7.477(2.7); 6.952(0.9); 4.563(9.6); 4.085(0.5); 4.068(1.3); 4.050(1.3); 4.032(0.5); 3.823(0.7); 3.802(16.0); 3.067(1.0); 2.877(0.7); 2.868(0.9); 2.859(1.4); 2.849(1.5); 2.840(1.0); 2.831(0.7); 2.469(1.1); 2.465(1.5); 2.460(1.0); 2.456(0.6); 2.165(519.2); 2.120(1.3); 2.114(1.9); 2.108(2.3); 2.102(1.6); 2.096(0.9); 1.972(8.1); 1.965(14.4); 1.959(35.3); 1.953(157.2); 1.947(275.4); 1.941(360.5); 1.934(245.6); 1.928(124.7); 1.781(0.9); 1.775(1.6); 1.769(2.1); 1.763(1.4); 1.757(0.7); 1.271(0.4); 1.222(1.5); 1.204(3.0); 1.186(1.5); 1.168(2.0); 0.801(0.7); 0.788(2.5); 0.783(3.1); 0.770(3.3); 0.765(2.4); 0.753(1.1); 0.616(1.1); 0.605(2.9); 0.598(3.0); 0.589(2.5); 0.576(0.8); 0.146(1.5); 0.008(15.1); 0.000(325.6); -0.009(12.8); -0.150(1.5) Example Ic-115: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.266(4.8); 8.239(5.2); 7.763(3.0); 7.757(3.6); 7.726(1.9); 7.720(1.4); 7.705(2.2); 7.699(1.8); 7.575(1.3); 7.525(3.4); 7.504(2.8); 5.328(4.1); 5.206(4.1); 4.085(0.3); 4.067(1.0); 4.050(1.0); 4.032(0.3); 3.835(13.5); 2.139(40.9); 2.120(0.4); 2.114(0.5); 2.108(0.6); 2.101(0.4); 1.972(4.5); 1.964(2.9); 1.958(7.6); 1.953(36.3); 1.946(64.9); 1.940(85.2); 1.934(57.8); 1.928(29.2); 1.775(0.4); 1.769(0.5); 1.763(0.3); 1.605(1.5); 1.591(3.8); 1.584(3.7); 1.570(1.9); 1.437(16.0); 1.364(2.0); 1.350(3.8); 1.344(3.8); 1.329(1.5); 1.222(1.2); 1.204(2.3); 1.186(1.1); 0.146(0.4); 0.008(4.2); 0.000(101.9); -0.009(3.6); -0.150(0.5) Example Ic-116: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.278(5.6); 8.254(5.3); 7.756(3.3); 7.751(3.9); 7.699(1.9); 7.694(1.6); 7.678(2.3); 7.673(2.1); 7.520(3.9); 7.500(3.8); 7.484(0.9); 4.510(0.6); 4.503(0.4); 4.491(0.6); 4.484(1.2); 4.477(0.3); 4.472(0.3); 4.465(1.3); 4.458(0.7); 4.446(0.5); 4.439(0.7); 4.139(0.5); 4.133(1.9); 4.125(1.6); 4.121(0.7); 4.114(1.9); 4.110(2.0); 4.106(1.9); 4.102(2.3); 4.095(0.8); 4.091(1.5); 4.083(1.9); 4.077(0.6); 3.755(16.0); 3.256(0.6); 3.250(1.9); 3.242(1.4); 3.224(2.5); 3.219(2.5); 3.201(1.3); 3.193(1.8); 3.188(0.6); 2.166(14.4); 1.972(0.6); 1.965(0.6); 1.958(1.4); 1.953(7.4); 1.947(13.4); 1.940(18.0); 1.934(12.6); 1.928(6.7); 0.008(1.2); 0.000(30.8); -0.008(1.6) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ic-117: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.271(5.7); 8.247(5.3); 7.769(3.5); 7.763(3.9); 7.710(2.0); 7.705(1.7); 7.689(2.7); 7.684(2.7); 7.528(3.7); 7.507(3.0); 4.686(0.4); 4.674(0.5); 4.664(1.0); 4.654(0.7); 4.650(1.0); 4.642(0.9); 4.635(0.4); 4.628(0.8); 4.616(0.4); 4.571(2.1); 4.565(0.9); 4.552(0.9); 4.548(1.3); 4.543(1.3); 4.535(2.6); 4.529(0.5); 4.522(0.7); 4.514(1.7); 4.200(2.5); 4.188(2.7); 4.184(1.1); 4.171(0.8); 4.163(2.0); 4.151(2.0); 4.067(0.4); 4.049(0.4); 3.754(16.0); 2.163(24.4); 1.972(1.9); 1.964(0.8); 1.953(9.1); 1.946(16.3); 1.940(21.6); 1.934(15.0); 1.928(7.9); 1.436(0.5); 1.270(0.6); 1.221(0.5); 1.203(1.0); 1.186(0.5); 0.000(34.9); -0.008(1.8) Example Ic-118: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.386(3.3); 8.307(3.7); 8.270(3.2); 7.912(1.5); 7.895(0.6); 7.890(2.0); 7.726(5.4); 7.721(2.0); 7.709(1.2); 7.704(0.7); 7.619(0.4); 7.026(0.6); 4.068(0.7); 4.050(0.7); 3.938(16.0); 3.900(1.6); 3.757(10.5); 2.872(0.4); 2.863(0.6); 2.854(0.9); 2.845(0.9); 2.836(0.6); 2.827(0.4); 2.135(38.8); 2.134(45.2); 2.119(0.4); 2.113(0.4); 2.107(0.5); 2.101(0.4); 1.972(3.5); 1.964(2.9); 1.958(6.8); 1.952(33.7); 1.946(60.0); 1.940(79.6); 1.933(54.4); 1.927(27.7); 1.914(0.3); 1.768(0.5); 1.270(0.4); 1.221(0.9); 1.204(1.7); 1.186(0.8); 0.794(0.5); 0.782(1.5); 0.776(2.1); 0.764(2.1); 0.759(1.6); 0.747(0.7); 0.628(0.7); 0.617(1.7); 0.610(1.9); 0.606(1.6); 0.601(1.6); 0.589(0.5); 0.146(0.6); 0.008(5.4); 0.000(125.8); -0.009(4.1); -0.150(0.6) Example Ic-119: H-NMR(600.1 MHz, DMSO-d ): δ= 8.870(0.4); 8.856(0.4); 8.844(1.2); 8.824(1.2); 8.811(1.2); 8.791(3.7); 8.588(1.3); 8.529(4.0); 7.794(1.1); 7.791(1.6); 7.787(0.5); 7.781(1.2); 7.777(1.9); 7.773(0.6); 7.753(2.6); 7.749(2.1); 7.742(0.9); 7.738(0.7); 7.573(2.6); 7.559(2.4); 4.641(0.5); 4.629(0.8); 4.616(0.5); 4.323(0.3); 3.818(10.2); 3.680(0.6); 3.678(0.6); 3.668(0.7); 3.346(0.5); 3.325(140.9); 2.614(0.3); 2.523(0.6); 2.520(0.7); 2.517(0.8); 2.505(39.3); 2.502(52.9); 2.499(38.3); 2.496(18.1); 2.292(0.3); 2.288(0.4); 2.284(0.5); 2.279(0.6); 2.275(0.4); 2.271(0.5); 2.267(0.6); 2.251(0.4); 2.237(0.6); 2.224(0.5); 2.218(0.5); 2.206(0.5); 2.192(0.6); 2.181(0.5); 2.177(0.5); 2.165(0.7); 2.153(0.3); 2.148(0.4); 2.105(5.0); 2.030(16.0); 1.745(0.4); 1.736(0.4); 1.733(0.4); 1.728(0.6); 1.719(0.5); 1.710(0.4); 1.398(3.5); 1.236(0.7); 0.000(4.9) Example Ic-120: H-NMR(400.0 MHz, DMSO-d ): δ= 8.823(4.9); 8.742(2.1); 8.723(2.1); 8.573(5.0); 7.778(2.2); 7.757(2.8); 7.737(4.6); 7.562(2.8); 7.544(2.3); 7.541(2.4); 4.154(0.3); 4.132(1.2); 4.112(1.7); 4.093(1.2); 4.075(0.4); 4.052(0.7); 4.038(1.9); 4.034(1.9); 4.020(2.0); 4.017(2.0); 4.002(0.8); 3.820(14.3); 3.327(20.8); 3.323(17.5); 2.733(1.0); 2.721(1.2); 2.701(1.6); 2.690(1.8); 2.598(1.3); 2.576(2.0); 2.544(2.0); 2.499(51.1); 2.326(0.4); 2.169(0.6); 2.150(1.6); 2.129(1.6); 2.106(0.8); 2.059(15.9); 2.055(16.0); 2.052(13.8); BCS 13-3006 Foreign Countries THS/mr 201420 1.989(7.5); 1.986(7.5); 1.983(6.6); 1.907(0.5); 1.885(1.4); 1.863(1.7); 1.845(1.6); 1.830(1.6); 1.807(1.6); 1.783(1.0); 1.759(0.3); 1.456(0.4); 1.431(1.3); 1.408(1.6); 1.385(1.1); 1.234(0.9); 1.193(2.1); 1.189(2.1); 1.186(1.9); 1.175(4.1); 1.172(4.0); 1.168(3.5); 1.157(2.3); 1.154(2.1); 1.151(1.8); 0.000(11.7); -0.004(11.6); -0.007(10.0) Example Ic-121: H-NMR(400.0 MHz, acetonitrile-d ): δ= 9.839(1.2); 8.383(1.6); 8.277(1.6); 7.757(0.9); 7.752(1.1); 7.723(0.6); 7.717(0.5); 7.702(0.7); 7.696(0.6); 7.581(0.4); 7.528(1.1); 7.507(0.9); 6.869(0.3); 3.881(4.9); 2.611(1.2); 2.139(3.2); 1.971(1.3); 1.958(0.7); 1.952(3.6); 1.946(6.5); 1.940(8.7); 1.934(5.9); 1.927(3.0); 1.603(0.5); 1.589(1.2); 1.582(1.2); 1.569(0.6); 1.365(0.6); 1.352(1.2); 1.345(1.2); 1.330(0.5); 1.221(0.3); 1.203(0.7); 1.186(0.3); 1.134(16.0); 0.008(0.6); 0.000(15.2); -0.009(0.5) Example Ic-122: H-NMR(400.0 MHz, DMSO-d ): δ= 9.010(0.5); 8.991(0.5); 8.950(1.6); 8.932(1.7); 8.838(5.1); 8.591(5.1); 8.585(1.9); 7.817(2.3); 7.812(3.3); 7.802(1.8); 7.796(1.0); 7.780(2.3); 7.775(2.1); 7.768(1.0); 7.583(2.8); 7.568(1.1); 7.562(2.4); 7.546(0.7); 4.560(0.5); 4.541(0.9); 4.521(0.9); 4.502(0.5); 4.056(1.3); 4.038(3.8); 4.020(3.9); 4.002(1.4); 3.895(0.5); 3.882(0.6); 3.871(0.9); 3.859(0.7); 3.846(0.6); 3.825(13.4); 3.771(0.4); 3.325(36.5); 2.967(15.0); 2.888(5.0); 2.748(0.6); 2.738(0.8); 2.727(0.8); 2.712(1.4); 2.702(1.1); 2.690(1.1); 2.680(0.9); 2.589(0.4); 2.583(0.5); 2.559(0.5); 2.540(0.4); 2.506(34.2); 2.502(43.3); 2.498(33.2); 2.476(1.8); 2.465(1.4); 2.446(0.6); 2.440(0.7); 2.363(0.6); 2.357(0.5); 2.338(0.6); 2.333(0.7); 1.989(16.0); 1.275(0.3); 1.259(0.8); 1.244(0.6); 1.193(4.2); 1.175(8.3); 1.157(4.2); 0.000(1.0) Example Ic-123: H-NMR(400.0 MHz, DMSO-d ): δ= 8.830(5.5); 8.814(2.7); 8.578(4.6); 8.565(2.2); 7.801(1.1); 7.795(1.6); 7.789(1.3); 7.783(2.4); 7.772(2.9); 7.767(5.6); 7.573(2.3); 7.562(1.5); 7.557(0.8); 7.550(2.0); 7.541(1.1); 4.273(0.3); 4.253(0.6); 4.242(0.8); 4.232(0.6); 4.222(1.1); 4.201(0.8); 4.055(0.9); 4.038(2.6); 4.020(2.7); 4.002(0.9); 3.822(16.0); 3.324(170.5); 3.011(0.4); 2.995(0.6); 2.978(0.8); 2.966(3.1); 2.951(2.1); 2.944(2.0); 2.925(0.6); 2.905(0.7); 2.892(0.3); 2.872(0.4); 2.704(0.4); 2.675(1.0); 2.671(1.2); 2.666(1.1); 2.641(0.7); 2.622(0.4); 2.540(16.1); 2.534(8.3); 2.506(105.5); 2.502(129.8); 2.497(95.8); 2.332(0.7); 2.328(0.9); 2.229(0.5); 2.208(1.2); 2.188(1.3); 2.165(0.6); 1.989(11.3); 1.955(0.8); 1.947(0.9); 1.934(2.2); 1.923(1.7); 1.911(1.6); 1.888(0.8); 1.578(0.4); 1.555(0.8); 1.533(1.0); 1.510(0.6); 1.236(2.0); 1.193(3.0); 1.175(5.8); 1.157(2.9); 0.146(0.6); 0.000(115.5); -0.150(0.6) Example Ic-124: H-NMR(400.0 MHz, DMSO-d6): δ= 8.953(1.7); 8.934(1.8); 8.744(5.1); 8.467(5.4); 8.316(0.7); 7.804(4.2); 7.779(2.0); 7.774(1.6); BCS 13-3006 Foreign Countries THS/mr 201420 7.573(3.0); 7.553(2.5); 4.915(0.9); 4.895(1.4); 4.874(0.9); 4.172(0.4); 4.151(0.9); 4.136(0.9); 4.119(0.4); 4.056(0.6); 4.038(1.8); 4.020(1.8); 4.002(0.6); 3.815(13.5); 3.322(203.0); 2.979(16.0); 2.671(2.0); 2.506(228.5); 2.502(301.1); 2.498(236.9); 2.441(0.7); 2.414(1.2); 2.391(1.1); 2.367(0.8); 2.328(2.8); 2.303(0.9); 2.292(1.1); 2.279(0.8); 2.267(1.1); 2.247(1.2); 2.225(1.0); 2.217(0.7); 2.204(0.4); 2.194(0.5); 1.989(7.5); 1.298(0.7); 1.259(0.9); 1.235(0.9); 1.193(2.0); 1.175(4.0); 1.157(2.0); 0.146(1.3); 0.008(11.0); 0.000(273.4); -0.150(1.3) Example Ic-125: H-NMR(400.0 MHz, DMSO-d ): δ= 9.081(1.2); 9.060(1.3); 8.953(0.9); 8.935(0.9); 8.794(2.7); 8.731(3.7); 8.528(2.9); 8.453(4.0); 7.987(2.2); 7.982(2.3); 7.794(3.3); 7.789(1.7); 7.781(1.6); 7.777(2.3); 7.761(1.5); 7.755(1.4); 7.574(1.5); 7.557(2.8); 7.551(1.5); 7.536(2.0); 4.968(0.6); 4.949(0.9); 4.928(0.6); 4.801(0.4); 4.783(0.6); 4.763(0.4); 4.056(1.3); 4.038(3.8); 4.021(3.8); 4.003(1.3); 3.818(14.9); 3.664(0.8); 3.647(1.1); 3.636(0.9); 3.326(21.9); 2.561(11.9); 2.506(37.1); 2.502(47.0); 2.468(0.7); 2.442(0.4); 2.415(9.1); 2.364(0.5); 2.353(0.6); 2.331(1.0); 2.325(0.9); 2.319(0.8); 2.314(0.9); 2.292(0.9); 2.281(0.5); 2.268(0.8); 2.240(0.8); 2.235(0.7); 2.221(0.7); 2.204(0.7); 2.193(0.7); 2.173(1.0); 2.151(1.0); 2.130(0.5); 1.989(16.0); 1.875(0.5); 1.863(0.4); 1.852(0.6); 1.299(0.4); 1.259(0.5); 1.193(4.4); 1.175(8.8); 1.157(4.3); 0.008(2.4); 0.000(48.9); -0.009(2.4) Example Ic-126: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.261(5.3); 8.244(0.8); 8.235(4.9); 7.701(3.3); 7.696(4.1); 7.683(0.6); 7.666(2.5); 7.660(1.9); 7.645(2.9); 7.639(2.3); 7.584(0.6); 7.493(3.8); 7.472(3.0); 6.903(0.9); 4.140(0.9); 4.068(0.4); 4.050(0.4); 3.760(16.0); 3.746(1.2); 2.882(0.4); 2.873(0.9); 2.863(1.2); 2.855(1.7); 2.845(1.7); 2.836(1.0); 2.827(0.9); 2.818(0.4); 2.614(0.5); 2.467(0.4); 2.448(0.3); 2.139(489.2); 2.123(40.4); 2.114(16.3); 2.107(10.9); 2.101(6.1); 2.095(3.3); 1.964(56.6); 1.958(101.0); 1.952(373.8); 1.946(646.9); 1.940(854.8); 1.934(602.7); 1.927(335.8); 1.780(1.9); 1.774(3.5); 1.768(4.8); 1.762(3.3); 1.756(1.8); 1.437(0.6); 1.285(0.4); 1.271(0.8); 1.222(0.4); 1.204(0.9); 1.186(0.5); 1.135(7.6); 0.799(0.9); 0.787(2.6); 0.781(3.4); 0.769(3.6); 0.763(2.6); 0.751(1.5); 0.613(1.2); 0.601(2.9); 0.596(3.1); 0.592(2.8); 0.586(2.7); 0.574(1.1); 0.146(9.4); 0.137(0.8); 0.008(129.3); 0.000(2345.5); - 0.009(130.3); -0.014(94.8); -0.066(0.9); -0.075(0.7); -0.142(0.9); -0.150(9.4) Example Ic-127: H-NMR(400.0 MHz, acetonitrile-d ): δ= 19.989(0.5); 8.273(5.2); 8.250(4.8); 7.750(3.0); 7.745(3.8); 7.716(2.0); 7.710(1.6); 7.695(2.2); 7.689(1.9); 7.585(1.7); 7.525(3.5); 7.504(2.8); 4.813(1.0); 4.086(0.4); 4.068(1.0); 4.050(1.1); 4.032(0.4); 3.762(16.0); 2.596(0.6); 2.463(1.7); 2.334(0.5); 2.145(1113.7); 2.120(7.4); 2.113(8.4); 2.107(9.6); 2.101(6.6); 2.095(3.8); 1.971(10.0); 1.964(44.6); 1.958(113.6); 1.952(549.2); 1.946(983.1); 1.940(1305.2); 1.934(901.0); 1.927(463.8); 1.780(3.0); 1.774(5.6); 1.768(7.5); 1.762(5.2); 1.756(2.7); BCS 13-3006 Foreign Countries THS/mr 201420 1.602(1.6); 1.587(4.1); 1.581(4.1); 1.567(2.1); 1.363(2.2); 1.348(4.0); 1.342(4.3); 1.327(1.6); 1.269(0.8); 1.222(1.2); 1.204(2.6); 1.186(1.3); 1.135(2.7); 0.146(16.7); 0.008(156.8); 0.000(3428.8); - 0.008(157.6); -0.047(1.5); -0.150(16.6) Example Ic-128: H-NMR(400.0 MHz, acetonitrile-d ): δ= 10.225(0.4); 8.295(5.5); 8.275(5.1); 7.935(3.5); 7.930(3.7); 7.788(2.0); 7.783(1.8); 7.767(2.4); 7.762(2.3); 7.600(3.8); 7.579(3.1); 6.716(3.6); 6.714(3.5); 5.447(0.3); 4.068(0.5); 4.050(0.5); 3.757(16.0); 2.307(15.3); 2.305(15.1); 2.296(0.7); 2.134(62.3); 2.120(0.7); 2.113(0.8); 2.107(1.0); 2.101(0.7); 2.095(0.3); 1.972(2.9); 1.964(4.9); 1.958(11.6); 1.952(62.2); 1.946(113.0); 1.940(151.7); 1.934(103.3); 1.927(52.5); 1.914(0.6); 1.780(0.3); 1.774(0.6); 1.768(0.9); 1.762(0.6); 1.437(5.0); 1.285(0.4); 1.270(1.5); 1.222(0.7); 1.204(1.3); 1.186(0.7); 0.146(1.9); 0.024(0.4); 0.019(0.7); 0.008(15.5); 0.000(439.3); -0.009(15.0); -0.150(1.9) Example Ic-129: H-NMR(400.0 MHz, DMSO-d ): δ= 9.241(4.1); 8.753(5.8); 8.517(6.3); 7.710(1.6); 7.706(1.8); 7.691(1.7); 7.686(2.1); 7.660(3.7); 7.656(3.0); 7.343(2.6); 7.323(2.3); 4.056(0.9); 4.038(2.8); 4.020(2.8); 4.003(1.0); 3.930(2.5); 3.813(14.8); 3.326(63.0); 2.507(33.7); 2.502(43.6); 2.498(32.3); 2.338(13.6); 1.989(12.1); 1.591(1.5); 1.577(3.7); 1.570(3.9); 1.557(1.7); 1.294(1.8); 1.281(3.7); 1.274(3.9); 1.260(1.4); 1.193(3.2); 1.175(6.4); 1.158(3.2); 1.069(16.0); 0.008(0.5); 0.000(10.7); -0.008(0.4) Example Ic-130: H-NMR(400.0 MHz, DMSO-d ): δ= 8.729(6.2); 8.501(6.7); 8.357(2.1); 8.346(2.0); 8.316(1.3); 7.648(1.9); 7.644(2.0); 7.629(1.9); 7.624(2.2); 7.594(4.0); 7.589(3.2); 7.297(2.9); 7.277(2.5); 4.038(0.7); 4.020(0.7); 4.002(0.4); 3.930(0.4); 3.813(16.0); 3.739(0.5); 3.424(0.4); 3.405(0.4); 3.348(2.4); 3.324(578.9); 2.862(0.7); 2.853(0.9); 2.844(1.4); 2.834(1.4); 2.825(1.0); 2.816(0.7); 2.805(0.3); 2.675(2.6); 2.671(3.5); 2.666(2.6); 2.524(11.1); 2.510(198.0); 2.506(385.4); 2.502(500.9); 2.497(365.3); 2.493(177.0); 2.359(0.4); 2.349(0.6); 2.333(2.8); 2.328(4.0); 2.318(15.7); 1.989(3.0); 1.298(0.4); 1.286(0.6); 1.271(0.8); 1.259(0.9); 1.249(0.7); 1.235(0.7); 1.205(0.3); 1.193(1.0); 1.175(1.7); 1.157(0.9); 1.068(2.2); 0.716(0.8); 0.704(2.5); 0.698(3.5); 0.686(3.3); 0.680(2.8); 0.669(1.2); 0.556(1.2); 0.545(3.6); 0.539(3.2); 0.536(3.0); 0.530(2.8); 0.518(0.9); 0.146(0.6); 0.008(4.8); 0.000(136.1); - 0.009(5.4); -0.150(0.6) Example Ic-131: H-NMR(400.0 MHz, DMSO-d ): δ= 10.437(2.9); 8.783(4.5); 8.613(4.0); 8.557(5.0); 8.372(4.3); 7.819(2.6); 7.815(2.9); 7.802(1.9); 7.790(2.1); 7.785(1.5); 7.780(2.2); 7.767(2.1); 7.742(1.4); 7.738(1.3); 7.723(1.5); 7.718(1.5); 7.389(2.0); 7.369(1.8); 7.217(2.0); 7.195(3.7); 7.178(0.8); 7.173(1.9); 4.057(1.2); 4.039(3.8); BCS 13-3006 Foreign Countries THS/mr 201420 4.021(3.8); 4.003(1.3); 3.824(12.5); 3.812(10.3); 3.326(37.4); 2.511(16.0); 2.507(31.6); 2.503(41.6); 2.498(31.1); 2.494(15.8); 2.393(10.3); 1.989(16.0); 1.193(4.3); 1.176(8.5); 1.158(4.2); 0.008(0.5); 0.000(12.2); -0.008(0.5) Example Ic-132: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.729(0.6); 8.264(0.3); 8.250(5.6); 8.228(5.2); 7.649(3.3); 7.643(4.1); 7.608(2.4); 7.602(1.7); 7.587(2.7); 7.581(2.3); 7.457(4.1); 7.437(3.1); 4.050(0.3); 3.746(16.0); 3.429(0.5); 3.421(0.6); 3.416(0.6); 3.411(1.0); 3.408(0.7); 3.401(0.7); 3.398(1.0); 3.392(0.6); 3.388(0.6); 3.380(0.5); 2.463(0.3); 2.169(89.4); 2.114(0.4); 2.108(0.5); 2.102(0.3); 1.972(1.7); 1.965(2.6); 1.959(6.1); 1.953(32.8); 1.947(59.0); 1.940(79.1); 1.934(54.3); 1.928(27.8); 1.775(0.3); 1.769(0.5); 1.437(0.3); 1.269(0.4); 1.222(0.4); 1.204(0.8); 1.186(0.4); 0.954(0.7); 0.941(2.2); 0.936(3.0); 0.923(3.2); 0.918(2.2); 0.905(1.0); 0.785(1.1); 0.773(2.6); 0.767(2.7); 0.763(2.3); 0.757(2.3); 0.745(0.7); 0.146(0.7); 0.008(5.8); 0.000(161.4); -0.009(5.6); -0.150(0.7) Example Ic-133: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.265(0.5); 8.252(14.8); 7.709(3.5); 7.704(4.3); 7.672(2.6); 7.667(1.8); 7.651(2.9); 7.646(2.4); 7.492(4.1); 7.471(3.3); 6.964(0.8); 6.917(1.6); 6.783(3.2); 6.650(1.6); 3.806(16.0); 2.874(0.8); 2.864(1.0); 2.856(1.6); 2.846(1.6); 2.838(1.0); 2.828(0.8); 2.170(33.3); 1.965(1.5); 1.959(2.8); 1.953(13.6); 1.947(24.3); 1.940(32.1); 1.934(21.9); 1.928(11.1); 0.799(0.9); 0.786(2.7); 0.781(3.4); 0.769(3.7); 0.763(2.4); 0.751(1.2); 0.615(1.1); 0.605(2.9); 0.603(2.7); 0.597(2.9); 0.593(2.5); 0.588(2.5); 0.576(0.8); 0.008(3.1); 0.000(75.5); -0.009(2.4) Example Ic-134: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.385(4.4); 8.269(4.1); 7.925(0.9); 7.755(0.5); 7.747(2.4); 7.742(2.8); 7.735(0.4); 7.713(1.7); 7.708(1.2); 7.692(1.6); 7.687(1.3); 7.586(1.2); 7.568(0.6); 7.547(0.4); 7.522(2.6); 7.501(2.1); 6.870(0.4); 5.447(1.8); 4.068(0.6); 4.050(0.6); 3.830(12.6); 3.772(0.8); 2.888(8.5); 2.767(16.0); 2.670(0.9); 2.137(8.2); 2.114(0.3); 2.108(0.3); 1.972(2.8); 1.964(1.4); 1.957(3.3); 1.952(15.3); 1.946(27.0); 1.940(35.9); 1.934(24.7); 1.927(12.7); 1.600(1.2); 1.586(3.3); 1.579(3.4); 1.565(1.6); 1.437(1.4); 1.363(1.6); 1.350(3.4); 1.343(3.4); 1.328(1.2); 1.312(0.3); 1.305(0.4); 1.300(0.4); 1.285(0.7); 1.271(0.8); 1.221(0.7); 1.204(1.4); 1.186(0.7); 0.146(0.5); 0.008(4.7); 0.000(95.8); - 0.008(4.1); -0.149(0.5) Example Ic-135: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.731(0.9); 8.298(4.5); 8.271(4.2); 7.897(2.9); 7.892(3.0); 7.743(1.6); 7.738(1.4); 7.722(1.9); 7.717(1.8); 7.702(2.4); 7.699(2.8); 7.680(3.1); 7.584(0.4); 7.573(3.2); 7.552(2.5); 7.418(2.0); 7.399(3.2); 7.378(2.0); 7.194(1.1); 7.176(1.9); 7.157(0.8); 3.768(15.3); 2.192(0.4); 2.137(159.7); BCS 13-3006 Foreign Countries THS/mr 201420 2.120(1.5); 2.113(1.8); 2.107(2.1); 2.101(1.5); 2.095(0.8); 1.964(10.3); 1.958(25.2); 1.952(133.0); 1.946(237.7); 1.940(317.3); 1.934(216.9); 1.927(110.3); 1.915(1.2); 1.780(0.7); 1.774(1.3); 1.768(1.8); 1.762(1.2); 1.756(0.6); 1.437(16.0); 1.270(0.8); 0.146(4.1); 0.037(0.5); 0.031(0.7); 0.028(0.9); 0.027(0.9); 0.008(35.2); 0.000(911.9); -0.009(31.9); -0.149(4.0) Example Ic-168: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.268(5.2); 8.245(4.9); 7.745(3.3); 7.740(3.7); 7.690(1.9); 7.685(1.5); 7.669(2.3); 7.664(2.0); 7.520(3.6); 7.499(2.8); 7.098(0.7); 5.447(2.7); 4.647(1.7); 4.635(3.0); 4.622(1.8); 4.529(1.7); 4.517(3.0); 4.504(1.8); 4.068(0.7); 4.050(0.7); 3.763(16.0); 3.718(0.9); 3.705(1.9); 3.692(1.8); 3.679(0.9); 3.650(0.9); 3.637(1.9); 3.624(1.8); 3.611(0.8); 2.135(21.9); 1.972(3.2); 1.964(1.8); 1.958(4.4); 1.952(19.7); 1.946(35.0); 1.940(46.1); 1.934(31.9); 1.928(16.3); 1.437(0.6); 1.270(0.4); 1.221(0.8); 1.204(1.5); 1.186(0.7); 0.146(0.6); 0.008(5.5); 0.000(111.7); -0.008(5.2); -0.150(0.5) Example Ic-169: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.272(5.4); 8.253(5.0); 7.746(2.9); 7.741(3.9); 7.722(2.3); 7.716(1.5); 7.701(2.6); 7.696(2.1); 7.543(3.7); 7.522(2.9); 7.338(0.7); 6.996(0.6); 4.145(0.8); 4.129(0.9); 4.122(2.5); 4.105(2.5); 4.098(2.6); 4.081(2.5); 4.074(1.0); 4.058(0.9); 3.763(16.0); 2.134(37.3); 2.120(0.7); 2.113(0.7); 2.107(0.8); 2.101(0.6); 1.964(3.7); 1.958(9.3); 1.952(51.2); 1.946(92.7); 1.940(124.4); 1.934(86.0); 1.927(44.5); 1.774(0.5); 1.768(0.7); 1.762(0.5); 1.437(0.4); 0.146(1.4); 0.008(11.5); 0.000(310.6); - 0.009(12.4); -0.150(1.4) Example Ic-170: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.268(4.8); 8.247(4.5); 7.749(3.0); 7.744(3.6); 7.707(2.0); 7.701(1.5); 7.686(2.4); 7.681(2.1); 7.532(3.6); 7.511(2.8); 7.165(0.6); 6.192(0.4); 6.182(0.8); 6.172(0.4); 6.052(0.8); 6.042(1.7); 6.033(0.8); 5.913(0.4); 5.903(0.9); 5.893(0.4); 3.817(0.8); 3.807(0.9); 3.801(0.8); 3.792(0.8); 3.778(1.8); 3.763(16.0); 3.753(1.8); 3.739(0.9); 3.729(0.9); 3.724(0.9); 3.714(0.8); 2.139(52.3); 2.107(0.4); 1.972(1.5); 1.964(1.5); 1.958(3.9); 1.952(20.6); 1.946(37.0); 1.940(49.4); 1.934(34.0); 1.928(17.5); 1.437(0.9); 1.270(0.6); 1.221(0.4); 1.204(0.7); 1.186(0.4); 0.146(0.5); 0.008(4.4); 0.000(115.7); -0.009(4.6); -0.150(0.5) Example Ic-176: H-NMR(601.6 MHz, acetonitrile-d ): δ= 8.270(5.6); 8.248(5.1); 7.738(1.2); 7.700(3.3); 7.696(4.1); 7.676(2.4); 7.672(1.8); 7.662(2.7); 7.658(2.3); 7.500(3.7); 7.487(3.1); 3.752(16.0); 3.719(1.8); 3.708(5.7); 3.696(5.7); 3.684(1.8); 2.583(0.6); 2.178(4.2); 1.967(0.3); 1.958(0.9); 1.954(1.1); 1.951(5.7); 1.946(9.9); 1.942(14.7); 1.938(10.0); 1.934(5.0); 1.268(0.4); 1.155(5.7); 1.143(12.0); 1.132(5.8); 1.118(0.3); 1.105(1.4); BCS 13-3006 Foreign Countries THS/mr 201420 1.096(3.8); 1.092(3.9); 1.084(2.1); 1.000(2.1); 0.992(3.8); 0.988(3.9); 0.979(1.4); 0.000(5.2) Example Ic-177: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.260(5.2); 8.234(4.8); 7.713(3.0); 7.708(4.0); 7.681(2.0); 7.675(1.5); 7.660(2.3); 7.655(2.0); 7.502(3.5); 7.482(2.8); 6.919(0.8); 4.807(0.6); 4.802(0.6); 4.799(0.6); 4.793(0.6); 4.790(0.7); 4.785(0.6); 4.782(0.6); 4.651(0.6); 4.643(0.6); 4.637(0.6); 4.634(0.6); 4.629(0.6); 4.626(0.6); 4.068(0.5); 4.050(0.6); 3.760(16.0); 3.218(0.4); 3.215(0.3); 3.207(0.5); 3.193(0.6); 3.190(0.6); 3.182(0.6); 3.168(0.5); 3.155(0.4); 2.582(1.0); 2.464(0.3); 2.161(140.4); 2.120(0.5); 2.114(0.6); 2.108(0.8); 2.102(0.6); 1.972(2.8); 1.965(3.7); 1.959(9.2); 1.953(47.0); 1.947(84.9); 1.940(113.7); 1.934(79.6); 1.928(41.8); 1.775(0.5); 1.769(0.6); 1.763(0.5); 1.471(0.4); 1.463(0.5); 1.450(0.6); 1.437(8.0); 1.426(0.7); 1.418(0.6); 1.411(0.5); 1.403(0.5); 1.391(0.5); 1.386(0.6); 1.383(0.6); 1.378(0.5); 1.366(0.5); 1.358(0.5); 1.222(0.6); 1.204(1.2); 1.186(0.6); 1.098(0.5); 1.081(0.7); 1.078(0.6); 1.067(0.9); 1.064(0.7); 1.061(0.7); 1.055(0.7); 1.052(0.8); 1.049(0.8); 1.038(0.6); 1.035(0.7); 1.032(0.6); 1.018(0.4); 0.146(1.2); 0.008(10.6); 0.000(259.6); -0.009(12.7); -0.150(1.2) Example Ic-180: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.259(5.6); 8.258(5.5); 8.231(5.1); 7.696(3.3); 7.691(4.3); 7.667(2.4); 7.661(1.7); 7.646(2.8); 7.640(2.3); 7.493(4.1); 7.472(3.2); 7.197(0.3); 6.844(0.9); 3.748(16.0); 3.725(1.2); 3.719(0.7); 3.708(1.2); 3.701(2.2); 3.690(0.5); 3.683(2.2); 3.670(0.8); 3.666(0.8); 3.652(2.2); 3.646(0.4); 3.635(2.3); 3.628(1.2); 3.617(0.8); 3.611(1.2); 3.593(0.4); 3.569(0.7); 3.556(0.8); 3.551(2.0); 3.538(2.1); 3.534(2.0); 3.520(2.0); 3.516(0.7); 3.503(0.7); 3.344(1.0); 3.340(1.0); 3.335(1.1); 3.331(1.1); 3.327(1.1); 3.323(1.1); 3.317(1.1); 3.313(1.1); 2.839(0.5); 2.835(0.6); 2.830(0.6); 2.827(1.1); 2.823(0.7); 2.818(0.9); 2.814(0.9); 2.808(0.7); 2.804(1.1); 2.801(0.6); 2.796(0.6); 2.792(0.5); 2.467(0.4); 2.455(0.6); 2.328(1.4); 2.153(14.0); 2.143(25.1); 2.114(0.4); 2.107(0.4); 1.964(1.8); 1.958(4.6); 1.952(25.4); 1.946(46.0); 1.940(61.6); 1.934(42.1); 1.928(21.4); 1.768(0.4); 1.270(0.5); 1.197(7.1); 1.188(0.5); 1.179(14.3); 1.170(0.7); 1.161(6.9); 1.153(0.3); 1.131(4.4); 1.114(8.6); 1.096(4.2); 1.080(1.0); 1.070(1.1); 1.063(1.3); 1.057(1.2); 1.053(1.3); 1.048(1.1); 1.041(1.2); 1.031(1.2); 0.893(1.4); 0.881(1.4); 0.876(2.4); 0.864(2.0); 0.859(1.3); 0.847(1.0); 0.146(0.4); 0.008(3.6); 0.000(101.9); -0.009(3.1); -0.150(0.4) Example Ic-181: H-NMR(400.0 MHz, DMSO-d ): δ= 8.848(2.2); 8.837(2.3); 8.818(6.3); 8.571(6.9); 8.316(0.4); 7.819(3.2); 7.813(4.6); 7.802(2.7); 7.797(1.4); 7.782(2.7); 7.776(2.1); 7.581(4.3); 7.560(3.5); 3.820(16.0); 3.326(164.0); 3.253(0.5); 3.241(1.0); 3.232(1.4); 3.220(1.4); 3.211(1.0); 3.199(0.5); 2.675(0.6); 2.671(0.8); 2.666(0.6); 2.538(0.3); 2.524(2.1); 2.511(46.7); 2.506(93.9); 2.502(122.9); 2.497(88.5); 2.493(42.0); 2.333(0.6); 2.329(0.8); 2.324(0.6); 2.300(1.2); 2.056(0.4); 2.048(0.4); 2.041(0.6); 2.038(0.6); 2.032(0.8); BCS 13-3006 Foreign Countries THS/mr 201420 2.023(0.7); 2.014(0.8); 2.008(0.6); 2.005(0.6); 1.998(0.5); 1.989(0.5); 1.288(0.7); 1.272(1.7); 1.267(0.9); 1.256(1.3); 1.251(1.8); 1.236(2.0); 1.225(0.9); 1.211(1.2); 1.200(1.0); 1.187(1.1); 1.173(0.5); 0.146(0.8); 0.019(0.3); 0.018(0.3); 0.008(6.4); 0.000(178.7); -0.009(6.3); -0.150(0.7) Example Ic-182: H-NMR(400.0 MHz, DMSO-d ): δ= 8.750(4.8); 8.523(5.1); 8.416(1.6); 8.406(1.6); 7.741(1.4); 7.736(1.5); 7.721(1.6); 7.716(1.8); 7.656(3.2); 7.651(2.8); 7.388(2.7); 7.367(2.4); 4.056(1.2); 4.038(3.7); 4.021(3.7); 4.003(1.2); 3.816(11.9); 3.327(23.3); 2.842(0.5); 2.833(0.7); 2.824(1.0); 2.814(1.0); 2.806(0.7); 2.796(0.5); 2.525(0.5); 2.511(8.9); 2.507(17.6); 2.502(23.1); 2.498(16.7); 2.493(8.0); 2.428(15.5); 1.989(16.0); 1.193(4.4); 1.175(8.6); 1.158(4.3); 0.720(0.7); 0.708(1.9); 0.702(2.6); 0.690(2.4); 0.684(2.0); 0.673(0.9); 0.568(0.9); 0.558(2.7); 0.551(2.3); 0.548(2.2); 0.542(2.0); 0.530(0.6); 0.008(1.5); 0.000(38.8); -0.009(1.5) Example Ic-183: H-NMR(400.0 MHz, DMSO-d ): δ= 8.835(0.5); 8.819(6.2); 8.601(0.4); 8.572(6.8); 8.498(2.7); 8.488(2.7); 7.772(1.6); 7.766(2.9); 7.757(4.3); 7.752(6.6); 7.549(3.6); 7.541(1.0); 7.534(0.9); 7.526(3.0); 5.755(3.8); 3.837(1.3); 3.819(16.0); 3.686(0.3); 3.668(1.1); 3.662(0.8); 3.650(1.3); 3.644(2.1); 3.633(0.7); 3.626(2.0); 3.614(0.8); 3.609(0.8); 3.597(2.0); 3.590(0.7); 3.579(2.1); 3.572(1.3); 3.561(0.9); 3.555(1.1); 3.537(0.4); 3.324(113.0); 3.260(2.3); 3.247(1.9); 3.244(1.8); 2.671(0.5); 2.667(0.4); 2.506(58.2); 2.502(74.9); 2.497(58.0); 2.410(1.5); 2.405(2.0); 2.401(2.3); 2.391(1.2); 2.329(0.5); 1.989(0.5); 1.538(0.3); 1.236(1.0); 1.179(5.8); 1.170(1.7); 1.162(11.6); 1.144(6.1); 1.136(1.6); 1.112(13.8); 1.095(2.1); 1.083(1.2); 1.067(1.0); 0.941(0.6); 0.923(0.3); 0.629(0.4); 0.613(0.4); 0.146(0.4); 0.000(82.2); -0.150(0.4) Example Ic-184: H-NMR(400.0 MHz, DMSO-d ): δ= 9.137(2.5); 9.124(2.6); 8.836(6.4); 8.825(1.1); 8.574(7.4); 8.561(0.6); 8.315(0.3); 7.838(2.0); 7.832(2.4); 7.817(2.4); 7.812(3.1); 7.803(0.7); 7.797(0.9); 7.788(5.0); 7.782(3.8); 7.764(0.8); 7.614(4.5); 7.593(4.0); 7.576(0.4); 7.552(0.3); 3.818(16.0); 3.803(1.4); 3.608(0.9); 3.596(1.1); 3.591(1.3); 3.583(1.2); 3.579(1.3); 3.571(1.3); 3.567(1.2); 3.554(1.0); 3.324(105.5); 3.306(5.8); 3.033(1.0); 2.824(1.0); 2.675(0.6); 2.671(0.7); 2.666(0.5); 2.511(42.7); 2.506(80.1); 2.502(105.9); 2.497(79.4); 2.493(42.4); 2.333(0.5); 2.329(0.7); 2.324(0.5); 2.081(1.7); 2.060(2.2); 2.056(2.1); 2.035(1.7); 1.735(1.9); 1.718(2.2); 1.714(2.0); 1.698(1.8); 1.235(0.7); 1.073(0.3); 1.056(0.6); 1.038(0.3); 0.146(0.6); 0.008(7.8); 0.000(139.6); -0.009(7.5); -0.012(5.0); -0.017(6.5); -0.150(0.6) Example Ic-185: H-NMR(400.0 MHz, DMSO-d6): δ= 8.958(0.3); 8.945(5.1); 8.664(5.5); 8.379(2.0); 8.369(2.0); 8.316(0.8); 7.912(1.1); 7.907(1.1); BCS 13-3006 Foreign Countries THS/mr 201420 7.891(2.5); 7.886(2.6); 7.862(4.0); 7.841(1.7); 7.740(3.3); 7.736(3.1); 4.038(0.5); 4.020(0.5); 3.840(0.9); 3.824(13.0); 3.323(158.4); 3.294(2.1); 3.276(6.6); 3.258(6.7); 3.241(2.0); 2.774(0.5); 2.765(0.8); 2.756(1.2); 2.746(1.2); 2.737(0.8); 2.728(0.6); 2.675(1.2); 2.671(1.6); 2.666(1.2); 2.524(4.4); 2.511(94.1); 2.506(188.5); 2.502(246.3); 2.497(177.2); 2.493(84.7); 2.333(1.2); 2.328(1.6); 2.324(1.2); 1.989(2.2); 1.236(1.4); 1.193(0.6); 1.175(1.2); 1.157(0.6); 1.058(7.3); 1.040(16.0); 1.022(7.0); 0.692(0.6); 0.679(1.7); 0.674(2.6); 0.663(2.2); 0.656(2.1); 0.645(1.0); 0.580(1.0); 0.570(2.9); 0.562(2.6); 0.555(1.8); 0.542(0.7); 0.146(1.5); 0.008(12.7); 0.000(348.2); -0.009(13.4); - 0.150(1.5) Example Ic-186: H-NMR(601.6 MHz, acetonitrile-d ): δ= 8.264(3.7); 8.239(3.4); 7.700(2.2); 7.697(2.4); 7.662(1.4); 7.659(1.1); 7.649(1.5); 7.645(1.3); 7.490(2.4); 7.476(2.0); 6.994(0.5); 3.749(10.3); 3.361(0.8); 3.351(0.8); 3.344(1.2); 3.333(1.3); 3.321(16.0); 3.314(0.5); 3.291(1.0); 3.281(1.2); 3.269(1.3); 3.264(0.8); 3.252(0.9); 3.042(0.7); 2.782(0.7); 2.776(1.0); 2.769(0.9); 2.763(0.7); 2.195(17.3); 2.190(16.0); 2.187(17.4); 2.186(17.0); 2.179(21.7); 1.967(0.9); 1.959(2.4); 1.954(3.1); 1.951(14.6); 1.947(25.5); 1.942(36.5); 1.938(24.2); 1.934(11.9); 1.313(0.4); 1.308(0.5); 1.303(0.6); 1.297(0.7); 1.292(0.6); 1.286(0.7); 1.281(0.5); 1.270(0.6); 0.836(0.5); 0.827(0.7); 0.820(1.0); 0.812(0.7); 0.804(0.6); 0.762(0.7); 0.752(1.1); 0.740(1.0); 0.730(0.5); 0.000(34.8); -0.006(1.4) Example Ic-187: H-NMR(601.6 MHz, DMSO-d ): δ= 9.360(4.3); 8.842(6.0); 8.833(0.4); 8.589(6.5); 8.321(0.4); 7.805(0.5); 7.790(1.8); 7.786(2.2); 7.776(2.0); 7.772(2.7); 7.762(4.5); 7.758(3.0); 7.569(3.8); 7.555(3.4); 3.835(0.7); 3.823(16.0); 3.339(103.5); 3.319(23.1); 3.263(0.6); 2.615(0.7); 2.524(1.2); 2.521(1.5); 2.509(44.6); 2.506(94.0); 2.503(129.1); 2.500(95.8); 2.387(0.7); 1.989(0.4); 1.235(0.6); 1.057(1.3); 1.048(3.9); 1.045(4.2); 1.037(1.9); 0.916(1.8); 0.908(3.9); 0.905(4.4); 0.896(1.4); 0.096(0.4); 0.005(2.4); 0.000(86.7); - 0.006(4.5); -0.019(0.5); -0.100(0.5) Example Ic-188: H-NMR(601.6 MHz, DMSO-d ): δ= 19.967(0.6); 8.835(6.1); 8.674(4.1); 8.574(6.8); 8.321(0.5); 7.759(1.9); 7.755(2.1); 7.745(2.3); 7.742(2.6); 7.671(4.2); 7.667(3.9); 7.538(4.3); 7.524(4.0); 3.820(16.0); 3.339(162.7); 2.615(1.1); 2.524(1.4); 2.521(1.7); 2.518(1.8); 2.509(56.6); 2.506(123.8); 2.503(171.4); 2.500(124.0); 2.497(57.2); 2.387(1.0); 1.371(0.9); 1.366(0.9); 1.357(1.8); 1.349(1.0); 1.343(0.9); 1.335(0.5); 1.234(0.6); 0.715(1.4); 0.703(4.2); 0.696(1.7); 0.600(1.8); 0.593(4.0); 0.590(4.2); 0.581(1.4); 0.396(1.0); 0.389(2.7); 0.386(2.9); 0.379(1.4); 0.375(2.8); 0.372(2.8); 0.365(1.1); 0.242(1.1); 0.233(3.4); 0.224(3.3); 0.217(1.0); 0.097(0.7); 0.005(4.0); 0.000(121.0); -0.006(4.2); -0.100(0.4) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ic-189: H-NMR(400.0 MHz, DMSO-d ): δ= 8.848(5.3); 8.835(1.8); 8.825(1.7); 8.601(5.4); 8.128(0.4); 8.107(7.5); 8.082(0.4); 8.053(3.7); 4.056(0.7); 4.038(2.2); 4.021(2.2); 4.003(0.8); 3.823(12.8); 3.326(36.5); 2.867(0.5); 2.858(0.8); 2.849(1.2); 2.840(1.2); 2.831(0.9); 2.821(0.8); 2.806(16.0); 2.672(0.4); 2.507(40.5); 2.503(50.7); 2.498(38.5); 2.330(0.3); 1.989(9.1); 1.193(2.4); 1.176(4.8); 1.158(2.4); 0.772(0.7); 0.754(2.7); 0.742(2.6); 0.737(2.2); 0.725(0.9); 0.619(1.0); 0.608(2.9); 0.602(2.9); 0.593(2.3); 0.581(0.7); 0.008(2.5); 0.000(38.0) Example Ic-190: H-NMR(400.0 MHz, DMSO-d ): δ= 8.973(1.4); 8.687(1.7); 8.673(0.6); 7.994(0.8); 7.990(0.8); 7.979(1.2); 7.958(0.3); 7.849(0.9); 7.846(0.9); 4.056(1.4); 4.039(4.0); 4.021(4.1); 4.003(1.4); 3.830(3.5); 3.374(4.0); 3.324(6.0); 2.791(0.3); 2.507(6.6); 2.503(8.7); 2.498(6.7); 1.989(16.0); 1.398(0.5); 1.194(4.4); 1.176(8.5); 1.158(4.4); 0.709(0.5); 0.704(0.7); 0.692(0.7); 0.686(0.6); 0.590(0.8); 0.582(0.8); 0.575(0.6); 0.007(0.5); 0.000(7.4) Example Ic-191: H-NMR(601.6 MHz, DMSO-d ): δ= 9.410(3.9); 8.303(5.0); 7.660(1.5); 7.656(1.6); 7.646(1.9); 7.642(2.2); 7.616(3.7); 7.612(2.9); 7.554(3.6); 7.540(2.9); 5.759(16.0); 5.492(4.7); 3.842(13.0); 3.340(32.5); 2.892(0.8); 2.732(0.7); 2.521(0.9); 2.509(20.9); 2.506(40.9); 2.503(52.9); 2.500(37.6); 2.497(17.5); 1.605(1.4); 1.596(3.3); 1.592(3.5); 1.583(1.4); 1.284(1.5); 1.275(3.2); 1.270(3.4); 1.261(1.3); 0.000(58.8); -0.006(2.5) Example Ic-192: H-NMR(601.6 MHz, DMSO-d ): δ= 19.977(0.6); 8.512(2.3); 8.504(2.4); 8.321(0.4); 8.280(6.1); 7.952(1.0); 7.603(1.6); 7.600(2.0); 7.590(2.0); 7.586(2.7); 7.561(4.3); 7.558(3.5); 7.509(4.4); 7.495(3.4); 5.463(5.8); 4.034(1.0); 4.022(1.0); 3.842(16.0); 3.340(145.6); 2.891(6.5); 2.842(0.6); 2.836(0.9); 2.830(1.4); 2.823(1.3); 2.817(0.9); 2.811(0.7); 2.731(5.8); 2.614(0.8); 2.521(1.5); 2.518(1.6); 2.506(100.8); 2.503(140.1); 2.500(105.3); 2.387(0.9); 1.990(4.3); 1.187(1.1); 1.175(2.2); 1.163(1.1); 0.723(0.8); 0.715(2.5); 0.712(3.4); 0.703(3.2); 0.700(2.7); 0.692(1.0); 0.544(1.0); 0.536(3.2); 0.532(3.0); 0.526(2.9); 0.518(0.9); 0.096(0.4); 0.005(3.5); 0.000(99.9); -0.006(4.1); -0.100(0.4) Example Ic-193: H-NMR(400.0 MHz, DMSO-d ): δ= 9.007(2.3); 8.987(2.3); 8.842(6.1); 8.584(6.6); 7.795(1.7); 7.790(2.0); 7.775(2.0); 7.769(2.6); 7.743(4.2); 7.738(3.5); 7.570(3.9); 7.549(3.3); 4.814(0.8); 4.808(0.9); 4.794(1.2); 4.791(1.2); 4.777(0.9); 4.772(0.8); 3.822(16.0); 3.326(108.0); 3.228(3.8); 3.222(4.0); 3.128(0.5); 3.123(0.5); 2.671(0.7); 2.506(75.4); 2.502(101.5); 2.498(81.0); 2.329(0.7); 2.324(0.6); 2.054(0.3); 2.035(0.6); BCS 13-3006 Foreign Countries THS/mr 201420 2.017(0.4); 1.405(8.6); 1.388(8.6); 1.359(0.3); 1.258(1.7); 1.234(9.3); 0.869(0.4); 0.854(1.1); 0.836(0.5); 0.000(7.1) Example Ic-194: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.312(5.7); 8.260(5.4); 8.201(0.3); 7.765(3.1); 7.759(4.1); 7.732(2.2); 7.726(1.6); 7.711(2.4); 7.705(2.2); 7.584(0.6); 7.568(1.5); 7.526(3.8); 7.505(3.1); 6.822(0.3); 4.085(0.5); 4.068(1.4); 4.050(1.4); 4.032(0.5); 3.960(1.1); 3.805(16.0); 3.753(0.4); 2.135(117.2); 2.120(1.8); 2.113(1.9); 2.107(2.2); 2.101(1.5); 2.095(0.8); 1.972(6.8); 1.964(9.3); 1.958(22.9); 1.952(133.4); 1.946(243.9); 1.940(330.1); 1.934(228.3); 1.928(118.5); 1.781(0.8); 1.774(1.4); 1.768(1.9); 1.762(1.4); 1.756(0.7); 1.604(1.7); 1.590(4.3); 1.583(4.3); 1.569(2.2); 1.437(1.6); 1.366(2.2); 1.352(4.1); 1.345(4.4); 1.331(1.7); 1.222(1.7); 1.204(3.3); 1.186(1.6); 0.146(2.1); 0.008(14.0); 0.000(456.7); -0.009(17.3); - 0.150(2.0) Example Ic-196: H-NMR(400.0 MHz, DMSO-d ): δ= 8.952(6.2); 8.677(6.9); 8.592(2.3); 8.582(2.5); 7.957(1.5); 7.936(2.1); 7.845(3.7); 7.824(3.4); 7.803(2.5); 4.056(1.2); 4.039(3.6); 4.021(3.7); 4.003(1.3); 3.848(0.6); 3.833(16.0); 3.326(18.9); 2.833(0.6); 2.823(0.9); 2.814(1.4); 2.805(1.5); 2.796(1.0); 2.787(0.7); 2.507(22.6); 2.503(30.2); 2.498(23.6); 1.989(15.2); 1.193(4.1); 1.176(8.1); 1.158(4.1); 0.731(0.9); 0.718(2.6); 0.713(3.6); 0.701(3.5); 0.695(2.9); 0.684(1.2); 0.538(1.1); 0.528(3.4); 0.521(3.4); 0.518(3.3); 0.512(3.2); 0.500(1.0); 0.000(1.7) Example Ic-197: H-NMR(600.1 MHz, DMSO-d ): δ= 9.207(0.5); 8.978(6.0); 8.695(6.6); 7.986(1.5); 7.983(1.5); 7.972(2.6); 7.969(2.7); 7.934(4.4); 7.920(2.7); 7.800(3.9); 7.797(3.8); 7.713(0.9); 7.6044(0.9); 7.6035(0.9); 7.190(2.8); 7.185(2.9); 4.048(0.6); 4.036(1.7); 4.024(1.7); 4.012(0.6); 3.840(16.0); 3.740(2.6); 3.649(0.7); 3.637(1.0); 3.627(1.0); 3.615(0.8); 3.323(104.6); 3.311(1.6); 3.300(1.1); 3.289(0.8); 3.162(0.5); 3.150(0.8); 3.137(1.3); 3.125(1.2); 3.114(0.6); 3.102(1.0); 3.089(1.2); 3.077(0.8); 3.065(0.5); 2.615(0.4); 2.524(0.6); 2.521(0.7); 2.517(0.7); 2.508(20.7); 2.506(43.5); 2.503(59.4); 2.500(43.2); 2.497(20.5); 2.386(0.4); 2.210(0.8); 2.205(1.1); 2.200(1.0); 2.194(0.9); 2.183(0.4); 2.179(0.6); 1.989(7.5); 1.259(0.6); 1.236(8.3); 1.187(2.2); 1.180(4.2); 1.175(4.7); 1.169(8.6); 1.164(2.8); 1.157(4.0); 1.057(4.0); 1.045(8.4); 1.033(3.9); 0.866(0.5); 0.854(1.2); 0.842(0.6); 0.561(0.6); 0.558(0.7); 0.549(1.4); 0.546(1.7); 0.542(1.1); 0.537(2.1); 0.523(1.6); 0.449(0.4); 0.440(0.6); 0.437(0.8); 0.429(0.9); 0.425(0.9); 0.422(0.7); 0.415(0.8); 0.410(0.4); 0.352(0.4); 0.345(0.7); 0.338(1.0); 0.332(1.0); 0.324(0.9); 0.318(0.5); 0.000(9.1); -0.006(0.3) Example Ic-198: H-NMR(400.0 MHz, DMSO-d ): BCS 13-3006 Foreign Countries THS/mr 201420 δ= 8.916(2.2); 8.896(2.2); 8.838(6.3); 8.584(6.8); 8.317(0.3); 7.783(1.7); 7.778(2.0); 7.763(1.9); 7.757(2.8); 7.733(4.1); 7.728(3.2); 7.557(3.9); 7.536(3.3); 4.791(0.6); 4.786(0.6); 4.772(0.9); 4.769(0.9); 4.755(0.6); 4.749(0.6); 3.823(16.0); 3.327(108.6); 2.676(0.6); 2.671(0.8); 2.667(0.6); 2.506(85.8); 2.502(113.4); 2.498(85.7); 2.333(0.5); 2.329(0.7); 2.324(0.6); 2.104(0.6); 1.795(10.5); 1.789(10.6); 1.374(8.0); 1.356(8.0); 1.243(0.6); 1.235(0.7); 1.227(0.6); 0.008(1.1); 0.000(29.4); - 0.008(1.4) Example Ic-200: H-NMR(400.0 MHz, DMSO-d ): δ= 8.827(6.2); 8.662(4.1); 8.571(6.6); 7.759(1.8); 7.753(2.0); 7.738(2.1); 7.732(2.5); 7.692(4.2); 7.687(3.6); 7.535(4.1); 7.514(3.5); 5.757(2.1); 3.819(15.5); 3.327(61.1); 2.671(0.4); 2.667(0.3); 2.507(51.0); 2.502(67.0); 2.498(51.1); 2.333(0.3); 2.329(0.4); 2.325(0.3); 1.405(16.0); 1.235(0.6); 0.764(1.2); 0.747(4.3); 0.736(1.7); 0.620(1.9); 0.609(4.4); 0.605(4.5); 0.592(1.4); 0.000(2.3) Example Ic-203: H-NMR(400.0 MHz, DMSO-d ): δ= 9.514(4.5); 8.974(6.1); 8.689(6.7); 8.023(1.6); 8.002(2.1); 7.900(3.7); 7.885(3.4); 7.864(2.5); 4.062(0.5); 4.044(1.6); 4.027(1.6); 4.009(0.6); 3.835(16.0); 3.337(104.4); 2.678(0.5); 2.513(60.3); 2.509(77.5); 2.505(58.9); 2.340(0.4); 2.336(0.5); 1.996(6.6); 1.626(1.6); 1.611(4.0); 1.605(4.2); 1.591(1.7); 1.266(1.9); 1.252(4.1); 1.246(4.5); 1.231(1.6); 1.199(1.8); 1.182(3.5); 1.164(1.8) Example Ic-204: H-NMR(400.0 MHz, DMSO-d ): δ= 8.858(5.3); 8.801(1.4); 8.600(5.7); 8.535(1.4); 7.891(1.1); 7.854(0.6); 7.831(3.6); 7.826(4.4); 7.821(4.3); 7.814(3.4); 7.676(0.8); 7.655(0.7); 7.617(3.1); 7.606(1.0); 7.595(2.5); 4.056(1.2); 4.038(3.5); 4.021(3.5); 4.003(1.3); 3.827(16.0); 3.327(83.4); 3.191(0.7); 3.175(0.8); 3.058(0.8); 3.042(0.6); 2.677(0.4); 2.672(0.6); 2.668(0.4); 2.525(1.4); 2.512(29.9); 2.507(62.0); 2.503(84.7); 2.498(66.2); 2.494(36.1); 2.334(0.4); 2.330(0.6); 2.325(0.4); 1.989(15.1); 1.826(0.4); 1.806(0.8); 1.788(0.9); 1.747(1.8); 1.735(1.8); 1.714(1.1); 1.694(1.7); 1.676(2.7); 1.657(2.8); 1.639(1.6); 1.621(0.6); 1.583(0.8); 1.569(0.8); 1.398(1.3); 1.235(0.4); 1.193(4.1); 1.176(8.1); 1.158(4.0); 1.022(1.1); 1.004(2.1); 0.986(1.1); 0.813(3.9); 0.794(7.9); 0.776(3.6); 0.146(0.6); 0.008(4.6); 0.000(124.5); -0.008(8.8); -0.150(0.6) Example Ic-205: H-NMR(400.0 MHz, DMSO-d ): δ= 8.801(6.3); 8.544(6.9); 7.954(2.7); 7.949(2.9); 7.860(2.0); 7.855(1.8); 7.839(2.3); 7.834(2.3); 7.630(4.2); 7.609(3.6); 4.056(0.5); 4.038(1.6); 4.020(1.6); 4.003(0.6); 3.816(16.0); 3.323(61.4); 2.835(0.7); 2.818(1.9); 2.801(1.9); 2.784(0.8); 2.675(0.4); 2.671(0.5); 2.667(0.4); 2.511(27.8); 2.507(55.4); 2.502(73.8); 2.498(55.9); 2.333(0.4); 2.329(0.5); 2.324(0.4); 1.989(6.9); 1.843(2.0); 1.581(0.9); 1.236(0.3); 1.193(1.8); 1.175(3.6); 1.157(1.8); 1.058(4.6); 1.040(9.7); 1.022(4.5); BCS 13-3006 Foreign Countries THS/mr 201420 1.005(0.4); 0.986(0.6); 0.146(0.3); 0.008(2.8); 0.000(71.2); -0.008(3.9); -0.150(0.3) Example Ic-206: H-NMR(400.0 MHz, DMSO-d ): δ= 8.835(0.7); 8.580(0.7); 7.832(0.7); 7.617(0.4); 3.823(2.9); 3.323(14.6); 2.525(0.4); 2.511(8.0); 2.507(15.6); 2.502(20.3); 2.498(14.9); 2.494(7.6); 1.689(0.5); 1.398(16.0); 0.008(0.8); 0.000(20.3); - 0.009(1.0) Example Ic-207: H-NMR(400.0 MHz, DMSO-d ): δ= 8.838(6.2); 8.577(6.7); 8.423(2.0); 8.402(2.0); 8.316(0.3); 7.773(1.7); 7.767(1.9); 7.752(2.0); 7.747(2.4); 7.700(4.1); 7.695(3.5); 7.556(3.9); 7.535(3.2); 3.822(16.0); 3.540(0.7); 3.521(1.3); 3.504(1.3); 3.484(0.7); 3.322(69.5); 2.671(1.0); 2.506(113.3); 2.502(143.2); 2.498(107.4); 2.332(0.7); 2.329(0.9); 1.223(8.6); 1.206(8.4); 0.957(0.4); 0.949(0.6); 0.937(1.2); 0.930(0.8); 0.925(0.9); 0.917(1.2); 0.905(0.7); 0.897(0.5); 0.469(0.4); 0.460(1.0); 0.452(0.9); 0.447(1.1); 0.438(1.3); 0.426(0.7); 0.416(1.0); 0.404(0.9); 0.392(1.0); 0.384(1.2); 0.371(1.5); 0.360(1.2); 0.350(1.6); 0.338(1.5); 0.327(1.1); 0.314(0.4); 0.289(0.6); 0.277(1.1); 0.267(1.4); 0.255(1.1); 0.245(0.7); 0.146(0.6); 0.000(120.2); -0.150(0.6) Example Ic-208: H-NMR(400.0 MHz, DMSO-d ): δ= 8.858(3.7); 8.826(0.3); 8.804(0.8); 8.601(3.9); 8.572(0.4); 8.539(0.8); 7.907(0.6); 7.840(3.2); 7.834(2.3); 7.813(1.6); 7.808(1.2); 7.673(0.5); 7.652(0.4); 7.623(2.2); 7.602(1.8); 4.056(1.2); 4.038(3.7); 4.020(3.7); 4.003(1.3); 3.825(13.4); 3.639(0.5); 3.327(64.3); 3.255(0.5); 3.251(0.5); 3.244(0.5); 3.184(0.4); 3.171(0.5); 2.676(0.3); 2.672(0.4); 2.667(0.3); 2.525(1.1); 2.512(24.7); 2.507(50.0); 2.503(66.9); 2.498(49.5); 2.494(24.6); 2.399(0.7); 2.329(0.4); 1.989(16.0); 1.741(1.8); 1.541(0.5); 1.482(0.4); 1.422(0.6); 1.398(0.6); 1.355(0.8); 1.337(1.4); 1.320(0.7); 1.226(2.4); 1.208(4.9); 1.193(5.8); 1.175(8.7); 1.158(4.4); 1.140(0.4); 0.146(0.5); 0.008(3.7); 0.000(100.2); - 0.009(4.3); -0.019(0.4); -0.150(0.5) Example Ic-209: H-NMR(400.0 MHz, DMSO-d ): δ= 10.636(4.3); 8.860(6.2); 8.619(6.9); 8.316(0.9); 7.988(3.8); 7.982(4.2); 7.860(1.9); 7.855(1.8); 7.839(2.3); 7.834(2.3); 7.780(2.6); 7.768(2.9); 7.763(1.9); 7.758(3.1); 7.750(1.3); 7.745(2.9); 7.646(4.2); 7.625(3.6); 7.234(2.8); 7.229(1.1); 7.212(5.1); 7.195(1.0); 7.190(2.7); 3.854(0.3); 3.829(16.0); 3.568(0.5); 3.322(169.4); 2.675(1.3); 2.671(1.8); 2.666(1.4); 2.524(4.5); 2.510(96.1); 2.506(197.9); 2.502(268.1); 2.497(204.6); 2.493(108.0); 2.333(1.3); 2.328(1.8); 2.324(1.3); 1.672(0.4); 1.234(0.6); 0.146(1.1); 0.008(8.7); 0.000(241.9); -0.008(13.3); -0.150(1.1) Example Ic-210: H-NMR(400.0 MHz, DMSO-d ): BCS 13-3006 Foreign Countries THS/mr 201420 δ= 8.822(6.3); 8.657(4.3); 8.576(0.4); 8.564(6.8); 8.316(0.5); 7.759(1.9); 7.754(2.0); 7.738(2.2); 7.733(2.5); 7.654(4.1); 7.649(3.9); 7.539(4.3); 7.518(3.6); 7.269(0.3); 7.250(0.9); 7.231(0.8); 7.182(1.0); 7.164(0.8); 7.143(0.4); 3.817(16.0); 3.322(100.0); 2.696(0.8); 2.675(2.1); 2.655(1.1); 2.633(0.4); 2.524(2.1); 2.510(52.8); 2.506(107.9); 2.502(145.2); 2.497(111.4); 2.333(0.7); 2.328(1.0); 2.324(0.7); 2.300(4.0); 1.989(0.6); 1.918(0.4); 1.890(1.4); 1.870(2.0); 1.854(1.0); 1.845(0.7); 1.833(0.6); 1.808(1.4); 1.783(1.9); 1.766(2.4); 1.752(1.8); 1.744(1.4); 1.729(0.5); 1.720(1.0); 1.697(0.6); 1.667(0.8); 1.653(1.3); 1.632(0.8); 1.625(0.6); 1.398(0.6); 1.234(3.7); 1.175(0.4); 0.854(0.6); 0.727(0.6); 0.704(5.0); 0.679(4.8); 0.656(0.7); 0.146(0.6); 0.008(4.9); 0.000(138.6); - 0.008(8.8); -0.150(0.7) Example Id-1: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.969(0.6); 7.962(4.0); 7.957(2.5); 7.946(3.0); 7.938(2.1); 7.577(1.0); 7.565(2.7); 7.557(0.6); 7.549(0.6); 7.542(2.3); 7.040(3.0); 7.033(2.9); 3.771(11.0); 2.132(64.2); 2.119(0.8); 2.113(0.9); 2.107(1.1); 2.101(0.8); 2.095(0.4); 1.964(9.7); 1.958(15.9); 1.952(71.5); 1.946(125.4); 1.940(163.3); 1.933(110.9); 1.927(56.4); 1.914(0.8); 1.780(0.4); 1.774(0.7); 1.768(1.0); 1.762(0.7); 1.756(0.3); 1.594(1.1); 1.579(2.8); 1.572(2.7); 1.559(1.5); 1.437(16.0); 1.372(0.6); 1.367(1.6); 1.353(2.7); 1.346(2.9); 1.332(1.2); 1.277(0.6); 1.135(1.3); 0.146(0.7); 0.008(6.3); 0.000(168.8); -0.009(5.4); - 0.150(0.7) Example Id-2: H-NMR(400.0 MHz, acetonitrile-d ): δ= 7.937(3.0); 7.930(3.0); 7.919(2.4); 7.914(7.2); 7.908(0.8); 7.893(2.6); 7.888(1.7); 7.526(2.8); 7.506(2.6); 7.026(4.1); 7.019(4.0); 6.923(0.9); 5.447(2.7); 4.085(0.6); 4.068(1.7); 4.050(1.8); 4.032(0.6); 3.770(16.0); 2.867(0.7); 2.858(1.0); 2.849(1.5); 2.840(1.5); 2.831(1.0); 2.822(0.7); 2.609(1.4); 2.135(16.5); 1.971(7.8); 1.964(2.4); 1.958(3.9); 1.952(17.6); 1.946(31.0); 1.940(40.5); 1.934(27.6); 1.927(14.2); 1.437(4.7); 1.270(0.5); 1.221(2.0); 1.204(4.0); 1.186(2.0); 1.135(13.3); 0.792(0.8); 0.780(2.4); 0.774(3.2); 0.762(3.3); 0.757(2.4); 0.744(1.1); 0.611(1.1); 0.600(2.8); 0.594(2.9); 0.590(2.5); 0.585(2.5); 0.572(0.8); 0.008(1.6); 0.000(41.8); -0.009(1.5) Example Ie-1: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.652(4.8); 8.189(8.6); 8.170(2.7); 8.165(1.7); 7.625(3.1); 7.622(2.7); 7.606(2.1); 7.603(2.6); 7.347(0.4); 6.877(0.3); 6.872(0.7); 4.068(0.5); 4.050(0.5); 3.813(16.0); 2.727(0.3); 2.131(44.1); 2.119(0.8); 2.113(1.0); 2.107(1.1); 2.101(0.8); 2.095(0.5); 1.971(3.2); 1.964(10.3); 1.958(17.6); 1.952(79.9); 1.946(140.5); 1.940(183.6); 1.933(124.7); 1.927(63.7); 1.780(0.4); 1.774(0.8); 1.768(1.1); 1.762(0.7); 1.756(0.4); 1.590(1.6); 1.576(4.0); 1.569(3.9); 1.555(2.1); 1.543(0.5); 1.437(3.4); 1.380(2.2); 1.367(3.9); 1.360(4.0); 1.345(1.6); 1.312(0.5); 1.306(0.5); 1.222(0.6); 1.204(1.2); 1.186(0.6); 0.146(1.1); 0.008(10.0); 0.000(243.3); -0.009(8.3); -0.150(1.1) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ie-2: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.645(4.8); 8.148(2.7); 8.144(4.8); 8.140(4.0); 8.134(1.4); 8.119(2.7); 8.114(1.9); 7.691(0.3); 7.587(3.2); 7.586(3.1); 7.566(2.8); 7.565(2.9); 6.966(1.0); 6.838(0.7); 4.068(0.3); 3.811(16.0); 2.867(0.8); 2.858(1.1); 2.849(1.7); 2.840(1.7); 2.831(1.1); 2.822(0.8); 2.812(0.4); 2.132(52.6); 2.113(1.6); 2.107(1.5); 2.101(1.1); 2.095(0.6); 1.971(3.9); 1.964(14.4); 1.958(25.4); 1.952(99.3); 1.946(172.4); 1.940(222.3); 1.933(152.6); 1.927(78.9); 1.780(0.5); 1.774(1.0); 1.768(1.2); 1.762(0.9); 1.756(0.4); 1.437(1.1); 1.222(0.4); 1.204(0.8); 1.196(0.3); 1.186(0.4); 1.178(0.5); 1.135(1.1); 0.793(0.9); 0.781(2.7); 0.776(3.5); 0.763(3.8); 0.758(2.7); 0.746(1.5); 0.728(0.4); 0.724(0.3); 0.618(1.3); 0.606(3.1); 0.600(3.3); 0.596(2.9); 0.591(2.8); 0.578(0.9); 0.556(0.4); 0.146(1.2); 0.008(14.7); 0.000(291.0); -0.009(14.1); -0.150(1.2) Example Ie-3: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.651(5.0); 8.520(3.2); 8.275(1.8); 8.256(1.8); 7.889(1.6); 7.869(1.8); 7.609(1.8); 7.590(3.2); 7.571(1.5); 7.209(0.8); 3.823(16.0); 2.888(0.6); 2.879(0.9); 2.870(1.3); 2.861(1.3); 2.852(0.9); 2.842(0.6); 2.135(28.8); 2.113(0.3); 2.107(0.4); 1.972(1.2); 1.964(3.8); 1.958(6.2); 1.952(26.3); 1.946(45.9); 1.940(59.5); 1.934(40.7); 1.927(20.9); 1.768(0.3); 1.320(0.3); 1.204(0.4); 0.784(0.7); 0.772(2.1); 0.766(2.9); 0.754(2.9); 0.748(2.2); 0.737(1.0); 0.645(1.1); 0.634(2.9); 0.627(2.8); 0.618(2.2); 0.606(0.7); 0.008(2.9); 0.000(61.7); -0.008(2.4) Example Ie-4: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.652(2.7); 8.562(1.0); 8.558(1.8); 8.298(1.0); 8.279(1.0); 7.934(0.8); 7.914(1.0); 7.738(0.4); 7.634(1.0); 7.614(1.7); 7.595(0.8); 7.292(1.0); 7.289(1.1); 7.280(1.1); 7.277(1.2); 7.053(0.9); 7.045(1.1); 6.978(1.1); 6.969(1.0); 6.965(1.1); 6.956(0.8); 4.739(2.7); 4.724(2.7); 3.822(8.6); 2.134(24.0); 2.132(32.1); 2.113(0.4); 2.107(0.5); 2.101(0.3); 1.964(3.8); 1.958(6.4); 1.952(27.1); 1.946(47.3); 1.940(62.1); 1.933(42.8); 1.927(22.3); 1.768(0.4); 1.437(16.0); 0.008(2.9); 0.000(66.1); - 0.008(3.0) Example Ie-5: H-NMR(400.0 MHz, acetonitrile-d ): δ= 9.121(1.3); 8.734(2.8); 8.728(2.8); 8.706(2.0); 8.702(3.4); 8.698(2.0); 8.681(4.9); 8.375(1.8); 8.372(1.3); 8.355(1.9); 8.352(1.3); 8.234(1.9); 8.227(1.9); 8.212(2.0); 8.205(1.9); 8.084(1.2); 8.081(1.5); 8.077(1.2); 8.065(1.3); 8.061(1.7); 8.058(1.3); 7.711(1.8); 7.692(3.2); 7.672(1.5); 7.422(3.2); 7.401(2.9); 5.447(6.3); 3.837(16.0); 3.249(0.4); 2.136(132.2); 2.120(1.0); 2.113(1.1); 2.107(1.3); 2.101(1.0); 2.095(0.5); 1.964(12.5); 1.958(20.8); 1.952(85.5); 1.946(150.6); 1.940(195.4); 1.934(132.9); 1.927(67.6); 1.780(0.5); 1.774(0.8); 1.768(1.1); 1.762(0.8); 1.756(0.4); 1.437(1.0); 1.372(0.7); 1.277(1.0); 1.270(0.7); 0.146(0.9); 0.008(8.9); 0.000(195.9); -0.009(7.6); -0.150(0.9) BCS 13-3006 Foreign Countries THS/mr 201420 Example Ie-6: H-NMR (400.0 MHz, CDCl ): δ= 8.667(5.3); 8.604(1.9); 8.600(3.4); 8.596(1.9); 8.311(1.8); 8.292(1.9); 8.144(0.7); 8.084(0.6); 7.970(1.2); 7.967(1.6); 7.963(1.2); 7.950(1.4); 7.947(1.8); 7.817(1.6); 7.648(1.8); 7.629(3.2); 7.609(1.5); 5.448(6.9); 4.068(0.6); 4.050(0.6); 3.829(16.0); 2.888(1.3); 2.770(1.2); 2.726(0.4); 2.158(26.7); 1.972(3.4); 1.964(6.0); 1.958(4.0); 1.953(14.1); 1.946(21.9); 1.940(27.7); 1.934(18.8); 1.928(9.6); 1.436(0.6); 1.372(1.9); 1.361(4.7); 1.352(4.5); 1.341(1.7); 1.221(0.7); 1.204(1.3); 1.186(0.7); 0.008(1.0); 0.000(25.7); -0.009(1.0) Example Ie-7: H-NMR(400.0 MHz, acetonitrile-d ): δ= 8.667(2.7); 8.555(1.9); 8.331(1.0); 8.315(0.8); 8.312(1.1); 7.952(0.8); 7.943(1.0); 7.941(1.2); 7.924(0.9); 7.921(1.1); 7.920(1.1); 7.653(1.0); 7.634(1.7); 7.614(0.8); 3.828(9.1); 2.167(64.5); 1.972(1.0); 1.965(3.2); 1.959(5.5); 1.953(22.7); 1.947(39.7); 1.940(51.6); 1.934(35.6); 1.928(18.4); 1.575(0.9); 1.561(2.3); 1.553(2.3); 1.540(1.2); 1.437(16.0); 1.376(1.2); 1.363(2.3); 1.356(2.3); 1.341(0.9); 0.008(2.2); 0.000(49.3); -0.009(2.3) Preparation of the starting materials All starting materials employed can either be prepared by or analogously to processes known from the literature or are commercially available. Thus, for example, 5-fluoromethyl(pentafluoroethyl) (trifluoromethyl)-1H-pyrazole can be prepared by a method known from the literature [Russian Chemical Bulletin 1990, 39, 11, 2338 – 2344]. [4-Chloro(methoxycarbonyl)phenyl]boronic acid, for example, is commercially available.
Preparation of 2-chloro-N-cyclopropyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)benzamide 75.0 g (318 mmol) of 5-bromochlorobenzoic acid are dissolved in 1.50 l of dimethylformamide, and 156 g (1.59 mol) of potassium acetate are added. The reaction mixture is degassed, 26.0 g (31.8 mmol) of 1,1'-bis(diphenylphosphine)ferrocenepalladium(II) dichloride dichloromethane are then added and the mixture is degassed again. The mixture is then heated at 80°C for 30 minutes and cooled back to room temperature. 121 g (477 mmol) of bis(pinacolato)diboron are then added, and the reaction mixture is BCS 13-3006 Foreign Countries THS/mr 201420 stirred at 80°C for 4 h. After cooling to room temperature, the solvent is distilled off under reduced pressure. The residue is taken up in 500 ml of 2M aqueous sodium hydroxide solution. The aqueous phase is washed three times with in each case 500 ml of ethyl acetate. The aqueous phase is acidified with 2M hydrochloric acid, the resulting precipitated solid is filtered off and dried under reduced pressure.
This gives 70.0 g of 2-chloro(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)benzoic acid in the form of a grey solid. This can be reacted further without any further purification.
H-NMR (400 MHz, d -dimethyl sulphoxide): δ = 8.05 (d, 1H), 7.76 (dd, 1H), 7.56 (d, 1H), 1.30 (s, 12H) ppm. 25.0 g (88.5 mmol) of 2-chloro(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)benzoic acid are dissolved in 850 ml of dimethylformamide, and 33.7 g (88.5 mmol) of HATU (1- [bis(dimethylamino)methylene]-1H-1,2,3-triazol[4,5-b]pyridinium 3-oxide hexafluorophosphate) are then added. The reaction is stirred at room temperature for 15 minutes. 35.4 ml (199 mmol) of N-ethyl- diisopropylamine and 7.50 ml (106 mmol) of cyclopropylamine are added to the reaction solution. After 16 h at room temperature, the solvent is distilled off under reduced pressure. The residue is taken up in water, and the product is subsequently extracted three times with in each case 500 ml of ethyl acetate.
The combined organic phases are dried over sodium sulphate and filtered, and the solvent is removed under reduced pressure. The crude product is purified by column chromatography on silica gel.
This gives 16.6 g of 2-chloro-N-cyclopropyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)benzamide as a colourless solid.
H-NMR (400 MHz, d -dimethyl sulphoxide): δ = 8.50 (d, 1H), 7.66 (dd, 1H), 7.58 (d, 1H), 7.50 (d, 1H), 2.77-2.83 (m, 1H), 1.29 (s, 12H), 0.66-0.71 (m, 2H), 0.51-0.55 (m, 2H) ppm.
Preparation of 5-chloromethylnitro(pentafluoroethyl)-1H-pyrazole A little at a time, 3.80 g (purity 70%, 13.2 mmol) of 1-methyl(pentafluoroethyl)-1H-pyrazole [European Journal of Organic Chemistry 2002, 17, 2913-2920] are added to a mixture, heated to 70°C, BCS 13-3006 Foreign Countries THS/mr 201420 of 5.79 ml of conc. nitric acid (fuming) and 15.7 ml of conc. sulphuric acid such that the internal temperature does not exceed 90°C. After the addition, the reaction solution is stirred at an internal temperature of 75°C for a further 2 h. After cooling of the reaction mixture to room temperature, the reaction mixture is poured onto ice. The aqueous phase is extracted twice with in each case 50 ml of ethyl acetate. The combined organic phases are washed with 1N hydrochloric acid and saturated sodium chloride solution. The organic phase is dried over magnesium sulphate, filtered and concentrated on a rotary evaporator under reduced pressure. The crude product is purified by column chromatography on silica gel.
This gives 3.00 g of 1-methylnitro(pentafluoroethyl)-1H-pyrazole.
H-NMR (400 MHz, d -acetonitrile): δ = 8.52 (d, 1H), 3.95 (s, 3H) ppm. a) + HPLC-MS : logP = 2.51, mass (m/z) = 246 [M+H] . 980 mg (3.99 mmol) of 1-methylnitro(pentafluoroethyl)-1H-pyrazole are dissolved in abs. THF, and the solution is cooled to -78°C. 3.00 ml (5.99 mmol) of 2M lithium diisopropylamide solution are added to this solution dropwise, and the mixture is stirred at -78°C for another 30 minutes. In a second flask, 947 mg (3.99 mmol) of hexachloroethane are initially charged dissolved in abs. THF, and the solution is cooled to -78°C. The first solution is slowly added dropwise to the second solution such that the internal temperature does not exceed -70°C. The reaction is stirred at -78°C for another hour. The reaction is quenched by addition of sat. sodium bicarbonate solution. The reaction mixture is warmed to RT. The mixture is repeatedly extracted with ethyl acetate and the combined organic phases are dried over magnesium sulphate, filtered and concentrated on a rotary evaporator at 30 mbar and a water bath temperature of 37°C.
This gives 1.74 g (purity about 25%) of 5-chloromethylnitro(pentafluoroethyl)-1H-pyrazole.
The crude product is reacted further without additional work-up.
Preparation of 1-methyl(methylsulphanyl)(trifluoromethyl)-1H-pyrazolecarboxylic acid Analogously to the preparation of 1-methyl(methylsulphanyl)(pentafluoroethyl)-1H-pyrazole carboxylic acid [WO2013-092522], 1-methyl(methylsulphanyl)(trifluoromethyl)-1H-pyrazole BCS 13-3006 Foreign Countries THS/mr 201420 carboxylic acid was prepared from commercially available 1-methyl(trifluoromethyl)-1H-pyrazole carboxylic acid.
H-NMR (400 MHz, d -DMSO-d ): δ = 4.10 (s, 3H), 2.34 (s, 3H) ppm. a) + HPLC-MS : logP = 1.72, mass (m/z) = 241 [M+H] .
Preparation of 1-methyl(methylsulphanyl)(trifluoromethyl)-1H-pyrazoleamine 600 mg (2.49 mmol) of 1-methyl(trifluoromethyl)-1H-pyrazolecarboxylic acid is dissolved in a mixture of 40 ml of abs. toluene and 357 µl (2.56 mmol) of triethylamine. The solution is cooled to 0°C, and 704 mg (2.56 mmol) of diphenylphosphoryl azide are then added dropwise. The reaction mixture is stirred at an oil bath temperature of 100°C for 16 h. The mixture is cooled to RT and then carefully concentrated to dryness on a rotary evaporator. The residue is taken up in 2 ml of tert-butanol and then heated in a microwave at 120°C for 1 h. The reaction mixture is concentrated to dryness on a rotary evaporator. The residue is taken up in 6 ml of dichloromethane, and 4.35 ml of trifluoroacetic acid are then added. The mixture is stirred at RT for 16 h. The reaction mixture is concentrated on a rotary evaporator. The residue is then taken up in ethyl acetate and washed twice with 1N aqueous sodium hydroxide solution, dried over sodium sulphate, filtered and concentrated on a rotary evaporator.
The crude product is purified by column chromatography on silica gel. This gives 130 mg of 1-methyl- 4-(methylsulphanyl)(trifluoromethyl)-1H-pyrazoleamine.
H-NMR (400 MHz, d -DMSO-d ): δ = 5.90 (s, 2H), 3.60 (s, 3H), 2.10 (s, 3H) ppm. a) + HPLC-MS : logP = 1.66, mass (m/z) = 212 [M+H] .
Preparation of 4-bromo-2'-methyl-4'-(methylsulphinyl)-5'-(trifluoromethyl)-2'H-1,3'-bipyrazole BCS 13-3006 Foreign Countries THS/mr 201420 130 mg (0.61 mmol) of 1-methyl(methylsulphanyl)(trifluoromethyl)-1H-pyrazoleamine are dissolved in 14 ml of abs. acetonitrile and added dropwise to a suspension, heated to 70°C, of 146 µl (1.23 mmol) of tert-butyl nitrite, 99.3 mg (0.73 mmol) copper(II) chloride and 29 ml of abs. acetonitrile.
The reaction mixture is stirred at 70°C for 7 h, cooled to RT and then poured into 75 ml of 1N hydrochloric acid. The crude product is extracted repeatedly with ethyl acetate. The combined organic phases are washed twice with sat. sodium chloride solution, dried over magnesium sulphate, filtered and then concentrated to dryness under reduced pressure on a rotary evaporator.
This gives, as crude product, 219 mg of 5-chloromethyl(methylsulphanyl)(trifluoromethyl)-1H- pyrazole. The crude product was used further without additonal purification.
GC-MS: index = 1212, mass (m/z) = 230. 200 mg (content about 60%, about 0.52 mmol) of 5-chloromethyl(methylsulphanyl) (trifluoromethyl)-1H-pyrazole are dissolved in 5 ml of dichloromethane p.a. and then cooled in an ice bath. 64 mg (content about 70%, 0.26 mmol) of 3-chloroperbenzoic acid are added thereto a little at a time. The reaction is stirred with ice cooling for another 3 h and then diluted with 30 ml of dichloromethane p.a. The organic phase is washed with sat. sodium bicarbonate solution until the org. phase is free of peroxide. The organic phase is then dried over sodium sulphate, filtered and concentrated to dryness on a rotary evaporator under reduced pressure.
This gives, as crude product, 199 mg of 5-chloromethyl(methylsulphinyl)(trifluoromethyl)-1H- pyrazole. The crude product is used in the subsequent reactions without further purification.
GC-MS: index = 1454, mass (m/z) = 246. 199 mg (content about 60%, 0.48 mmol) of 5-chloromethyl(methylsulphinyl)(trifluoromethyl)- 1H-pyrazole and 135 mg (0.88 mmol) of 4-bromo-1H-pyrazole are dissolved in 3 ml of dimethylformamide p.a., and 526 mg (1.61 mmol) of caesium carbonate are then added. The reaction mixture is heated at an oil bath temperature of 100°C until no more starting material can be detected.
The mixture is filtered and diluted with tert-butyl methyl ether. The organic phase is then washed with 1N hydrochloric acid and sat. sodium chloride solution. The organic phase is then dried over sodium sulphate and concentrated on a rotary evaporator under reduced pressure. The crude product is then purified by column chromatography on silica gel.
BCS 13-3006 Foreign Countries THS/mr 201420 This gives 61 mg of 4-bromo-2'-methyl-4'-(methylsulphinyl)-5'-(trifluoromethyl)-2'H-1,3'-bipyrazole.
H-NMR (400 MHz, d -acetonitrile): δ = 8.13 (s, 1H), 7.91 (s, 1H), 3.77 (s, 3H), 2.73 (s, 3H) ppm. a) + HPLC-MS : logP = 1.90, mass (m/z) = 359 [M+H] .
BCS 13-3006 Foreign Countries THS/mr 201420 Biological working examples for applications in the animal health sector I.
A. Amblyomma hebaraeum test (AMBYHE) Solvent: dimethyl sulphoxide To produce a suitable preparation of active compound, 10 mg of active compound are mixed with 0.5 ml of dimethyl sulfoxide, and the concentrate is diluted with water to the desired concentration.
Tick nymphs (Amblyomma hebraeum) are placed into perforated plastic beakers and immersed in the desired concentration for one minute. The ticks are transferred on filter paper into a Petri dish and stored in a climate-controlled cabinet.
After 42 days, the kill in % is determined. 100% means that all of the ticks have been killed; 0% means that none of the ticks have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 ppm: Ia-1, Ia-2, Ib-3, Ic-1, Ic-2, Ic-11, Ic-16, Ic-21, Ic-23, Ic-24, Ic- 27, Ic-34, Ic-36, Ic-37, Ic-47, Ic-49, Ic-83, Ic-84, Ic-85, Ic-87, Ic-91, Ic-94, Ic-95 B. Boophilus microplus - dip test (BOOPMI Dip) Test animals: cattle ticks (Boophilus microplus) Parkhurst strain, SP-resistant Solvent: dimethyl sulphoxide mg of active compound are dissolved in 0.5 ml of dimethyl sulphoxide. For the purpose of preparing a suitable formulation, the active compound solution is diluted with water to the concentration desired in each case.
This active compound preparation is pipetted into tubes. 8-10 adult engorged female cattle ticks (Boophilus microplus) are transferred into a further tube with holes. The tube is immersed into the active compound formulation, and all ticks are completely wetted. After the liquid has run out, the ticks are transferred on filter discs into plastic dishes and stored in a climate-controlled room.
The activity is assessed after 7 days by laying of fertile eggs. Eggs whose fertility is not visible from the outside are stored in a climate-controlled cabinet until the larvae hatch after about 42 days. An efficacy of 100% means that none of the ticks has laid any fertile eggs; 0% means that all eggs are fertile.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 ppm: Ia-1, Ia-2, Ib-2, Ib-3, Ic-1, Ic-2, Ic-11, Ic-16, Ic-21, Ic-23, Ic-24, Ic-27, Ic-34, Ic-36, Ic-37, Ic-47, Ic-49, Ic-65, Ic-66, Ic-77, Ic-78, Ic-81, Ic-83, Ic-84, Ic-85, Ic-86, Ic-87, BCS 13-3006 Foreign Countries THS/mr 201420 Ic-90, Ic-91, Ic-94, Ic-95, Ic-96, Ic-109, Ic-111, Ic-112, Ic-113, Ic-130, Ic-139, Ic-147, Ic-151, Ic-152, Ic-153, Ic-158, Ic-160, Ic-164, Ic-166 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 100 ppm: Ic-97, Ic-103, Ic-175 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 100 ppm: Ic-29, Ic-48, Ic-80, Ic-159 C. Boophilus microplus - injection test (BOOPMI Inj) Solvent: dimethyl sulphoxide To produce a suitable preparation of active compound, 10 mg of active compound are mixed with 0.5 ml of solvent, and the concentrate is diluted with solvent to the desired concentration. 1 µl of the active compound solution is injected into the abdomen of 5 engorged adult female cattle ticks (Boophilus microplus). The animals are transferred into dishes and kept in a climate-controlled room.
The activity is assessed after 7 days by laying of fertile eggs. Eggs whose fertility is not visible from the outside are stored in a climate-controlled cabinet until the larvae hatch after about 42 days. An efficacy of 100% means that none of the ticks has laid any fertile eggs; 0% means that all eggs are fertile.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 20 µg/animal: Ia-1, Ia-2, Ib-2, Ib-3, Ic-1, Ic-2, Ic-3, Ic-4, Ic-6, Ic-7, Ic-8, Ic-10, Ic-11, Ic-12, Ic-13, Ic-14, Ic-16, Ic-17, Ic-18, Ic-19, Ic-20, Ic-21, Ic-22, Ic-23, Ic-24, Ic-25, Ic-27, Ic-28, Ic-29, Ic-32, Ic-33, Ic-34, Ic-36, Ic-37, Ic-38, Ic-39, Ic-40, Ic-41, Ic-42, Ic-43, Ic-44, Ic-46, Ic-47, Ic-48, Ic-49, Ic-53, Ic-54, Ic-55, Ic-56, Ic-58, Ic-59, Ic-60, Ic-61, Ic-62, Ic-63, Ic-64, Ic-65, Ic-66, Ic-67, Ic-68, Ic-70, Ic-71, Ic-72, Ic-73, Ic-74, Ic-75, Ic-76, Ic-77, Ic-78, Ic-80, Ic-81, Ic-83, Ic-84, Ic-85, Ic-86, Ic-87, Ic-88, Ic-89, Ic-90, Ic-91, Ic-92, Ic-94, Ic-95, Ic-96, Ic-97, Ic-99, Ic-103, Ic-106, Ic-136, Ic-137, Ic-139, Ic-140, Ic-147, Ic-149, Ic-150, Ic-151, Ic-152, Ic-153, Ic-154, Ic-157, Ic-158, Ic-159, Ic-160, Ic- 161, Ic-163, Ic-164, Ic-165, Ic-166, Ic-174, Ic-175, Id-1, Id-2, Ie-1 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 20 µg/animal: Ic-156 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 20 µg/animal: Ic-15, Ic-35 D. Ctenocephalides felis - oral test (CTECFE) Solvent: dimethyl sulphoxide BCS 13-3006 Foreign Countries THS/mr 201420 To produce a suitable preparation of active compound, 10 mg of active compound are mixed with 0.5 ml of dimethyl sulphoxide. Dilution with citrated cattle blood gives the desired concentration.
About 20 unfed adult cat fleas (Ctenocephalides felis) are placed into a chamber which is closed at the top and bottom with gauze. A metal cylinder whose bottom end is closed with a parafilm is placed onto the chamber. The cylinder contains the blood/active ingredient preparation, which can be imbibed by the fleas through the parafilm membrane.
After 2 days, the kill in % is determined. 100% means that all of the fleas have been killed; 0% means that none of the fleas have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 ppm: Ia-1, Ia-2, Ib-2, Ib-3, Ic-1, Ic-2, Ic-3, Ic-4, Ic-6, Ic-7, Ic-8, Ic- 11, Ic-12, Ic-13, Ic-16, Ic-18, Ic-19, Ic-20, Ic-21, Ic-22, Ic-23, Ic-24, Ic-27, Ic-28, Ic-29, Ic-31, Ic-32, Ic- 33, Ic-34, Ic-35, Ic-36, Ic-37, Ic-38, Ic-39, Ic-40, Ic-41, Ic-42, Ic-43, Ic-44, Ic-45, Ic-46, Ic-47, Ic-48, Ic- 49, Ic-53, Ic-54, Ic-55, Ic-56, Ic-57, Ic-58, Ic-59, Ic-60, Ic-61, Ic-64, Ic-65, Ic-66, Ic-67, Ic-68, Ic-70, Ic- 71, Ic-73, Ic-74, Ic-75, Ic-76, Ic-77, Ic-78, Ic-80, Ic-81, Ic-83, Ic-84, Ic-85, Ic-86, Ic-87, Ic-90, Ic-91, Ic- 94, Ic-95, Ic-96, Ic-97, Ic-99, Ic-103, Ic-106, Ic-136, Ic-137, Ic-139, Ic-140, Ic-147, Ic-149, Ic-150, Ic- 151, Ic-152, Ic-153, Ic-154, Ic-156, Ic-158, Ic-159, Ic-160, Ic-161, Ic-163, Ic-164, Ic-165, Ic-166, Ic- 174, Ic-175, Id-1, Id-2, Ie-1 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 98% at an application rate of 100 ppm: Ic-10 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 95% at an application rate of 100 ppm: Ic-25, Ic-62, Ic-63 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 100 ppm: Ic-17, Ic-89, Ic-157 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 100 ppm: Ic-92 E. Lucilia cuprina test (LUCICU) Solvent: dimethyl sulphoxide To produce a suitable preparation of active compound, 10 mg of active compound are mixed with 0.5 ml of dimethyl sulphoxide, and the concentrate is diluted with water to the desired concentration.
About 20 L1 larvae of the Australian sheep blowfly (Lucilia cuprina) are transferred into a test vessel containing minced horsemeat and the active compound preparation of the desired concentration.
BCS 13-3006 Foreign Countries THS/mr 201420 After 2 days, the kill in % is determined. 100% means that all of the larvae have been killed; 0% means that none of the larvae have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 ppm: Ia-1, Ia-2, Ib-2, Ib-3, Ic-1, Ic-2, Ic-3, Ic-4, Ic-6, Ic-7, Ic-8, Ic- 10, Ic-11, Ic-12, Ic-13, Ic-14, Ic-16, Ic-17, Ic-18, Ic-19, Ic-20, Ic-21, Ic-22, Ic-23, Ic-24, Ic-25, Ic-27, Ic- 28, Ic-29, Ic-32, Ic-33, Ic-34, Ic-35, Ic-36, Ic-37, Ic-38, Ic-39, Ic-40, Ic-41, Ic-42, Ic-43, Ic-44, Ic-45, Ic- 46, Ic-47, Ic-48, Ic-49, Ic-53, Ic-54, Ic-55, Ic-56, Ic-57, Ic-58, Ic-59, Ic-60, Ic-61, Ic-62, Ic-63, Ic-64, Ic- 65, Ic-66, Ic-67, Ic-68, Ic-70, Ic-71, Ic-73, Ic-74, Ic-75, Ic-76, Ic-77, Ic-78, Ic-80, Ic-81, Ic-83, Ic-84, Ic- 85, Ic-86, Ic-87, Ic-88, Ic-89, Ic-90, Ic-91, Ic-94, Ic-95, Ic-96, Ic-97, Ic-103, Ic-106, Ic-136, Ic-137, Ic- 140, Ic-147, Ic-149, Ic-150, Ic-151, Ic-152, Ic-153, Ic-154, Ic-157, Ic-158, Ic-159, Ic-160, Ic-161, Ic- 163, Ic-164, Ic-165, Ic-166, Ic-174, Ic-175, Id-1 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 95% at an application rate of 100 ppm: Ic-92, Id-2 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 100 ppm: Ic-31 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 100 ppm: Ic-72, Ic-99 F. Musca domestica test (MUSCDO) Solvent: dimethyl sulphoxide To produce a suitable preparation of active compound, 10 mg of active compound are mixed with 0.5 ml of dimethyl sulphoxide, and the concentrate is diluted with water to the desired concentration.
Vessels containing a sponge treated with sugar solution and the active compound preparation of the desired concentration are populated with 10 adult houseflies (Musca domestica).
After 2 days, the kill in % is determined. 100% means that all of the flies have been killed; 0% means that none of the flies have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 ppm: Ib-2, Ib-3, Ic-1, Ic-2, Ic-3, Ic-7, Ic-11, Ic-12, Ic-16, Ic-18, Ic-19, Ic-21, Ic-23, Ic-24, Ic-27, Ic-28, Ic-29, Ic-32, Ic-33, Ic-34, Ic-36, Ic-37, Ic-38, Ic-39, Ic-40, Ic-41, Ic-43, Ic-45, Ic-46, Ic-47, Ic-48, Ic-49, Ic-55, Ic-57, Ic-59, Ic-60, Ic-62, Ic-65, Ic-66, Ic-70, Ic-77, Ic-78, Ic-80, Ic-81, Ic-83, Ic-84, Ic-85, Ic-86, Ic-87, Ic-90, Ic-91, Ic-94, Ic-95, Ic-96, Ic-97, Ic-106, Ic-147, Ic-151, Ic- 152, Ic-153, Ic-159, Ic-160, Ic-166, Ic-174, Ic-175, Id-1 BCS 13-3006 Foreign Countries THS/mr 201420 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 95% at an application rate of 100 ppm: Ic-67 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 100 ppm: Ia-2, Ic-6, Ic-25, Ic-73, Ic-136, Ic-140, Ic-154, Ic-158, Ic-163, Ic-164 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 100 ppm: Ia-1, Ic-44, Ic-58, Ic-61, Ic-64, Ic-68, Ic-71, Ic-76, Ic-103, Ic-161 Biological working examples for applications in the crop protection sector G. Myzus persicae - spray test (MYZUPE) Solvents: 78 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is dissolved using the stated parts by weight of solvent and made up with water comprising an emulsifier concentration of 1000 ppm until the desired concentration is reached. To produce further test concentrations, the preparation is diluted with emulsifier-containing water.
Discs of Chinese cabbage leaves (Brassica pekinensis) infested by all stages of the green peach aphid (Myzus persicae) are sprayed with an active compound preparation of the desired concentration.
After 6 days, the efficacy in % is determined. 100% here means that all of the aphids have been killed; 0% means that no aphids have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 500g/ha: Ic-40, Ic-41, Ic-47, Ic-55, Ic-71, Ic-84, Ic-85, Ic-86, Ic-90, Ic-91, Ic-94, Ic-97, Ic-139, Ic-141, Ic-147, Ic-151, Ic-152, Ic-159, Ic-181, Ic-188 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 500g/ha: Ic-1, Ic-24, Ic-27, Ic-49, Ic-70, Ic-95, Ic-116, Ic-117, Ic-153, Ic-156, Ic-163, Ic-164, Ic-166, Ic-167, Ic-180, Ic-187 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 g/ha: Ic-2, Ic-11, Ic-77, Ic-96, Ic-109, Ic-111, Ic-112, Ic-118, Ic-121, Ic-126, Ic-127, Ic-133, Ic-134, Ic-182, Ic-185, Ic-190 BCS 13-3006 Foreign Countries THS/mr 201420 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 100 g/ha: Ib-2, Ic-28, Ic-34, Ic-36, Ic-48, Ic-65, Ic-66, Ic-78, Ic-79, Ic-80, Ic-81, Ic-87, Ic-108, Ic-113, Ic-115, Ic-122, Ic-129, Ic-132, Ic-147, Ic-186 H. Phaedon cochleariae - spray test (PHAECO) Solvents: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is dissolved using the stated parts by weight of solvent and made up with water comprising an emulsifier concentration of 1000 ppm until the desired concentration is reached. To produce further test concentrations, the preparation is diluted with emulsifier-containing water.
Discs of Chinese cabbage leaves (Brassica pekinensis) are sprayed with an active compound preparation of the desired concentration and, after drying, populated with larvae of the mustard beetle (Phaedon cochleariae).
After 7 days, the efficacy in % is determined. 100% means that all of the beetle larvae have been killed; 0% means that none of the beetle larvae have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 500g/ha: Ic-1, Ic-24, Ic-27, Ic-33, Ic-38, Ic-39, Ic-40, Ic-41, Ic-42, Ic-43, Ic-44, Ic-45, Ic-46, Ic-47, Ic-48, Ic-49, Ic-51, Ic-52, Ic-54, Ic-55, Ic-56, Ic-58, Ic-59, Ic-60, Ic-61, Ic-62, Ic-63, Ic-64, Ic-70, Ic-71, Ic-72, Ic-73, Ic-74, Ic-75, Ic-76, Ic-84, Ic-85, Ic-86, Ic-87, Ic-88, Ic-89, Ic-90, Ic-91, Ic-92, Ic-93, Ic-94, Ic-95, Ic-97, Ic-105, Ic-106, Ic-107, Ic-116, Ic-117, Ic-136, Ic-139, Ic-140, Ic- 141, Ic-142, Ic-147, Ic-149, Ic-150, Ic-151, Ic-152, Ic-153, Ic-154, Ic-156, Ic-157, Ic-159, Ic-161, Ic- 163, Ic-164, Ic-165, Ic-166, Ic-167, Ic-171, Ic-173, Ic-174, Ic-175, Ic-176, Ic-179, Ic-180, Ic-181, Ic- 183, Ic-184, Ic-186, Ic-187, Ic-188, Ic-193, Ic-198, Ic-200 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 83% at an application rate of 500g/ha: Ic-69, Ic-137 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 g/ha: Ia-1, Ia-2, Ib-2, Ib-3, Ic-2, Ic-3, Ic-6, Ic-7, Ic-10, Ic-11, Ic-12, Ic-13, Ic-14, Ic-15, Ic-16, Ic-17, Ic-18, Ic-19, Ic-20, Ic-21, Ic-22, Ic-23, Ic-25, Ic-28, Ic-29, Ic-30, Ic-31, Ic-32, Ic-34, Ic-35, Ic-36, Ic-37, Ic-53, Ic-65, Ic-66, Ic-67, Ic-68, Ic-78, Ic-79, Ic-80, Ic-81, Ic-83, Ic-96, Ic-99, Ic-103, Ic-104, Ic-108, Ic-109, Ic-110, Ic-111, Ic-113, Ic-115, Ic-118, Ic-119, Ic-121, Ic-122, Ic- BCS 13-3006 Foreign Countries THS/mr 201420 124, Ic-125, Ic-126, Ic-127, Ic-128, Ic-129, Ic-130, Ic-131, Ic-132, Ic-133, Ic-134, Ic-168, Ic-169, Ic- 170, Ic-177, Ic-178, Ic-182, Ic-185, Ic-189, Ic-190, Ic-191, Ic-192, Id-1, Id-2, Ie-1, Ie-4, Ie-5 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 83% at an application rate of 100 g/ha: Ib-1, Ic-5, Ic-57, Ic-120, Ic-135 I. Spodoptera frugiperda - spray test (SPODFR) Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is dissolved using the stated parts by weight of solvent and made up with water comprising an emulsifier concentration of 1000 ppm until the desired concentration is reached. To produce further test concentrations, the preparation is diluted with emulsifier-containing water.
Leaf discs of maize (Zea mays) are sprayed with an active compound preparation of the desired concentration and, after drying, populated with caterpillars of the armyworm (Spodoptera frugiperda).
After 7 days, the efficacy in % is determined. 100 % means that all of the caterpillars have been killed; 0 % means that none of the caterpillars have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 500g/ha: Ic-1, Ic-24, Ic-27, Ic-38, Ic-39, Ic-40, Ic-41, Ic-43, Ic-44, Ic-45, Ic-46, Ic-47, Ic-48, Ic-49, Ic-55, Ic-59, Ic-60, Ic-62, Ic-70, Ic-71, Ic-73, Ic-74, Ic-75, Ic-76, Ic-84, Ic-85, Ic-86, Ic-87, Ic-90, Ic-91, Ic-94, Ic-95, Ic-97, Ic-105, Ic-107, Ic-116, Ic-117, Ic-136, Ic-139, Ic-140, Ic- 141, Ic-142, Ic-147, Ic-149, Ic-150, Ic-151, Ic-152, Ic-153, Ic-154, Ic-156, Ic-157, Ic-159, Ic-161, Ic- 163, Ic-164, Ic-165, Ic-166, Ic-167, Ic-171, Ic-174, Ic-175, Ic-176, Ic-180, Ic-181, Ic-183, Ic-184, Ic- 186, Ic-187, Ic-188, Ic-193, Ic-198, Ic-200 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 83% at an application rate of 500g/ha: Ic-33, Ic-42, Ic-89, Ic-106 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 g/ha: Ia-1, Ia-2, Ib-2, Ib-3, Ic-2, Ic-3, Ic-6, Ic-7, Ic-10, Ic-11, Ic-12, Ic-13, Ic-14, Ic-16, Ic-17, Ic-18, Ic-19, Ic-20, Ic-21, Ic-22, Ic-23, Ic-25, Ic-28, Ic-29, Ic-32, Ic-34, Ic-36, Ic-37, Ic-39, Ic-61, Ic-64, Ic-66, Ic-73, Ic-77, Ic-78, Ic-79, Ic-80, Ic-81, Ic-83, Ic-96, Ic-103, Ic-109, Ic- 110, Ic-111, Ic-112, Ic-113, Ic-115, Ic-118, Ic-122, Ic-124, Ic-126, Ic-127, Ic-128, Ic-129, Ic-131, Ic- 132, Ic-133, Ic-135, Ic-169, Ic-170, Ic-177, Ic-182, Ic-185, Ic-190, Id-1, Id-2 BCS 13-3006 Foreign Countries THS/mr 201420 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 83% at an application rate of 100 g/ha: Ic-68, Ic-65, Ic-108, Ic-119, Ic-125, Ic-168 J. Tetranychus urticae – spray test, OP-resistant (TETRUR) Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is dissolved using the stated parts by weight of solvent and made up with water comprising an emulsifier concentration of 1000 ppm until the desired concentration is reached. To produce further test concentrations, the preparation is diluted with emulsifier-containing water.
Discs of bean leaves (Phaseolus vulgaris) which are infested by all stages of the greenhouse red spider mite (Tetranychus urticae) are sprayed with an active compound preparation of the desired concentration.
After 6 days, the efficacy in % is determined. 100% means that all of the spider mites have been killed; 0% means that none of the spider mites have been killed.
In this test, for example, the following compounds of the Preparation Examples show, at an application rate of 500 g/ha, an efficacy of 100%: Ic-1, Ic-24, Ic-27, Ic-40, Ic-41, Ic-71, Ic-84, Ic-85, Ic-86, Ic-87, Ic-91, Ic-94, Ic-95, Ic-97, Ic-107, Ic-116, Ic-117, Ic-136, Ic-137, Ic-139, Ic-140, Ic-141, Ic-142, Ic-147, Ic-149, Ic-150, Ic-151, Ic-152, Ic-153, Ic-154, Ic-156, Ic-157, Ic-159, Ic-161, Ic-163, Ic-164, Ic-165, Ic- 166, Ic-167, Ic-175, Ic-176, Ic-180, Ic-181, Ic-183, Ic-184, Ic-187, Ic-188, Ic-193, Ic-198, Ic-200 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 500 g/ha: Ic-49, Ic-69, Ic-90, Ic-105, Ic-171, Ic-186 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 500 g/ha: Ic-44, Ic-55, Ic-76 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 100 g/ha: Ia-1, Ib-2, Ib-3, Ic-2, Ic-10, Ic-17, Ic-19, Ic-20, Ic-21, Ic-22, Ic- 23, Ic-28, Ic-32, Ic-34, Ic-36, Ic-37, Ic-39, Ic-63, Ic-64, Ic-65, Ic-66, Ic-67, Ic-68, Ic-73, Ic-77, Ic-78, Ic- 79, Ic-80, Ic-81, Ic-83, Ic-96, Ic-99, Ic-103, Ic-104, Ic-108, Ic-109, Ic-110, Ic-111, Ic-112, Ic-113, Ic- 115, Ic-118, Ic-119, Ic-120, Ic-121, Ic-122, Ic-123, Ic-124, Ic-125, Ic-126, Ic-127, Ic-128, Ic-129, Ic- 131, Ic-132, Ic-133, Ic-134, Ic-135, Ic-168, Ic-169, Ic-170, Ic-177, Ic-185, Ic-189, Ic-190 BCS 13-3006 Foreign Countries THS/mr 201420 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 100 g/ha: Ia-2, Ic-3, Ic-9, Ic-11, Ic-13, Ic-48, Ic-56, Ic-59, Ic-182 K. Meloidogyne incognita test (MELGIN) Solvent: 125.0 parts by weight of acetone To prepare a suitable active compound preparation, 1 part by weight of active compound is mixed with the stated amount of solvent and the concentrate is diluted with water to the desired concentration.
Vessels are filled with sand, active compound solution, an egg/larvae suspension of the southern root- knot nematode (Meloidogyne incognita) and lettuce seeds. The lettuce seeds germinate and the plants develop. On the roots, galls are formed.
After 14 days, the nematicidal efficacy in % is determined by the formation of galls. 100% means that no galls have been found; 0% means that the number of galls on the treated plants corresponds to the untreated control.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 20 ppm: Ic-152 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 90% at an application rate of 20 ppm: Ic-1, Ic-26, Ic-120, Ic-156 Biological working examples for applications in the animal health sector II: T1. Ctenocephalides felis – in vitro contact tests with adult cat fleas For the coating of the test tubes, initially 9 mg of active compound are dissolved in 1 ml of acetone p.a. and then diluted with acetone p.a. to the desired concentration. By turning and rocking on an orbital shaker (2 h of rocking rotation at 30 rpm), 250 µl of the solution are distributed homogeneously on the internal walls and the floor of a 25 ml test tube. At 900 ppm active compound solution and 44.7 cm² internal surface, an area dose of 5 µg/cm² is achieved for homogeneous distribution.
After evaporation of the solvent, the tubes are populated with 5-10 adult cat fleas (Ctenocephalides felis), sealed with a perforated plastic lid and incubated in a horizontal position at room temperature and ambient humidity. After 48 h, the efficacy is determined. To this end, the test tubes are stood upright and the fleas are knocked to the floor of the tube. Fleas which remain motionless on the floor or move in an uncoordinated manner are considered to be dead or moribund.
BCS 13-3006 Foreign Countries THS/mr 201420 A substance shows good activity against Ctenocephalides felis if, in this test, an efficacy of at least 80% was achieved at an application rate of 5 µg/cm². An efficacy of 100% means that all fleas were dead or moribund. 0% efficacy means that none of the fleas had been damaged.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 5 µg/cm²: Ia-1, Ia-2, Ib-2, Ib-3, Ic-1, Ic-2, Ic-11, Ic-12, Ic-16, Ic-18, Ic-19, Ic-21, Ic-23, Ic-24, Ic-27, Ic-28, Ic-29, Ic-34, Ic-36, Ic-37, Ic-41, Ic-47, Ic-48, Ic-49, Ic-65, Ic-66, Ic-68, Ic-70, Ic-71, Ic-77, Ic-78, Ic-81, Ic-83, Ic-84, Ic-85, Ic-86, Ic-87, Ic-90, Ic-91, Ic-94, Ic-95, Ic-96, Ic-97, Ic-107, Ic-108, Ic-109, Ic-110, Ic-111, Ic-112, Ic-113, Ic-118, Ic-139, Ic-140, Ic-141, Ic-142, Ic-143, Ic- 144, Ic-145, Ic-147, Ic-148, Ic-149, Ic-151, Ic-152, Ic-153, Ic-155, Ic-158, Ic-159, Ic-160, Ic-163, Ic- 164, Ic-165, Ic-166, Ic-167, Ic-175, Ic-199, Ic-211 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 5 µg/cm²: Ic-32, Ic-138, Ic-146, Ic-154 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 1 µg/cm²: Ia-1, Ia-2, Ib-2, Ib-3, Ic-1, Ic-2, Ic-11, Ic-12, Ic-16, Ic-18, Ic-19, Ic-21, Ic-23, Ic-24, Ic-27, Ic-28, Ic-29, Ic-34, Ic-36, Ic-37, Ic-41, Ic-47, Ic-48, Ic-49, Ic-65, Ic-66, Ic-70, Ic-71, Ic-77, Ic-78, Ic-81, Ic-83, Ic-84, Ic-85, Ic-86, Ic-87, Ic-90, Ic-91, Ic-94, Ic-95, Ic-96, Ic-97, Ic- 107, Ic-108, Ic-109, Ic-111, Ic-112, Ic-113, Ic-118, Ic-139, Ic-140, Ic-141, Ic-142, Ic-143, Ic-144, Ic- 145, Ic-147, Ic-151, Ic-152, Ic-153, Ic-154, Ic-155, Ic-158, Ic-159, Ic-160, Ic-163, Ic-163, Ic-164, Ic- 165, Ic-166, Ic-167, Ic-175, Ic-199, Ic-211 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 1 µg/cm²: Ic-146, Ic-149 T2. Rhipicephalus sanguineus - in vitro contact tests with adult brown dog ticks For the coating of the test tubes, initially 9 mg of active compound are dissolved in 1 ml of acetone p.a. and then diluted with acetone p.a. to the desired concentration. By turning and rocking on an orbital shaker (2 h of rocking rotation at 30 rpm), 250 µl of the solution are distributed homogeneously on the internal walls and the floor of a 25 ml test tube. At 900 ppm active compound solution and 44.7 cm² internal surface, an area dose of 5 µg/cm² is achieved for homogeneous distribution.
After evaporation of the solvent, the tubes are populated with 5-10 adult dog ticks (Rhipicephalus sanguineus), sealed with a perforated plastic lid and incubated in a horizontal position in the dark at room temperature and ambient humidity. After 48 h, the efficacy is determined. To this end, the ticks are knocked to the floor of the tube and incubated on a hotplate at 45-50°C for at most 5 min. Ticks which remain motionless on the floor or move in an uncoordinated manner such that they are not able to deliberately avoid the heat by climbing upwards are considered to be dead or moribund.
BCS 13-3006 Foreign Countries THS/mr 201420 A substance shows good activity against Rhipicephalus sanguineus if, in this test, an efficacy of at least 80% was achieved at an application rate of 5 µg/cm². An efficacy of 100% means that all ticks were dead or moribund. 0% efficacy means that none of the ticks had been damaged.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 5 µg/cm²: Ia-1, Ia-2, Ic-1, Ic-2, Ic-11, Ic-16, Ic-18, Ic-21, Ic-23, Ic-24, Ic- , Ic-27, Ic-28, Ic-34, Ic-36, Ic-37, Ic-47, Ic-48, Ic-49, Ic-54, Ic-66, Ic-70, Ic-71, Ic-77, Ic-78, Ic-81, Ic- 83, Ic-84, Ic-85, Ic-86, Ic-87, Ic-90, Ic-94, Ic-95, Ic-96, Ic-103, Ic-106, Ic-109, Ic-111, Ic-112, Ic-113, Ic-141, Ic-142, Ic-143, Ic-151, Ic-152, Ic-155, Ic-160, Ic-161, Ic-164, Ic-166, Ic-167, Ic-174, Ic-201 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 5 µg/cm²: Ib-3, Ic-19, Ic-61, Ic-73, Ic-91, Ic-108, Ic-153 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 1 µg/cm²: Ia-1, Ia-2, Ib-3, Ic-1, Ic-2, Ic-11, Ic-16, Ic-18, Ic-19, Ic-21, Ic- 23, Ic-24, Ic-25, Ic-27, Ic-36, Ic-37, Ic-43, Ic-46, Ic-47, Ic-48, Ic-49, Ic-54, Ic-59, Ic-66, Ic-68, Ic-70, Ic- 77, Ic-78, Ic-81, Ic-83, Ic-84, Ic-85, Ic-86, Ic-87, Ic-90, Ic-94, Ic-95, Ic-96, Ic-103, Ic-109, Ic-111, Ic- 112, Ic-143, Ic-151, Ic-152, Ic-155, Ic-160, Ic-163, Ic-164, Ic-166, Ic-167, Ic-174, Ic-201 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 1 µg/cm²: Ic-32, Ic-34, Ic-67, Ic-71, Ic-73, Ic-113, Ic-141, Ic-142, Ic-147, Ic- 148, Ic-153, Ic-161 T3. Ixodes ricinus - in vitro contact tests with adult castor bean ticks For the coating of the test tubes, initially 9 mg of active compound are dissolved in 1 ml of acetone p.a. and then diluted with acetone p.a. to the desired concentration. By turning and rocking on an orbital shaker (2 h of rocking rotation at 30 rpm), 250 µl of the solution are distributed homogeneously on the internal walls and the floor of a 25 ml test tube. At 900 ppm active compound solution and 44.7 cm² internal surface, an area dose of 5 µg/cm² is achieved for homogeneous distribution.
After evaporation of the solvent, the tubes are populated with 5-10 adult castor bean ticks (Ixodes ricinus), sealed with a perforated plastic lid and incubated in a horizontal position in the dark at 22°C and 90% humidity in a climate-controlled cabinet. After 48 h, the efficacy is determined. To this end, the ticks are knocked to the floor of the tube and incubated on a hotplate at 45-50°C for at most 5 min.
Ticks which remain motionless on the floor or move in an uncoordinated manner such that they are not able to deliberately avoid the heat by climbing upwards are considered to be dead or moribund.
BCS 13-3006 Foreign Countries THS/mr 201420 A substance shows good activity against Ixodes ricinus if, in this test, an efficacy of at least 80% was achieved at an application rate of 5 µg/cm². An efficacy of 100% means that all ticks were dead or moribund. 0% efficacy means that none of the ticks had been damaged.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 5 µg/cm²: Ia-1, Ia-2, Ic-1, Ic-2, Ic-11, Ic-16, Ic-21, Ic-23, Ic-37, Ic-47, Ic- 48, Ic-81, Ic-83, Ic-84, Ic-86, Ic-87, Ic-90, Ic-94 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 5 µg/cm²: Ib-3, Ic-18 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 1 µg/cm²: Ia-1, Ia-2, Ic-1, Ic-2, Ic-16, Ic-23, Ic-37, Ic-81, Ic-84, Ic-90, Ic- In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 1 µg/cm²: Ib-3, Ic-11, Ic-21, Ic-48, Ic-86, Ic-87 T4. Amblyomma hebraeum – in vitro contact tests with nymphs of the bont tick For the coating of the test tubes, initially 9 mg of active compound are dissolved in 1 ml of acetone p.a. and then diluted with acetone p.a. to the desired concentration. By turning and rocking on an orbital shaker (2 h of rocking rotation at 30 rpm), 250 µl of the solution are distributed homogeneously on the internal walls and the floor of a 25 ml test tube. At 900 ppm active compound solution and 44.7 cm² internal surface, an area dose of 5 µg/cm² is achieved for homogeneous distribution.
After evaporation of the solvent, the tubes are populated with 5-10 bont tick nymphs (Amblyomma hebraeum), sealed with a perforated plastic lid and incubated in a horizontal position in the dark at 27°C and 85% humidity in a climate-controlled cabinet. After 48 h, the efficacy is determined. To this end, the ticks are knocked to the floor of the tube and incubated on a hotplate at 45-50°C for at most 5 min.
Ticks which remain motionless on the floor or move in an uncoordinated manner such that they are not able to deliberately avoid the heat by climbing upwards are considered to be dead or moribund.
A substance shows good activity against Amblyomma hebraeum nymphs if, in this test, an efficacy of at least 80% was achieved at an application rate of 5 µg/cm². An efficacy of 100% means that all ticks were dead or moribund. 0% efficacy means that none of the ticks had been damaged.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 5 µg/cm²: Ia-1, Ia-2, Ib-2, Ib-3, Ic-1, Ic-2, Ic-3, Ic-11, Ic-16, Ic-18, Ic-19, Ic-21, Ic-23, Ic-32, Ic-37, Ic-47, Ic-48, Ic-49, Ic-81, Ic-83, Ic-84, Ic-86, Ic-87, Ic-90, Ic-94, Ic-95 BCS 13-3006 Foreign Countries THS/mr 201420 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 100% at an application rate of 1 µg/cm²: Ia-1, Ia-2, Ib-2, Ic-1, Ic-2, Ic-11, Ic-16, Ic-18, Ic-19, Ic-21, Ic- 23, Ic-32, Ic-37, Ic-47, Ic-48, Ic-81, Ic-83, Ic-84, Ic-86, Ic-87, Ic-90, Ic-94, Ic-95 In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 1 µg/cm²: Ib-3, Ic-3 T6. Dermacentor variabilis - systemic in vivo activity against American dog tick nymphs on rats In a randomized open placebo-controlled study, the efficacy of preparation examples of the halogen- substituted compounds of the formula (I) according to the invention against nymphs of the American dog tick (Dermacentor variabilis) on rats (Rattus norvegicus; strain: Whistar Unilever, HsdCpb:WU) is examined following intraperitoneal treatment. To this end, a suitable amount of the active compound is dissolved in glycerol formal and injected intraperitoneally. The volume administered is, depending on the active compound concentration, between 30 and 90 µl/100 g of body weight. 5 rats per group are used, the results are reported as arithmetic means. Prior to the tick infestations, all rats are provided with collars. For the infestation with ticks and counting, the rats are sedated with 30-50 µl of medetomidine hydrochloride (e.g. Domitor®) s.c./rat. All rats are infested on day 0 (at least 1 h after the treatemt), day 7, day 14 etc. with 30 unengorged Dermacentor variabilis nymphs. On day 2, day 9, day 16 etc. the collar is removed and the entire body of the sedated rats is examined systematically for ticks. Ticks are removed with tweezers and, by being squashed on blotting paper, examined for blood sucked.
The efficacy of the treatment is determined by comparison with a placebo-treated control group. A compound is considered to be highly effective if, at a dosage of 10 mg/kg, it shows an efficacy of 90% against nymphs of the American dog tick (Dermacentor variabilis) on day 2 after intraperitoneal treatment. The effect is considered to be longer-lasting if the efficacy on day 9 is still higher than 80%.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of >90% against tick nymphs on day 2 at an application rate of 10 mg/kg: Ic-1, Ic-2 In this test, for example, the following compounds of the Preparation Examples show an efficacy of >80% against tick nymphs on day 9 at an application rate of 10 mg/kg: Ic-1, Ic-2 T7. Ctenocephalides felis - systemic in vivo activity against fleas on rats In a randomized open placebo-controlled study, the efficacy of preparation examples of the halogen- substituted compounds of the formula (I) according to the invention against adult cat fleas (Ctenocephalides felis) on rats (Rattus norvegicus; strain: Whistar Unilever, HsdCpb:WU) is examined following intraperitoneal treatment. To this end, a suitable amount of the active compound is dissolved in glycerol formal and injected intraperitoneally. The volume administered is, depending on the active BCS 13-3006 Foreign Countries THS/mr 201420 compound concentration, between 30 and 90 µl/100 g of body weight. 5 rats per group are used, the results are reported as arithmetic means. Prior to the flea infestations, all rats are provided with collars.
For the infestation with fleas and counting, the rats are sedated with 30-50 µl of medetomidine hydrochloride (e.g. Domitor®) s.c./rat. All rats are infested on day 0 (at least 1 h after the treatemt), day 7, day 14 etc. with 30 unfed Ctenocephalides felis adults. On day 2, day 9, day 16 etc. the collar is removed and the entire body of the sedated rats is examined systematically for fleas using a flea comb.
The fleas are counted and removed.
The efficacy of the treatment is determined by comparison with a placebo-treated control group. A compound is considered to be highly effective if, at a dosage of 10 mg/kg, it shows an efficacy of 95% against adult fleas (Ctenocephalides felis) on day 2 after intraperitoneal treatment. The effect is considered to be longer-lasting if the efficacy on day 9 is still higher than 90%.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of >95% against fleas on day 2 at an application rate of 10 mg/kg: Ic-1, Ic-2 In this test, for example, the following compounds of the Preparation Examples show an efficacy of >90% against fleas on day 9 at an application rate of 10 mg/kg: Ic-1, Ic-2 T8. Haemonchus contortus-test (HAEMCO) Solvent: dimethyl sulphoxide To produce a suitable preparation of active compound, 10 mg of active compound are mixed with 0.5 ml of dimethyl sulphoxide, and the concentrate is diluted with "Ringer solution" to the desired concentration.
Vessels containing the active compound preparation of the desired concentration are populated with about 40 larvae of the red stomach worm (Haemonchus contortus).
After 5 days, the kill in % is determined. 100% means that all of the larvae have been killed; 0% means that none of the larvae have been killed.
In this test, for example, the following compounds of the Preparation Examples show an efficacy of 80% at an application rate of 20 ppm: Ic-1, Ic-16 BCS 13-3006 Foreign Countries THS/mr 201420
Claims (11)
1. Compounds of the general formula (I), 5 in which R represents hydrogen or represents C -C -alkyl, C -C -alkenyl, C -C -alkynyl, C -C - 1 6 2 6 3 6 3 7 cycloalkyl, C -C -cycloalkyl-C -C -alkyl, C -C -alkylcarbonyl, C -C -alkoxycarbonyl, aryl-(C - 3 7 1 3 1 6 1 6 1 10 C )-alkyl, heteroaryl-(C -C )-alkyl which are optionally mono- or polysubstituted independently 3 1 3 of one another by halogen, cyano, alkoxy and alkoxycarbonyl, the chemical groupings A represents CR or nitrogen, A represents CR or nitrogen, 15 A represents CR or nitrogen and A represents CR or nitrogen, but where not more than three of the chemical groupings A to A simultaneously represent nitrogen; 2 3 4 5 R , R , R and R independently of one another represent hydrogen, halogen, cyano, nitro, 20 optionally substituted C -C -alkyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C -C - 1 6 3 6 1 6 1 6 1 3 alkyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N-C -C -alkylamino or 1 6 1 6 1 6 1 6 N,N-di-C -C -alkylamino; BCS 13-3006 Foreign Countries THS/mr 201420 W represents oxygen or sulphur; Q represents hydrogen, hydroxy, formyl or one of the groupings C -C -alkyl, C -C -alkenyl, 1 6 3 6 C -C -alkynyl, C -C -cycloalkyl, C -C -heterocycloalkyl, C -C -alkoxy, C -C -alkyl-C -C - 3 6 3 6 1 5 1 4 1 6 3 6 cycloalkyl, C -C -cycloalkyl-C -C -alkyl, C -C -hydroxyalkyl, aryl-(C -C )-alkyl, heteroaryl-(C - 3 6 1 6 1 6 1 3 1 5 C )-alkyl, N-C -C -alkylamino, N-C -C -alkylcarbonylamino or N,N-di-C -C -alkylamino which 3 1 4 1 4 1 4 are optionally mono- or polysubstituted independently of one another by hydroxy, nitro, amino, halogen, alkoxy, cyano, hydroxycarbonyl, alkoxycarbonyl, alkylcarbamoyl, cycloalkylcarbamoyl, phenyl; or Q represents aryl substituted by 0 – 4 substituents V or a 5- or 6-membered heteroaromatic 10 substituted by 0 – 4 substituents V, where V independently of one another represent halogen, cyano, nitro, optionally substituted C -C - alkyl, C -C -alkenyl, C -C -alkynyl, C -C -cycloalkyl, C -C -alkoxy, N-C -C -alkoxy-imino-C - 2 4 2 4 3 6 1 6 1 6 1 C -alkyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, N,N-di-(C -C - 3 1 6 1 6 1 6 1 6 alkyl)amino; 15 T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) n (R ) T1 T2 T3 T4 (R ) (R ) (R ) n T5 T6 T7 where R independently of one another represent halogen, cyano, nitro, amino or optionally halogen- substituted C -C -alkyl, C -C -alkyloxy, C -C -alkylcarbonyl, C -C -alkylsulphanyl, C -C - 1 6 1 6 1 6 1 6 1 6 alkylsulphinyl, C -C -alkylsulphonyl, and n represents the values 0-1; BCS 13-3006 Foreign Countries THS/mr 201420 Z represents optionally substituted C -C -alkyl, C -C -cycloalkyl, and 1 6 3 6 Z represents hydrogen, halogen, cyano, nitro, amino or optionally substituted C -C -alkyl, C - 1 6 1 C -alkylcarbonyl, C -C -alkylsulphanyl, C -C -alkylsulphinyl, C -C -alkylsulphonyl, and 6 1 6 1 6 1 6 Z represents hydrogen or optionally substituted C -C -alkyl, C -C -cycloalkyl, C -C -alkenyl, 1 6 3 6 2 4 5 C -C -alkynyl, aryl and hetaryl; wherein at least one of Z or Z represents a halogenated substituted C -C -alkyl group; 2 3 4 5 1 2 3 wherein the optional substituents of R , R , R , R , V, Z , Z and Z are independently selected from: amino, hydroxy, halogen, nitro, cyano, isocyano, mercapto, isothiocyanato, carboxyl, carboxamide, SF , aminosulphonyl, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, N- 10 monoalkylamino, N,N-dialkylamino, N-alkanoylamino, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy, cycloalkenyloxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkanoyl, alkenylcarbonyl, alkynylcarbonyl, arylcarbonyl, alkylsulphanyl, cycloalkylsulphanyl, alkenylthio, cycloalkenylthio, alkynylthio, alkylsulphenyl, both enantiomers of alkylsulphinyl, alkylsulphonyl, N-monoalkylaminosulphonyl, N,N-dialkylaminosulphonyl, both 15 enantiomers of alkylphosphinyl, both enantiomers of alkylphosphonyl, N-alkylaminocarbonyl, N,N-dialkylaminocarbonyl, N-alkanoylaminocarbonyl, N-alkanoyl-N-alkylaminocarbonyl, aryl, aryloxy, benzyl, benzyloxy, benzylthio, arylthio, arylamino, benzylamino, heterocyclyl, trialkylsilyl, alkoxyalkyl, alkylsulphanylalkyl, alkylsulphanylalkoxy, alkoxyalkoxy, phenethyl, benzyloxy, haloalkyl, halocycloalkyl, haloalkoxy, haloalkylsulphanyl, haloalkylsulphinyl, 20 haloalkylsulphonyl, haloalkanoyl, haloalkylcarbonyl, haloalkoxycarbonyl, haloalkoxyalkoxy, haloalkoxyalkylsulphanyl, haloalkoxyalkanoyl, and haloalkoxyalkyl.
2. Compounds according to Claim 1 in which R represents hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, 25 methoxymethyl, ethoxymethyl, propoxymethyl, methylcarbonyl, ethylcarbonyl, n- propylcarbonyl, isopropylcarbonyl, s-butylcarbonyl, t-butylcarbonyl, methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, s-butoxycarbonyl, t- butoxycarbonyl, cyanomethyl, 2-cyanoethyl, benzyl, 4-methoxybenzyl, pyridylmethyl, pyridylmethyl, pyridylmethyl, 4-chloropyridylmethyl; 30 the chemical groupings A represents CR or nitrogen, BCS 13-3006 Foreign Countries THS/mr 201420 A represents CR or nitrogen, A represents CR or nitrogen and A represents CR or nitrogen, but where not more than three of the chemical groupings A to A simultaneously represent 5 nitrogen; R and R independently of one another represent hydrogen, methyl, fluorine or chlorine and R and R independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlorodifluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, methoxy, ethoxy, n-propoxy, 1-methylethoxy, 10 fluoromethoxy, difluoromethoxy, chlorodifluoromethoxy, dichlorofluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N- methoxyiminomethyl, 1-(N-methoxyimino)ethyl, methylsulphanyl, trifluoromethylsulphanyl, methylsulphonyl, methylsulphinyl, trifluoromethylsulphonyl, trifluoromethylsulphinyl; 15 W represents oxygen or sulphur; Q represents hydrogen, methyl, ethyl, n-propyl, 1-methylethyl, 1,1-dimethylethyl, 1- methylpropyl, n-butyl, 2-methylpropyl, 2-methylbutyl, hydroxyethyl, 2-hydroxypropyl, cyanomethyl, 2-cyanoethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1- trifluoromethylethyl, 2,2-difluoropropyl, 3,3,3-trifluoropropyl, 2,2- 20 dimethylfluoropropyl, cyclopropyl, 1-cyanocyclopropyl, 1-methoxycarbonylcyclopropyl, 1-(N- methylcarbamoyl)cyclopropyl, 1-(N-cyclopropylcarbamoyl)cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-cyclopropylethyl, bis(cyclopropyl)methyl, 2,2-dimethylcyclopropylmethyl, 2-phenylcyclopropyl, 2,2- dichlorocyclopropyl, transchlorocyclopropyl, cischlorocyclopropyl, 2,2- 25 difluorocyclopropyl, transfluorocyclopropyl, cisfluorocyclopropyl, trans hydroxycyclohexyl, 4-trifluoromethylcyclohexyl, propenyl, 2-methylpropenyl, propynyl, 1,1-dimethylbutynyl, 3-chloropropenyl, 3,3-dichloropropenyl, 3,3-dichloro-1,1-dimethylpropenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 30 oxetanyl, thietanyl, isoxazolylmethyl, 1,2,4-triazolylmethyl, benzyl, 2,6- difluorophenylmethyl, 3-fluorophenylmethyl, 2-fluorophenylmethyl, 2,5- BCS 13-3006 Foreign Countries THS/mr 201420 difluorophenylmethyl, 1-phenylethyl, 4-chlorophenylethyl, 2-trifluoromethylphenylethyl, 1-pyridinylethyl, pyridinylmethyl, 5-fluoropyridinylmethyl, (6-chloropyridin yl)methyl, pyrimidinylmethyl, methoxy, 2-ethoxyethyl, methoxycarbonylmethyl, N- ethylamino, N,N-dimethylamino, N,N-diethylamino; or 5 Q represents phenyl, naphthyl, pyridazine, pyrazine, pyrimidine, triazine, pyridine, pyrazole, thiazole, isothiazole, oxazole, isoxazole, triazole, imidazole, furan, thiophene, pyrrole, oxadiazole, thiadiazole substituted by 0 – 4 substituents V, where V independently of one another represent fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, 10 dichlorofluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,2,2,2-tetrafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2,2,2- trichloroethyl, 2-chloro-2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, pentafluoro- tert-butyl, heptafluoro-n-propyl, heptafluoroisopropyl, nonafluoro-n-butyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, n-propoxy, 1-methylethoxy, fluoromethoxy, 15 difluoromethoxy, chlorodifluoromethoxy, dichlorofluoromethoxy, trifluoromethoxy, 2,2,2- trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N-methoxyiminomethyl, 1-(N-methoxyimino)ethyl, methylsulphanyl, methylsulphonyl, methylsulphinyl, trifluoromethylsulphonyl, trifluoromethylsulphinyl, trifluoromethylsulphanyl, N,N- dimethylamino; 20 T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) n (R ) T1 T2 T3 T4 (R ) (R ) (R ) n T5 T6 T7 where 25 R independently of one another represent halogen, cyano, nitro, amino, methyl, ethyl, 1- methylethyl, tert-butyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, trifluoromethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, methylcarbonyl, ethylcarbonyl, trifluoromethylcarbonyl, BCS 13-3006 Foreign Countries THS/mr 201420 methylsulphanyl, methylsulphinyl, methylsulphonyl, trifluoromethylsulphonyl, trifluoromethylsulphanyl, trifluoromethylsulphinyl, and n represents the values 0-1; Z represents methyl, ethyl, 1,1-dimethylethyl, difluoromethyl, trichloromethyl, 5 chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1- fluoroethyl, 1-fluoromethylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,2,2,2-tetrafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro- 2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, pentafluoro-tert-butyl, heptafluoro-n- propyl, heptafluoroisopropyl, nonafluoro-n-butyl, cyclopropyl, 1-chlorocyclopropyl, 1- 10 fluorocyclopropyl, 1-bromocyclopropyl, 1-cyanocyclopropyl, 1- trifluoromethylcyclopropyl, cyclobutyl and 2,2-difluoromethylcyclopropyl, and Z represents hydrogen, halogen, cyano, nitro, amino, methyl, ethyl, 1,1-dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1-fluoroethyl, 1-fluoromethylethyl, 2- 15 fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,2,2,2-tetrafluorethyl, 1-chloro-1,2,2,2- tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, pentafluoro-tert-butyl, heptafluoro-n-propyl, heptafluoroisopropyl, nonafluoro-n-butyl, methylsulphanyl, methylsulphinyl, methylsulphonyl, ethylthio, ethylsulphinyl, ethylsulphonyl, trifluoromethylsulphanyl, trifluoromethylsulphinyl, 20 trifluoromethylsulphonyl, chlorodifluoromethylsulphanyl, chlorodifluoromethylsulphinyl, chlorodifluoromethylsulphonyl, dichlorofluoromethylsulphanyl, dichlorofluoromethylsulphinyl, dichlorofluoromethylsulphonyl and Z represents hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1-propenyl, 2-propenyl, 1-propynyl, 1-butynyl, difluoromethyl, trichloromethyl, 25 chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1-fluoroethyl, 1-fluoro methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,5-dichlorophenyl, 3,4-dichlorophenyl, 2,6- dichlorophenyl 2,6-dichlorotrifluoromethylphenyl, 3-chlorotrifluoromethylpyridin
3. Compounds according to Claim 1 in which Z represents trifluoromethyl, 1-chlorocyclopropyl, 1-fluorocyclopropyl or pentafluoroethyl, BCS 13-3006 Foreign Countries THS/mr 201420 Z represents trifluoromethyl, nitro, methylsulphanyl, methylsulphinyl, methylsulphonyl, fluorine, chlorine, bromine, cyano or iodine, Z represents methyl, ethyl, n-propyl or hydrogen, R represents hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, 5 methoxymethyl, ethoxymethyl, propoxymethyl, methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, s-butylcarbonyl, t-butylcarbonyl, methoxycarbonyl, ethoxycarbonyl, n- propoxycarbonyl, isopropoxycarbonyl, s-butoxycarbonyl, t-butoxycarbonyl, cyanomethyl, 2- cyanoethyl, benzyl, 4-methoxybenzyl, pyridylmethyl, pyridylmethyl, pyridylmethyl, 4- chloropyridylmethyl, 10 A and A each represent CH, A represents CH or N, A represents CR and R represents methyl, ethyl, fluorine, chlorine, bromine or iodine, 15 T represents one of the 5-membered heteroaromatics T1-T7 listed below, where the bond to the pyrazole head group is marked with an asterisk, N 6 6 (R ) (R ) (R ) n (R ) T1 T2 T3 T4 (R ) (R ) (R ) n T5 T6 T7 where 20 R represents methyl, ethyl, 2-methylethyl, 2,2-dimethylethyl, fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, amino, and n represents the values 0-1; BCS 13-3006 Foreign Countries THS/mr 201420 W represents oxygen and Q represents hydrogen, methyl, ethyl, n-propyl, 1-methylethyl, 1,1-dimethylethyl, n-butyl, 1- methylpropyl, 2-methylpropyl, 2-methylbutyl, hydroxyethyl, 2-hydroxypropyl, cyanomethyl, 2- cyanoethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1-trifluoromethylethyl, 2,2- 5 difluoropropyl, 3,3,3-trifluoropropyl, 2,2-dimethylfluoropropyl, cyclopropyl, 1- cyanocyclopropyl, 1-methoxycarbonylcyclopropyl, 1-(N-methylcarbamoyl)cyclopropyl, 1-(N- cyclopropylcarbamoyl)cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, 1- cyclopropylethyl, 2,2-dimethylcyclopropylmethyl, 2-phenylcyclopropyl, 2,2-dichlorocyclopropyl, transchlorocyclopropyl, cischlorocyclopropyl, 2,2-difluorocyclopropyl, trans 10 fluorocyclopropyl, cisfluorocyclopropyl, transhydroxycyclohexyl, 4- trifluoromethylcyclohexyl, propenyl, 2-methylpropenyl, propynyl, 1,1-dimethylbut ynyl, 3-chloropropenyl, 3,3-dichloropropenyl, 3,3-dichloro-1,1-dimethylpropenyl, 2- chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, oxetanyl, thietanyl, isoxazolylmethyl, 1,2,4-triazolylmethyl, benzyl, 2,6-difluorophenylmethyl, 3-fluorophenylmethyl, 2- 15 fluorophenylmethyl, 2,5-difluorophenylmethyl, 1-phenylethyl, 4-chlorophenylethyl, 1-pyridin ylethyl, pyridinylmethyl, (6-chloropyridinyl)methyl, 5-fluoropyridinylmethyl, pyrimidin- 2-ylmethyl, methoxy, 2-ethoxyethyl, methoxycarbonylmethyl, N-ethylamino, N,N- dimethylamino, N,N-diethylamino; or Q represents phenyl, naphthyl, pyridazine, pyrazine, pyrimidine, triazine, pyridine, pyrazole, 20 thiazole, isothiazole, oxazole, isoxazole, triazole, imidazole, furan, thiophene, pyrrole, oxadiazole, thiadiazole substituted by 0 – 4 substituents V, where V independently of one another represent fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 25 2,2,2-trifluoroethyl, 1,2,2,2-tetrafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2,2,2- trichloroethyl, 2-chloro-2,2-difluoroethyl, 1,1-difluoroethyl, pentafluoroethyl, pentafluoro- tert-butyl, heptafluoro-n-propyl, heptafluoroisopropyl, nonafluoro-n-butyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, n-propoxy, 1-methylethoxy, fluoromethoxy, difluoromethoxy, chlorodifluoromethoxy, dichlorofluoromethoxy, trifluoromethoxy, 2,2,2- 30 trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N-methoxyiminomethyl, 1-(N-methoxyimino)ethyl, methylsulphanyl, methylsulphonyl, methylsulphinyl, trifluoromethylsulphonyl, trifluoromethylsulphinyl, trifluoromethylsulphanyl, N,N- dimethylamino. BCS 13-3006 Foreign Countries THS/mr 201420
4. Compounds of the general formula (Ic) (R ) (Ic) 1 2 3 4 1 6 1 2 3 in which the radicals A , A , A , A , Q, R , R , W, Z , Z and Z are defined according to any of 5 Claims 1 to 3.
5. Use of compounds of the general formula (I) according to any of Claims 1 to 4 for controlling insects, arachnids and nematodes in a non-human animal. 10
6. Pharmaceutical compositions comprising at least one compound according to any of Claims 1 to
7. Compounds according to any of Claims 1 to 4 for use as medicaments. 15
8. Use of compounds according to any of Claims 1 to 4 for preparing pharmaceutical compositions for controlling parasites on animals.
9. Process for preparing crop protection compositions comprising compounds according to any of Claims 1 to 4 and customary extenders and/or surfactants.
10. Use of compounds according to any of Claims 1 to 4 for protecting the propagation material of plants. BCS 13-3006 Foreign Countries THS/mr 201420
11. The Compound: 4-bromo-2'-methyl-4'-(methylsulphinyl)-5'-(trifluoromethyl)-2'H-1,3'-bipyrazole.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13154269 | 2013-02-06 | ||
EP13154269.8 | 2013-02-06 | ||
EP13180076.5 | 2013-08-12 | ||
EP13180076 | 2013-08-12 | ||
PCT/EP2014/051989 WO2014122083A1 (en) | 2013-02-06 | 2014-02-03 | Halogen-substituted pyrazol derivatives as pest-control agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ709564A NZ709564A (en) | 2020-09-25 |
NZ709564B2 true NZ709564B2 (en) | 2021-01-06 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9487489B2 (en) | Halogen-substituted pyrazole derivatives as pest-control agents | |
CA2830117C (en) | N-(3-carbamoylphenyl)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests | |
US9675070B2 (en) | Halogen-substituted compounds | |
US9204645B2 (en) | Insecticidal aromatic amides | |
NZ709564B2 (en) | Halogen-substituted pyrazol derivatives as pest-control agents |